116HG,Prader-Willi syndrome,"Long ncRNA 116HG has been shown to play a role in the development of Prader–Willi syndrome (PWS) (Powell et al., 2013)."
1B FGF-antisense transcripts,endometriosis,"Mihalich et al, reported patients with endometriosis show low expression of 1B FGF-antisense transcripts, which correlates with endometrial cell proliferation"
4930503E24Rik,ischaemia-reperfusion injury,Classification and validation of deregulated LncRNAs in ischemia/reperfusion-treated mouse livers.
51A,Alzheimer's disease,"51A expression drives a splicing shift of SORL1 from the synthesis of the canonical long protein variant 1 to an alternatively spliced protein form. This process, resulting in a decreased synthesis of SORL1 variant 1, is associated with an impaired processing of APP, leading to increase of A formation. "
5730458M16Rik,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 22 downregulated in HF hearts as compared with control hearts.
RN7SK,AIDS,Stable expression of cdNIPP1 increased CDK9 phosphorylation on Thr(186) and the association of CDK9 with 7SK RNA. The stable expression of cdNIPP1 disrupted the interaction of Tat and PP1 and inhibited HIV-1 transcription. Expression of cdNIPP1 as a part of the HIV-1 genome inhibited HIV-1 replication.
RN7SK,AIDS,HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP.
RN7SK,AIDS,"Tat efficiently replaces HEXIM1 on the 7SK snRNA in vivo and therefore, it promotes the disassembly of the 7SK/HEXIM/P-TEFb negative transcriptional regulatory snRNP to augment the nuclear level of active P-TEFb.  The human 7SK snRNA carries a TAR RNA-like Tat-binding element that is essential for the normal transcriptional regulatory function of 7SK questions the viability of HIV therapeutic approaches based on small drugs blocking the Tat-binding site of HIV TAR."
RN7SK,AIDS,"The 7SK-HMGA1 interaction not only adds an essential facet to the comprehension of transcriptional plasticity at the coupling of initiation and elongation, but also might provide a molecular link between HIV reprogramming of cellular gene expression-associated oncogenesis."
RN7SK,AIDS,The HIV-1 Tat protein also releases P-TEFb from the 7SK/HEXIM complex during viral infection to promote viral transcription and replication.
RN7SK,cancer,"Together with the HEXIM proteins, 7SK RNA associates with and sequesters a fraction of cellular P-TEFb into a catalytically inactive complex. Active and inactive forms of P-TEFb are kept in a functional and dynamic equilibrium tightly linked to the transcriptional requirement of the cell. Importantly, cardiac hypertrophy and development of various types of human malignancies have been associated with increased P-TEFb activity, consequence of a disruption of this regulatory equilibrium."
RN7SK,cardiac hypertrophy,"Together with the HEXIM proteins, 7SK RNA associates with and sequesters a fraction of cellular P-TEFb into a catalytically inactive complex. Active and inactive forms of P-TEFb are kept in a functional and dynamic equilibrium tightly linked to the transcriptional requirement of the cell. Importantly, cardiac hypertrophy and development of various types of human malignancies have been associated with increased P-TEFb activity, consequence of a disruption of this regulatory equilibrium."
RN7SK,gastric cancer,Transfection of an siRNA directed against LARP7 (anti-LARP7 siRNA) into non-neoplastic gastric epithelial cells decreased 7sk levels by 72% relative to a control siRNA (P<0.01).
RN7SL1,AIDS,"7SL RNA, but not the 54-kd signal recognition particle protein, is an abundant component of both infectious HIV-1 and minimal virus-like particles."
RN7SL1,AIDS,7SL RNA binding is a conserved feature of human anti-HIV-1 cytidine deaminases.
RN7SL1,dermatomyositis,Autoantibodies against signal recognition particle (SRP) are detected in patients with polymyositis/dermatomyositis (PM/DM). The SRP consists of 7SL RNA and 6 protein components.
RN7SL1,Leishmaniasis,Down-regulation of 7SL RNA expression and impairment of vesicular protein transport pathways by Leishmania infection of macrophages.
RN7SL1,Leishmaniasis,High-resolution melt analysis PCR (HRM PCR) for diagnosis of Old World Leishmania was developed using the 7SL RNA gene. Cutaneous leishmaniasis samples were analyzed. Sensitivity and specificity of HRM PCR were significantly better (P < 0.001) than those of internal transcribed spacer 1 PCR and similar to those of kinetoplast DNA PCR.
RN7SL1,Leishmaniasis,Leishmania 7SLRNA is an informative target for clinical and epidemiologic investigations of human leishmaniasis.
RN7SL1,Leishmaniasis,"The 7SL RNA PCR has proven useful for direct diagnosis of Old World leishmaniasis, especially when combined with the RBD assay for species identification."
RN7SL1,polymyositis,Autoantibodies against signal recognition particle (SRP) are detected in patients with polymyositis/dermatomyositis (PM/DM). The SRP consists of 7SL RNA and 6 protein components.
A130040M12Rik,cancer,These results indicate that PSF is a major tumor-suppressor protein and VL30-1 RNA is a major tumor-promoter RNA in mice.
AC002511.1,enterovirus 71 infection,"A general consistency between the qPCR and microarray analysis results was confirmed in four lncRNAs (AP000688.29, AC002511.1, RP5-843L14.1, and RP4-620F22.3) in terms of regulation direction and significance. Specifically, a 3.31-fold down-regulation "
ACTA2-AS1,lung adenocarcinoma,Enhanced expression of long non-coding RNA ZXF1 promoted the invasion and metastasis in lung adenocarcinoma.
ADAMTS9-AS2,glioma,A new tumor suppressor LncRNA ADAMTS9-AS2 is regulated by DNMT1 and inhibits migration of glioma cells.
AF086415,nasopharyngeal carcinoma,"Six lncRNAs (AF086415, AK095147, RP1-179N16.3, MUDENG, AK056098 and AK294004) were confirmed by qPCR. "
AFAP1-AS1,Barrett's Esophagus,"Hypomethylation of Noncoding DNA Regions and Overexpression of the Long Noncoding RNA, AFAP1-AS1, in Barrett's Esophagus and Esophageal Adenocarcinoma."
Airn,alcoholic liver disease,"Up regulation in liver  by DDC (Diethyl 1,4-dihydro-2,4,6,-trimethyl-3,5-pyridinedicarboxylate )."
Airn,chronic nonalcoholic liver disease,"Up regulation in liver  by DDC (Diethyl 1,4-dihydro-2,4,6,-trimethyl-3,5-pyridinedicarboxylate )."
Airn,hepatocellular carcinoma,"Up regulation in liver  by DDC (Diethyl 1,4-dihydro-2,4,6,-trimethyl-3,5-pyridinedicarboxylate ). Furthermore, over expression of H19 and AIR was demonstrated in tumors formed in mice withdrawn for 9 months."
AK023948,papillary thyroid carcinoma,Gene expression analysis indicated that AK023948 is significantly down-regulated in most PTC tumors. The putative noncoding RNA gene AK023948 is a candidate susceptibility gene for PTC.
AK028007,ischaemia-reperfusion injury,Classification and validation of deregulated LncRNAs in ischemia/reperfusion-treated mouse livers.
AK038798,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 16 downregulated in HF hearts as compared with control hearts.
AK042766,restless legs syndrome,"A recent study suggested that the predisposition to RLS results from reduced expression of Meis1 mediated by intronic cis-regulatory elements. Intriguingly, in the developing mouse brain, Meis1 is co-expressed in the developing cerebellar granule cell layer along with a genomically-associated lncRNA AK042766"
AK044955,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 7 downregulated in HF hearts as compared with control hearts.
AK049728,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 5 downregulated in HF hearts as compared with control hearts.
AK056098,nasopharyngeal carcinoma,"Six lncRNAs (AF086415, AK095147, RP1-179N16.3, MUDENG, AK056098 and AK294008) were confirmed by qPCR."
AK095147,nasopharyngeal carcinoma,"Six lncRNAs (AF086415, AK095147, RP1-179N16.3, MUDENG, AK056098 and AK294005) were confirmed by qPCR."
AK137898,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 4 downregulated in HF hearts as compared with control hearts.
AK139328,ischaemia-reperfusion injury,Silencing of Long Noncoding RNA AK139328 Attenuates Ischemia/Reperfusion Injury in Mouse Livers.
AK139328,ischaemia-reperfusion injury,Classification and validation of deregulated LncRNAs in ischemia/reperfusion-treated mouse livers.
AK143294,ischaemia-reperfusion injury,Classification and validation of deregulated LncRNAs in ischemia/reperfusion-treated mouse livers.
AK143693,ischaemia-reperfusion injury,Classification and validation of deregulated LncRNAs in ischemia/reperfusion-treated mouse livers.
AK144081,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 21 downregulated in HF hearts as compared with control hearts.
AK153778,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 26 downregulated in HF hearts as compared with control hearts.
AK294004,nasopharyngeal carcinoma,"Six lncRNAs (AF086415, AK095147, RP1-179N16.3, MUDENG, AK056098 and AK294009) were confirmed by qPCR."
Alg2,ischaemia-reperfusion injury,Classification and validation of deregulated LncRNAs in ischemia/reperfusion-treated mouse livers.
Alu lncRNAs,macular degeneration,"Biogenesis, metabolism, and functions of lncRNAs are otherwise interconnected with known pathogenic mechanisms"
CDKN2B-AS1,atherosclerosis,Chr9p21 encodes the long non-coding RNA (ncRNA) antisense non-coding RNA in the INK4 locus (ANRIL). ANRIL expression is associated with the Chr9p21 genotype and correlated with atherosclerosis severity
CDKN2B-AS1,atherosclerosis,"The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10."
CDKN2B-AS1,cancer,"The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10."
CDKN2B-AS1,periodontitis,"The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10."
CDKN2B-AS1,prostate cancer,"Recent studies have linked their mis-expression to diverse cancers (ANRIL: prostate cancer, XIST: female cancers, HOTAIR: breast cancer, KCNQ1OT1: colorectal cancer)."
anti-NOS2A,glioblastoma,anti-NOS2A is a lncRNA that is expressed in meningiomas and glioblastomas from a genomic locus that evolved by duplication of the NOS2A gene followed by internal DNA inversion.
anti-NOS2A,meningioma,anti-NOS2A is a lncRNA that is expressed in meningiomas and glioblastomas from a genomic locus that evolved by duplication of the NOS2A gene followed by internal DNA inversion.
AP000688.29,enterovirus 71 infection,"A general consistency between the qPCR and microarray analysis results was confirmed in four lncRNAs (AP000688.29, AC002511.1, RP5-843L14.1, and RP4-620F22.3) in terms of regulation direction and significance. Specifically, a 3.31-fold down-regulation (2.25-fold in microarray analysis) was observed in AP000688.29, 3.33-fold up-regulation (2.77-fold in microarray analysis) in AC002511.1, 2.29-fold up-regulation (2.40-fold in microarray analysis) in RP5-843L14.1, and 2.99-fold up-regulation (2.22-fold in microarray analysis) in RP4-620F22.3"
FMR1-AS1,fragile X syndrome,ASFMR1 is silenced in FXS patients and up regulated in pre-mutation carriers suggesting that a common process is responsible for regulating the expression these transcripts.
ATP6V1G2-DDX39B,dilated cardiomyopathy,"The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy."
ATP6V1G2-DDX39B,hepatitis C virus-associated dilated cardiomyopathy,"The haplotype block, NFKBIL1-ATP6V1G2-BAT1-MICB-MICA, within the class III-class I boundary region of the human major histocompatibility complex may control susceptibility to hepatitis C virus-associated dilated cardiomyopathy."
ATXN8OS,spinocerebellar ataxia,RNA gain-of-function plays a significant role in SCA8: 1) CUG(exp) transcripts accumulate as ribonuclear inclusions that co-localize with MBNL1 in selected neurons in the brain.
ATXN8OS,spinocerebellar ataxia,RNA gain-of-function plays a significant role in SCA8: 1) CUG(exp) transcripts accumulate as ribonuclear inclusions that co-localize with MBNL1 in selected neurons in the brain.
ATXN8OS,spinocerebellar ataxia,Spinocerebellar ataxia type 8 (SCA8) involves bidirectional expression of CUG (ATXN8OS) and CAG (ATXN8) expansion transcripts.
ATXN8OS,spinocerebellar ataxia,"Patients show a trinucleotide (CUG) expansion in a noncoding RNA termed ataxin 8 opposite strand (ATXN8OS), an antisense transcript to the KLHL1 gene."
ATXN8OS,spinocerebellar ataxia,The ATXN8OS (CTA)n(CTG)n composite repeat expansion is transmitted in an autosomal dominant manner with reduced penetrance.
ATXN8OS,spinocerebellar ataxia,The low prevalence of SCA8 seems to be correlated with the low frequency of large (CTA/CTG)n copy number alleles in Chinese population.
ATXN8OS,spinocerebellar ataxia,Genetic variation in lncRNA genes causes disease and influences susceptibility
ATXN8OS,spinocerebellar ataxia,ATXN8OS transcript contributes to SCA8 pathogenesis by altering the activity of MBNL/CELF alternative splicing proteins.
ATXN8OS,spinocerebellar ataxia,Expansion repeats in the ATXN8OS lncRNA gene are partly responsible for the pathology of spinocerebellar ataxia type 8 through a toxic RNA gain-of-function mechanism that includes formation of ribonuclear inclusions in the cerebellum and deregulation of muscleblind-like splicing regulator 1-mediated alternative splicing
B1 SINE RNA,infection of mouse minute virus,Increased levels of B1 and B2 SINE transcripts in mouse fibroblast cells due to minute virus of mice infection.
B2 SINE RNA,infection of chicken embryo lethal orphan adenovirus,CELO protein Gam1 was able to mediate transcriptional activation of these B2 SINE-containing RNAs. Upregulation of B2-SINE-containing RNAs could be a novel contribution of Gam1 to CELO host cell infection.
B2 SINE RNA,infection of mouse minute virus,Increased levels of B1 and B2 SINE transcripts in mouse fibroblast cells due to minute virus of mice infection.
B2 SINE RNA,pain,"Comt1 is differentially expressed among the strains, and this differential expression is cis-regulated. A B2 short interspersed nuclear element (SINE) was inserted in the 3'-untranslated region (3'-UTR) of Comt1 in 14 strains generating a common haplotype that correlates with gene expression. A haplotype, defined by a 3'-UTR B2 SINE element, regulates Comt1 expression and some mouse behaviors."
BACE1-AS,Alzheimer's disease,"Elevated levels of Ab, BACE1 proteins, as well as BACE1-AS have been detected in subjects with Alzheimer's disease (AD), suggesting that altered BACE1 expression plays a role in the pathogenesis of the disease."
BACE1-AS,Alzheimer's disease,The BACE1-antisense transcript (BACE1-AS) is markedly upregulated in brain samples from AD patients and promotes the stability of the (sense) BACE1 transcript.
BACE1-AS,Alzheimer's disease,BACE1-AS is directly implicated in the increased abundance of Aβ1-42 in Alzheimer's disease.
BACE1-AS,Alzheimer's disease,BACE1-AS is directly implicated in the increased abundance of Aβ1-42 in Alzheimer's disease.
BACE1-AS,Alzheimer's disease,The BACE1-antisense transcript (BACE1-AS) regulates BACE1 mRNA and subsequently BACE1 protein expression in vitro and in vivo. BACE1 mRNA expression is under the control of a regulatory noncoding RNA that may drive Alzheimer's disease-associated pathophysiology.
BACE1-AS,Alzheimer's disease,"BACE1 is one of two peptidases that carry out the initial proteolytic cleavage of APP, allowing it to accumulate in the brain. BACE1AS levels were found to be higher in human subjects with AD, and also in BACE1 transgenic mouse models of AD "
BACE1-AS,Alzheimer's disease,"BACE1-AS is elevated in brains of patients with AD, suggesting that the lncRNA is the driving force behind BACE1 dysregulation in AD"
BACE1-AS,Alzheimer's disease,The expression of BACE1 antisense transcript (BACE1-AS) was linked to increased amyloid-β 1-42 in patients with Alzheimer's disease and gave rise for a stabilizing function of the lncRNA.
BACE1-AS,Alzheimer's disease,he accumulation of this protein has been implicated in many neurological disorders and elevated levels of both BACE1 and BACE1-AS have been detected in subjects with Alzheimer's disease
BACE1-AS,Alzheimer's disease,Genomic context links lncRNAs to disease genes/loci and related pathways
BACE1-AS,Alzheimer's disease,"In Alzheimer disease, the protein-coding gene BACE-1 (β-site amyloid precursor protein-cleaving enzyme) cleaves amyloid precursor protein (APP) to β-amyloid peptide (Aβ), the accumulation of which (amyloid plaques) is associated with disease. LncRNA BACE1-AS, located on the antisense strand to BACE1, binds complementarily to BACE1 mRNA, increases its stability, regulates BACE1 translation, and thereby the production of Aβ."
BACE1-AS,Alzheimer's disease,"BACE1-AS has been shown that misexpression of lncRNAs contributes to numerous diseases. For example, an lncRNA may influence the pathogenesis of Alzheimer's disease. The BACE1-AS can regulate BACE1 mRNA expression. BACE1 mRNA expression is under the control of a regulatory non-coding RNA that may drive Alzheimer's disease-associated pathophysiology"
BACE1-AS,inclusion body myositis,Genomic context links lncRNAs to disease genes/loci and related pathways
BANCR,melanoma,"BRAF-regulated lncRNA 1 (BANCR) was identified as a recurrently overexpressed, previously unannotated 693-bp transcript on chromosome 9 with a potential functional role in melanoma cell migration. "
BANCR,melanoma,"This screen revealed a 693 bp novel lncRNA transcript, named BRAF-activated non-coding RNA (BANCR).Depletion of BANCR in melanoma cells resulted in profound migration defects, indicating a significant role of BANCR in regulation of melanoma cell motility. "
BANCR,non-small cell lung cancer,Downregulation of BRAF activated non-coding RNA is associated with poor prognosis for non-small cell lung cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
BC040587,osteosarcoma,These CNAs (copy number alterations) in osteosarcoma often involve the noncoding RNAs LOC285194 and BC040587.
BCAR4,breast cancer,BCAR4 is expressed in 27% of primary breast tumors. Forced expression of BCAR4 in human ZR-75-1 and MCF7 breast cancer cells resulted in cell proliferation in the absence of estrogen and in the presence of various antiestrogens.BCAR4 may be a good target for treating antiestrogen-resistant breast cancer.
BCAR4,breast cancer,"High BCAR4 mRNA levels were associated with poor MFS and overall survival, reflecting tumour aggressiveness."
BCAR4,breast cancer,"Breast cancer anti-estrogen resistance 4 (BCAR4), caused OH-TAM resistance and anchorage-independent cell growth in ZR-75-1 cells."
BCAR4,breast cancer,BCAR4 induces antioestrogen resistance but sensitises breast cancer to lapatinib.
BCYRN1,aging,"In normal aging, BC200 levels in cortical areas were reduced by >60% between the ages of 49 and 86. In contrast, BC200 RNA was significantly up-regulated in AD brains, in comparison with age-matched normal brains."
BCYRN1,Alzheimer's disease,"In normal aging, BC200 levels in cortical areas were reduced by >60% between the ages of 49 and 86. In contrast, BC200 RNA was significantly up-regulated in AD brains, in comparison with age-matched normal brains."
BCYRN1,Alzheimer's disease,"Increased levels of BC200 were found in brain regions that are preferentially affected in AD. Further, in advanced stages of AD, BC200 was mis-localized and clustered in the perikaryon. These observations suggest that deregulation of these synaptic lncRNAs is involved in the synaptic and neural network dysfunction that is found in both early and later stages of AD."
BCYRN1,Alzheimer's disease,"BC200 levels in Brodmann's area 9 (the area of brain affected in AD) were found to be higher in age-matched AD brains compared with normal brains, and the relative levels of BC200 RNA in affected areas increased with the severity of AD."
BCYRN1,breast cancer,"BC200 RNA was expressed in carcinomas of the breast, cervix, oesophagus, lung, ovary, parotid, and tongue, but not in corresponding normal tissues."
BCYRN1,breast cancer,"In ductal carcinomas in situ, furthermore, significant BC200 (BCYRN1) expression was associated with high nuclear grade, suggesting that the presence of BC200 RNA in such tumors may be used as a prognostic indicator of tumor progression."
BCYRN1,cervical cancer,"BC200 RNA was expressed in carcinomas of the breast, cervix, oesophagus, lung, ovary, parotid, and tongue, but not in corresponding normal tissues."
BCYRN1,lung cancer,"BC200 RNA was expressed in carcinomas of the breast, cervix, oesophagus, lung, ovary, parotid, and tongue, but not in corresponding normal tissues."
BCYRN1,esophageal cancer,"BC200 RNA was expressed in carcinomas of the breast, cervix, oesophagus, lung, ovary, parotid, and tongue, but not in corresponding normal tissues."
BCYRN1,ovarian cancer,"BC200 RNA was expressed in carcinomas of the breast, cervix, oesophagus, lung, ovary, parotid, and tongue, but not in corresponding normal tissues."
BCYRN1,parotid cancer,"BC200 RNA was expressed in carcinomas of the breast, cervix, oesophagus, lung, ovary, parotid, and tongue, but not in corresponding normal tissues."
BCYRN1,tongue cancer,"BC200 RNA was expressed in carcinomas of the breast, cervix, oesophagus, lung, ovary, parotid, and tongue, but not in corresponding normal tissues."
BDNF-AS,depression,"The lncRNA BDNF-AS is related to many neurological disorders, including Huntington's disease (HD), schizophrenia, and depression."
BDNF-AS,Huntington's disease,"The lncRNA BDNF-AS is related to many neurological disorders, including Huntington's disease (HD), schizophrenia, and depression."
BDNF-AS,Huntington's disease,"Thus, BDNF-AS inhibits BDNF transcription by recruiting EZH2 to the BDNF promoter region and in that way plays an important role in the development of HD."
BDNF-AS,psychiatric disease,"Examples of recently discovered chromatin-bound long non-coding RNAs important for neuronal health and function include the brain-derived neurotrophic factor antisense transcript (Bdnf-AS) which regulates expression of the corresponding sense transcript, and LOC389023 which is associated with human-specific histone methylation signatures at the chromosome 2q14.1 neurodevelopmental risk locus by regulating expression of DPP10, an auxillary subunit for voltage-gated K(+) channels."
BDNF-AS,schizophrenia,"The lncRNA BDNF-AS is related to many neurological disorders, including Huntington's disease (HD), schizophrenia, and depression."
BDNF-AS1,obesity,"This locus maps near key hypothalamic regulators of energy balance, may be associated with obesity."
BDNF-AS1,obesity,"Association identified by GWAS (rs4074134, A118887G)."
BLACAT1,bladder cancer,Theseguilty by association studies have found numerous bladder-cancer associated lncRNAs
BOK-AS1,cancer,The expression of BOKAS was found in testis and certain cancer tissues but not in other normal adult tissues. Overexpression of BOKAS was able to inhibit Bok-induced apoptosis in HeLa cells.
BOK-AS1,testicular cancer,"A natural antisense transcript, BOKAS, regulates the pro-apoptotic activity of human Bok. The mRNA expression of BOKAS was only detected in testis and certain cancer tissues but not in other normal adult tissues examined."
BPESC1,blepharophimosis syndrome,"BPESC1 is disrupted by a balanced chromosomal translocation, t(3;4)(q23;p15.2), in a patient with BPES."
BX118339,West syndrome,"A de novo balanced t(2;6)(p15;p22.3) in a patient with West Syndrome disrupts a lnc-RNA, BX118339."
BX118339,West syndrome,Genetic variation in lncRNA genes causes disease and influences susceptibility
C15orf2,Angelman syndrome,C15orf2 and a novel noncoding transcript from the Prader-Willi/Angelman syndrome region show monoallelic expression in fetal brain.
C15orf2,Prader-Willi syndrome,C15orf2 and a novel noncoding transcript from the Prader-Willi/Angelman syndrome region show monoallelic expression in fetal brain.
C1QTNF9B-AS1,prostate cancer,"PCOTH, a novel gene overexpressed in prostate cancers, promotes prostate cancer cell growth through phosphorylation of oncoprotein TAF-Ibeta/SET."
CASC2,endometrial cancer,"CASC2, in a region of common allelic loss at chromosome 10q26 is a novel candidate gene in human endometrial cancer."
CBR3-AS1,esophageal squamous cell carcinoma,Upregulation of the long non-coding RNA PlncRNA-1 promotes esophageal squamous carcinoma cell proliferation and correlates with advanced clinical stage.
CBR3-AS1,prostate cancer,Oncogene; putative therapeutic target
CBR3-AS1,prostate cancer,The prostate cancer-up-regulated long noncoding RNA PlncRNA-1 (CBR3-AS1) modulates apoptosis and proliferation through reciprocal regulation of androgen receptor.
CCAT1,colorectal cancer,"Recently, colon cancer associated transcript 1 (CCAT1) lncRNA was found to be expressed in colorectal cancer (CRC) tumors but not in normal tissue."
CCAT1,gastric cancer,"Another study reported that lncRNA CCAT1 was up-regulated in gastric carcinoma tissues, and its expression was closely related to the transcription factor c-Myc."
CCAT1,gastric cancer,"Level of lncRNA CCAT1 was markedly increased in gastric carcinoma tissue comparing with normal tissue, and overexpressed CCAT1 promoted cancer cell proliferation and migration"
CCAT1,gastric cancer,"Long noncoding RNA CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma."
CCAT2,breast cancer,"CCAT2, a novel long non-coding RNA in breast cancer."
CCAT2,non-small cell lung cancer,CCAT2 is a lung adenocarcinoma-specific long non-coding RNA and promotes invasion of non-small cell lung cancer.
CCDC26,glioma,"In the pooled analysis, the odds ratio for low-grade glioma associated with rs55705857 was 4.3 (P = 2.31 ×10(-94)). rs55705857 maps to a highly evolutionarily conserved sequence within the long non-coding RNA CCDC26 raising the possibility of direct functionality. "
CDKN2B-AS1,abdominal aortic aneurysm,"Genetic risk (rs10757278, A>G) for abdominal aortic aneurysm."
CDKN2B-AS1,acute lymphoblastic leukemia,Higher p15AS levels were often found in acute lymphoblastic (ALL) and myeloid leukemias (AML).
CDKN2B-AS1,acute lymphoblastic leukemia,Higher p15AS levels were often found in acute lymphoblastic (ALL) and myeloid leukemias (AML).
CDKN2B-AS1,acute lymphoblastic leukemia,"rs564398 (A>G), mapping to the CDKN2BAS locus that encodes for ANRIL antisense non-coding RNA, showed a statistically significant correlation with the ALL phenotype, with a risk pattern that was compatible with an overdominant model of disease susceptibility."
CDKN2B-AS1,Alzheimer's disease,"Recent studies showed that single nucleotide polymorphisms (rs3217992, A>G;rs1063192, C>T) mapping in the vicinity of ANRIL are linked to a wide spectrum of conditions, including cardiovascular disease, ischemic stroke, type 2 diabetes, frailty and Alzheimer's disease."
CDKN2B-AS1,Alzheimer's disease,Genetic variation in lncRNA genes causes disease and influences susceptibility
CDKN2B-AS1,aortic aneurysm,"Significantly reduced expression of all INK4/ARF transcripts (p15(INK4b), p16(INK4a), ARF and ANRIL) was found in PBTL of individuals harboring a common SNP (rs10757278) associated with increased risk of coronary artery disease, stroke and aortic aneurysm."
CDKN2B-AS1,atherosclerosis,Genetic variation in lncRNA genes causes disease and influences susceptibility
CDKN2B-AS1,atherosclerosis,"9p21.3 may promote atherosclerosis by regulating expression of ANRIL, which in turn is associated with altered expression of genes controlling cellular proliferation pathways."
CDKN2B-AS1,atherosclerosis,ANRIL expression is associated with atherosclerosis risk. Expression of ANRIL transcripts was directly correlated with severity of atherosclerosis.
CDKN2B-AS1,atherosclerosis,Gene expression studies have found that expression levels of CDKN2A/CDKN2B/ANRIL are co-regulated and associated with the risk haplotype and atherosclerosis severity.
CDKN2B-AS1,atherosclerosis,abundantly expressed in atherosclerotic lesions.
CDKN2B-AS1,atherosclerosis,ANRIL DQ485454 which is not genetically determined by the 9p21 genotype was significantly correlated with MTAP expression.
CDKN2B-AS1,atherosclerosis,A genetic susceptibility locus.
CDKN2B-AS1,atherosclerosis,"Genotypes of rs10757278 linked to increased risk of atherosclerotic diseases are also associated with decreased expression in PBTL of the INK4/ARF locus, near CDKN2B-AS1 locus."
CDKN2B-AS1,atherosclerosis,"Individuals homozygous for the atherosclerotic risk allele (rs3217992, A>G;rs1063192, C>T) show decreased expression of ANRIL."
CDKN2B-AS1,atherosclerosis,The risk alleles for atherosclerosis-related phenotypes were consistently associated with a lower expression of ANRIL when evaluating exons 1-2. Common carotid artery stenosis was associated with a significantly lower (P<0.01) expression of ANRIL (exons 1-2). ANRIL knock-down in VSMC caused significant variation in expression of CDKN2A/B (P<0.05) and reduction of cell growth (P<0.05) in vitro.
CDKN2B-AS1,atherosclerosis,Transcripts EU741058 and NR_003529 of antisense noncoding RNA in the INK4 locus (ANRIL) were significantly increased in carriers of the risk haplotype.
CDKN2B-AS1,basal cell carcinoma,A genetic susceptibility locus.
CDKN2B-AS1,basal cell carcinoma,"More recent GWAS also identified ANRIL as a risk locus (rs3217992, A>G;rs1063192, C>T) for gliomas and basal cell carcinomas in accordance with the princeps observation."
CDKN2B-AS1,breast cancer,Expression of ANRIL mainly coclustered with p14/ARF both in physiologic (various normal human tissues) and in pathologic conditions (human breast tumors).
CDKN2B-AS1,breast cancer,A genetic susceptibility locus.
CDKN2B-AS1,breast cancer,A locus associated with breast cancer.
CDKN2B-AS1,breast cancer,"More recently, additional GWAS identified ANRIL as a risk locus (rs3217992, A>G;rs1063192, C>T) for several cancers including breast cancer, nasopharyngeal carcinoma, basal cell carcinoma, and glioma."
CDKN2B-AS1,cancer,Down-regulated in cells were incubated in the presence of BLM for 24 h or irradiated.
CDKN2B-AS1,cancer,"RNA immunoprecipitation demonstrates that ANRIL binds to SUZ12 in vivo. Collectively, these results suggest a model in which ANRIL binds to and recruits PRC2 to repress the expression of p15(INK4B) locus."
CDKN2B-AS1,cancer,High expression of ANRIL has been found in certain cancer tissues such as melanoma and prostate cancers.
CDKN2B-AS1,cancer,"Furthermore, genome wide association studies have identified the ANRIL gene as a risk locus for coronary disease, intracranial aneurism, type 2 diabetes and several cancers including glioma. "
CDKN2B-AS1,cancer,"CDKN2B-AS1 has also been shown that the tumor suppressor gene p15 is silenced by its natural antisense RNA, a lncRNA ANRIL."
CDKN2B-AS1,cancer,"ANRIL is a recently discovered long non-coding RNA encoded in the chromosome 9p21 region. This locus is a hotspot for disease-associated polymorphisms, and it has been consistently associated with cardiovascular disease, and more recently with several cancers, diabetes, glaucoma, endometriosis among other conditions."
CDKN2B-AS1,cancer,"Another lncRNA associated with human cancers is ANRIL, a long, antisense transcript found in the INK4a/Arf locus. ANRIL is overexpressed in human leukemias and prostate cancers, and its expression leads to epigenetic silencing of the nearby tumor suppressor p15 (Yu et al., 2008; Yap et al., 2010). "
CDKN2B-AS1,cardiovascular disease,Aberrant ANRIL transcripts and mutations were associated with cardiovascular disease and cancer .
CDKN2B-AS1,cardiovascular disease,"Recent studies showed that single nucleotide polymorphisms (rs3217992, A>G;rs1063192, C>T) mapping in the vicinity of ANRIL are linked to a wide spectrum of conditions, including cardiovascular disease, ischemic stroke, type 2 diabetes, frailty and Alzheimer's disease."
CDKN2B-AS1,cardiovascular disease,"ANRIL is a recently discovered long non-coding RNA encoded in the chromosome 9p21 region. This locus is a hotspot for disease-associated polymorphisms, and it has been consistently associated with cardiovascular disease, and more recently with several cancers, diabetes, glaucoma, endometriosis among other conditions."
CDKN2B-AS1,cardiovascular disease,Aberrant ANRIL transcripts and mutations were associated with cardiovascular disease and cancer .
CDKN2B-AS1,cardiovascular disease,"Recently, ANRIL, a multi-exonic lncRNA, has been shown to be implicated in epigenetic modulation in cardiac development and adult heart and also it has been associated with a locus implicated in cardiovascular disease."
CDKN2B-AS1,coronary artery disease,"Significantly reduced expression of all INK4/ARF transcripts (p15(INK4b), p16(INK4a), ARF and ANRIL) was found in PBTL of individuals harboring a common SNP (rs10757278) associated with increased risk of coronary artery disease, stroke and aortic aneurysm."
CDKN2B-AS1,coronary artery disease,Whole blood RNA expression of the short variants of ANRIL was increased by 2.2-fold whereas expression of the long ANRIL variant was decreased by 1.2-fold in healthy subjects homozygous for the risk allele.
CDKN2B-AS1,coronary artery disease,"Whole blood RNA expression of the short variants of ANRIL was increased by 2.2-fold whereas expression of the long ANRIL variant was decreased by 1.2-fold in healthy subjects homozygous for the risk allele. Expression levels of the long and short ANRIL variants were positively correlated with that of the cyclin-dependent kinase inhibitor, CDKN2B (p15) and TDGF1 (Cripto), respectively."
CDKN2B-AS1,coronary artery disease,"Sequence polymorphisms in a 58-kilobase (kb) interval on chromosome 9p21 confer a markedly increased risk (rs3217992, A>G;rs1063192, C>T) of coronary artery disease (CAD), the leading cause of death worldwide."
CDKN2B-AS1,coronary artery disease,"Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs (rs2891168, A>G) in the ANRIL locus on chromosome 9p."
CDKN2B-AS1,coronary artery disease,"However, overexpression of 1 ANRIL variant altered the expression of many genes involved in nuclear regulation and chromatin architecture, indicating diverse trans-regulatory effects that go beyond the cis-effects seen at 9p21."
CDKN2B-AS1,coronary artery disease,A genetic susceptibility locus
CDKN2B-AS1,coronary artery disease,"Common disease genome wide association studies (GWAS) have surprisingly identified the ANRIL gene as a genetic susceptibility locus (rs3217992, A>G;rs1063192, C>T) shared associated by coronary disease, intracranial aneurysm and also type 2 diabetes."
CDKN2B-AS1,coronary artery disease,"Risk SNPs (rs3217992, A>G;rs1063192, C>T) for coronary disease, stroke, diabetes, melanoma, and glioma were all associated with allelic expression of ANRIL."
CDKN2B-AS1,coronary artery disease,"Risk SNPs (rs3217992, A>G;rs1063192, C>T) for coronary disease, stroke, diabetes, melanoma, and glioma were all associated with allelic expression of CDKN2B-AS1."
CDKN2B-AS1,coronary artery disease,"Furthermore, genome wide association studies have identified the ANRIL gene as a risk locus for coronary disease, intracranial aneurism, type 2 diabetes and several cancers including glioma. "
CDKN2B-AS1,coronary heart disease,"CHD and periodontitis are genetically related by at least one susceptibility locus, which is possibly involved in ANRIL activity and independent of diabetes associated risk variants within this region. Elucidation of the interplay of ANRIL transcript variants and their involvement in increased susceptibility to the interactive diseases CHD and periodontitis promises new insight into the underlying shared pathogenic mechanisms of these complex common diseases."
CDKN2B-AS1,coronary heart disease,"Association of a genetic susceptibility locus (rs2891168, A>G;rs1333042, A>G;rs1333048, A>C)."
CDKN2B-AS1,coronary heart disease,"Association identified by GWAS (rs10757274, A>G;rs2383206, A>G)."
CDKN2B-AS1,diabetes mellitus,Genetic variation in lncRNA genes causes disease and influences susceptibility
CDKN2B-AS1,diabetes mellitus,"Risk SNPs (rs3217992, A>G;rs1063192, C>T) for coronary disease, stroke, diabetes, melanoma, and glioma were all associated with allelic expression of CDKN2B-AS1."
CDKN2B-AS1,diabetes mellitus,"ANRIL is a recently discovered long non-coding RNA encoded in the chromosome 9p21 region. This locus is a hotspot for disease-associated polymorphisms, and it has been consistently associated with cardiovascular disease, and more recently with several cancers, diabetes, glaucoma, endometriosis among other conditions."
CDKN2B-AS1,endometriosis,"The authors identified a significant association of endometriosis with rs10965235 (A>C, P = 5.57 x 10(-12), odds ratio = 1.44), which is located in CDKN2BAS on chromosome 9p21, encoding the cyclin-dependent kinase inhibitor 2B antisense RNA.the SNP showing the strongest association was located in intron 16 of CDKN2BAS and was implicated in regulating the expression of p15, p16 and p14."
CDKN2B-AS1,endometriosis,"ANRIL is a recently discovered long non-coding RNA encoded in the chromosome 9p21 region. This locus is a hotspot for disease-associated polymorphisms, and it has been consistently associated with cardiovascular disease, and more recently with several cancers, diabetes, glaucoma, endometriosis among other conditions."
CDKN2B-AS1,esophageal squamous cell carcinoma,ANRIL inhibits p15INK4b through the TGFβ11 signaling pathway in human esophageal squamous cell carcinoma.
CDKN2B-AS1,intracranial aneurysm,All 6 index cases from IA families had the rs1333040-T allele (C>T) in CDKN2BAS.
CDKN2B-AS1,frailty,"Recent studies showed that single nucleotide polymorphisms (rs3217992, A>G;rs1063192, C>T) mapping in the vicinity of ANRIL are linked to a wide spectrum of conditions, including cardiovascular disease, ischemic stroke, type 2 diabetes, frailty and Alzheimer's disease."
CDKN2B-AS1,gastric cancer,Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a.
CDKN2B-AS1,glaucoma,Genetic variation in lncRNA genes causes disease and influences susceptibility
CDKN2B-AS1,glaucoma,"Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1 (rs4977756, A>G)."
CDKN2B-AS1,glaucoma,"ANRIL is a recently discovered long non-coding RNA encoded in the chromosome 9p21 region. This locus is a hotspot for disease-associated polymorphisms, and it has been consistently associated with cardiovascular disease, and more recently with several cancers, diabetes, glaucoma, endometriosis among other conditions."
CDKN2B-AS1,glaucoma,CDKN2B-AS1 genotype-glaucoma feature correlations in primary open-angle glaucoma patients from the United States.
CDKN2B-AS1,glioma,Genetic variation in lncRNA genes causes disease and influences susceptibility
CDKN2B-AS1,glioma,A genetic susceptibility locus.
CDKN2B-AS1,glioma,Association identified by GWAS.
CDKN2B-AS1,glioma,"More recent GWAS also identified ANRIL as a risk locus (rs3217992, A>G;rs1063192, C>T) for gliomas and basal cell carcinomas in accordance with the princeps observation."
CDKN2B-AS1,glioma,"Risk SNPs (rs3217992, A>G;rs1063192, C>T) for coronary disease, stroke, diabetes, melanoma, and glioma were all associated with allelic expression of ANRIL."
CDKN2B-AS1,glioma,"Risk SNPs (rs3217992, A>G;rs1063192, C>T) for coronary disease, stroke, diabetes, melanoma, and glioma were all associated with allelic expression of CDKN2B-AS1."
CDKN2B-AS1,glioma,"Variants (rs1412829, C>T) in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility."
CDKN2B-AS1,hereditary cutaneous malignant melanoma,"Long ncRNA antisense non-coding RNA in the INK4 locus (ANRIL) has been associated to hereditary cutaneous malignant melanoma, prostate cancer and tumors of the neural system (Pasmant et al., 2011). "
CDKN2B-AS1,intracranial aneurysm,"Furthermore, genome wide association studies have identified the ANRIL gene as a risk locus for coronary disease, intracranial aneurism, type 2 diabetes and several cancers including glioma. "
CDKN2B-AS1,intracranial aneurysm,Genetic variation in lncRNA genes causes disease and influences susceptibility
CDKN2B-AS1,intracranial aneurysm,A genetic susceptibility locus.
CDKN2B-AS1,intracranial aneurysm,We also confirmed prior associations near CDKN2A-CDKN2B locus.
CDKN2B-AS1,intracranial aneurysm,"Association identified by GWAS (rs1333040, C>T)."
CDKN2B-AS1,intracranial aneurysm,"Common disease genomewide association studies (GWAS) have surprisingly identified the ANRIL gene as a genetic susceptibility locus (rs3217992, A>G;rs1063192, C>T)shared associated by coronary disease, intracranial aneurysm and also type 2 diabetes."
CDKN2B-AS1,ischemic stroke,Regulation of CARD8 expression by ANRIL and association of CARD8 single nucleotide polymorphism rs2043211 (p.C10X) with ischemic stroke.
CDKN2B-AS1,leukemia,Gene silencing of INK4b-ARF-INK4a and p15/CDKN2B by recruitment of PRC1 and PRC2.
CDKN2B-AS1,melanoma,A genetic susceptibility locus.
CDKN2B-AS1,melanoma,A large germline deletion (403231 bp) encompassing the INK4/ARF locus and the ANRIL lncRNA has been associated with hereditary cutaneous malignant melanoma (CMM) and neural system tumors (NST) syndrome.
CDKN2B-AS1,melanoma,Association identified by GWAS.
CDKN2B-AS1,melanoma,"Risk SNPs (rs3217992, A>G;rs1063192, C>T) for coronary disease, stroke, diabetes, melanoma, and glioma were all associated with allelic expression of ANRIL."
CDKN2B-AS1,melanoma,"Risk SNPs (rs3217992, A>G;rs1063192, C>T) for coronary disease, stroke, diabetes, melanoma, and glioma were all associated with allelic expression of CDKN2B-AS1."
CDKN2B-AS1,myocardial infarction,Association identified by GWAS.
CDKN2B-AS1,myocardial infarction,"association identified by GWAS (rs4977574, A>G)."
CDKN2B-AS1,nasopharyngeal carcinoma,A genetic susceptibility locus.
CDKN2B-AS1,nasopharyngeal carcinoma,A SNP rs1412829 (C49137T) at CDKN2A-CDKN2B gene cluster on 9p21 is associated with this disease.
CDKN2B-AS1,nasopharyngeal carcinoma,"More recently, additional GWAS identified ANRIL as a risk locus (rs3217992, A>G;rs1063192, C>T) for several cancers including breast cancer, nasopharyngeal carcinoma, basal cell carcinoma, and glioma."
CDKN2B-AS1,nasopharyngeal carcinoma,"In recent years, GWAS has identified ANRIL as a risk locus for NPC and other cancers."
CDKN2B-AS1,neural system tumors syndrome,A large germline deletion (403231 bp) encompassing the INK4/ARF locus and the ANRIL lncRNA has been associated with hereditary cutaneous malignant melanoma (CMM) and neural system tumors (NST) syndrome.
CDKN2B-AS1,neurofibromatosis,"Single-nucleotide polymorphism rs2151280 (C>T, located in ANRIL) was statistically significantly associated with the number of PNFs (P < .001) in NF1 patients. In addition, allele T of rs2151280 was statistically significantly associated with reduced ANRIL transcript levels (P < .001), suggesting that modulation of ANRIL expression mediates PNF susceptibility."
CDKN2B-AS1,periodontitis,"CHD and periodontitis are genetically related by at least one susceptibility locus, which is possibly involved in ANRIL activity and independent of diabetes associated risk variants within this region. Elucidation of the interplay of ANRIL transcript variants and their involvement in increased susceptibility to the interactive diseases CHD and periodontitis promises new insight into the underlying shared pathogenic mechanisms of these complex common diseases."
CDKN2B-AS1,periodontitis,"Association of a genetic susceptibility locus (rs2891168, A>G;rs1333042, A>G;rs1333048, A>C)."
CDKN2B-AS1,peripheral artery disease,SNP rs2383207 on ANRIL was most significantly associated with lower ABI.
CDKN2B-AS1,plexiform neurofibroma,Genetic variation in lncRNA genes causes disease and influences susceptibility
CDKN2B-AS1,prostate cancer,Gene silencing of INK4b-ARF-INK4a and p15/CDKN2B by recruitment of PRC1 and PRC2.
CDKN2B-AS1,prostate cancer,"ANRIL is an antisense lncRNA elevated in PCa that overlaps this locus, interacting directly with polycomb repressive complex 1 and histone H3K27 methylation to repress CDKN2A-CDKN2B expression"
CDKN2B-AS1,prostate cancer,"Here we report that chromobox 7 (CBX7) within the polycomb repressive complex 1 binds to ANRIL, and both CBX7 and ANRIL are found at elevated levels in prostate cancer tissues."
CDKN2B-AS1,prostate cancer,"Long ncRNA antisense non-coding RNA in the INK4 locus (ANRIL) has been associated to hereditary cutaneous malignant melanoma, prostate cancer and tumors of the neural system (Pasmant et al., 2011). "
CDKN2B-AS1,prostate cancer,"ANRIL is upregulated in prostate cancer and is required for the repression of the tumor suppressors INK4a/p16 and INK4b/p15 (Yap et al., 2010; Kotake et al., 2011). "
CDKN2B-AS1,prostate cancer,"ANRIL, also upregulated in prostate cancer, is required for the repression of the tumor suppressors INK4a/p16 and INK4b/p15."
CDKN2B-AS1,stroke,Genetic variation in lncRNA genes causes disease and influences susceptibility
CDKN2B-AS1,stroke,"Significantly reduced expression of all INK4/ARF transcripts (p15(INK4b), p16(INK4a), ARF and ANRIL) was found in PBTL of individuals harboring a common SNP (rs10757278) associated with increased risk of coronary artery disease, stroke and aortic aneurysm."
CDKN2B-AS1,stroke,"Risk SNPs (rs3217992, A>G;rs1063192, C>T) for coronary disease, stroke, diabetes, melanoma, and glioma were all associated with allelic expression of ANRIL."
CDKN2B-AS1,stroke,"Risk SNPs (rs3217992, A>G;rs1063192, C>T) for coronary disease, stroke, diabetes, melanoma, and glioma were all associated with allelic expression of CDKN2B-AS1."
CDKN2B-AS1,stroke,"Variants (rs3217992, A>G;rs1063192, C>T) on chromosome 9p21.3 correlated with ANRIL expression contribute to stroke risk and recurrence in a large prospective stroke population."
CDKN2B-AS1,stroke,Levels of CDKN2B-AS1/ANRIL in human carotid atherosclerotic plaques and peripheral blood T lymphocytes are linked to rates of ischemic and hemorrhagic stroke. 
CDKN2B-AS1,cancer,"ANRIL, GAS5 and lincRNA-p23 are involved in the escape of growth suppression by regulating tumor suppressor genes (ANRIL) or apoptosis regulators."
CDKN2B-AS1,cancer,"Long ncRNA antisense non-coding RNA in the INK4 locus (ANRIL) has been associated to hereditary cutaneous malignant melanoma, prostate cancer and tumors of the neural system (Pasmant et al., 2011). "
CDKN2B-AS1,type 2 diabetes mellitus,A genetic susceptibility locus.
CDKN2B-AS1,type 2 diabetes mellitus,Association identified by GWAS.
CDKN2B-AS1,type 2 diabetes mellitus,"Common disease genomewide association studies (GWAS) have surprisingly identified the ANRIL gene as a genetic susceptibility locus (rs3217992, A>G;rs1063192, C>T) shared associated by coronary disease, intracranial aneurysm and also type 2 diabetes."
CDKN2B-AS1,type 2 diabetes mellitus,"Recent studies showed that single nucleotide polymorphisms (rs3217992, A>G;rs1063192, C>T) mapping in the vicinity of ANRIL are linked to a wide spectrum of conditions, including cardiovascular disease, ischemic stroke, type 2 diabetes, frailty and Alzheimer's disease."
CDKN2B-AS1,type 2 diabetes mellitus,"Risk SNPs (rs3217992, A>G;rs1063192, C>T) for coronary disease, stroke, diabetes, melanoma, and glioma were all associated with allelic expression of ANRIL."
CDKN2B-AS1,type 2 diabetes mellitus,"Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs (rs2891168, A>G) in the ANRIL locus on chromosome 9p."
CDKN2B-AS1,type 2 diabetes mellitus,"Furthermore, genome wide association studies have identified the ANRIL gene as a risk locus for coronary disease, intracranial aneurism, type 2 diabetes and several cancers including glioma. "
CDKN2B-AS10,stroke,Genetic variants that affect the expression of the ANRIL transcript have been correlated with stroke risk and recurrence in a large prospective study 
CDKN2B-AS11,stroke,"Moreover, genome-wide association studies have demonstrated that the 9p21 genomic locus is a hotspot for the risk of stroke, glioma, plexiform neurofibroma and other disorders"
CDKN2B-AS12,glioma,"Moreover, genome-wide association studies have demonstrated that the 9p21 genomic locus is a hotspot for the risk of stroke, glioma, plexiform neurofibroma and other disorders"
CDKN2B-AS13,plexiform neurofibroma,"Moreover, genome-wide association studies have demonstrated that the 9p21 genomic locus is a hotspot for the risk of stroke, glioma, plexiform neurofibroma and other disorders"
CDKN2B-AS2,coronary heart disease,"Interestingly, genome wide association studies (GWAS) identified several variants in the intergenic region encompassing ANRIL to be associated with several diseases such as coronary heart disease, intracranial aneurysm, many type of cancers and T2D"
CDKN2B-AS3,intracranial aneurysm,"Interestingly, genome wide association studies (GWAS) identified several variants in the intergenic region encompassing ANRIL to be associated with several diseases such as coronary heart disease, intracranial aneurysm, many type of cancers and T3D"
CDKN2B-AS4,cancer,"Interestingly, genome wide association studies (GWAS) identified several variants in the intergenic region encompassing ANRIL to be associated with several diseases such as coronary heart disease, intracranial aneurysm, many type of cancers and T4D"
CDKN2B-AS5,type 2 diabetes mellitus,"Interestingly, genome wide association studies (GWAS) identified several variants in the intergenic region encompassing ANRIL to be associated with several diseases such as coronary heart disease, intracranial aneurysm, many type of cancers and T5D"
CDKN2B-AS6,neuroblastoma,"Disruptions to the expression of ANRIL have accordingly been associated with the development of several cancer types, including neuroblastoma , acute lymphocytic leukaemia, melanoma and prostate"
CDKN2B-AS7,acute lymphoblastic leukemia,"Disruptions to the expression of ANRIL have accordingly been associated with the development of several cancer types, including neuroblastoma , acute lymphocytic leukaemia, melanoma and prostate"
CDKN2B-AS8,melanoma,"Disruptions to the expression of ANRIL have accordingly been associated with the development of several cancer types, including neuroblastoma , acute lymphocytic leukaemia, melanoma and prostate"
CDKN2B-AS9,prostate cancer,"Disruptions to the expression of ANRIL have accordingly been associated with the development of several cancer types, including neuroblastoma , acute lymphocytic leukaemia, melanoma and prostate"
CECR3,cat eye syndrome,"Cat eye syndrome chromosome region, candidate 3"
CHL1-AS2,adolescent idiopathic scoliosis,"We found strongest evidence of association with chromosome 3p26.3 SNPs (rs1400180,A>C) in the proximity of the CHL1 gene (P < 8*10^(-8) for rs1400180)."
CHRF,cardiac hypertrophy,The Long Noncoding RNA CHRF Regulates Cardiac Hypertrophy by Targeting miR-489.
CRNDE,colorectal cancer,"An uncharacterized gene locus (Chr16:hCG_1815491), now named colorectal neoplasia differentially expressed (gene symbol CRNDE), is activated early in colorectal neoplasia."
CTBP1-AS,prostate cancer,CTBP1-AS is the oncogene of prostate cancer
CTBP1-AS,prostate cancer,"The prostate cancer-associated ncRNA transcript 1 lncRNA PCAT1, SchlAP1 (second chromosome locus associated with prostate-1), and CTBP1-AS indicate cancer cell invasiveness and metastasis in prostate cancer progression. "
D4Z4,facioscapulohumeral muscular dystrophy,"The genetic lesion involved in FSHD is unusual as it does not target a protein-coding gene, but rather affects the copy number of the 3.3 kb macrosatellite D4Z4 mapping at the subtelomeric region of chromosome 4 (4q35)."
DANCR,bone diseases,"These data suggest that ANCR is an essential mediator of osteoblast differentiation, thus offering a new target for the development of therapeutic agents to treat bone diseases."
DAOA-AS1,bipolar disorder,"Polymorphisms at the G72/G30 gene locus, on 13q33, are associated with bipolar disorder in two independent pedigree series."
DAOA-AS1,panic disorder,Panic disorder associated.
DAOA-AS1,schizophrenia,Markers of the G72/G30 genes are associated with schizophrenia in a non-Caucasian population.
DAOA-AS1,schizophrenia,Meta-analysis revealed that there is weak evidence of association between the G72/G30 genes and schizophrenia.
DAOA-AS1,schizophrenia,"Significant associations of schizophrenia with the A allele of rs947267 (A>C,P=0.012) and haplotype A-A-G (rs2391191-rs947267-rs778294) (P=0.008) were found in early-onset schizophrenic patients."
DAOA-AS1,schizophrenia,"Transmission disequilibrium analysis revealed a significant association between the rs947267 polymorphism (A>C) and schizophrenia (P=0.016), with the A allele more commonly transmitted to patients."
DAOA-AS1,schizophrenia,"rs778294 (A>G) and rs947267 (A>C), were found to be associated with the risk of schizophrenia."
DAOA-AS1,schizophrenia,Association with schizophrenia.
DAOA-AS1,schizophrenia,G72/G30 (DAOA-AS1) are important candidate genes for explaining schizophrenia in the Han Chinese population.
DAOA-AS1,schizophrenia,G72/G30 genes are involved in conferring susceptibility to schizophrenia.
DBET,facioscapulohumeral muscular dystrophy,"As a result, this region becomes more prone to transcription and gives rise to the activatory lncRNA DBE-T. DBE-T is mainly produced in FSHD patients and mediates the aberrant activation of the FSHD locus."
DBET,facioscapulohumeral muscular dystrophy,Epigenetic deregulation of lncRNAs genes is associated with disease
DBET,facioscapulohumeral muscular dystrophy,The activatory long non-coding RNA DBE-T reveals the epigenetic etiology of facioscapulohumeral muscular dystrophy.
DBET,facioscapulohumeral muscular dystrophy,"In contrast, in FSHD patients, a deletion of D4Z4 repeats results in cis production of the DBE-T lncRNA that binds to protein complexes, reorganizes the chromatin state of the FSHD locus, and reactivates the repressed 4q35 genes."
DGCR5,DiGeorge syndrome,"The DiGeorge syndrome-associated noncoding RNA, DGCR5, is repressed by REST through a proximal upstream binding site."
DGCR5,DiGeorge syndrome,DGCR5 is disrupted by the patient ADU breakpoint.
DGCR5,Huntington's disease,"Interestingly, many of these lncRNAs contain genomic binding sites for the transcriptional repressor REST, a key mediator of transcriptional changes in HD, including the known REST target lncRNA, DGCR5."
DGCR5,velocardiofacial syndrome,DGCR5 is associated with velocardiofacial syndrome
DISC2,affective disorder,DISC2 is a likely susceptibility locus for both schizophrenia and affective disorders.
DISC2,autism spectrum disorder,Genomic context links lncRNAs to disease genes/loci and related pathways
DISC2,autism spectrum disorder,"The disruption of the DISC genomic locus, which encodes both the DISC1 protein-coding gene and the DISC2 lncRNA, has been linked in a number of genetic analyses to the risk of developing schizophrenia, schizophrenia, bipolar disorder, major depression, and autistic spectrum disorders."
DISC2,autism spectrum disorder,"DISC1 is regulated by its lncRNA, DISC6, which may also represent an excellent candidate for susceptibility to these disorders."
DISC2,bipolar disorder,Genomic context links lncRNAs to disease genes/loci and related pathways
DISC2,bipolar disorder,"The disruption of the DISC genomic locus, which encodes both the DISC1 protein-coding gene and the DISC2 lncRNA, has been linked in a number of genetic analyses to the risk of developing schizophrenia, schizophrenia, bipolar disorder, major depression, and autistic spectrum disorders."
DISC2,bipolar disorder,"DISC1 is regulated by its lncRNA, DISC4, which may also represent an excellent candidate for susceptibility to these disorders."
DISC2,depression,"The disruption of the DISC genomic locus, which encodes both the DISC1 protein-coding gene and the DISC2 lncRNA, has been linked in a number of genetic analyses to the risk of developing schizophrenia, schizophrenia, bipolar disorder, major depression, and autistic spectrum disorders."
DISC2,major depressive affective disorder,Genomic context links lncRNAs to disease genes/loci and related pathways
DISC2,major depressive affective disorder,"DISC1 is regulated by its lncRNA, DISC5, which may also represent an excellent candidate for susceptibility to these disorders."
DISC2,schizophrenia,"The disruption of the DISC genomic locus, which encodes both the DISC1 protein-coding gene and the DISC2 lncRNA, has been linked in a number of genetic analyses to the risk of developing schizophrenia, schizophrenia, bipolar disorder, major depression, and autistic spectrum disorders."
DISC2,schizophrenia,"DISC1 is regulated by its lncRNA, DISC3, which may also represent an excellent candidate for susceptibility to these disorders."
DISC2,schizophrenia,"The Disrupted in Schizophrenia (DISC) locus on human chromosome 1q42 has been strongly implicated by genetic studies as a susceptibility locus for major mental illnesses.DISC2, a putative noncoding transcript partially antisense to DISC1, is not conserved."
DISC2,schizophrenia,Genomic context links lncRNAs to disease genes/loci and related pathways
DISC2,schizophrenia,DISC2 should be considered a formal candidate gene for susceptibility to psychiatric illness (schizophrenia).
DISC2,schizophrenia,"The disruption of the DISC genomic locus, which encodes both the DISC1 protein-coding gene and the DISC2 lncRNA, has been linked in a number of genetic analyses to the risk of developing schizophrenia, schizophrenia, bipolar disorder, major depression, and autistic spectrum disorders."
DISC2,schizophrenia,DISC1 and DISC2 should be considered formal candidate genes for susceptibility to psychiatric illness.
DISC2,schizophrenia,DISC2 is a likely susceptibility locus for both schizophrenia and affective disorders.
DISC2,schizophrenia,"DISC1 is regulated by its lncRNA, DISC2, which may also represent an excellent candidate for susceptibility to these disorders. "
DLEU1,chronic lymphocytic leukemia,"In 13q14.3, where several tumor suppressor genes, including the miRNA genes miR-16-1 and miR-15a, are co-regulated by the two long non-coding RNA genes DLEU1 and DLEU2 that span the critical region."
DLEU1,chronic lymphocytic leukemia,Frequently deleted in B-cell chronic lymphocytic leukemia.
DLEU1,chronic lymphocytic leukemia,Leu1 and Leu2 genes are strong candidates as tumor suppressor gene(s) involved in B-CLL leukemogenesis.
DLEU1,chronic lymphocytic leukemia,"The microRNAs miR-15a and miR-16-1 are downregulated in multiple tumor types and are frequently deleted in chronic lymphocytic leukemia (CLL), myeloma and mantle cell lymphoma. DLEU2 negatively regulates the G1 Cyclins E1 and D1 through miR-15a/miR-16-1 and provide evidence that these oncoproteins are subject to miR-15a/miR-16-1-mediated repression under normal conditions. We also demonstrate that DLEU2 overexpression blocks cellular proliferation and inhibits the colony-forming ability of tumor cell lines in a miR-15a/miR-16-1-dependent way."
DLEU1,chronic lymphocytic leukemia,"In 13q14.3, where several tumor suppressor genes, including the miRNA genes miR-16-1 and miR-15a, are co-regulated by the two long non-coding RNA genes DLEU1 and DLEU2 that span the critical region."
DLEU1,chronic lymphocytic leukemia,B-cell chronic lymphocytic leukemia: frequent chromosomal imbalance.
DLEU1,chronic lymphocytic leukemia,Frequently deleted in B-cell chronic lymphocytic leukemia.
DLEU1,chronic lymphocytic leukemia,Leu1 and Leu2 genes are strong candidates as tumor suppressor gene(s) involved in B-CLL leukemogenesis.
DLEU1,lymphocytic leukemia,"Dleu2 is an antisense transcript that encompasses the Kcnrg and Trim13 genes, as well as two microRNA genes, Mirn16-1 and Mirn15a, which have been previously identified in lymphocytic leukemia."
DLEU1,lymphoma,"The microRNAs miR-15a and miR-16-1 are downregulated in multiple tumor types and are frequently deleted in chronic lymphocytic leukemia (CLL), myeloma and mantle cell lymphoma. DLEU2 negatively regulates the G1 Cyclins E1 and D1 through miR-15a/miR-16-1 and provide evidence that these oncoproteins are subject to miR-15a/miR-16-1-mediated repression under normal conditions. We also demonstrate that DLEU2 overexpression blocks cellular proliferation and inhibits the colony-forming ability of tumor cell lines in a miR-15a/miR-16-1-dependent way."
DLEU1,lymphoma,mantle-cell lymphoma: frequent chromosomal imbalance.
DLEU1,myeloma,"The microRNAs miR-15a and miR-16-1 are downregulated in multiple tumor types and are frequently deleted in chronic lymphocytic leukemia (CLL), myeloma and mantle cell lymphoma. DLEU2 negatively regulates the G1 Cyclins E1 and D1 through miR-15a/miR-16-1 and provide evidence that these oncoproteins are subject to miR-15a/miR-16-1-mediated repression under normal conditions. We also demonstrate that DLEU2 overexpression blocks cellular proliferation and inhibits the colony-forming ability of tumor cell lines in a miR-15a/miR-16-1-dependent way."
DLX6-AS1,split hand/split foot malformation disorder,"The lncRNA EVF2, which recruits the transcription factor Dlx2 to activate the protein coding genes DLX5 and DLX6 that are associated with the Split Hand/ Split Foot malformation disorder."
DNM3OS,ovarian cancer,pri-miR-199a2 within the human Dnm3os gene. The regulation of MIR199A2/214 expression may be used as a potential therapeutic approach in EOC (epithelial ovarian cancer) patients.
DQ786243,Crohn's disease,LncRNA DQ786243 affects Treg related CREB and Foxp3 expression in Crohn's disease.
Dreh,hepatocellular carcinoma,"Further experiments showed that Dreh can specifically bind to vimentin, a type III intermediate filament and the major cytoskeletal component of mesenchymal cells and then inhibit HCC metastasis by modifying the expression and reorganization of vimentin. "
Dreh,hepatocellular carcinoma,"lncRNA-Dreh could bind to the intermediate filament protein vimentin, repress its expression, and thus change the cytoskeleton structure and inhibit tumor metastasis. It acts as a tumor suppressor in the development of HBV-HCC, which inhibits HCC growth and metastasis in vitro and in vivo. These findings support a role of lncRNA-Dreh in tumor suppression and survival prediction of HCC patients."
DSCAM-AS1,adolescent idiopathic scoliosis,"Other top associations in our GWAS were with SNPs (rs2222973, C>T) in the DSCAM gene."
DSCAM-AS1,breast cancer,M41 (DSCAM-AS1) mRNA is expressed at a statistically significantly higher level in human breast cancer specimens than in normal human breast and benign lesions.
TTTY7,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
ENSG00000196096,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
LINC00336,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
ENSG00000203325,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
ENSG00000206129,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
LINC01020,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
FAM66B,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
LINC01139,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
LINC00323,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
LINC01204,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
LINC01721,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
HAR1B,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
ENSG00000231185,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
LEF1-AS1,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
LINC01798,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
SNHG15,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
LINC01762,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
ENSG00000233251,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
SMIM2-IT1,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
SNHG6,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
ENSG00000248176,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
ENSG00000249364,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
ENSG00000249772,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
ENSG00000250195,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
ENSG00000250608,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
ENSG00000254154,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
ENSG00000255471,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
ENSG00000256218,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
LINC00929,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
LINC00667,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
ENSG00000264772,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
LINC01538,hereditary haemorrhagic telangiectasia,Top 42 long non-coding RNAs (q<0.001) differentially expressed in HHT telangiectasia.
Tdpx-ps1,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 30 downregulated in HF hearts as compared with control hearts.
Gm15054,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 15 downregulated in HF hearts as compared with control hearts.
Gm12919,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 24 downregulated in HF hearts as compared with control hearts.
Gm7327,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 14 downregulated in HF hearts as compared with control hearts.
Gm14155,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 8 downregulated in HF hearts as compared with control hearts.
Gm10371,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 27 downregulated in HF hearts as compared with control hearts.
SMAD1-AS1,ventricular septal defects,"Furthermore, our established filtering pipeline indicated an association of two lncRNAs, ENST00000513542 and RP11-473L15.2, with VSD. "
EPB41L4A-AS1,cancer,Ectopic expression of TIGA1 (EPB41L4A-AS1) inhibited not only tumor cell proliferation but also anchorage-independent growth of cancer cell lines.
CASC9,esophageal squamous cell carcinoma,"In addition, we confirmed another two upregulated lncRNAs that are differentially expressed in ESCC and that we have named ESCCAL-1, and ESCCAL-5."
ESCCAL-5,esophageal squamous cell carcinoma,"In addition, we confirmed another two upregulated lncRNAs that are differentially expressed in ESCC and that we have named ESCCAL-1, and ESCCAL-5."
ESRG,embryonal carcinoma,"HESRG was expressed strongly and diffusively in the nuclei of tumor cells in intracranial germinoma and embryonal  carcinoma as well as in human embryonic stem cells.In embryonal carcinoma, 6 of 9 showed intensive (3+) immunostaining and 3 of 9 showed moderate (2+) immunostaining."
ESRG,intracranial aneurysm,"HESRG was expressed strongly and diffusively in the nuclei of tumor cells in intracranial germinoma and embryonal  carcinoma as well as in human embryonic stem cells.In germinomas, 25 of 31 showed intensive (3+) expression, four cases showed moderate (2+) immunostaining  and the remaining 2 cases showed weak (1+) immunostaining."
FENDRR,heart failure,The tissue-specific lncRNA FENDRR is an essential regulator of heart and body wall development in the mouse.
FGF10-AS1,ventricular septal defects,"Furthermore, our established filtering pipeline indicated an association of two lncRNAs, ENST00000513542 and RP11-473L15.2, with VSD. "
FMR1-AS1,fragile X syndrome,Genomic context links lncRNAs to disease genes/loci and related pathways
FMR1-AS1,fragile X syndrome,A novel RNA transcript with antiapoptotic function is silenced in fragile X syndrome.
FMR1-AS1,fragile X syndrome,FMR4 is also silenced in FXS patients because of a CGG expansion repeat in the 5'-untranslated region (UTR) of the FMR1 gene and up regulated in pre-mutation carriers
FMR1-AS1,fragile X-associated tremor and ataxia syndrome,Genomic context links lncRNAs to disease genes/loci and related pathways
FMR5,fragile X syndrome,Comprehensive analysis of the transcriptional landscape of the human FMR1 gene reveals two new long noncoding RNAs differentially expressed in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome.
FMR5,fragile X-associated tremor and ataxia syndrome,Comprehensive analysis of the transcriptional landscape of the human FMR1 gene reveals two new long noncoding RNAs differentially expressed in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome.
FMR6,fragile X syndrome,Comprehensive analysis of the transcriptional landscape of the human FMR1 gene reveals two new long noncoding RNAs differentially expressed in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome.
FMR6,fragile X-associated tremor and ataxia syndrome,Comprehensive analysis of the transcriptional landscape of the human FMR1 gene reveals two new long noncoding RNAs differentially expressed in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome.
GAS5,autoimmune disease,Increased lncRNA GAS5 activity in immune cells could suppress GR-induced transcriptional activity and contribute to the development of autoimmune disease.
GAS5,B-cell neoplasms,"HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients."
GAS5,breast cancer,"GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer."
GAS5,breast cancer,GAS5 has also been linked with breast cancer because GAS5 transcript levels are significantly reduced compared to unaffected normal breast epithelia.
GAS5,breast cancer,"GAS5 lncRNA promoted the apoptosis of triple-negative and oestrogen receptor-positive cells but only dual PI3K/mTOR inhibition was able to enhance GAS5 levels in all cell types. Reduced GAS5 expression attenuates apoptosis induction by classical chemotherapeutic agents in breast cancer cells, providing an explanation for the relationship between GAS5 expression and breast cancer patient prognosis."
GAS5,cancer,"Pickard et al. showed that GAS5 promotes apoptosis of prostate cells after irradiation with UV, and low GAS5 expression therefore reduces the effectiveness of chemotherapeutic agents."
GAS5,kidney cancer,GAS5 is the tumour suppressor of kidney cancer
GAS5,lymphoma,"Chromosomal translocations affecting the 1q25 locus containing the GAS5 gene have been detected in melanoma, B-cell lymphoma, and prostate and breast cancer."
GAS5,lymphoma,The GAS5 (growth arrest-specific transcript 5) gene fuses to BCL6 as a result of t(1;3)(q25;q27) in a patient with B-cell lymphoma.
GAS5,melanoma,"Chromosomal translocations affecting the 1q25 locus containing the GAS5 gene have been detected in melanoma, B-cell lymphoma, and prostate and breast cancer."
GAS5,prostate cancer,Tumour suppressor; putative oncogene host 
GAS5,prostate cancer,"Chromosomal translocations affecting the 1q25 locus containing the GAS5 gene have been detected in melanoma, B-cell lymphoma, and prostate and breast cancer."
GAS5,systemic lupus erythematosus,"The GAS5 transcript has been linked with increased susceptibility to systemic lupus erythaematosus in mouse models, presumably as a result of its effect on the immunosuppressant role of glucocorticoids"
GAS5,cancer,"ANRIL, GAS5 and lincRNA-p23 are involved in the escape of growth suppression by regulating tumor suppressor genes (ANRIL) or apoptosis regulators."
GAS5,cancer,"Binding to GR as a decoy and blocking transcriptional induction by GR, induces growth arrest and apoptosis."
GAS5,cancer,"Our own work suggests that while RoR (Zhang et al., 2013a) may function as an oncogene through suppression of p53 in response to DNA damage, loc285194 (Liu et al., 2013) and GAS5 (Zhang et al., 2013b) may play a tumor suppressive role through the "" ompetitive endogenous RNA"" (CeRNA) mechanism (Salmena et al., 2011). "
GDNF-AS1,Alzheimer's disease,The findings of novel GDNF and GDNFOS isoforms and differences in tissue expression patterns dysregulated in AD brains may further reveal the role of endogenous GDNF in human brain diseases.
GHET1,gastric cancer,Long non-coding RNA GHET1 promotes gastric carcinoma cell proliferation by increasing c-Myc mRNA stability.
Gm12839,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 29 downregulated in HF hearts as compared with control hearts.
Bvht,cardiovascular disease,"Here, we identified Braveheart (Bvht), a heart-associated lncRNA in mouse. Using multiple embryonic stem cell (ESC) differentiation strategies, we show that Bvht is required for progression of nascent mesoderm toward a cardiac fate. "
Gm6644,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 12 downregulated in HF hearts as compared with control hearts.
GNAS-AS1,pseudohypoparathyroidism type Ib,Deletion of the nespas causes pseudohypoparathyroidism Type Ib.
H19,adrenocortical carcinoma,"This disease has been associated with structural abnormalities at the 11p15 locus, which harbors the IGF2 gene as well as the genes coding for insulin, H19, and p57kip2."
H19,atherosclerosis,The most pronounced differences of atherosclerotic plaques in DNA methylation levels were registered for a site which is located in CpG-island of imprinted gene H19.
H19,Beckwith-Wiedemann syndrome,Allelic methylation of H19 and IGF2 in the Beckwith-Wiedemann syndrome.
H19,Beckwith-Wiedemann syndrome,Epigenetic alterations of H19 and LIT1 distinguish patients with Beckwith-Wiedemann syndrome with cancer and birth defects.
H19,Beckwith-Wiedemann syndrome,Mosaicism for 11p15 UPD and hypermethylation of the H19 gene in blood cells were associated with an increased risk of tumour.
H19,Beckwith-Wiedemann syndrome,The H19 locus acts in vivo as a tumor suppressor.
H19,Beckwith-Wiedemann syndrome,Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome.
H19,hydatidiform mole,H19 is abnormally methylated on the maternal alleles in BiCHMs.
H19,bladder cancer,Prognostic marker low-risk marker  Oncogene  targeted therapy agent
H19,bladder cancer,"Control of imprinting breast, cervix, oesophagus prostate, endometrial, colon"
H19,bladder cancer,The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma.
H19,bladder cancer,A significantly decreased risk of bladder cancer was found for the rs2839698 TC genotype but not for CC homozygotes.The rs2839698 TC genotype was especially associated with a reduced risk of developing non-muscle-invasive disease. Borderline significantly
H19,bladder cancer,"An SNP polymorphism in the non-protein-encoding H19 gene is associated with a decreased risk of developing non-muscle-invasive bladder cancer. A significantly decreased risk of bladder cancer was found for the rs2839698 TC genotype, but not for CC homozygotes."
H19,bladder cancer,Bladder tumors may be successfully treated by intravesical instillation of the double promoter vector H19-DTA-P4-DTA.
H19,bladder cancer,The H19 non-coding RNA is essential for human tumor growth.
H19,bladder cancer,Theseguilty by association studies have found numerous bladder-cancer associated lncRNAs
H19,bladder cancer,Control of imprinting. Containing miRNA miR-675.
H19,bladder cancer,Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression.
H19,bladder cancer,Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression.
H19,breast cancer,"Down-regulation of H19 significantly decreases breast and lung cancer cell clonogenicity and anchorage-independent growth. In addition, c-Myc and H19 expression shows strong association in primary breast and lung carcinomas."
H19,breast cancer,H19 RNA and insulin-like growth factor II mRNA were up-regulated significantly in non-neoplastic WAP-CRD-BP mammary tissue.
H19,breast cancer,Overexpression of an ectopic H19 gene enhances the tumorigenic properties of breast cancer cells.
H19,breast cancer,the transcript is stabilized in breast cancer cells and overexpressed in human breast tumors.91H expression is upregulated in breast cancer.
H19,breast cancer,Different SNPs in LSP1 and H19 and in minor genes probably were associated with BC risk.
H19,breast cancer,"rs2107425 (C>T) near H19 was significantly associated with shorter metastasis-free survival in uni- and multi-variate analysis , with the more aggressive minor allele displaying a recessive trait."
H19,breast cancer,Control of imprinting. Containing miRNA miR-675.
H19,cancer,"H19 expression was found in the hepatic metastases of 64 of 80 patients. High expression (higher staining grades) of H19 in the metastases was found in 43 of 80 patients. However, H19 expression status in the hepatic metastases did not correlate with either the length of time to development of metastasis or overall survival."
H19,cancer,The human H19 gene is frequently overexpressed in myometrium and stroma during pathological endometrial proliferative events.
H19,cervical cancer,High incidence of loss of heterozygosity and abnormal imprinting of H19 and IGF2 genes in invasive cervical carcinomas.
H19,choriocarcinoma,Control of imprinting. Containing miRNA miR-675.
H19,chronic myeloproliferative disorders,Reduced expression of H19 in bone marrow cells from chronic myeloproliferative disorders.
H19,colon cancer,"DT-A was preferentially expressed in liver metastases after being transfected with H19 or IGF2-P3 promoter-driven DT-A expression plasmids, causing a very significant inhibition of tumor growth as a result of its cytotoxic effect."
H19,colon cancer,Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer.
H19,colon cancer,Regional therapy with DTA-H19 vector suppresses growth of colon adenocarcinoma metastases in the rat liver.
H19,colon cancer,Control of imprinting. Containing miRNA miR-675.
H19,congenital hyperinsulinism,"In agreement with the loss of the maternal chromosome, the level of expression of a maternally expressed tumor suppressor gene, H19, was greatly reduced compared to the level of expression of the paternally expressed growth promoter gene, IGF2."
H19,esophageal squamous cell carcinoma,Long non-coding RNA 91H contributes to the occurrence and progression of esophageal squamous cell carcinoma by inhibiting IGF2 expression.
H19,esophageal squamous cell carcinoma,Control of imprinting. Containing miRNA miR-675.
H19,gastric cancer,Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer.
H19,gastric cancer,"Using real-time RT-PCR, flow cytometry, RNA immunoprecipitation and other methods, Yang et al confirmed that H19 expression in gastric cancer accelerated cell proliferation."
H19,gastric cancer,"c-Myc-induced, long, noncoding H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer."
H19,germ cell tumor,IGF2/H19 methylation status in GCTs might reflect preservation of the physiologic imprinting erasure in PGCs rather than a loss of imprinting in a sense that is accepted for somatic tumors.
H19,gestational choriocarcinoma,Prominent expression of H19 was found in placental site trophoblastic tumor and gestational choriocarcinoma.
H19,gestational trophoblastic diseases,"LOI, deregulation of IGF2 promoters, and the altered expression levels of IGF2 and H19 genes might be associated with the progression of GTD."
H19,glioblastoma,"Another study performed in CD133+ and CD133- glioblastoma derived primary cell lines revealed levels of H19 expression that were relatively high and low, respectively."
H19,glioma,Epigenetic deregulation of lncRNAs genes is associated with disease
H19,glioma,Long non-coding RNA H19 promotes glioma cell invasion by deriving miR-675.
H19,growth restriction,A loss of methylation at H19.
H19,malignant hematopoiesis,Down-regulation of the IGF-2/H19 locus during normal and malignant hematopoiesis is independent of the imprinting pattern.
H19,hepatocellular carcinoma,Dysregulation and functional roles of lncRNAs in HCC
H19,hepatocellular carcinoma,We found that imbalances in levels of IGF2 and H19 transcripts were correlated with advanced tumor stage and poor outcome in HCC patients.
H19,hepatocellular carcinoma,The H19 non-coding RNA is essential for human tumor growth.
H19,hepatocellular carcinoma,Overexpression of H19 was found in hepatocellular carcinoma.
H19,hepatocellular carcinoma,Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma.
H19,hyperhomocysteinemia,The effect of hyperhomocysteinemia on H19 DMD methylation was tissue-specific. hyperhomocysteinemia produces tissue-specific changes in H19 DMD methylation and increased vascular expression of H19 in adult mice.
H19,infertility,H19 expression was lower in the infertility group as compared to the control group.
H19,kidney cancer,Tumour suppressor; tumour suppressor host
H19,liver cancer,H19 ICR showed loss-of-imprinting in two steps and allelic histone marker signature during tumorigenesis showed similarity with ES cells.
H19,liver cancer,"Control of imprinting breast, cervix, oesophagus prostate, endometrial, colon"
H19,liver cancer,Control of imprinting. Containing miRNA miR-675.
H19,lung cancer,"Down-regulation of H19 significantly decreases breast and lung cancer cell clonogenicity and anchorage-independent growth. In addition, c-Myc and H19 expression shows strong association in primary breast and lung carcinomas."
H19,lung cancer,"Control of imprinting breast, cervix, oesophagus prostate, endometrial, colon"
H19,lung cancer,Control of imprinting. Containing miRNA miR-675.
H19,Marek's disease,The mutant CVI/rpp38 was not only reactive with MAb H19 in IFA but also in immunoprecipitation.
H19,medulloblastoma,Epigenetic deregulation of lncRNAs genes is associated with disease
H19,medulloblastoma,A study of medulloblastomas and medulloblastoma cell lines showed partial loss of imprinting (LOI) and biallelic expression of H19.
H19,melanoma,"The study of 4 sensitive and 2 resistant cell lines allowed the identification of 4 genes (RCC1, IFI16, hox2 and h19) preferentially transcribed in sensitive ((IFN-alpha therapy) cells and 2 (SHB and PKC-zeta) preferentially expressed in resistant cells."
H19,melanoma,"Although the IGF2 and H19 genotypes/haplotypes were not significantly associated with melanoma, two of the most severe cases (very early onset or multiple melanomas) showed to be heterozygous for both genes."
H19,melanoma,H19 RNA downregulation stimulated melanogenesis in melasma.
H19,meningioma,Epigenetic deregulation of lncRNAs genes is associated with disease
H19,meningioma,An examination of meningiomas (World Health Organization grades I-III) demonstrated more robustly that the imprinting status of H19 is perturbed with LOI in a significant number of these tumors.
H19,Mullerian aplasia,Methylation of H19 and its imprinted control region (H19 ICR1) in Mullerian aplasia.
H19,myeloproliferative polycythaemia vera,Expression of the imprinted tumour-suppressor gene H19 is tightly regulated during normal haematopoiesis and is reduced in haematopoietic precursors of patients with the myeloproliferative disease polycythaemia vera.
H19,neural tube defects,"The methylation levels of H19 DMR1 in the NTD and control groups are 73.3%鍗?5.9 and 58.3%鍗?1.2, respectively. Hyper-methylation of the H19 DMR1 may be correlated with the occurrence of NTDs."
H19,neuroblastoma,Epigenetic deregulation of lncRNAs genes is associated with disease
H19,obesity,Insulin-like Growth Factor 2/H19 Methylation at Birth and Risk of Overweight and Obesity in Children.
H19,ovarian cancer,H19 RNA was detected in 90% of patients with OCAF (Ovarian cancer ascites fluid ) as determined by ISH. Intratumoral injection of DTA-H19 into ectopically developed tumors caused 40% inhibition of tumor growth.
H19,pheochromocytoma,"Tumor DNA from the index patient revealed loss of heterozygosity (LOH) at 11q23, causing loss of the wild-type paternal SDHD allele and LOH affecting maternal 11p15, including H19."
H19,pituitary adenoma,Epigenetic deregulation of lncRNAs genes is associated with disease
H19,Prader-Willi syndrome,Epigenetic deregulation of lncRNAs genes is associated with disease
H19,pre-eclampsia,"LOI of H19 can be identified in pre-eclamptic placentas and is associated with maternal blood pressures, which implies the involvement of H19 gene LOI in the pathogenesis of pre-eclampsia and its potential relationship with the severity of the disease."
H19,prostate cancer,Putative susceptibility and diagnostic marker
H19,Silver-Russell syndrome,The major finding (~44%) is a hypomethylation of the imprinting control region 1 (ICR1) in 11p15.5 affecting the expression of H19 and IGF2. 4-10% of the patients carry a maternal UPD of chromosome 7 (UPD(7)mat).
H19,Silver-Russell syndrome,Epigenetic mutations of the imprinted IGF2-H19 domain in Silver-Russell syndrome
H19,trophoblastic tumor,Prominent expression of H19 was found in placental site trophoblastic tumor and gestational choriocarcinoma.
H19,cancer,"In recent years, we have extensively investigated the expression of the H19 gene in a number of human cancers and explored the role of H19 RNA in tumor development."
H19,cancer,Oncofetal H19 RNA promotes tumor metastasis.
H19,cancer,"H19, a lncRNA with oncogenic properties, is upregulated in a wide range of tumours. "
H19,Beckwith-Wiedemann syndrome,Genetic analyses of the patient's blood showed hypermethylation at the H19 locus on chromosome 11p.
H19,Wilms' tumor,37% of patients with Wilms' tumor were H19 epimutations.
H19,Wilms' tumor,Gain of methylation at the H19 DMR is an early event in Wilms' tumorigenesis that is independent of chromosomal losses.
HAR1A,Alzheimer's disease,Schizophrenia spectrum disorders and AD have also been linked with the rheelin (RELN) gene and its antisense transcript HAR1
HAR1A,Huntington's disease,"HAR1, a deeply conserved genomic region consisting of a cis-antisense pair of structured lncRNAs (HAR1F and HAR1R) (2, 23) located ~80 kb from the neural microRNA, miR-124-3. HAR1 levels are significantly lower in the striatum of HD patients."
HAR1A,Huntington's disease,"HAR1 has also been implicated in HD, where the transcriptional repressor RE-1-silencing transcription factor (REST) enters pathologically into the nucleus, leading to the repression of several important neuronal genes."
HAR1A,schizophrenia,Schizophrenia spectrum disorders and AD have also been linked with the rheelin (RELN) gene and its antisense transcript HAR1
HAR1B,Alzheimer's disease,Schizophrenia spectrum disorders and AD have also been linked with the rheelin (RELN) gene and its antisense transcript HAR1
HAR1B,Huntington's disease,"HAR1, a deeply conserved genomic region consisting of a cis-antisense pair of structured lncRNAs (HAR1F and HAR1R) (2, 23) located ~80 kb from the neural microRNA, miR-124-3. HAR1 levels are significantly lower in the striatum of HD patients."
HAR1B,Huntington's disease,"HAR1 has also been implicated in HD, where the transcriptional repressor RE-1-silencing transcription factor (REST) enters pathologically into the nucleus, leading to the repression of several important neuronal genes."
HAR1B,schizophrenia,Schizophrenia spectrum disorders and AD have also been linked with the rheelin (RELN) gene and its antisense transcript HAR1
HCP5,AIDS,"A total of 245 HIV patients were included in the study. A good correlation between HLA-B*5701 and HCP5 was observed (negative and positive predictive values of 100% and 93%, respectively)."
HCP5,AIDS,"A polymorphism (rs2395029, G824T) in the HCP5 gene associated with HLA-B*5701 does not restrict HIV-1 in vitro."
HCP5,AIDS,HCP5 genotyping could serve as a simple screening tool for ABC-HSR.
HEIH,hepatocellular carcinoma,"Dr. Yang and his colleagues found that one lncRNA, named lncRNA-HEIH, was overexpressed in HCC tissue compared with normal liver tissues using microarray."
HIF1A-AS1,kidney cancer,The antitumor DNA topoisomerase I (Top1) inhibitor camptothecin (CPT) increases the cellular levels of two antisense lncRNAs at the 5' (5'aHIF-1 alpha) and 3' (3'aHIF-1 alpha) ends of the human HIF1A-AS1 gene.
HIF1A-AS1,kidney cancer,HIF1A-AS1 is Diagnostic and discriminative marker of kidney cancer
HIF1A-AS1,kidney cancer,overexpressed in human renal cancer and during hypoxia.
HIF1A-AS2,kidney cancer,HIF1A-AS2 is Diagnostic and discriminative marker of kidney cancer
LINC01370,type 2 diabetes mellitus,"Depletion of HI-LNC25, a β cell-specific lncRNA, downregulated GLIS3 mRNA, thus exemplifying a gene regulatory function of islet lncRNAs. Finally, selected islet lncRNAs were dysregulated in type 2 diabetes or mapped to genetic loci underlying diabetes susceptibility."
HLA-AS1,AIDS,"HIV-1 disease-influencing effects associated with ZNRD1, HCP5 and HLA-C alleles are attributable mainly to either HLA-A10 or HLA-B*57 alleles."
HLA-AS1,liver injury,HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin.
HLA-AS1,multiple sclerosis,"We identified significant effects on MS susceptibility of HLA-A*2 , and two coding polymorphisms in the MOG gene after full conditioning on HLA-DRB1."
HLA-AS1,psoriasis,HLA-Cw*0602 associates more strongly to psoriasis in the Swedish population than variants of the novel 6p21.3 gene PSORS1C3.
HNF1A-AS1,adenocarcinoma,Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells.
HNF1A-AS1,esophageal adenocarcinoma,Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells.
HOTAIR,B-cell neoplasms,"HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients."
HOTAIR,breast cancer,Epigenetically silences gene expression via LSD1/CoREST & PRC2; metastasis
HOTAIR,breast cancer,A subsequent study revealed that HOTAIR is overexpressed in approximately one quarter of human breast cancers.
HOTAIR,breast cancer,Elevated expression of HOTAIR is observed in primary and metastatic breast cancer.
HOTAIR,breast cancer,HOTAIR expression level in primary tumors is a powerful predictor of eventual metastasis and death.
HOTAIR,breast cancer,"HOTAIR is increased in expression in primary breast tumours and metastases, and HOTAIR expression level in primary tumours is a powerful predictor of eventual metastasis and death."
HOTAIR,breast cancer,HOTAIR showed positive association with 'hang Serum Response'.
HOTAIR,breast cancer,"Recently, augmented levels of HOTAIR in primary breast tumors were shown to correlate with breast cancer invasiveness and metastasis."
HOTAIR,breast cancer,The lncRNA HOTAIR is a strong predictor of metastasis in breast tumors and its over-expression in various breast carcinoma cell lines promotes invasion.
HOTAIR,breast cancer,"For example, HOTAIR is remarkably overexpressed in breast tumors and the expression of HOTAIR in primary breast tumors is a strong prognosis marker of patient outcomes such as metastasis and patient survival "
HOTAIR,breast cancer,"HOTAIR was proposed as a diagnostic marker in breast and colorectal cancer. Its depletion resulted in reduced invasiveness, and its expression level correlated with differentially regulated genes of the PRC2 complex."
HOTAIR,breast cancer,"In approximately one-quarter of human breast cancers, HOTAIR is highly induced, while its elevated levels are also predictive of metastasis and disease progression in other cancers, such as colon, colorectal, gastrointestinal, pancreatic and liver cancer."
HOTAIR,breast cancer,"Overexpression of the HOTAIR transcript, a cis-lncRNA associated with the HOXD gene cluster, has been associated with hepatocellular carcinoma [32], colorectal cancer [33] and breast cancer [13] by deregulation of HOXD cluster genes"
HOTAIR,breast cancer,"Recent studies have linked their mis-expression to diverse cancers (ANRIL: prostate cancer, XIST: female cancers, HOTAIR: breast cancer, KCNQ1OT3: colorectal cancer)."
HOTAIR,breast cancer,"The wellstudied lincRNA, HOTAIR, is highly expressed in breast cancer metastases, and its overexpression in various breast carcinoma cell lines promotes invasion"
HOTAIR,breast cancer,Gene silencing by interacting with PRC2 and LSD1/CoREST complexes.
HOTAIR,breast cancer,"On a more mechanistic level, recent studies have revealed the contribution of lncRNAs as proto-oncogenes, e.g. GAGE6, as tumor suppressor genes, e.g. 15 antisense RNA and lincP21' (36,91), as drivers of metastatic transformation, e.g. HOTAIR in breast cancer, and as regulators of alternative splicing, e.g. MALAT1"
HOTAIR,breast cancer,Gupta et al found that lncRNA HOTAIR overexpression was a strong predictor of breast tumor metastasis. 
HOTAIR,breast cancer,Gene silencing by interacting with PRC2 and LSD1/CoREST complexes.
HOTAIR,cancer,Epigenetically silences gene expression at many loci by recruitment of LSD1/CoREST/REST and PRC2 repressive chromatin modifying complexes. Oncogene: promotes tumour metastasis.
HOTAIR,cancer,Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis.
HOTAIR,cancer,HOTAIR is causally involved in tumor progression. It is significantly overexpressed in metastatic breast cancer.
HOTAIR,cancer,Overexpression of HOTAIR was found in breast and colon cancers and was associated with metastasis and poor prognosis.
HOTAIR,cancer,Long Non-coding RNA HOTAIR Is Targeted and Regulated by miR-141 in Human Cancer Cells.
HOTAIR,cancer,Forced expression of HOTAIR in epithelial cancer cells altered the localization of PRC2 on chromatin. Genome-wide studies revealed PRC2 localization more resembling occupancy in embryonic fibroblasts.
HOTAIR,cancer,HOTAIR overexpression has been linked to increased invasiveness and poorer outcomes in several human cancers.
HOTAIR,cancer,"HOTAIR overexpression is associated with poor prognosis in breast (Gupta et al. 2010), liver (Z. Yang et al. 2011), colorectal (Kogo et al. 2011), gastrointestinal (Niinuma et al. 2012), and pancreatic (Kim et al. 2012) cancers and is proposed to increase tumor invasiveness and metastasis (Gupta et al. 2010)."
HOTAIR,cancer,HOTAIR is overexpressed in various carcinomas including breast cancer. 
HOTAIR,cervical cancer,Overexpression of long noncoding RNA HOTAIR predicts a poor prognosis in patients with cervical cancer.
HOTAIR,colon cancer,"In approximately one-quarter of human breast cancers, HOTAIR is highly induced, while its elevated levels are also predictive of metastasis and disease progression in other cancers, such as colon, colorectal, gastrointestinal, pancreatic and liver cancer."
HOTAIR,colorectal cancer,"HOTAIR was proposed as a diagnostic marker in breast and colorectal cancer. Its depletion resulted in reduced invasiveness, and its expression level correlated with differentially regulated genes of the PRC2 complex."
HOTAIR,colorectal cancer,Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers.patients with high HOTAIR expression had a relatively poorer prognosis.
HOTAIR,colorectal cancer,"In approximately one-quarter of human breast cancers, HOTAIR is highly induced, while its elevated levels are also predictive of metastasis and disease progression in other cancers, such as colon, colorectal, gastrointestinal, pancreatic and liver cancer."
HOTAIR,colorectal cancer,"Overexpression of the HOTAIR transcript, a cis-lncRNA associated with the HOXD gene cluster, has been associated with hepatocellular carcinoma [32], colorectal cancer [33] and breast cancer [13] by deregulation of HOXD cluster genes"
HOTAIR,colorectal cancer,"HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients."
HOTAIR,endometrial cancer,Lentivirus-Mediated RNA Interference Targeting the Long Noncoding RNA HOTAIR Inhibits Proliferation and Invasion of Endometrial Carcinoma Cells In Vitro and In Vivo.
HOTAIR,endometrial cancer,The long non-coding RNA HOTAIR is upregulated in endometrial carcinoma and correlates with poor prognosis.
HOTAIR,ovarian cancer,Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer.
HOTAIR,esophageal squamous cell carcinoma,"Similarly, patients with high HOTAIR expression suffered a significantly poorer prognosis than those with low expression."
HOTAIR,esophageal squamous cell carcinoma,"The result showed that the expression levels of HOTAIR were upregulated in samples from patients with higher tumor burdens, which were defined as those with larger tumors, advanced clinical staging, increased lymph node tumor burdens and the presence of distant metastases."
HOTAIR,esophageal squamous cell carcinoma,"Expression of HOTAIR lncRNA is increased in various cancers, and it is also significantly increased in our analysis of ESCC."
HOTAIR,esophageal squamous cell carcinoma,"Upregulation of HOTAIR is associated with metastasis of gastric cancer, lung cancer, and esophageal squamous cell carcinoma."
HOTAIR,gastric cancer,"Upregulation of HOTAIR is associated with metastasis of gastric cancer, lung cancer, and esophageal squamous cell carcinoma."
HOTAIR,gastric cancer,Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer.
HOTAIR,gastrointestinal cancer,"In approximately one-quarter of human breast cancers, HOTAIR is highly induced, while its elevated levels are also predictive of metastasis and disease progression in other cancers, such as colon, colorectal, gastrointestinal, pancreatic and liver cancer."
HOTAIR,gastrointestinal cancer,Overexpression of HOTAIR was also strongly associated with high-risk grade and metastasis among GIST specimens.
HOTAIR,gastrointestinal cancer,Upregulation of miR-196a and HOTAIR drive malignant character in gastrointestinal stromal tumors.
HOTAIR,hepatocellular carcinoma,Dysregulation and functional roles of lncRNAs in HCC
HOTAIR,hepatocellular carcinoma,Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation.
HOTAIR,hepatocellular carcinoma,The HOTAIR gene was significantly overexpressed in HCC tissues compared with adjacent non-tumour tissues. Patients with high HOTAIR gene expression in their tumours had an increased risk of recurrence after hepatectomy.
HOTAIR,hepatocellular carcinoma,The high expression level of HOTAIR in HCC could be a candidate biomarker for predicting tumor recurrence in HCC patients who have undergone liver transplant therapy and might be a potential therapeutic target.
HOTAIR,hepatocellular carcinoma,Clinical significance of the expression of long non-coding RNA HOTAIR in primary hepatocellular carcinoma.
HOTAIR,hepatocellular carcinoma,"Overexpression of the HOTAIR transcript, a cis-lncRNA associated with the HOXD gene cluster, has been associated with hepatocellular carcinoma [32], colorectal cancer [33] and breast cancer [13] by deregulation of HOXD cluster genes"
HOTAIR,hepatocellular carcinoma,Long non-coding RNA HOTAIR promotes cell migration and invasion via down-regulation of RNA binding motif protein 38 in hepatocellular carcinoma cells.
HOTAIR,laryngeal squamous cell carcinoma,"Inspired observed that HOTAIR was higher expressed in primary LSCC than in adjacent noncancerous tissues. It is noteworthy that over-expression of HOTAIR was related to poor differentiation, lymph node metastasis, or advanced clinical stages of LSCC. The results suggested that HOTAIR promotes the malignant progression of LSCC."
HOTAIR,liver cancer,"In approximately one-quarter of human breast cancers, HOTAIR is highly induced, while its elevated levels are also predictive of metastasis and disease progression in other cancers, such as colon, colorectal, gastrointestinal, pancreatic and liver cancer."
HOTAIR,lung adenocarcinoma,"In this study, the lncRNA HOTAIR was upregualted in lung adenocarcinoma cells grown in 3-D cell culture supplemented with collagen."
HOTAIR,lung cancer,"Upregulation of HOTAIR is associated with metastasis of gastric cancer, lung cancer, and esophageal squamous cell carcinoma"
HOTAIR,nasopharyngeal carcinoma,"The result showed that, the expression levels of HOTAIR wereup-regulated in NPC tissues than in non-cancerous tissues. Further study demonstrated that HOTAIR was up-regulated in NPC cell lines with high invasive potential and the capacity for migration, invasion and proliferation was suppressed after knocking down HOTAIR expression."
HOTAIR,non-small cell lung cancer,Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer.
HOTAIR,esophageal squamous cell carcinoma,"Long non-coding RNA HOTAIR, a driver of malignancy, predicts negative prognosis and exhibits oncogenic activity in oesophageal squamous cell carcinoma."
HOTAIR,oral squamous cell carcinoma,"Subsequently, they confirmed that the expression levels of HOTAIR, NEAT-1 and UCA1 in metastasized samples was prominent higher than the non-metastatic samples."
HOTAIR,pancreatic cancer,"In approximately one-quarter of human breast cancers, HOTAIR is highly induced, while its elevated levels are also predictive of metastasis and disease progression in other cancers, such as colon, colorectal, gastrointestinal, pancreatic and liver cancer."
HOTAIR,rheumatoid arthritis,PBMC and exosome-derived HOTAIR is a critical regulator and potent marker for rheumatoid arthritis.
HOTAIR,small cell lung cancer,"Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer."
HOTAIR,cancer,"Expression of the long non-coding RNAs MEG3, HOTAIR, and MALAT-1 in non-functioning pituitary adenomas and their relationship to tumor behavior."
HOTAIR,cancer,"HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients."
HOTTIP,hepatocellular carcinoma,"Currently, upregulated HOTTIP and HOXA13 expressions were associated with the prognosis and progression of the hepatocellular carcinoma (HCC). "
HOTTIP,hepatocellular carcinoma,Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
HOTTIP,hepatocellular carcinoma,lncRNA HOTTIP / HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
HTT-AS,Huntington's disease,"Levels of HTTAS_v1 are  reduced in human HD frontal cortex. In cell systems, overexpression of HTTAS_v1 specifically reduces endogenous HTT transcript levels, while siRNA knockdown of HTTAS_v1 increases HTT transcript levels."
HTTAS_v1,Huntington's disease,Long ncRNA HTTAS_v1 is regulating the expression of Hungtiontonin (HTT) and is potentially involved in the development of HD. 
HULC,hepatic colorectal metastasis,"HULC expression is not confined to HCC, but also to those colorectal carcinomas that metastasize to the liver."
HULC,hepatocellular carcinoma,Dysregulation and functional roles of lncRNAs in HCC
HULC,hepatocellular carcinoma,"Here we focus on two best-characterized lncRNAs-HULC and LALR, which can impact proliferation through targeting various key regulators in different pathways."
HULC,hepatocellular carcinoma,"A lncRNA, highly upregulated in liver cancer (HULC), was found to contribute to tumorigenesis of HCC."
HULC,hepatocellular carcinoma,"A similar genome-wide differential expression screen in hepatocellular carcinoma (HCC) has uncovered another cancer-associated lncRNA, Highly Upregulated in Liver Cancer, or HULC."
HULC,hepatocellular carcinoma,Highly up-regulated in liver cancer.
HULC,hepatocellular carcinoma,"Long non-coding RNA (lncRNA), highly up-regulated in liver cancer (HULC) plays an important role in tumorigenesis. Depletion of HULC resulted in a significant deregulation of several genes involved in liver cancer. Although up-regulation of HULC expression."
HULC,hepatocellular carcinoma,The lncRNA HULC is one of the most upregulated of all genes in hepatocellular carcinoma.
HULC,hepatocellular carcinoma,"Moreover, HULC correlated with upregulated hepatitis B virus X protein (HBx) that importantly contributes to HCC and that was able to promote HULC expression. The HULC-mediated downregulation of the tumor suppressor p18 supported the HCC proliferation."
HULC,liver cancer,"PCGEM1, PCA3 (prostate cancer antigen 3, known also as DD3, differential display code 3) and PCNCR1 (prostate cancer ncRNA 4) are involved in prostate cancer, while HULC (highly up-regulated in liver cancer) is involved with liver cancer."
HULC,liver cancer,"The highly upregulated lncRNA HULC in liver cancer was found in the blood of HCC patients, promising a potential biomarker. "
HYMAI,transient neonatal diabetes mellitus,"In TNDM fibroblasts, the monoallelic expression of both ZAC and HYMAI is relaxed, providing strong supportive evidence that the presence of two unmethylated alleles of this locus is indeed associated with the inappropriate gene expression of neighbouring genes."
IFNG-AS1,multiple sclerosis,Tmevpg1 (IFNG-AS1) is another lncRNA that may be involved in MS.
IGF2-AS,hepatocellular carcinoma,IGF-IR and IGF-IIR antisense genes could significantly restrain the malignant behavior of human hepatoma cells and might be useful in investigating a potential route for hepatocellular carcinoma gene therapy.
IGF2-AS,prostate cancer,Association identified by GWAS.
IGF2-AS,type 1 diabetes mellitus,Association identified by GWAS.
IGF2-AS,Wilms' tumor,Loss of imprinting of IGF2 sense and antisense transcripts in Wilms' tumor.
IGF2-AS,Wilms' tumor,"PEG8/IGF2AS and IGF2 were found to be overexpressed in Wilms' tumor samples, at levels over ten and a hundred times higher than that in normal kidney tissues neighboring the tumors, respectively."
IPW,Prader-Willi syndrome,"The Prader-Willi syndrome (PWS) is caused by genomic alterations that inactivate imprinted, paternally expressed genes in human chromosome region 15q11-q13. IPW, a paternally expressed gene cloned from this region, is not expressed in individuals with PWS."
IPW,Prader-Willi syndrome,IPW (Imprinted gene in the Prader-Willi syndrome region) was isolated using the direct selection method and yeast artificial chromosomes localized to the deletion region. the mRNA product of IPW may play a role in the imprinting process.
IPW,Prader-Willi syndrome,Genetic variation in lncRNA genes causes disease and influences susceptibility
IPW,Prader-Willi syndrome,"Subsequently, we determined that IPW, along noncoding RNAin the critical region of the PWS locus, is a regulator of the DLK1-DIO3 region, as its overexpression in PWS and parthenogenetic iPSCs resulted in downregulation of MEGs in this locus."
Kcna2 antisense RNA,neuropathic pain,A long noncoding RNA contributes to neuropathic pain by silencing Kcna2 in primary afferent neurons.
KCNQ1DN,aging,Continuously hypermethylated upon aging.
KCNQ1DN,Wilms' tumor,"A novel imprinted gene, KCNQ1DN, within the WT2 critical region of human chromosome 11p15.5 and its reduced expression in Wilms' tumors."
KCNQ1OT1,Beckwith-Wiedemann syndrome,"In Beckwith-Wiedemann syndrome (BWS), approximately 50% of patients show loss of DNA methylation accompanied by loss of histone H3 Lys9 dimethylation on maternal KCNQ1OT-DMR, namely an imprinting disruption, leading to diminished expression of CDKN1C."
KCNQ1OT1,Beckwith-Wiedemann syndrome,The 5'end of the KCNQ1OT1 gene is hypomethylated in the Beckwith-Wiedemann syndrome.
KCNQ1OT1,Beckwith-Wiedemann syndrome,"In the human and mouse BWS imprinting regions, two major elements for regulation of imprinted gene expression have been identified athe imprinting centers IC1 and IC2.IC2 appears to be the promoter of the paternally expressed probably noncoding transcript."
KCNQ1OT1,Beckwith-Wiedemann syndrome,KvDMR1 and/or its associated antisense RNA (KvLQT1-AS) represents an additional imprinting control element or center in the human 11p15.5 and mouse distal 7 imprinted domains.
KCNQ1OT1,Beckwith-Wiedemann syndrome,"The LIT1 CpG island can act as a negative regulator in cis for coordinate imprinting at the centromeric domain, thereby suggesting a role for the LIT1 locus in a BWS pathway leading to functional inactivation of p57(KIP2)."
KCNQ1OT1,Beckwith-Wiedemann syndrome,In vitro fertilization may increase the risk of Beckwith-Wiedemann syndrome related to the abnormal imprinting of the KCN1OT gene.
KCNQ1OT1,Beckwith-Wiedemann syndrome,LIT1 (KCNQ1OT1) may play a role in Beckwith-Wiedemann syndrome.
KCNQ1OT1,Beckwith-Wiedemann syndrome,Epigenetic deregulation of lncRNAs genes is associated with disease
KCNQ1OT1,colorectal cancer,KCNQ1OT1 has epigenetic disruption in colorectal cancer
KCNQ1OT1,colorectal cancer,"Recent studies have linked their mis-expression to diverse cancers (ANRIL: prostate cancer, XIST: female cancers, HOTAIR: breast cancer, KCNQ1OT4: colorectal cancer)."
KCNQ1OT1,hepatocellular carcinoma,A novel tetranucleotide repeat polymorphism within KCNQ1OT1 confers risk for hepatocellular carcinoma.
KCNQ1OT1,kidney cancer,KCNQ1OT1 is the oncogene of kidney cancer
KRAS1P,cancer,"Similarly, KRAS and KRAS1P transcript levels were found to be positively correlated, corroborating that pseudogene functions mirror the role of their cognate genes as explained by the miRNA decoy mechanism."
LINC00850,Duchenne muscular dystrophy,Molecular characterization of an X(p21.2;q28) chromosomal inversion in a Duchenne muscular dystrophy patient with mental retardation reveals a novel long non-coding gene on Xq28
LINC00850,Duchenne muscular dystrophy,"KUCG1 is a 648-bp nuclear lncRNA expressed in a tissue specific manner. Since it is normally expressed in the brain, its deregulation could contribute to the neurological impairment of the patient as already reported for other pathologies."
LALR,hepatocellular carcinoma,"Here we focus on two best-characterized lncRNAs-HULC and LALR, which can impact proliferation through targeting various key regulators in different pathways."
LINC00032,melanoma,"An analysis of genome-wide DNA copy number alterations in melanoma tumors revealed the loss of the C9orf14 locus, located proximal to CDKN2A, in approximately one-fourth of tumors."
PICSAR,narcolepsy,Association identified by GWAS.
LINC00271,schizophrenia,This gene is associated with susceptibility to schizophrenia.
LINC00271,type 2 diabetes mellitus,Association identified by GWAS.
LINC00299,intellectual and developmental disability,Genetic variation in lncRNA genes causes disease and influences susceptibility
LINC00312,nasopharyngeal carcinoma,NAG-7 is a novel gene downregulated in human nasopharyngeal carcinoma.
LINC00312,nasopharyngeal carcinoma,NAG7 (LINC00312) gene re-expression could inhibit overproliferation of NPC cell by delaying the progression of G1 into S in cell cycle and inducing cell apoptosis.
LINC00312,nasopharyngeal carcinoma,NAG7 (LINC00312) promotes human nasopharyngeal carcinoma invasion through inhibition of estrogen receptor alpha and up-regulation of JNK2/AP-1/MMP1 pathways.
LINC00312,nasopharyngeal carcinoma,"Expression of LINC00312, a long intergenic non-coding RNA, is negatively correlated with tumor size but positively correlated with lymph node metastasis in nasopharyngeal carcinoma."
LINC00963,prostate cancer,"Linc00963: a novel, long non-coding RNA involved in the transition of prostate cancer from androgen-dependence to androgen-independence."
LINC01262,Parkinson's disease,"These included the U1 spliceosomal lncRNA and RP11-462G22.1, each entailing sequence complementarity to numerous microRNAs."
LINCMD1,Duchenne muscular dystrophy,"Interestingly, the levels of linc-MD1 are strongly reduced in primary myoblasts of DMD patients and its ectopic expression rescues the myogenic differentiation potential of these cells, restoring the correct expression pattern of MAML1, MEF2C, MYOG and MHC. "
lincRNA-p21,lung cancer,"lincRNAp21 is required for the global repression of genes that interfere with p53 function regulating cellular apoptosis. lincRNAp21 can mediate gene repression by physically interacting with the protein hnRNP-K, allowing its localization to promoters of genes to be repressed in a p53-dependent manner, and its overexpression in a lung cancer cell line sensitizes the cells to DNA"
lincRNA-p21,cancer,"Global gene repression in the p53 transcriptional response by binding hnRNP-K, inducing cellular apoptosis."
lincRNA-p21,cancer,"Thus, similar to its activator p53, lincRNA-p21 may play an important role in tumour suppression by operating as a transcriptional repressor."
LIPCAR,heart failure,"Circulating Long Noncoding RNA, LIPCAR, Predicts Survival in Patients With Heart Failure.The mitochondrial long noncoding RNA uc022bqs.1 (LIPCAR) was downregulated early after myocardial infarction but upregulated during later stages. LIPCAR levels identified patients developing cardiac remodeling and were independently to other risk markers associated with future cardiovascular deaths."
lnc-AL355149.1-1,nasopharyngeal carcinoma,"Results. In primary NPC, upregulation of lnc-C22orf32-1, lnc-AL355149.1-1, and lnc-ZNF674-1 was observed. High levels of lnc-C22orf32-1 and lnc-AL355149.1-1 were significantly associated with the male patients"
LINC01315,nasopharyngeal carcinoma,"Results. In primary NPC, upregulation of lnc-C22orf32-1, lnc-AL355149.1-1, and lnc-ZNF674-1 was observed. High levels of lnc-C22orf32-1 and lnc-AL355149.1-1 were significantly associated with the male patients"
lncRNA-ATB,hepatocellular carcinoma,"Thus, these findings suggest that lncRNA-ATB, a mediator of TGF-β1 signaling, could predispose HCC patients to metastases and may serve as a potential target for antimetastatic therapies."
LncRNA-LALR1,liver cancer,LncRNA-LALR1 accelerates hepatocyte proliferation during liver regeneration by activating Wnt/β1-Catenin signaling
NPTN-IT1,cancer,"Aberrant Expression of lncRNA-LET in Tumor Tissue. In this study, we found that the lncRNA Low Expression in Tumor (lncRNA-LET) was generally downregulated in hepatocellular carcinomas, colorectal cancers, and squamous-cell lung carcinomas. "
lncRNA-MVIH,hepatocellular carcinoma,Dr. Yuan et al. found that lncRNA-MVIH could promote tumor growth and intrahepatic metastasis by contributing to active angiogenesis both in vitro and in vivo through the inhibition of phosphoglycerate kinase 1 (PGK1) secretion
lncRNA-MVIH,hepatocellular carcinoma,Yuan et al discovered that the lncRNA MVIH (long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma) was overexpressed in hepatocellular carcinoma. 
lncRNA-MVIH,non-small cell lung cancer,Long non-coding RNA MVIH indicates a poor prognosis for non-small cell lung cancer and promotes cell proliferation and invasion.
lnc-ZNF674-1,nasopharyngeal carcinoma,"Results. In primary NPC, upregulation of lnc-C22orf32-1,lnc-AL355149.1-1, and lnc-ZNF674-1 was observed. High levels of lnc-C22orf32-1 and lnc-AL355149.1-1 were significantly associated with the male patients"
LOC102635190,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 11 downregulated in HF hearts as compared with control hearts.
LOC389023,psychiatric disease,"Examples of recently discovered chromatin-bound long non-coding RNAs important for neuronal health and function include the brain-derived neurotrophic factor antisense transcript (Bdnf-AS) which regulates expression of the corresponding sense transcript, and LOC389023 which is associated with human-specific histone methylation signatures at the chromosome 2q14.1 neurodevelopmental risk locus by regulating expression of DPP10, an auxillary subunit for voltage-gated K(+) channels."
LOC554202,breast cancer,Long non-coding RNA Loc554202 regulates proliferation and migration in breast cancer cells.
LOC728606,prostate cancer,"The most highly up-regulated transcript was LOC728606, a lncRNA now designated PCAT18. PCAT18 is specifically expressed in the prostate compared to 11 other normal tissues (p<0.05) and up-regulated in PCa compared to 15 other neoplasms (p<0.001)."
TUSC7,osteosarcoma,These CNAs (copy number alterations) in osteosarcoma often involve the noncoding RNAs LOC285194 and BC040587.
LSINCT5,breast cancer,LSINCT5 is overexpressed in breast and ovarian cancer cell lines and tumor tissues.
LSINCT5,breast cancer,"Ovarian and breast tumours have also been associated with the expression of the LSINCT5 lncRNA; this transcript acts to target several other transcripts, including the antisense RNA NEAT-1 and the PSPC1 gene, which codes for a splicing regulatory factor"
LSINCT5,ovarian cancer,LSINCT5 is overexpressed in breast and ovarian cancer cell lines and tumor tissues.
LSINCT5,ovarian cancer,"Ovarian and breast tumours have also been associated with the expression of the LSINCT5 lncRNA; this transcript acts to target several other transcripts, including the antisense RNA NEAT-1 and the PSPC1 gene, which codes for a splicing regulatory factor"
MALAT1,B-cell neoplasms,"HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients."
MALAT1,bladder cancer,MALAT1 is the oncogene of bladder cancer
MALAT1,bladder cancer,Theseguilty by association studies have found numerous bladder-cancer associated lncRNAs
MALAT1,breast cancer,"On a more mechanistic level, recent studies have revealed the contribution of lncRNAs as proto-oncogenes, e.g. GAGE6, as tumor suppressor genes, e.g. 15 antisense RNA and lincP21' (36,91), as drivers of metastatic transformation, e.g. HOTAIR in breast cancer, and as regulators of alternative splicing, e.g. MALAT1"
MALAT1,breast cancer,Sequesters SR splicing factors to regulate alternative splicing.
MALAT1,breast cancer,"invasion & metastasis pancreas, colon, prostate liver, cervix, neuroblastoma osteosarcoma"
MALAT1,cancer,MALAT1 is a highly conserved long ncRNA originally identified as a transcript overexpressed in many cancers.
MALAT1,cancer,"The expression of the long ncRNA MALAT1 correlates with tumor development, progression or survival in lung, liver and breast cancer."
MALAT1,cancer,MALAT1 is upregulated in several cancer types and its overexpression has been linked to an increase in cell proliferation and migration in lung and colorectal cancer cells.
MALAT1,cancer,"They found that MALAT1 did not alter alternative splicing but rather actively regulated gene expression including a set of metastasis-associated genes. Consequently, MALAT1-deficient cells were impaired in migration and formed fewer tumor nodules in mouse xenograft. Antisense oligonucleotides (ASO) that block MALAT1 prevented metastasis formation after tumor implantation."
MALAT1,cancer,"MALAT1 (metastasis-associated lung adenocarcinoma transcript 1),another lncRNA associated with various cancers and metastasis (Ji et al. 2003; Lin et al. 2011), is found to affect the transcriptional and post-transcriptional regulation of cytoskeletal and extracellular matrix genes."
MALAT1,cervical cancer,"MALAT1 was involved in cervical cancer cell growth, cell cycle progression, and invasion through the regulation of gene expression, such as caspase-3, -8, Bax, Bcl-2, and BclxL."
MALAT1,cervical cancer,"Overexpressed MALAT1 was found in many solid tumors such as lung cancer, cervical cancer, and HCC."
MALAT1,colon cancer,Sequesters SR splicing factors to regulate alternative splicing.
MALAT1,colorectal cancer,The 3' end of MALAT-1 is an important biological motif in the invasion and metastasis of CRC cells.
MALAT1,decreased myogenesis,The myostatin-induced inhibition of the long noncoding RNA MALAT1 is associated with decreased myogenesis.
MALAT1,diabetes mellitus,"In addition, MALAT1, a conserved lncRNA, was significantly upregulated in an RF/6A cell model of hyperglycemia, in the aqueous humor samples, and in fibrovascular membranes of diabetic patients."
MALAT1,endometrial cancer,MALAT-1 gene is one of the major genes upregulated in ESS.
MALAT1,gallbladder cancer,MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway.
MALAT1,hepatocellular carcinoma,Dysregulation and functional roles of lncRNAs in HCC
MALAT1,hepatocellular carcinoma,"HCC and HPBL have clearly different patterns of gene expression, with genes IGF2, Fibronectin, DLK1, TGFb1, MALAT1 and MIG6 being over-expressed in HPBL versus HCC"
MALAT1,hepatocellular carcinoma,"HCC and HPBL have clearly different patterns of gene expression, with genes IGF2, Fibronectin, DLK1, TGFb1, MALAT1 and MIG6 being over-expressed in HPBL versus HCC."
MALAT1,hepatocellular carcinoma,Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation.
MALAT1,hepatocellular carcinoma,"Quantitative analyses indicated a 6-7-fold increased RNA level in HCCs versus uninvolved liver, advancing this as a molecule of interest."
MALAT1,hepatocellular carcinoma,"We conducted a case-control study and genotyped two SNPs, rs7763881 in HULC and rs619586 in MALAT1 Furthermore, the variant genotypes of rs619586 was associated with decreased HCC risk with a borderline significance."
MALAT1,hepatocellular carcinoma,"Overexpressed MALAT1 was found in many solid tumors such as lung cancer, cervical cancer, and HCC."
MALAT1,kidney cancer,MALAT1 is the oncogene of kidney cancer
MALAT1,laryngeal squamous cell carcinoma,The result suggested that the MALAT1 was up-regulated in primary LSCC compared with adjacent non-cancerous tissues.
MALAT1,liver cancer,Sequesters SR splicing factors to regulate alternative splicing.
MALAT1,liver cancer,"Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, MALAT1-induced tumourigenesis in liver cancer."
MALAT1,lung adenocarcinoma,Metastasis associated lung adenocarcinoma transcript 1 is up-regulated in placenta previa increta/percreta and strongly associated with trophoblast-like cell invasion in vitro.
MALAT1,lung cancer,MALAT-1 is a novel class of non-coding RNA that promotes cell motility of lung adenocarcinoma cells through transcriptional and post-transcriptional regulation of motility related gene expression.
MALAT1,lung cancer,"Overexpressed MALAT1 was found in many solid tumors such as lung cancer, cervical cancer, and HCC."
MALAT1,lung cancer,"MALAT1, also known as NEAT2 (nuclear-enriched abundant transcript 2), was initially discovered as a predictive biomarker for metastasis development in lung cancer."
MALAT1,lung cancer,Sequesters SR splicing factors to regulate alternative splicing.
MALAT1,lung cancer,The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells.
MALAT1,lung cancer,"invasion & metastasis pancreas, colon, prostate liver, cervix, neuroblastoma osteosarcoma"
MALAT1,nasopharyngeal carcinoma,"The result found that MALAT1 was most highly expressed in 5-8F cells (high rate to be tumor and metastasis), and up-regulated in CNE-2, C666-1 and HONE-1 which is higher malignant and poorly differentiated nasopharyngeal squamous cell carcinoma, while least expressed in NP69 epithelial cells of the eternal life. The data indicated that MALAT1 might be related to the metastasis and differentiation of NPC cells."
MALAT1,neuroblastoma,We identified a shorter transcriptional initiation site and found that CREB binds to the defined proximal promoter of the MALAT1 gene. The expression of the tumor marker MALAT1 ncRNA is sensitive to cell surface receptor activation by oxytocin in a neuroblastoma cell line.
MALAT1,non-small cell lung cancer,"In NSCLC metastasizing tumors, MALAT-1 expression is three-fold higher than in non-metastasizing tumors. Furthermore, in patients with stage I disease, MALAT-1 expression is closely correlated with poor prognosis."
MALAT1,non-small cell lung cancer,"Increased expression of the lncRNA MALAT-1 has been observed in several types of tumors, including metastatic non-small cell lung cancer."
MALAT1,non-small cell lung cancer,"Specific lncRNAs can serve as predictors of tumor outcome, as shown with the expression of the lncRNA MALAT-1 in early-stage non-small cell lung cancer."
MALAT1,non-small cell lung cancer,The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth.
MALAT1,non-small cell lung cancer,"MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer."
MALAT1,non-small cell lung cancer,lncRNA-associated disruption to alternative splicing has also been reported in non-small cell lung cancer by virtue of overexpression of MALAT1
MALAT1,osteosarcoma,Osteosarcoma patients' survival is significantly associated with MALAT-1 expression levels.
MALAT1,osteosarcoma,Sequesters SR splicing factors to regulate alternative splicing.
MALAT1,pancreatic cancer,Sequesters SR splicing factors to regulate alternative splicing.
MALAT1,prostate cancer,MALAT1 is the putative marker of prostate cancer
MALAT1,prostate cancer,Sequesters SR splicing factors to regulate alternative splicing.
MALAT1,small cell lung cancer,"For other LncRNAs, specific targets have yet to be identified. This is the case of MALAT1, a LncRNA whose expression is three times higher in metastasizing early-stage non-small cell lung cancer vs. non-metastasizing tumours"
MALAT1,TDP-43-associated pathological states,"Biogenesis, metabolism, and functions of lncRNAs are otherwise interconnected with known pathogenic mechanisms"
MALAT1,cancer,"Expression of the long non-coding RNAs MEG3, HOTAIR, and MALAT-1 in non-functioning pituitary adenomas and their relationship to tumor behavior."
MALAT1,cancer,"MALAT1 plays a role in cell migration and tumor metastasis, as demonstrated by knockout of MALAT1 in lung cancer cell lines (Gutschner et al., 2013). "
MALAT1,uterus cancer,Sequesters SR splicing factors to regulate alternative splicing.
MALAT1,uterus cancer,"invasion & metastasis pancreas, colon, prostate liver, cervix, neuroblastoma osteosarcoma"
MAP3K14,pancreatic ductal adenocarcinoma,MAP3K14 differentially express in pancreatic ductal adenocarcinoma
MEG3,acute myeloid leukemia,"MEG3 hypermethylation occurred in 15 MDS patients (34.9%), and in 20 AML patients (47.6%)."
MEG3,bladder cancer,MEG3 is the tumour suppressor of bladder cancer
MEG3,bladder cancer,MEG3 expression is lost.
MEG3,bladder cancer,Theseguilty by association studies have found numerous bladder-cancer associated lncRNAs
MEG3,bladder cancer,Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer.
MEG3,breast cancer,MEG3 expression is lost.
MEG3,cancer,A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells.
MEG3,cancer,MEG3 could represent a tumor suppressor gene located in chromosome 14q32 and its association with tumorigenesis is growing every day.
MEG3,cancer,MEG3 functions as a novel lncRNA tumor suppressor.
MEG3,chronic myeloid leukemia,MEG3 expression is lost.
MEG3,colon cancer,MEG3 expression is lost.
MEG3,gastric cancer,Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer.
MEG3,gastric cancer,Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer.
MEG3,glioma,Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation.
MEG3,hepatocellular carcinoma,Braconi et al. found that the expression of maternally expressed gene 3 (MEG3) is markedly reduced in four human HCC cell lines compared with normal hepatocytes and enforced expression of MEG3 in HCC cells significantly induce apoptosis. 
MEG3,hepatocellular carcinoma,"Enforced expression of MEG3 in HCC cells significantly decreased both anchorage-dependent and -independent cell growth, and induced apoptosis. Methylation-dependent tissue-specific regulation of the lncRNA MEG3 by miR-29a may contribute to HCC growth."
MEG3,hepatocellular carcinoma,"Expression of MEG3 in tumor cells results in growth suppression, p53 protein increase, and activation of p53 downstream targets."
MEG3,drug abuse,Intriguingly a genome-wide association study has implicated MEG3 in the vulnerability to heroin addiction.
MEG3,Huntington's disease,"LncRNAs TUG1 (necessary for retinal development), and NEAT-1 (a structural component of nuclear paraspeckles) are upregulated in HD caudate, while the brain-specific tumor-suppressor MEG3 is downregulated in HD."
MEG3,kidney cancer,MEG3 is the tumour suppressor of kidney cancer
MEG3,lung cancer,MEG3 expression is lost.
MEG3,meningioma,"Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression."
MEG3,meningioma,MEG3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas.
MEG3,myelodysplastic syndrome,"MEG3 hypermethylation occurred in 15 MDS patients (34.9%), and in 20 AML patients (47.6%)."
MEG3,neuroblastoma,MEG3-DMR is completely methylated in neuroblastoma cell lines.
MEG3,pituitary adenoma,"Maternally Expressed Gene 3 (MEG3), which is specifically associated with clinically non-functioning pituitary adenomas of a gonadotroph lineage."
MEG3,pituitary adenoma,Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors.
MEG3,pituitary adenoma,Selective loss of MEG3 expression and intergenic differentially methylated region hypermethylation in the MEG3/DLK1 locus in human clinically nonfunctioning pituitary adenomas.
MEG3,pituitary adenoma,The DLK1-MEG3 locus is silenced in NFAs (nonfunctioning adenomas). The DLK1-MEG3 locus plays a tumor suppressor role in human NFAs.
MEG3,pituitary adenoma,"Another potential angiogenic lncRNA, Maternally expressed gene 3 (MEG3) was found to be silenced in pituitary adenomas."
MEG3,prostate cancer,MEG3 expression is lost.
MEG3,cancer,"Expression of the long non-coding RNAs MEG3, HOTAIR, and MALAT-1 in non-functioning pituitary adenomas and their relationship to tumor behavior."
MEG3,type 2 diabetes mellitus,The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes.
MESTIT1,Silver-Russell syndrome,MESTIT1 is associated with Silver-Russell syndrome
MIAT,cancer,Another lncRNA serving as oncogene is retinal noncoding RNA 2 (RNCR2).
MIAT,drug abuse,"MIAT turned out to be one of the top twenty-five, of nearly 39,000, transcripts differentially expressed in the nucleus accumbens,a midbrain region pivotal in drug abuse, in a case-control study of human heroin and cocaine abusers."
MIAT,drug abuse,The lncRNA MIAT is upregulated in heroin abusers.
MIAT,myocardial infarction,MIAT lincRNA Variants Confer Susceptibility to Myocardial Infarction
MIAT,myocardial infarction,The altered expression of MIAT by the SNP may play some role in the pathogenesis of MI.
MIAT,myocardial infarction,"In vitro functional analyses revealed that the minor variant of one SNP in exon 5 increased transcriptional level of MIAT. Moreover, unidentified nuclear protein(s) bound more intensely to risk allele than non-risk allele. These results indicate that the altered expression of MIAT by the SNP may play some role in the pathogenesis of MI."
MIAT,myocardial infarction,SNPs associated with myocardial infarction localized to a haplotype block that encompassed the last 3 exons of MIAT.
MIAT,myocardial infarction,"A myocardial infarction-associated transcript (MIAT), also known as RNCR2 or Gomafu, is a long intergenic non-coding RNA that presents many genetic variants implicated in different processes. A large scale case-control association study regarding cardiovascular disease demonstrates that a MIAT variant (rs2301523) confers susceptibility to myocardial infarction."
MIAT,schizophrenia,"Finally, we show that Gomafu is downregulated in post-mortem cortical gray matter from the superior temporal gyrus in SZ. "
MINA,esophageal squamous cell carcinoma,"Dysfunction of MDIG was found in several types of solid cancers including gastric carcinoma, esophageal squamous cell carcinoma, and lung cancer. Overexpression of MDIG was observed in hepatocellular carcinoma."
MINA,gastric cancer,"Dysfunction of MDIG was found in several types of solid cancers including gastric carcinoma, esophageal squamous cell carcinoma, and lung cancer. Overexpression of MDIG was observed in hepatocellular carcinoma."
MINA,hepatocellular carcinoma,"Dysfunction of MDIG was found in several types of solid cancers including gastric carcinoma, esophageal squamous cell carcinoma, and lung cancer. Overexpression of MDIG was observed in hepatocellular carcinoma."
MINA,lung cancer,"Dysfunction of MDIG was found in several types of solid cancers including gastric carcinoma, esophageal squamous cell carcinoma, and lung cancer. Overexpression of MDIG was observed in hepatocellular carcinoma."
MIR100HG,myopia,LOC399959 was identified within a 200-kb DNA encompassing rs577948.
MIR155HG,chronic lymphocytic leukemia,MYB transcriptionally regulates the miR-155 host gene in chronic lymphocytic leukemia.
MIR17HG,cancer,Aurora kinase A induces miR-17-92 cluster through regulation of E2F1 transcription factor.
MIR17HG,lymphoma,C13orf25 (MIR17HG) is a target for 13q31-q32 amplification in malignant lymphoma.
MIR17HG,syndromic developmental defect,"Here we report the identification of germline hemizygous deletions of MIR17HG, encoding the miR-17~92 polycistronic miRNA cluster, in individuals with microcephaly, short stature and digital abnormalities."
MIR31HG,breast cancer,miR-31 and its host gene lncRNA LOC554202 (MIR31HG) are regulated by promoter hypermethylation in triple-negative breast cancer.Both miR-31 and the host gene LOC554202 are down-regulated in the TNBC cell lines of basal subtype and over-expressed in the luminal counterparts.
MIR7-3HG,hepatocellular carcinoma,"Besides, another study showed that liver cancer-downregulated lncRNA uc002mbe.2 could be induced by trichostatin A (TSA) treatment and its expression is positively correlated with the apoptotic effect of TSA in HCC cells. "
NAMA,papillary thyroid carcinoma,"Identification of a novel noncoding RNA gene, NAMA, that is downregulated in papillary thyroid carcinoma with BRAF mutation and associated with growth arrest."
SNHG16,neuroblastoma,SNHG16 is now becoming increasingly evident that N-myc also regulates the expression of long noncoding RNAs such as T-UCRs and ncRAN.
NDM29,neuroblastoma,"The synthesis of a pol III-transcribed noncoding (nc) RNA (NDM29) strongly restricts NB development by promoting cell differentiation, a drop of malignancy processes. NDM29 expression leads to NB cell differentiation."
NEAT1,AIDS,"We found NEAT-1 to be one of several lncRNAs whose expression is changed by HIV-1 infection, and we have characterized its role in HIV-1 replication."
NEAT1,amyotrophic lateral sclerosis,The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of amyotrophic lateral sclerosis.
NEAT1,frontotemporal lobar degeneration,Analysis of RNA binding by TDP-43 in brains from subjects with FTLD revealed that the greatest increases in binding were to the MALAT1 and NEAT-1 noncoding RNAs.
NEAT1,Huntington's disease,"LncRNAs TUG1 (necessary for retinal development), and NEAT-1 (a structural component of nuclear paraspeckles) are upregulated in HD caudate, while the brain-specific tumor-suppressor MEG3 is downregulated in HD."
NEAT1,intrauterine growth restriction,"The long non-coding RNA NEAT-1 is increased in IUGR placentas, leading to potential new hypotheses of IUGR origin/development."
NEAT1,TDP-43-associated pathological states,"Biogenesis, metabolism, and functions of lncRNAs are otherwise interconnected with known pathogenic mechanisms"
NEAT1,oral squamous cell carcinoma,"Subsequently, they confirmed that the expression levels of HOTAIR, NEAT-1 and UCA2 in metastasized samples was prominent higher than the non-metastatic samples."
np_17856,progressive kidney injury,Real-time PCR confirmed these findings and revealed the functional link between Smad3-dependent lncRNAs np_5318/np_17856 and progressive kidney injury.
np_5318,progressive kidney injury,Real-time PCR confirmed these findings and revealed the functional link between Smad3-dependent lncRNAs np_5318/np_17856 and progressive kidney injury.
NPPA-AS1,cardiovascular disease,The NPPA-AS lncRNA has been shown to be a modulator of the alternative splicing of the NPPA gene. This lncRNA thus has potential to be involved in cardiovascular disease 
NPTN-IT1,colorectal cancer,"In this study, we found that the lncRNA Low Expression in Tumor (lncRNA-LET) was generally downregulated in hepatocellular carcinomas, colorectal cancers, and squamous-cell lung carcinomas."
NPTN-IT1,hepatocellular carcinoma,"Importantly, another lncRNA-LET (lncRNA low expression in tumor) is found to play a critical role in hypoxia-induced metastasis in HCC "
NPTN-IT1,hepatocellular carcinoma,"In this study, we found that the lncRNA Low Expression in Tumor (lncRNA-LET) was generally downregulated in hepatocellular carcinomas, colorectal cancers, and squamous-cell lung carcinomas."
NPTN-IT1,squamous cell lung carcinoma,"In this study, we found that the lncRNA Low Expression in Tumor (lncRNA-LET) was generally downregulated in hepatocellular carcinomas, colorectal cancers, and squamous-cell lung carcinomas."
NRON,Down's syndrome,"NRON is a lncRNA that mediates the cytoplasmic to nuclear shuttling of the NFAT transcription factor . In animal models, deregulation of the DSCR1 and DYRK1A genes act synergistically to prevent nuclear occupancy of NFATc transcription factors leading to reduced NFATc activity and to many features of DS, suggesting a potential link between NRON activity and DS pathophysiology."
PAN,Kaposi's sarcoma,KSHV infected cells express a highly abundant long noncoding transcript referred to as polyadenylated nuclear RNA (PAN RNA).
PANDAR,p53-associated pathological states,"Biogenesis, metabolism, and functions of lncRNAs are otherwise interconnected with known pathogenic mechanisms"
PANDAR,cancer,"Another DNA damage-responsive, p53-induced lncRNA that lies upstream of p21, PANDA (P21 associated ncRNA DNA damage activated), is also implicated in the repression of pro-apoptotic genes, such as FAS and BIK, by acting as a decoy for the transcription factor NF-YA. In some cancer types, p53 mutations have been found that maintain the protein's ability to induce the PANDA pathway (and its antiapoptotic effects) while abolishing its ability to induce p21 and its promotion of cell-cycle arrest, thus leading to increased tumor cell survival (Hung et al. 2011). "
PCA3,prostate cancer,PCA3 is the diagnostic marker of prostate cancer
PCA3,prostate cancer,A PCA3 score threshold of 20 may have the highest utility for selecting men with clinically insignificant prostate cancer in whom active surveillance may be appropriate; a PCA3 score threshold of 50 may be used to identify men at high risk of harbouring significant prostate cancer who are candidates for RP.
PCA3,prostate cancer,PCA3 was found that the levels of the mRNA expression of DD3(PCA3) were significantly higher (p<0.045) in patients with PCa than in patients with benign prostatic hyperplasia.
PCA3,prostate cancer,Measurement of lncRNA PCA3 in patient urine samples has been shown to allow more sensitive and specific diagnosis of prostate cancer than the widely used marker prostate-specific antigen (PSA).
PCA3,prostate cancer,PCA3 is a highly prostate cancer-specific gene.
PCA3,prostate cancer,"PCA3 is one of the most prostate cancer-specific genes yet described, and this makes DD3 a promising marker for the early diagnosis of prostate cancer and provides a powerful tool for the development of new treatment strategies for prostate cancer patients."
PCA3,prostate cancer,PCA3 mRNA is prostate cancer specific and shows increased expression in prostate cancer.
PCA3,prostate cancer,PCA3 scores were significantly lower in low-volume disease and insignificant PCa. Higher PCA3 scores were associated with aggressive disease.
PCA3,prostate cancer,Patients with a positive biopsy showed significantly higher PCA3 values.
PCA3,prostate cancer,"The PCA3 assay is insensitive to pre-analytical factors, performs well analytically and correctly classifies a high percent of subjects with known prostate cancer status across research sites."
PCA3,prostate cancer,The probability of a positive repeat biopsy increases with rising PCA3 scores. The PCA3 score was superior to %fPSA for predicting repeat prostate biopsy outcome and may be indicative of clinical stage and significance of pCa.
PCA3,prostate cancer,Upregulation of two new PCA3 isoforms in PCa tissues improves discrimination between PCa and BPH.
PCA3,prostate cancer,The presence of the (TAAA)n short tandem repeat polymorphisms in the PCA3 promoter region may be a risk factor for prostate cancer in the Chinese population.
PCA3,prostate cancer,"PCGEM1, PCA3 (prostate cancer antigen 3, known also as DD3, differential display code 3) and PCNCR1 (prostate cancer ncRNA 2) are involved in prostate cancer, while HULC (highly up-regulated in liver cancer) is involved with liver cancer."
PCAT1,cancer,"PCAT1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer."
PCAT1,prostate cancer,"They described PCAT1,a novel PCa lincRNA on 8q24, in the locality of well-characterized PCa risk-related SNPs and the c-MYC oncogene."
PCAT1,prostate cancer,PCAT1 is Putative marker and oncogene of prostate cancer
PCAT1,prostate cancer,"PCAT1 is markedly overexpressed in a subset of prostate cancers, particularly metastases, and may contribute to cell proliferation in these tumors."
PCAT1,prostate cancer,PCAT1 is a prostate-specific regulator of cell proliferation and show that it is a target of the Polycomb Repressive Complex 2 (PRC2). Patterns of PCAT1 and PRC2 expression stratified patient tissues into molecular subtypes distinguished by expression signatures of PCAT1-repressed target genes.
PCAT1,prostate cancer,"The prostate cancer-associated ncRNA transcript 1 lncRNA PCAT1, SchlAP1 (second chromosome locus associated with prostate-1), and CTBP1-AS indicate cancer cell invasiveness and metastasis in prostate cancer progression. "
PCAT1,prostate cancer,"The prostate cancer-associated ncRNA transcript 1 lncRNA PCAT1, SchlAP1 (second chromosome locus associated with prostate-1), and CTBP1-AS indicate cancer cell invasiveness and metastasis in prostate cancer progression. "
PCAT1,prostate cancer,"For example, a recent RNA-Seq study in prostate cancer tissues and cell lines uncovered a lncRNA, PCAT1, that promotes cell proliferation and is a target of PRC2 regulation."
PCGEM1,prostate cancer,"One of the earliest lncRNAs described in PCa, was PCGEM1(prostate cancer gene expression marker 1), a prostate-specific transcript encoded on 2q32 (40). One of the earliest lncRNAs described in PCa, was PCGEM1 (prostate cancer gene expression marker 1), a prostate-specific transcript encoded on 2q32 (40). "
PCGEM1,prostate cancer,High-risk  and predictive marker Oncogene 
PCGEM1,prostate cancer,"Elevated expression of PCGEM1, a prostate-specific gene with cell growth-promoting function, is associated with high-risk prostate cancer patients."
PCGEM1,prostate cancer,Expression profiles of genes in CRPC support a role for the transcriptional activity of the PCGEM1.
PCGEM1,prostate cancer,PCGEM1 was originally discovered in a genome-wide gene expression screen as a cDNA sequence with prostate cancer overexpression and highly specific localization to glandular epithelial cells.
PCGEM1,prostate cancer,"PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer."
PCGEM1,prostate cancer,"The biomarkers had sensitivities ranging from 91% to 100%. Clinical specificities evaluated with the BPH tissue were the following: hTERT mRNA (93%), DD3 mRNA (57%), Survivin (29%) and PCGEM1 (14%)."
PCGEM1,prostate cancer,"Phytosterol inhibition of PCGEM1 and cell growth and the overexpression of caveolin-1, suggests that poor disease prognosis anchors on the ability of caveolin-1 to regulate downstream oncogene(s) and apoptosis genes."
PCGEM1,prostate cancer,"A prostate-specific and prostate cancer-associated noncoding gene, PCGEM1 regulates apoptosis."
PCGEM1,prostate cancer,"PCGEM1, PCA3 (prostate cancer antigen 3, known also as DD3, differential display code 3) and PCNCR1 (prostate cancer ncRNA 1) are involved in prostate cancer, while HULC (highly up-regulated in liver cancer) is involved with liver cancer."
PCGEM1,prostate cancer,"Here we report that two lncRNAs highly overexpressed in aggressive prostate cancer, PRNCR1 (also known as PCAT8) and PCGEM1, bind successively to the androgen receptor and strongly enhance both ligand-dependent and ligand-independent androgen-receptor-mediated gene activation programs and proliferation in prostate cancer cells. "
PCGEM1,prostate cancer,"We found a significantly decreased risk of PCa for rs6434568 AC and AC/AA genotype, as well as rs16834898 AC and AC/CC genotype, compared with the CC and AA genotypes, respectively."
PCGEM1,prostate cancer,"The focus of this Nature report13 is on two PCa-associated lncRNAs: PCGEM1 and PRNCR1. They cooperate in regulating the function of the male hormone receptor, the androgen receptor (AR), which plays central role in PCa onset and progression. AR pathway is activated in advanced CaPs including castration-resistant prostate cancer (CRPC)."
PCNA-AS1,cancer,Antisense long non-coding RNA PCNA-AS1 promotes tumor growth by regulating proliferating cell nuclear antigen in hepatocellular carcinoma.
PCNCR1,prostate cancer,Accumulating evidence indicated that prostate cancer non-coding RNA 1 (PCNCR1) lncRNA was identified in a gene deserton chromosome 8q24.2 and is associated with susceptibility to prostate cancer
PCNCR1,prostate cancer,"PCGEM1, PCA3 (prostate cancer antigen 3, known also as DD3, differential display code 3) and PCNCR1 (prostate cancer ncRNA 3) are involved in prostate cancer, while HULC (highly up-regulated in liver cancer) is involved with liver cancer."
PDZRN3-AS1,type 2 diabetes mellitus,SNP rs11128347 (C>G) in PDZRN3 is associated with African-Americans with type 2 diabetes.
Pinc,breast cancer,"In a finding of relevance to breast cancer pathogenesis, the mammary gland lncRNA PINC, whose genomic structure is substantially different between primates and rodents has been shown to function in both cell survival and cell cycle progression."
PINK1-AS,diabetes mellitus,"As the name suggests, PINK1 is induced by PTEN, which is an important inhibitor of insulin signalling. PINK1 depletion has been associated with diabetes status, impaired glucose uptake in neuronal cell lines and with mitochondrial gene expression in adipocytes , raising the possibility that disruption to naPINK1 may impact on glucose metabolism. "
PINK1-AS,Parkinson's disease,Mutations in the PTEN induced putative kinase 1 (PINK1) are implicated in early-onset Parkinson's disease. Welective targeting of naPINK1 results in loss of the PINK1 splice variant in neuronal cell lines.
PISRT1,blepharophimosis syndrome,"The blepharophimosis syndrome (BPES) is driven by dysregulation of the FOXL2 gene, numerous extragenic mutations have been reported in patients. One particular deletion occurring 283 kb away from FOXL2 disrupts a lncRNA, PISRT1, that was shown by chromatin confirmation capture to physically loop with FOXL2."
PRNCR1,prostate cancer,"That same year, Chung et al reported PCa susceptibility SNPs within a 13 kb intron-less lincRNA also on 8q24, which they termed PRNCR1."
PRNCR1,prostate cancer,PRNCR1 is Susceptibility marker oncogene of prostate cancer
PRNCR1,prostate cancer,"Here we report that two lncRNAs highly overexpressed in aggressive prostate cancer, PRNCR1 (also known as PCAT8) and PCGEM1, bind successively to the androgen receptor and strongly enhance both ligand-dependent and ligand-independent androgen-receptor-mediated gene activation programs and proliferation in prostate cancer cells. "
PRNCR1,prostate cancer,"The focus of this Nature report13 is on two PCa-associated lncRNAs: PCGEM1 and PRNCR1. They cooperate in regulating the function of the male hormone receptor, the androgen receptor (AR), which plays central role in PCa onset and progression. AR pathway is activated in advanced CaPs including castration-resistant prostate cancer (CRPC)."
PSORS1C3,psoriasis,Psoriasis susceptibility 1 candidate 3
PSORS1C3,psoriasis,"The PSORS1C3*582A allele, an SNP in the 3'-untranslated region of the PSORS1C3 gene, was a major psoriasis vulgaris susceptibility allele in the Chinese population, and the association was much stronger in patients with early-onset psoriasis vulgaris."
PTCSC1,papillary thyroid carcinoma,papillary thyroid carcinoma susceptibility candidate
PTCSC3,papillary thyroid carcinoma,The study showed that the expression of PTCSC3 in six thyroid cancer cell lines is lower and no expression was detected in any of them.
PTCSC3,papillary thyroid carcinoma,"A thyroid-specific lncRNA, termed PTC susceptibility candidate 3 (PTCSC3), that was strongly downregulated in PTC was identified in this region and it was found that the repression was caused by the associated SNP. "
PTENP1,cancer,PTENP1 pseudogene belongs to the group of competing endogenous RNAs (ceRNAs). It may act as "decoy" by protecting PTEN mRNA from binding to common miRNA and therefore allowing expression of the tumor suppressor protein.
PTENP1,prostate cancer,PTENP1 is oncogene and tumor suppressor of prostate cancer
PTENP1,cancer,An example of this mechanism is represented by the tumour suppressor gene PTEN and its pseudogene PTENP1.
PTENpg1,cancer,"PTEN is a tumor-suppressor gene that has been shown to be under the regulatory control of a PTEN pseudogene expressed noncoding RNA, PTENpg1."
PVT1,breast cancer,Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.
PVT1,Burkitt lymphoma,PVT1 is frequently involved in the translocations occurring in variant Burkitt's lymphomas and murine plasmacytomas.
PVT1,cancer,The PVT gene frequently amplifies with MYC in tumor cells.
PVT1,cleft lip,"Association identified by GWAS (rs987525,A>G)."
PVT1,diabetic nephropathy,PVT1 may mediate the development and progression of diabetic nephropathy through mechanisms involving ECM accumulation.
PVT1,diabetic nephropathy,"Role of MicroRNA 1207-5P and Its Host Gene, the Long Non-Coding RNA PVT1, as Mediators of Extracellular Matrix Accumulation in the Kidney: Implications for Diabetic Nephropathy."
PVT1,Hodgkin's lymphoma,PVT1 is a new susceptibility loci for this disease.
PVT1,lymphoma,Burkitt lymphoma association
PVT1,lymphoma,Burkitt lymphoma association
PVT1,plasmacytoma,PVT1 is frequently involved in the translocations occurring in variant Burkitt's lymphomas and murine plasmacytomas.
PVT1,ovarian cancer,Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer.
PVT1,pancreatic cancer,PVT1 gene as a regulator of Gemcitabine sensitivity and showed that functional inactivation of the PVT1 gene led to enhanced Gemcitabine sensitivity in human pancreatic cancer ASPC-1 cells.
PVT1,prostate cancer,"The risk allele (G) of rs378854 (A>G) reduces binding of the transcription factor YY1 in vitro. The region surrounding rs378854 interacts with the MYC and PVT1 promoters.Expression of the PVT1 oncogene in normal prostate tissue increased with the presence of the risk allele of rs378854, while expression of MYC was not affected."
PVT1,kidney cancer,"Variants (rs13447075, A>C;rs2648862, A>C) in the plasmacytoma variant translocation gene (PVT1) are associated with end-stage renal disease attributed to type 1 diabetes."
PVT1,type 2 diabetes mellitus,"There is association between variants (rs2720709, A>G) in the plasmacytoma variant translocation 1 gene (PVT1) and end-stage renal disease (ESRD) attributed to both type 1 and type 2 diabetes."
PVT1,type 2 diabetes mellitus,"Identification of PVT1 (rs2720709, A>G) as a candidate gene for end-stage renal disease in type 2 diabetes using a pooling-based genome-wide single nucleotide polymorphism association study."
PVT1,type 2 diabetes mellitus,"There is association between variants (rs2720709, A>G) in the plasmacytoma variant translocation 1 gene (PVT1) and end-stage renal disease (ESRD) attributed to both type 1 and type 2 diabetes."
REST/CoREST-regulated lncRNAs,Huntington's disease,"Biogenesis, metabolism, and functions of lncRNAs are otherwise interconnected with known pathogenic mechanisms"
RMST,rhabdomyosarcoma,NCRMS (RMST) on chromosome 12q21 shows differential expression between rhabdomyosarcoma subtypes.
RNA polymerase III-dependent lncRNAs,diffuse cerebral hypomyelination,"Biogenesis, metabolism, and functions of lncRNAs are otherwise interconnected with known pathogenic mechanisms"
RNA-a,Opitz-Kaveggia syndrome,"A recent study indicated that a subset of long ncRNAs, called activating long ncRNAs (RNA-a), is associated with Opitz-Kaveggia (also known as FG) syndrome, a X-linked intellectual disability syndrome, characterized by various neuronal pathologies as well as developmental abnormalities."
RNase MRP,cartilage hair hypoplaisia,"Point mutations in RNase MRP cause human Cartilage Hair Hypoplaisia (CHH), and several disease-causing mutations map to RMRP-S1 and -S2. SHAPE chemical probing identified two alternative secondary structures altered by disease mutations."
RP1-179N16.3,nasopharyngeal carcinoma,"Six lncRNAs (AF086415, AK095147, RP1-179N16.3, MUDENG, AK056098 and AK294006) were confirmed by qPCR."
RP4-620F22.3,enterovirus 71 infection,"A general consistency between the qPCR and microarray analysis results was confirmed in four lncRNAs (AP000688.29, AC002511.1, RP5-843L14.1, and RP4-620F22.3) in terms of regulation direction and significance. Specifically, a 3.31-fold down-regulation "
RP5-843L14.1,enterovirus 71 infection,"A general consistency between the qPCR and microarray analysis results was confirmed in four lncRNAs (AP000688.29, AC002511.1, RP5-843L14.1, and RP4-620F22.3) in terms of regulation direction and significance. Specifically, a 3.31-fold down-regulation "
RUNXOR,malignant hematopoiesis,RUNXOR utilizes its 3'-terminal fragment to directly interact with the RUNX1 promoter and enhancers and participates in the orchestration of an intrachromosomal loop. The 3' region of RUNXOR also participates in long-range interchromosomal interactions with chromatin regions that are involved in multiple RUNX1 translocations.
Scarb2,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 18 downregulated in HF hearts as compared with control hearts.
SCHLAP1,prostate cancer,Prensner et al found that the lncRNA SChLAP1 was overexpresed in prostate tumors and where it is critical for tumor cell metastasis.
Sema3g,ischaemia-reperfusion injury,Classification and validation of deregulated LncRNAs in ischemia/reperfusion-treated mouse livers.
SLC7A2-IT1A/B,progressive encephalopathy with severe infantile anorexia,Genetic variation in lncRNA genes causes disease and influences susceptibility
SNHG11,obesity,New gene associated with obesity.
SNHG16,bladder cancer,"putative diagnostic, prognostic, and predictive marker "
SNHG16,colorectal cancer,"Down-regulation of ncRAN, a long non-coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients."
SNHG3,Alzheimer's disease,"We selected three differential signature genes specific for the early stage (Nudt19, Arl16, Aph1b), five common to both groups (Slc15a2, Agpat5, Sox2ot, 2210015, D19Rik, Wdfy1), and seven specific for late stage."
SNHG4,myelodysplastic syndrome,Association identified by GWAS.
SNHG5,lymphoma,snhg5 is located at the breakpoint of chromosomal translocation t(3;6)(q27;q15) involved in human B-cell lymphoma.
SOX2-OT,esophageal squamous cell carcinoma,"The results revealed a significant co-upregulation of SOX2OT along with SOX2 and OCT4 in tumor samples, compared to the non-tumor tissues obtained from the margin of same tumors. Therefore, the SOX2 gene might be a indicator for the early diagnosis of ESCC."
SOX2-OT,Alzheimer's disease,"We selected three differential signature genes specific for the early stage (Nudt19, Arl16, Aph1b), five common to both groups (Slc15a2, Agpat5, Sox2ot, 2210015, D19Rik, Wdfy1), and seven specific for late stage (D14Ertd449, Tia1, Txnl4, 1810014B01Rik)."
SOX2-OT,neurodevelopmental syndrome,Genomic context links lncRNAs to disease genes/loci and related pathways
Sox4,ischaemia-reperfusion injury,Classification and validation of deregulated LncRNAs in ischemia/reperfusion-treated mouse livers.
SPRY4-IT1,esophageal squamous cell carcinoma,Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis.
SPRY4-IT1,melanoma,The melanoma-upregulated long noncoding RNA SPRY4-IT1 modulates apoptosis and invasion.
SPRY4-IT1,melanoma,Another elegant study by Khaitan et al. utilized a non-coding RNA microarray approach to identify differentially regulated lncRNAs in melanoma cells and identified a 687 bp single exon lncRNA named SPRY4-IT1 which was highly up-regulated in melanoma patient samples and cell lines.
SPRY4-IT1,melanoma,"The lncRNA, SPRY4-IT1, which is up-regulated in human melanomas compared to melanocytes and keratinocytes, affects cell dynamics, including increased rate of wound closure upon ectopic expression."
Srsf9,ischaemia-reperfusion injury,Classification and validation of deregulated LncRNAs in ischemia/reperfusion-treated mouse livers.
SUMO1P3,gastric cancer,"Pseudogene-expressed lncRNAs are a major member of the lncRNA family. Recently, our group reported that small ubiquitin-like modifier (SUMO) 1 pseudogene 3, SUMO1P3, was markedly up-regulated in gastric cancer tissues compared with paired adjacent non-tumor tissues."
SUMO1P3,gastric cancer,Up-regulation of SUMO1 pseudogene 3 (SUMO1P3) in gastric cancer and its clinical association.
TC0100223,cancer,"Notably, three candidates (TC0100223, TC0101686 and TC0101441) were aberrantly expressed in ERα-positive compared to ERα-negative EOC tissues, showing correlations with some malignant cancer phenotypes such as advanced FIGO stage and/or high histological grade."
TC0101441,cancer,"Notably, three candidates (TC0100223, TC0101686 and TC0101441) were aberrantly expressed in ERα-positive compared to ERα-negative EOC tissues, showing correlations with some malignant cancer phenotypes such as advanced FIGO stage and/or high histological grade."
TC0101686,cancer,"Notably, three candidates (TC0100223, TC0101686 and TC0101441) were aberrantly expressed in ERα-positive compared to ERα-negative EOC tissues, showing correlations with some malignant cancer phenotypes such as advanced FIGO stage and/or high histological grade."
TCL6,leukemia,TCL6 is associated with leukemia
TCL6,lymphoma,TCL6 is associated with lymphoma
TDRG1,testicular cancer,The significantly reduced expression of the TDRG1 in patients with seminoma or teratoma indicates that TDRG1 may be a candidate cancer suppressor gene.
TERC,dyskeratosis congenita,"Mutations that alter the equilibrium between different conformational states of TERCs result in disease states such as dyskeratosis congenita, presumably through disruptions of the RNA scaffold structure into which are plugged modular binding sites for telomeric regulatory proteins."
TERC,prostate cancer,"TERC is expressed in all human tissues regardless of telomerase activity, whereas TERT is highly expressed in >90% of tumor cells"
TERRA,cancer,"In many cancer cells TERRA is downregulated, providing a possible link to the longevity of cancer cells by telomerase-mediated lengthening of chromosomal ends."
THRIL,Kawasaki disease,"Finally, THRIL expression was correlated with the severity of symptoms in patients with Kawasaki disease, an acute inflammatory disease of childhood. "
THRIL,Kawasaki disease,"Finally, THRIL expression was correlated with the severity of symptoms in patients with Kawasaki disease, an acute inflammatory disease of childhood. "
TINCR,squamous cell carcinoma,"Interestingly, the lncRNA TINCR, which is highly induced during keratinocyte differentiation, is repressed in squamous cell carcinoma specimens compared to normal adjacent epidermis."
TRAF3IP2-AS1,schizophrenia,TRAF3IP2-AS1 is associated with schizophrenia
Trp53cor1,cancer,"They identified lincRNA-p21 as a direct p53 target. Furthermore, they found that lincRNA-p21 is critical in regulating many of the genes that are repressed in response to p53 activity and they found that lincRNA-p21 associates with hnRNP-K. The lincRNA-p21/hnRNP-K interaction was found to be necessary for hnRNP-K genomic localization at sites of gene repression."
Trp53cor1,cancer,"lincRNA-p21 (named for its vicinity to the CDKN1A/p21 locus) is upregulated by p53 upon DNA damage and implicated in downstream repressive effects of the p53 pathway, particularly on genes regulating apoptosis, possibly by directing the recruitment of hnRNP-K to its genomic targets."
Trp53cor1,colorectal cancer,LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/β1-catenin signaling pathway.
Trp53cor1,colorectal cancer,LincRNA-p21 enhances the sensitivity of radiotherapy for human colorectal cancer by targeting the Wnt/β1-catenin signaling pathway.
Trp53cor1,cancer,"ANRIL, GAS5 and lincRNA-p23 are involved in the escape of growth suppression by regulating tumor suppressor genes (ANRIL) or apoptosis regulators."
Trp53cor1,cancer,Global gene regulation p53 repression via hnRNP-K; inducing cellular apoptosis
Trpm3,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 25 downregulated in HF hearts as compared with control hearts.
T-UCRs,neuroblastoma,T-UCRs is now becoming increasingly evident that N-myc also regulates the expression of long noncoding RNAs such as T-UCRs and ncRAN.
TUG1,B-cell neoplasms,"HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients."
TUG1,bladder cancer,Putative diagnostic and prognostic marker; oncogene
TUG1,bladder cancer,Theseguilty by association studies have found numerous bladder-cancer associated lncRNAs
TUG1,bladder cancer,Long intergenic non-coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder.
TUG1,Huntington's disease,"LncRNAs TUG1 (necessary for retinal development), and NEAT-1 (a structural component of nuclear paraspeckles) are upregulated in HD caudate, while the brain-specific tumor-suppressor MEG3 is downregulated in HD."
TUG1,Huntington's disease,"TUG1 is upregulated in Huntington's disease brains, which is from the reanalysis of the Affymetrix U133A and B microarray data on normal and HD brains in this review."
TUG1,non-small cell lung cancer,"P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer, partly through epigenetically regulating HOXB7 expression."
TUSC8,cervical cancer,Low expression of long noncoding XLOC_010588 indicates a poor prognosis and promotes proliferation through upregulation of c-Myc in cervical cancer.
U1 spliceosomal lncRNA,Parkinson's disease,"These included the U1 spliceosomal lncRNA and RP11-462G22.1, each entailing sequence complementarity to numerous microRNAs."
SNHG14,Angelman syndrome,"Ube3a-as is a lncRNA transcribed antisense to the maternally expressed Ube3a gene, a candidate gene for AS, suggesting that Ube3a-as may be responsible for repressing paternal Ube3a expression."
SNHG14,Angelman syndrome,"Prader-Willi and Angelman syndromes, due to UBE3A expression, are affected due to the presence of a 20-kb NAT, which shares complementary sequences of UBE3A"
SNHG14,Angelman syndrome,"Although in the majority of human tissues, both copies of the UBE3A gene are expressed, in neurons one copy is silenced by UBE3A-AS1 (ubiquitin-protein ligase E3A antisense RNA 1). In patients suffering from Angelman syndrome, the other (active) allele has either been deleted or inactivated."
SNHG14,Prader-Willi syndrome,"Prader-Willi and Angelman syndromes, due to UBE3A expression, are affected due to the presence of a 20-kb NAT, which shares complementary sequences of UBE3A"
UBE3A-ATS,Angelman syndrome,Genomic context links lncRNAs to disease genes/loci and related pathways
UBE3A-ATS,Angelman syndrome,"LncRNAs are also associated with imprinting disorders, such as ubiquitin protein ligase E3A (UBE3A)-ATS in Angelman syndrome."
uc.115-,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 10 downregulated in HF hearts as compared with control hearts.
uc.184+,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 19 downregulated in HF hearts as compared with control hearts.
UCA1,bladder cancer,UCA1 is Diagnostic marker oncogene of bladder cancer
UCA1,bladder cancer,"In adult human tissues, UCA1 gene was not expressed except in the heart and spleen. The expression level of UCA1 was increased in 8 common tumor tissues as compared with that in the corresponding normal tissues."
UCA1,bladder cancer,"Overexpression of UCA1a(CUDR) significantly enhanced proliferation, migration and invasion of the bladder cancer cell line UM-UC-2."
UCA1,bladder cancer,UCA1 was identified as a novel noncoding RNA gene dramatically up-regulated in TCC (bladder transitional cell carcinoma) and it is the most TCC-specific gene yet identified.
UCA1,bladder cancer,"UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion."
UCA1,bladder cancer,"With a high level of sensitivity and specificity, UCA1 is a promising urinary marker for the diagnosis of bladder cancer."
UCA1,bladder cancer,Long non-coding RNA UCA1 regulated cell cycle distribution via CREB through PI3-K dependent pathway in bladder carcinoma cells.
UCA1,bladder cancer,Theseguilty by association studies have found numerous bladder-cancer associated lncRNAs
UCA1,bladder cancer,Upregulation of long non-coding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein α contributes to bladder cancer cell growth and reduced apoptosis.
UCA1,bladder cancer,Long non-coding RNA UCA1 increases chemoresistance of bladder cancer cells by regulating Wnt signaling.
UCA1,oral squamous cell carcinoma,"Subsequently, they confirmed that the expression levels of HOTAIR, NEAT-1 and UCA3 in metastasized samples was prominent higher than the non-metastatic samples."
UCA1,pancreaticobiliary maljunction,Gene expression profiling reveals upregulated UCA1 and BMF in gallbladder epithelia of children with pancreaticobiliary maljunction.
UCA1,squamous cell carcinoma,"Cancer up-regulated drug resistant (CUDR) gene, was found to be overexpressed in a doxorubicin-resistant subline of human squamous carcinoma A431 and A10A cells."
UCA1,tongue squamous cell carcinoma,"Meaningfully, the expression levels of UCA1 lncRNA were dramatically higher in TSCC tissues than those in paired ANTs."
UCA1,cancer,Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1).
VL30 LTRs,hepatocellular carcinoma,"Trim24 (Tif1) and Trim33 (Tif1) interact to form a co-repressor complex that suppresses murine hepatocellular carcinoma. Here we show that Trim24 and Trim33 cooperatively repress retinoic acid receptor-dependent activity of VL30-class endogenous retroviruses (ERVs) in liver. In Trim24-knockout hepatocytes, VL30 derepression leads to accumulation of reverse-transcribed VL30 cDNA in the cytoplasm that correlates with activation of the viral-defense interferon responses mimicking the preneoplastic inflammatory state seen in human liver following exogenous viral infection. Furthermore, upon derepression, VL30 long terminal repeats (LTRs) act as promoter and enhancer elements deregulating expression of neighboring genes and generating enhancer RNAs that are required for LTR enhancer activity in hepatocytes in vivo. "
WRAP53,cancer,"A natural antisense transcript of TP53, WRAP53, was strongly augmented by idarubicin and etoposide."
WRAP53,cancer,WRAP53 promotes cancer cell survival and is a potential target for cancer therapy.
WRAP53,dyskeratosis congenita,Disruption of telomerase trafficking by WRAP53 mutation causes dyskeratosis congenita.
WT1-AS,acute myeloid leukemia,The incidence of WIT-1 methylation in primary refractory AML was significantly higher than that noted in chemosensitive AML.
WT1-AS,acute myeloid leukemia,"In AML, there is often abnormal splicing of WT1-AS, which may play a role in the development of this malignancy."
WT1-AS,Wilms' tumor,A CTCF-binding silencer regulates the imprinted genes AWT1 and WT1-AS and exhibits sequential epigenetic defects during Wilms' tumourigenesis.
WT1-AS,Wilms' tumor,"WT1 is a gene that is mutated in Wilms' tumor (WT) and acute myeloid leukaemia (AML) and has an antisense transcript (WT1-AS), which was found to regulate WT1 protein levels."
Wt1os,ischaemia-reperfusion injury,Classification and validation of deregulated LncRNAs in ischemia/reperfusion-treated mouse livers.
XIST,bladder cancer,Putative diagnostic and prognostic marker
XIST,breast cancer,"The intratumoral and intertumoral variability in XIST RNA domain number in BRCA1 tumors correlates with chromosomal genetic abnormalities, including gains, losses, reduplications, and rearrangements of the X-chromosome."
XIST,cancer,Dysfunction of XIST may trigger the chromatin instability and promote caner development.
XIST,cancer,The lncRNA XIST was found to be a potent tumor suppressor of hematologic malignancies in vivo.
XIST,cancer,"Recent studies have linked their mis-expression to diverse cancers (ANRIL: prostate cancer, XIST: female cancers, HOTAIR: breast cancer, KCNQ1OT2: colorectal cancer)."
XIST,Klinefelter's syndrome,"Severe XIST hypomethylation clearly distinguishes (SRY+) 46,XX-maleness from Klinefelter syndrome."
XIST,Klinefelter's syndrome,"We demonstrated by quantitative RT-PCR an active XIST RNA expression in blood lymphocytes from Klinefelter patients, comparable to that observed in control females and over 30,000-fold greater than in control males."
XIST,testicular cancer,XIST expression was common in seminomatous testicular germ cell tumors but not in nonseminomatous testicular germ cell tumors.
LINC00538,cancer,"Expression profiling revealed a general and regulated expression pattern of Yiya in major tissues, and more interestingly, identified  elevated mRNA levels in different cancers."
ZFAT-AS1,autoimmune disease,"SNPs in the promoter of a B cell-specific antisense transcript, SAS-ZFAT (ZFAT-AS1), determine susceptibility to autoimmune thyroid disease."
Zim3,heart failure,Quantitative-PCR identified the relative expression of 5 significantly upregulated and 5 downregulated LncRNAs from 10 HF mice. Five LncRNAs were upregulated and 13 downregulated in HF hearts as compared with control hearts.
ZFAS1,breast cancer,SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer.ZFAS1 is highly expressed in the mammary gland and is down-regulated in breast tumors compared to normal tissue. ZFAS1 is a putative tumor suppressor gene.
ZFAS1,breast cancer,SNORD-host RNA Zfas1 is a regulator of mammary development and a potential marker for breast cancer. ZFAS1 as a putative tumor suppressor gene.
ZFAS1,ductal carcinoma,Human ZFAS1 levels are reduced in ductal carcinoma relative to normal breast tissue.
PVT1,gastric cancer,Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance
LINC01133,lung squamous cell carcinoma,LSCC patients with higher expression level of LINC01133 had shorter survival time. LINC01133 is upregulated in lung squamous cell cancer and predicts survival
lnc-LCE5A-1,head and neck squamous cell carcinoma,"Ectopic expression of lnc-LCE5A-1 increased the expression of CDH-1 in HNSCC cells, while decreasing the expression of OCT-4, NANOG, and VIM."
FAM3D-AS1,head and neck squamous cell carcinoma,Overexpression of lnc-KCTD6-3 reduced the expression of NANOG
UCA1,gastric cancer,"UCA1 expression was remarkably increased in gastric cancer tissues and cell lines compared with that in the normal control; high UCA1 expression correlated with worse differentiation, tumor size, invasion depth and TNM stage in gastric cancer; increased UCA1 expression contributed to poor overall survival and disease-free survival of patients."
HOTAIR,oral squamous cell carcinoma,Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma.
AS Uchl1,Parkinson's disease,Uch1 RNA levels are strongly down-regulated in neurochemical models of PD in vitro and in vivo
H19,breast cancer,H19 lncRNA mediates 17beta-estradiol-induced cell proliferation in MCF-7 breast cancer cells; H19  lncRNA was much higher in estrogen receptor (ER)-positive MCF-7 breast cancer cells than in ER-negative MDA-MB-231 cells
SPRY4-IT1,gastric cancer,SPRY4-IT1 expression was elevated in GC tissues and cell lines
LOC728228,lung cancer,LOC728228 was upregulated relative to its expression in control untransformed16HBE (16HBE-N) cells.
MALAT1,glioblastoma,Extensive microRNA-mediated crosstalk between lncRNAs and mRNAs in mouse WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1.
H19,coronary artery disease,Re-expression of H19 has been observed in patients with atherosclerosis. Common polymorphisms of H19 are associated with the risk and severity of CAD in a Chinese population.
TUSC7,gastric cancer,TUSC7 was downregulated in GC samples and was an independent prognostic indicator of disease-free survival (DFS) and disease-specific survival (DSS) in GC patients; TUSC7 was a direct transcriptional target of p53 via interaction of p53 with the putative p53-response element in the upstream region of TUSC7
HIF1A-AS1,cardiovascular disease,Clopidogrel reduces apoptosis and promotes proliferation of human vascular endothelial cells induced by palmitic acid via suppression of the long non-coding RNA HIF1A-AS1 in vitro.
UCA1,hepatocellular carcinoma,Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway.
lncRNA-ATB,colorectal cancer,"High lncRNA-ATB expression was significantly associated with greater tumor size, depth of tumor invasion, lymphatic invasion, vascular invasion, and lymph node metastasis.  Additionally, levels of lncRNA-ATB expression were significantly higher in patients with hematogenous metastases."
Arid2-IR,renal inflammation,Arid2-IR is a novel lncRNA that functions to promote NF-KB-dependent renal inflammation. Overexpression of Arid2-IR promoted interleukin-1-induced NF-KB signaling and inflammatory cytokine expression without alteration of TGF-beta1-induced fibrotic response.
TINCR,gastric cancer,"TINCR is strongly upregulated in human gastric carcinoma (GC), where it was found to contribute to oncogenesis and cancer progression. TINCR overexpression is induced by nuclear transcription factor SP1. TINCR contributes to the oncogenic potential  of GC and may constitute a potential therapeutic target in this disease."
NRON,AIDS,The lncRNA NRON modulates HIV-1 replication in a NFAT-dependent manner and is differentially regulated by early and late viral proteins. Its expression was significantly altered following HIV-1 infection. Its levels were reduced by the early viral accessory protein Nef and increased by the late protein Vpu.
MALAT2,gastric cancer,MALAT2-activated long noncoding RNA indicates a biomarker of poor prognosis in gastric cancer. MALAT2 was frequently over-expressed in cancer tissues and this over-expression was found to significantly correlate with lymph node metastasis and tumor stage.
DRAIC,cancer,"The lncRNA DRAIC/PCAT29 Locus Constitutes a Tumor-Suppressive Nexus. Prostate cancers persisting in patients after androgen deprivation therapy (ADT) select for decreased DRAIC expression, and higher levels of DRAIC in prostate cancer are associated with longer disease-free survival (DFS).  DRAIC expression predicts good prognosis in a wide range of malignancies, including bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma, and stomach adenocarcinoma."
DANCR,postmenopausal osteoporosis,DANCR promoted the expression of IL6 and TNF-alpha at both mRNA level and protein level in MNCs. DANCR level was correlated with IL6 and TNF-alpha in postmenopausal women with low BMD
MRAK052686,nonalcoholic fatty liver disease,"Berberine ameliorates nonalcoholic fatty liver disease by a global modulation of hepatic mRNA and lncRNA expression profiles. MRAK052686, was found strongly correlated with the antioxidant factor Nrf2, and both genes were down-regulated by the steatotic liver. The reduced expression of MRAK052686 and Nrf2 was completely reversed by BBR treatment, suggesting a new mechanism accounting for the therapeutic effect of BBR."
Abhd11os,neurodegenerative diseases,"The striatal long noncoding RNA Abhd11os is neuroprotective against an N-terminal fragment of mutant huntingtin in vivo. Abhd11os overexpression produces neuroprotection against an N-terminal fragment of mutant huntingtin, whereas Abhd11os knockdown is protoxic."
HOTAIR,gastric cancer,HOTAIR Long Noncoding RNA Promotes Gastric Cancer Metastasis through Suppression of Poly r(C)-Binding Protein (PCBP) 1. Our findings provide mechanistic evidence for HOTAIR overexpression and PCBP1 downregulation and the ensuing malignant phenotype in both cultured and xenograft gastric cancer cells.
MALAT1,renal cell carcinoma,"Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205. MALAT1 expression was higher in human RCC tissues, where it was associated with reduced patient survival."
CTBP1-AS,polycystic ovary syndrome,C-Terminal binding protein 1 antisense (CTBP1-AS) was a novel long noncoding RNA  (lncRNA) to regulate AR activity. Expression level of CTBP1-AS in peripheral blood leukocytes was significantly higher in women with PCOS than that in controls after adjustment for age and body mass index (BMI).
LSINCT5,gastric cancer,"The expression of LSINCT5 is significantly upregulated in gastrointestinal cancer tissues and cell lines relative to their normal counterparts. Increased LSINCT5 expression was correlated with a larger tumor size, deeper tumor depth, and advanced clinical stage. Gastric cancer (GC) and colorectal cancer (CRC) patients with higher LSINCT5 expression levels have worse disease-free survival (DFS) and disease-specific survival (DSS) rates."
NBAT1,neuroblastoma,The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation.  Loss of NBAT-1 increases cellular proliferation and invasion.
PCGEM1,prostate cancer,"PCGEM1 overexpression is highly associated with prostate tumors. CGEM1 tumorigenic potential has been recently shown to be in part due to its ability to activate androgen receptor (AR). Here, we report a novel function of PCGEM1 that  provides growth advantages for cancer cells by regulating tumor metabolism via c-Myc activation. PCGEM1 promotes glucose uptake for aerobic glycolysis, coupling with the pentose phosphate shunt to facilitate biosynthesis of nucleotide and lipid, and generates NADPH for redox homeostasis."
SCHLAP1,prostate cancer,"SChLAP1 expression increases with prostate cancer progression,and high SChLAP1 expression by ISH is associated with poor outcome after radical prostatectomy in patients with clinically localized prostate cancer by both univariate and multivariate Cox regression analyses."
UBE3A-ATS,Angelman syndrome,ASO treatment achieved specific reduction of Ube3a-ATS and sustained unsilencing of paternal Ube3a in neurons in vitro and in vivo. Partial restoration of UBE3A protein in an Angelman syndrome mouse model ameliorated some cognitive deficits associated with the disease.
SCHLAP1,prostate cancer,The long non-coding RNA SChLAP1 was identified as the highest-ranked overexpressed gene in cancers with metastatic progression.
PCA3,prostate cancer,"By PCR-based cloning and sequencing in paired peripheral blood leukocytes and prostate tissues,5 PCA3 TAAA STR polymorphisms and 8 genotypes were found in both peripheral blood leukocytes and prostate tissues, the carriers with more TAAA repeats were associated with increased risk for PCa than individuals having less TAAA repeats"
LINC01158,glioma,"By using real-time PCR and gain-/loss-of-function studies,the authors revealed that linc-POU3F3 levels were extraordinarily associated with the tumor WHO grade.In related biochemical assays, overexpression of linc-POU3F3 promotes cell viability and proliferation in glioma cells, whereas knockdown of linc-POU3F3 showed the opposite effect. As expected, they also found that linc-POU3F3 expression was negatively correlated with the mRNA level of POU3F3."
BCAR4,breast cancer,"BCAR4 binding of SNIP1 and PNUTS in response to CCL21 releases the SNIP1's inhibition of p300-dependent histone acetylation, which in turn enables the BCAR4-recruited PNUTS to bind H3K18ac and relieve inhibition of RNA Pol II via activation of the PP1 phosphatase."
MALAT1,multiple myeloma,"MALAT1 was overexpressed in the newly diagnosed patients compared with post-treatment patients and healthy individuals. The expression of MALAT1 strongly correlated with disease status, and the magnitude of change in MALAT1 post-treatment had prognostic relevance. The patients with early progression had a significantly smaller change in MALAT1 after treatment."
NEAT1,infertility,"Neat1 knockout (KO) mice stochastically fail to become pregnant despite normal ovulation. Unilateral transplantation of wild-type ovaries or the administration of progesterone partially rescued the phenotype, suggesting that corpus luteum dysfunction and concomitant low progesterone were the primary causes of the decreased fertility. In contrast to the faint expression observed in most of the adult tissues, Neat1 was highly expressed in the corpus luteum, and the formation of luteal tissue was severely impaired in nearly half of the Neat1 KO mice"
MALAT1,diabetes mellitus,"MALAT1 expression is significantly upregulated in the retinas of STZ-induced diabetic rats and db/db mice. MALAT1 knockdown could obviously ameliorate DR in vivo, as shown by pericyte loss, capillary degeneration, microvascular leakage, and retinal inflammation. Moreover, MALAT1 knockdown could regulate retinal endothelial cell proliferation, migration, and tube formation in vitro. The crosstalk between MALAT1 and p38 MAPK signaling pathway is involved in the regulation of endothelial cell function."
ENST00000480739,pancreatic ductal adenocarcinoma,the ENST00000480739 expression level was remarkably
lnc-SCA7,spinocerebellar ataxia,"STAGA is required for the transcription initiation of miR-124, which in turn mediates the post-transcriptional cross-talk between lnc-SCA7, a conserved long noncoding RNA,and ATXN7 mRNA. In SCA7, mutations in ATXN7 disrupt these regulatory interactions and result in a neuron-specific increase in ATXN7 expression. Strikingly, in mice this increase is most prominent in the SCA7 disease-relevant tissues, namely the retina and cerebellum."
CERNA2,epithelial ovarian cancer,"EOC-specific lncRNA-HOST2, which acts as a miRNA sponge, sequesters let-7b to maintain the expression of oncogenes and further maintains EOC biological functions."
GAPLINC,gastric cancer,"GAPLINC is a 924-bp-long lncRNA that is highly expressed in gastric cancer tissues. GAPLINC suppression and with gene expression profiling in gastric cancer cells revealed alterations in cell migration pathways, with CD44 expression the most highly correlated. Manipulating GAPLINC"
RP5-833A20.1,atherosclerosis,"Using microarray analysis, the authors found that long noncoding RNA RP5-833A20.1 expression was upregulated, whereas nuclear factor IA (NFIA) expression was downregulated in human acute monocytic leukemia macrophage-derived foam cells. Moreover, they showed that long noncoding RNA RP5-833A20.1 maydecreases NFIA expression by inducing hsa-miR-382-5p expression in vitro. "
LINC-ROR,breast cancer,LincRNA-RoR is upregulated in TNBC and in metastatic disease and knockdown restores miR-145 expression.The lincRNA-RoR/miR-145/ARF6 pathway is critical to TNBC metastasis and could serve as biomarkers or therapeutic targets for improving survival.
AC006050.3,lung squamous cell carcinoma,"The expression of lncRNA AC006050.3-003 was significantly lower in PR samples compared to the PD samples in another 60 lung squamous cell carcinoma patients. Receiver operating characteristic curve analysis revealed that lncRNA AC006050.3-003 was a valuable biomarker for differentiating PR patients from PD patients with an area under the curve of 0.887 (95% confidence interval 0.779, 0.954)."
LOC285194,esophageal squamous cell carcinoma,"LOC285194 expression was significantly down-regulated in ESCC tumor tissues when compared with the adjacent normal tissues. Low expression of LOC285194 was associated with larger tumor size, advanced TNM stage, more lymph node metastases and distant metastases."
AB074278,bladder cancer,"We implicate upregulation of AB074278 in apoptosis avoidance and the maintenance of a proproliferative state in cancer through a potential interaction with EMP1, a tumor suppressor and a negative regulator of cell proliferation."
XIST,membranous nephropathy,"Urinary XIST is significantly elevated in  urine samples from patients with different types of glomerular nephritis, including MN, compared to normal counterparts."
CDKN2B-AS1,endometriosis,Rs10965235 SNP in the CDKN2B-AS gene was significantly associated with endometriosis in this Korean population.
WNT4,endometriosis,Rs10965235 SNP in the rs16826658 SNP near the WNT4 gene was significantly associated with endometriosis in this Korean population.
HOTAIR,renal carcinoma,Suppressed expression of long non-coding RNA HOTAIR inhibits proliferation and tumourigenicity of renal carcinoma cells.
UCA1,urinary bladder,UCA1 expression was found in T24 cell line and also found to be significantly higher in the cancer group as compared to the controls
HA117,Hirschsprung's disease,HA117 expression in stenotic segment was higher compared to proximal anastomosis and dilated segment (p < 0.05); HA117 may be a factor exerting an anti-differentiation or anti-maturation role in the genesis of HSCR.
HOTAIR,laryngeal squamous cell carcinoma,The expression of exosomal miR-21 and HOTAIR was significantly higher in patients with laryngeal squamous cell carcinomaLSCC than those with vocal cord  polyps; The patients with lymph node metastasis had higher serum exosomal miR-21 and HOTAIR expressions than those without.
TARID,cancer,Long noncoding RNA TARID directs demethylation and activation of the tumor suppressor TCF21 via GADD45A.
PVT1,hepatocellular carcinoma,Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2
PVT1,cancer,"A single supernumerary segment encompassing all four genes(Myc gene or the region encompassing PVT1, Ccdc26 and Gsdmc ) successfully promotes cancer; PVT1 RNA and MYC protein expression correlated in primary human tumours, and copy number of PVT1 was co-increased in more than 98% of MYC-copy-increase cancers."
HIF1A-AS1,acute myocardial infarction,Level of hypoxia inducible factor 1A antisense RNA 2 was higher in patients with MI than in healthy volunteers (P<0.01)
CDKN2B-AS1,acute myocardial infarction,Level of ANRIL was lower in patients with MI (P=0.003)Patients with ST-segment-elevation MI had lower level of ANRIL (P<0.001)when compared with patients with non-ST-segment-elevation MI.
KCNQ1OT1,acute myocardial infarction,Level of KCNQ1OT1 was higher in patients with MI than in healthy volunteers (P<0.01);Patients with ST-segment-elevation MI had lower levels of KCNQ1OT1 (P<0.001)when compared with patients with non-ST-segment-elevation
MALAT1,acute myocardial infarction,Level of metastasis-associated lung adenocarcinoma transcript 1 was higher in patients with MI than in healthy volunteers (P<0.01); Patients with ST-segment-elevation MI had lower levels of metastasis-associated lung adenocarcinoma transcript 1 (P=0.005) when compared with patients with non-ST-segment-elevation
MIAT,acute myocardial infarction,Patients with ST-segment-elevation MI had lower levels of myocardial infarction-associated transcript (P<0.001)when compared with patients with non-ST-segment-elevation
XLOC_004562,H.pylori-related diseases,"Using qPCR,the five lncRNAs were found differentially expressed in H. pylori-infected gastric epithelial cells"
XLOC_005912,H.pylori-related diseases,"Using qPCR,the five lncRNAs were found differentially expressed in H. pylori-infected gastric epithelial cells"
XLOC_000620,H.pylori-related diseases,"Using qPCR,the five lncRNAs were found differentially expressed in H. pylori-infected gastric epithelial cells"
XLOC_004122,H.pylori-related diseases,"Using qPCR,the five lncRNAs were found differentially expressed in H. pylori-infected gastric epithelial cells"
XLOC_014388,H.pylori-related diseases,"Using qPCR,the five lncRNAs were found differentially expressed in H. pylori-infected gastric epithelial cells"
Asb3,cardiovascular and renal disease,"The protein expression status of 4 target genes, Asb3, Chac2, Pex11b, and Sp5, were differentially expressed between the relevant strain comparisons, thereby suggesting that the differentially expressed lncRNAs associated with these genes are candidate genetic determinants of blood pressure"
Chac2,cardiovascular and renal disease,"The protein expression status of 4 target genes, Asb3, Chac2, Pex11b, and Sp5, were differentially expressed between the relevant strain comparisons, thereby suggesting that the differentially expressed lncRNAs associated with these genes are candidate genetic determinants of blood pressure"
Pex11b,cardiovascular and renal disease,"The protein expression status of 4 target genes, Asb3, Chac2, Pex11b, and Sp5, were differentially expressed between the relevant strain comparisons, thereby suggesting that the differentially expressed lncRNAs associated with these genes are candidate genetic determinants of blood pressure"
Sp5,cardiovascular and renal disease,"The protein expression status of 4 target genes, Asb3, Chac2, Pex11b, and Sp5, were differentially expressed between the relevant strain comparisons, thereby suggesting that the differentially expressed lncRNAs associated with these genes are candidate genetic determinants of blood pressure"
GSEC,colon cancer,GSEC plays an important role in colon cancer cell migration by inhibiting the function of DHX36 via its G-quadruplex structure.
AFAP1-AS1,lung adenocarcinoma,Knockdown of the up-regulated lncRNA AFAP1-AS1 impaired LUAD cell proliferation.
LINC00511,lung adenocarcinoma,Knockdown of the up-regulated lncRNA LINC00511 impaired LUAD cell proliferation
PVT1,lung squamous cell carcinoma,Knockdown of PVT1 inhibited LUSC cell growth.
H19,diabetic cardiomyopathy,LncRNA H19/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy.
NONHSAT076747,papillary thyroid carcinoma,The lncRNAs NONHSAT076747 was associated with lymph node metastasis.
NONHSAT122730,papillary thyroid carcinoma,The lncRNAs NONHSAT122730 was associated with lymph node metastasis
NONHSAG051968,papillary thyroid carcinoma,NONHSAG051968 expression was egatively correlated with tumor size
PVT1,gastric cancer,PVT1 which facilitates gastric cancer growth and invasion is an important epigenetic regulator with a critical role in human tumors.
PVT1,prostate cancer,LncRNA PVT1 was overexpressed in prostate cancer and played an oncogenic role in the progression of prostate cancer.
MEG3,bladder cancer,Low expression of MEG3 was associated with poor recurrence-free survival
HOXA11-AS,cervical cancer,The long noncoding RNA HOXA11 antisense induces tumor progression and stemness maintenance in cervical cancer.
NBR2,cancer,NBR2 deficiency sensitizes cancer cells to phenformin-induced cell death.
TUG1,breast cancer,LncRNA TUG1 promotes breast cancer cell proliferation via inhibiting miR-9
ASBEL,colorectal cancer,ASBEL-TCF3-mediated down-regulation of ATF3 expression is required for the proliferation and tumorigenicity of colon tumor cells.
HIT,non-small cell lung cancer,"LncRNA-HIT promotes cell migration, invasion, tumor growth, and metastasis."
FOXP4-AS1,colorectal cancer,FOXP4-AS1 was up-regulated in CRC tissues and cell lines and that its overexpression positively correlated with advanced pathological stages and larger tumour size.
HOTAIRM1,leukemia,HOTAIRM1 is a promising lncRNA biomarker in leukemia and solid tumors.
H19,calcific aortic valve disease,H19 induces a strong osteogenic phenotype by altering the NOTCH1 pathway and H19 silenced NOTCH1 by preventing the recruitment of p53 to its promoter.
H19,colorectal cancer,"H19 silencing blocked  G1-S transition, reduced cell proliferation, and inhibited cell migration."
SNHG18,glioma,The expression of SNHG18 was remarkably upregulated in clinical glioma tissues compared with normal brain tissues.
91H,breast cancer,91H may play essential role in breast cancer development.
AFAP1-AS1,esophageal squamous cell carcinoma,AFAP1-AS1 is upregulated and promotes esophageal squamous cell carcinoma cell proliferation and inhibits cell apoptosis.
PCAT14,prostate cancer,"Low PCAT-14 expression increased migration while overexpressing PCAT-14 reduced cellular growth, migration, and invasion."
HOTAIR,cervical cancer,"Exosomal lncRNA HOTAIR may have great potential to be used  for the early detection and diagnosis of cervical cancer, and serve as convenient and noninvasive biomarkers."
MALAT1,cervical cancer,"Exosomal lncRNA MALAT1 may have great potential to be used  for the early detection and diagnosis of cervical cancer, and serve as convenient and noninvasive biomarkers."
MEG3,cervical cancer,"Exosomal lncRNA MEG3 may have great potential to be used  for the early detection and diagnosis of cervical cancer, and serve as convenient and noninvasive biomarkers."
H19,gastric cancer,Its role is a potential non-invasive diagnostic biomarker in gastric cancer and as a novel tool in gastric cancer management
LOC100287225,colorectal cancer,The misregulation of DCC and LOC100287225 is concurrent in colorectal cancer.
AK098081,colorectal cancer,High expression of AK098081 indicated poor CRC differentiation.
BC040303,colorectal cancer,Low expression of BC040303 indicated poor CRC differentiation.
BC037331,colorectal cancer,Low expression of BC037331 indicated poor CRC differentiation.
CR749831,colorectal cancer,Low expression of CR749831 indicated poor CRC differentiation.
RAMP2-AS1,glioblastoma,RAMP2-AS1 might play a tumor suppressive role in GBM through an indirect inhibition of NOTCH3.
linc-cdh4-2,hepatocellular carcinoma,Long non-coding RNA linc-cdh4-2 inhibits the migration and invasion of HCC cells  by targeting R-cadherin pathway.
Uph,right ventricular hypoplasia,Hand2-associated long non-coding RNA upperhand (Uph) is required to maintain the super-enhancer signature and elongation of RNA polymerase II through the Hand2 enhancer locus.
HULC,hepatocellular carcinoma,"HULC promotes tumorigenesis by regulating multiple pathways, such as down-regulation of EEF1E1, promotion of abnormal lipid metabolism, and up-regulation of sphingosine kinase 1."
HULC,gastric cancer,"HULC promotes tumorigenesis by regulating multiple pathways, such as down-regulation of EEF1E1, promotion of abnormal lipid metabolism, and up-regulation of sphingosine kinase 1."
HULC,pancreatic cancer,"HULC promotes tumorigenesis by regulating multiple pathways, such as down-regulation of EEF1E1, promotion of abnormal lipid metabolism, and up-regulation of sphingosine kinase 1."
HULC,osteosarcoma,"HULC promotes tumorigenesis by regulating multiple pathways, such as down-regulation of EEF1E1, promotion of abnormal lipid metabolism, and up-regulation of sphingosine kinase 1."
HULC,colorectal cancer,"HULC promotes tumorigenesis by regulating multiple pathways, such as down-regulation of EEF1E1, promotion of abnormal lipid metabolism, and up-regulation of sphingosine kinase 1."
U90926,obesity,Overexpression lnc-U90926 attenuated 3T3-L1 adipocyte differentiation 
UCA1,breast cancer,UCA1 was upregulated by SATB1 depletion and SATB1 is highly expressed in aggressive breast cancer cells and promotes growth and metastasis by reprograming gene expression.
LINC-ROR,gallbladder cancer,LncRNA-ROR plays an important role in the development of gallbladder cancer and mediates the EMT in gallbladder cancer.
numb,uveal melanoma,LncRNA-numb is a newly proposed tumor suppressor that is involved in HIC1-induced phenotypes.
HOTAIRM1,colorectal cancer,HOTAIRM1 as a potential biomarker for diagnosis of colorectal cancer functions the role in the tumour suppressor.
MALAT1,breast cancer,Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer.
NEAT1,nasopharyngeal carcinoma,The long non-coding RNA NEAT1 regulates epithelial to mesenchymal transition and  radioresistance in through miR-204/ZEB1 axis in nasopharyngeal carcinoma.
GAS5,ovarian cancer,"Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer."
RP5-833A20.1,glioma,The mechanisms by which RP5-833A20.1 regulates the expression of NFIA in glioma were investigated.
MEG3,esophageal squamous cell carcinoma,"Ectopic expression of MEG3 in ESCC cells inhibited cell proliferation, promoted apoptosis, and suppressed metastasis."
MALAT1,non-small cell lung cancer,"MALAT1 is thought to regulate tumor cell viability, invasiveness and migration "
MALAT1,hepatocellular carcinoma,"MALAT1 is thought to regulate tumor cell viability, invasiveness and migration "
MALAT1,gastric cancer,"MALAT1 is thought to regulate tumor cell viability, invasiveness and migration "
MALAT1,pancreatic cancer,"MALAT1 is thought to regulate tumor cell viability, invasiveness and migration"
MALAT1,colorectal cancer,"MALAT1 is thought to regulate tumor cell viability, invasiveness and migration"
MALAT1,renal clear cell carcinoma,"MALAT1 is thought to regulate tumor cell viability, invasiveness and migration "
MALAT1,esophageal cancer,"MALAT1 is thought to regulate tumor cell viability, invasiveness and migration "
MALAT1,gallbladder cancer,"MALAT1 is thought to regulate tumor cell viability, invasiveness and migration "
MALAT1,bladder cancer,"MALAT1 is thought to regulate tumor cell viability, invasiveness and migration "
MALAT1,osteosarcoma,"MALAT1 is thought to regulate tumor cell viability, invasiveness and migration "
MALAT1,breast cancer,"MALAT1 is thought to regulate tumor cell viability, invasiveness and migration "
DBCCR1,bladder cancer,Long non-coding RNA DBCCR1-003 regulate the expression of DBCCR1 via DNMT1 in bladder cancer.
CRNDE,chronic lymphocytic leukemia,The novel lncRNA CRNDE was validated in an independent CLL sample cohort.
AC012065.7,chronic lymphocytic leukemia,The novel lncRNA AC012065.7 was validated in an independent CLL sample cohort.
JPX,hepatocellular carcinoma,JPX expression levels were independent prognostic factors for HCC overall survival rates.
XIST,hepatocellular carcinoma,XIST expression levels were independent prognostic factors for HCC overall survival rates.
ZEB2-AS1,hepatocellular carcinoma,Downregulation of ZEB2-AS1 decreased tumor growth and metastasis in hepatocellular carcinoma
UCA1,esophageal cancer,LncRNA-UCA1 enhances cell proliferation through functioning as a ceRNA of Sox4 in esophageal cancer.
SNHG7,lung cancer,"LncRNA-SNHG7 promotes the proliferation, migration and invasion and inhibits apoptosis of lung cancer cells by enhancing the FAIM2 expression."
MEG3,vulvar squamous cell carcinoma,LncRNAs (MEG3 and MALAT1) were also identified as potential biomarkers as they also correlated with VSCC carcinogenesis.
MALAT1,vulvar squamous cell carcinoma,LncRNAs (MEG3 and MALAT1) were also identified as potential biomarkers as they also correlated with VSCC carcinogenesis.
PVT1,cervical cancer,Long noncoding RNA PVT1 Is a novel serum biomarker for detection of cervical cancer.
HULC,cervical cancer,"The expression of HULC was upregulated in cervical cancer, and associated with overall survival, indicating that HULC may serve as a predictive biomarker for the prognosis of cervical cancer."
CRNDE,glioma,lncRNA CRNDE was associated with tumor progression and could be an independent prognostic factor for glioma patients.
AB073614,glioma,Knockdown of long noncoding RNA AB073614 inhibits glioma cell proliferation and migration via affecting epithelial-mesenchymal transition.
NEAT1,renal syndrome,The reduced NEAT1 level is correlated with the epidemic of HFRS
RP1130-1,hepatocellular carcinoma,"The expression of LINC RP1130-1 was associated with clinical stage, the number of tumors, portal vein tumor thrombus (PVTT), and microvascular invasion (MVI)."
H19,glioma,The lncRNA H19 interacts with miR-140 to modulate glioma growth by targeting iASPP.
MEG3,stroke,Long noncoding RNA MEG3 activation of p53 mediates ischemic neuronal death in stroke.
LINC00161,osteosarcoma,Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis.
H19,lung cancer,H19 lncRNA regulates the process of NSCLC metastasis.
Unigene56159,hepatocellular carcinoma,Long non-coding RNA Unigene56159 promotes epithelial-mesenchymal transition by acting as a ceRNA of miR-140-5p in hepatocellular carcinoma cells.
UCA1,pancreatic cancer,Long non-coding RNA UCA1 promotes the tumorigenesis in pancreatic cancer.
HCG11,prostate cancer,Downregulation of long non-coding RNA HCG11 predicts a poor prognosis in prostate cancer.
MEG3,thrombocytopenic purpura,Long non-coding RNA MEG3 inhibits microRNA-125a-5p expression and induces immune imbalance of Treg/Th17 in immune thrombocytopenic purpura.
CCDC26,pancreatic cancer,Long noncoding RNA CCDC26 as a potential predictor biomarker contributes to tumorigenesis in pancreatic cancer
MALAT1,Parkinson's disease,β1-Asarone functions as a neuroprotective effect in both in vivo and in vitro models of PD via regulating MALAT1 and α-synuclein expression.
MALAT1,esophageal cancer,The expression of MALAT1 could be a predictor for prognosis of EC patients.
CCEPR,hepatocellular carcinoma,Long noncoding RNA CCHE1 indicates a poor prognosis of hepatocellular carcinoma and promotes carcinogenesis via activation of the ERK/MAPK pathway.
MEG3,cholestatic liver injury,LncRNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate Shp mRNA decay.
RMRP,gastric cancer,LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer.
MALAT1,breast cancer,"MALAT1 overexpression was also associated with poor RFS in tamoxifen  treated ER-positive breast cancer patients, which might serve as a potential biomarker to predict endocrine treatment sensitivity."
DANCR,prostate cancer,Long noncoding RNA DANCR promotes invasion of prostate cancer throughepigenetically silencing expression of TIMP2/3.
MALAT1,gallbladder cancer,Long non-coding RNA MALAT1 promotes gallbladder cancer development by acting as a molecular sponge to regulate miR-206.
TUSC7,glioma,"Up-regulation of TUSC7 suppressed cellular proliferation and invasion of glioma cells, and accelerated cellular apoptosis."
UCA1,breast cancer,UCA1 confers tamoxifen resistance to breast cancer cells partly via activating the mTOR signaling pathway.
CCAT1,glioma,Long non-coding RNA CCAT1 promotes glioma cell proliferation via inhibiting microRNA-410.
H19,ovarian cancer,H19 may be involved in the pathogenesis of ovarian carcinomas.
UCA1,ovarian cancer,UCA1 may be involved in the pathogenesis of ovarian carcinomas.
MEG3,nasopharyngeal carcinoma,MEG3 is a tumor suppressive long non-coding RNA in NPC and encourages the development of precise long non-coding RNA-targeted epigenetic therapy against this malignancy.
UCA1,bladder cancer,Long non-coding RNA UCA1 promotes cisplatin/gemcitabine resistance through CREB modulating miR-196a-5p in bladder cancer cells.
AGAP2-AS1,glioma,"Knockdown of AGAP2-AS1 can inhibit the cell proliferation, migration and invasion, while increase the apoptosis cell rates in vitro."
TPT1-AS1,glioma,"AGAP2-AS1, LINC01198 and MIR155HG were increased with tumor grade, while TPT1-AS1 was decreased."
LINC01198,glioma,"AGAP2-AS1, LINC01198 and MIR155HG were increased with tumor grade, while TPT1-AS1 was decreased."
MIR155HG,glioma,"AGAP2-AS1, LINC01198 and MIR155HG were increased with tumor grade, while TPT1-AS1 was decreased."
TUG1,diabetes mellitus,A direct interaction between PGC-1α and TUG1 modulates mitochondrial bioenergetics in podocytes in the diabetic milieu.
TUG1,chronic kidney disease,The long noncoding RNA TUG1 connects metabolic changes with kidney disease in podocytes.
SRA,nonalcoholic fatty liver disease,A novel function of SRA is promoting hepatic steatosis through repression of ATGL expression.
MIR2052HG,breast cancer,"NAi-mediated silencing of MIR2052HG in breast cancer cell lines decreased Erα expression, cell proliferation and anchorage-independent colony formation."
Ppp1r1b,congenital heart defect,"Ppp1r1b-lncRNA was identified as a regulator of Tcap expression, with dynamic interaction in postnatal cardiac development and congenital heart defects."
GPC3-AS1,hepatocellular carcinoma,"GPC3-AS1 significantly promotes HCC progression via epigenetically activating GPC3, and identifies GPC3-AS1 as a potential therapeutic target for HCC."
GIHCG,hepatocellular carcinoma,Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
ENSMUST00000147869,diabetic nephropathy,Long non-coding RNA ENSMUST00000147869 protects mesangial cells from proliferation and fibrosis induced by diabetic nephropathy.
HOTAIR,gastric cancer,Dioscin inhibits gastric tumor growth through regulating the expression level of lncRNA HOTAIR.
RP11-702B10.1,esophageal cancer,LncRNA signature has clinical significance for the prognosis of patients with ESCC.
RP11-523H24.3,esophageal cancer,LncRNA signature has clinical significance for the prognosis of patients with ESCC.
H19,ulcerative colitis,The destructive effect of H19 overexpression on intestinal epithelial barrier function and suggests a potential role of H19 in the development of UC.
CYTOR,colon cancer,Linc00152 as a candidate prognostic indicator of outcome and drug responsiveness in colon cancer patients
H19,pancreatic ductal adenocarcinoma,The long noncoding RNA H19 promotes cell proliferation via E2F-1 in pancreatic ductal adenocarcinoma
HOTTIP,hepatocellular carcinoma,"Dysregulation of HOTTIP is associated with various malignancies including hepatocellular carcinoma, pancreatic cancer, gastric cancer and colorectal cancer."
HOTTIP,pancreatic cancer,"Dysregulation of HOTTIP is associated with various malignancies including hepatocellular carcinoma, pancreatic cancer, gastric cancer and colorectal cancer."
HOTTIP,gastric cancer,"Dysregulation of HOTTIP is associated with various malignancies including hepatocellular carcinoma, pancreatic cancer, gastric cancer and colorectal cancer."
HOTTIP,colorectal cancer,"Dysregulation of HOTTIP is associated with various malignancies including hepatocellular carcinoma, pancreatic cancer, gastric cancer and colorectal cancer."
KIAA0087,endometrial cancer,lncRNA may be the core regulators ofendometrial carcinogenesis.
RP11-501O2,endometrial cancer,lncRNA may be the core regulators ofendometrial carcinogenesis.
FAM212B-AS1,endometrial cancer,lncRNA may be the core regulators ofendometrial carcinogenesis.
LOC102723552,endometrial cancer,lncRNA may be the core regulators ofendometrial carcinogenesis.
RP11-140I24,endometrial cancer,lncRNA may be the core regulators ofendometrial carcinogenesis.
RP11-600K151,endometrial cancer,lncRNA may be the core regulators ofendometrial carcinogenesis.
HOTAIR,acute leukemia,HOTAIR may be involved in the development of leukemia by mediating methylation of DNA and histones.
GAS5,prostate cancer,LncRNA GAS5 inhibits proliferation and progression of prostate cancer by targeting miR-103 through AKT/mTOR signaling pathway.
PCA3,prostate cancer,"Snail-activated long non-coding RNA PCA3 up-regulates PRKD3 expression by miR-1261 sponging, thereby promotes invasion and migration of prostate cancer cells."
H19,malignant digestive cancer,"The patient group of high H19 expression had a higher risk of poorly differentiated grade, deep tumor invasion (T2 stage or more), lymph node metastasis, and advanced TNM stage than the group of low H19 expression,"
HOTTIP,glioma,Over-expression of the long non-coding RNA HOTTIP inhibits glioma cell growth by BRE.
GAPLINC,gastric cancer,GAPLINC was overexpressed in GC tissues and promoted tumor migration and invasive behavior.
ENST00000438347,hepatocellular carcinoma,ENST00000438347 was up-regulated in MHCC97H-OXA cells as well as chemo-resistant HCC cancerous tissues.
LINC00601,hepatocellular carcinoma,NR_073453 was up-regulated in MHCC97H-OXA cells as well as chemo-resistant HCC cancerous tissues.
CXCL1P1,hepatocellular carcinoma,ENST00000502804 was up-regulated in MHCC97H-OXA cells as well as chemo-resistant HCC cancerous tissues.
CASC11,hepatocellular carcinoma,The expression of ENST00000518376 was significantly associated with the tumor size and differentiation.
CTD-2616J11.14,gastric cancer,The lncRNA was significantly associated with the overall survival of patients with gastric cancer.
RP1-90G24.10,gastric cancer,The lncRNA was significantly associated with the overall survival of patients with gastric cancer.
RP11-150O12.3,gastric cancer,The lncRNA was significantly associated with the overall survival of patients with gastric cancer.
RP11-1149O23.2,gastric cancer,The lncRNA was significantly associated with the overall survival of patients with gastric cancer.
MAP3K20-AS1,gastric cancer,The lncRNA was significantly associated with the overall survival of patients with gastric cancer.
BC032469,esophageal squamous cell carcinoma,Upregulated long non-coding RNA BC032469 enhances carcinogenesis and metastasis of esophageal squamous cell carcinoma through regulating hTERT expression.
MALAT1,uveal melanoma,Long noncoding RNA MALAT1 promotes uveal melanoma cell growth and invasion by silencing of miR-140.
DANCR,breast cancer,The degradation of EZH2 mediated by lncRNA ANCR attenuated the invasion and metastasis of breast cancer.
H19,gallbladder cancer,Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer.
LRRC75A-AS1,rheumatoid arthritis,The dysregulation of ENST00000483588 may be involved in the pathological processes of RA
ENST00000438399,rheumatoid arthritis,The dysregulation of ENST00000438399 may be involved in the pathological processes of RA
uc004afb.1,rheumatoid arthritis,The dysregulation of uc004afb.1 may be involved in the pathological processes of RA
RPKG1-AS1,rheumatoid arthritis,The dysregulation of ENST00000452247 may be involved in the pathological processes of RA
CRNDE,renal cell carcinoma,Highly expressed lncRNA CRNDE promotes cell proliferation through Wnt/β1-catenin signaling in renal cell carcinoma.
NEXN-AS1,lung cancer,A Novel Genetic Variant in Long Non-coding RNA Gene NEXN-AS1 is Associated with Risk of Lung Cancer.
uc.338,lung cancer,Knockdown of Long Noncoding RNA uc.338 by siRNA Inhibits Cellular Migration and Invasion in Human Lung Cancer Cells.
MALAT1,hemangioma,MALAT1 knockdown induced apoptosis and S-phase cell cycle arrest in human umbilical vein endothelial cells (HUVECs).
PVT1,esophageal cancer,Upregulation of lncRNA PVT1 may induce epithelial-to-mesenchymal transition (EMT) by regulating the expression levels of EMT markers
LINC-ROR,colorectal cancer,The long non-coding RNA-ROR promotes the resistance of radiotherapy for human colorectal cancer cells by targeting the P53/miR-145 pathway.
MALAT1,thyroid cancer,MALAT1 may function both as an oncogene and as a tumor suppressor in different types of thyroid tumors.
HOTAIR,lung cancer,"A specific negative regulation loop of lncRNA HOTAIR and p53 in NSCLC cells, which revealed a new understanding of tumorigenesis in p53 dysfunction NSCLC cells."
UCA1,gastric cancer,Long Non-Coding RNA (LncRNA) Urothelial Carcinoma Associated 1 (UCA1) Increases Multi-Drug Resistance of Gastric Cancer via Downregulating miR-27b.
TUG1,ovarian cancer,Long non-coding RNA TUG1 regulates ovarian cancer proliferation and metastasis via affecting epithelial-mesenchymal transition.
HOTAIR,ovarian cancer,HOTAIR rs920778 polymorphism is associated with ovarian cancer susceptibility and poor prognosis in a Chinese population.
MSNP1AS,autism spectrum disorder,The mechanisms by which MSNP1AS overexpression impacts neuronal differentiation may involve protein synthesis and chromatin structure.
uc.345,pancreatic cancer,Long noncoding RNA uc.345 promotes tumorigenesis of pancreatic cancer by upregulation of hnRNPL expression.
GATA6-AS1,chronic lymphocytic leukemia,BM742401 is a tumor suppressor lncRNA inactivated by DNA methylation in chronic lymphocytic leukemia (CLL).
GATA6-AS1,gastric cancer,BM742401 is a tumor suppressor lncRNA downregulated in gastric cancer.
CDKN2B-AS1,osteosarcoma,Long noncoding RNA ANRIL is activated by hypoxia-inducible factor-1α and promotes osteosarcoma cell invasion and suppresses cell apoptosis upon hypoxia.
lnc-MGC,diabetic nephropathy,"A chemically modified oligonucleotide targeting lnc-MGC inhibits cluster microRNAs, glomerular ECM and hypertrophy in diabetic mice. "
HOTAIR,cervical cancer,Those exhibiting high HOTAIR levels and molecular signatures of metastasis and those lacking such signatures in the presence of low HOTAIR expression levels.
LOC285194,colorectal cancer,"Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls."
RP11-462C24.1,colorectal cancer,"Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls."
SNHG16,colorectal cancer,"Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls."
PCGEM1,prostate cancer,PCGEM1 is a long non-coding RNA (lncRNA) that is often upregulated in prostate cancer.
H19,gastric cancer,H19 plays a key role in tumorigenesis
lncCAMTA1,liver cancer,Long Noncoding RNA lncCAMTA1 Promotes Proliferation and Cancer Stem Cell-Like Properties of Liver Cancer by Inhibiting CAMTA1.
ASAP1-IT1,ovarian cancer,Long non-coding RNAs (lncRNAs) are a class of non-protein coding transcripts that has gained significant attention lately due to their important biological actions and potential involvement in cancer.
FAM215A,ovarian cancer,Long non-coding RNAs (lncRNAs) are a class of non-protein coding transcripts that has gained significant attention lately due to their important biological actions and potential involvement in cancer.
LINC00472,ovarian cancer,Long non-coding RNAs (lncRNAs) are a class of non-protein coding transcripts that has gained significant attention lately due to their important biological actions and potential involvement in cancer.
DSCAM-AS1,breast cancer,DSCAM-AS1 mediates tumour progression and tamoxifen resistance and identify hnRNPL as an interacting protein involved in the mechanism of DSCAM-AS1 action.
NEAT1,endometrial cancer,"Overexpression of long noncoding RNA, NEAT1 promotes cell proliferation, invasion and migration in endometrial endometrioid adenocarcinoma."
RP11-248E9.5,pneumonia,These novel lncRNAs and their target genes may be closely associated with the progression of pneumonia.
RP11-456D7.1,pneumonia,These novel lncRNAs and their target genes may be closely associated with the progression of pneumonia.
CPS1-IT1,lung cancer,Long noncoding RNA CPS1-IT1 suppresses cell proliferation and metastasis in human lung cancer.
HOTAIR,osteosarcoma,"HOTAIR functioned as a carcinogenic lncRNA, which could promote the proliferation and inhibit the apoptosis of MG-63 cells in vitro."
HOTAIR,gastrointestinal stromal tumor,Promoter methylation of PCDH10 by HOTAIR regulates the progression of gastrointestinal stromal tumors.
TUG1,osteosarcoma,Long non-coding RNA TUG1 contributes to tumorigenesis of human osteosarcoma by sponging miR-9-5p and regulating POU2F1 expression.
MALAT1,cervical cancer,MiR-375 Is Epigenetically Downregulated by HPV-16 E6 Mediated DNMT1 Upregulation  and Modulates EMT of Cervical Cancer Cells by Suppressing lncRNA MALAT1.
ERL,Marek's disease,"The 7493-nt ERL lncRNA (edited repeat-long long non-coding RNA), which may act as a natural antisense transcript (NAT) of the major GaHV-2 oncogene meq and of two of the three miRNA clusters."
MALAT1,renal cell carcinoma,lncRNA MALAT-1-mediated promotion of RCC proliferation and metastasis may be due to the upregulation of the expression of Livin.
ZFAS1,gastric cancer,LncRNAs play critical roles in gastric cancer (GC)
HOXA11-AS,gastric cancer,"LncRNA HOXA11-AS promotes proliferation and invasion of gastric cancer by scaffolding the chromatin modification factors PRC2, LSD1 and DNMT1."
lnc-RTN4R-1,acute lymphoblastic leukemia,Lnc-RTN4R-1 and lnc-NKX2-3-1 as lncRNAs that might be functionally implicated in the biology of this prevalent subtype of human leukemia.
lnc-NKX2-3-1,acute lymphoblastic leukemia,Lnc-RTN4R-1 and lnc-NKX2-3-1 as lncRNAs that might be functionally implicated in the biology of this prevalent subtype of human leukemia.
NONHSAT089447,schizophrenia,LncRNA NONHSAT089447 and NONHSAT041499 might be involved in the pathogenesis and development of SZ
NONHSAT041499,schizophrenia,LncRNA NONHSAT089447 and NONHSAT041499 might be involved in the pathogenesis and development of SZ
MALAT1,osteosarcoma,MALAT1 may be considered as a prognostic biomarker and therapeutic target for osteosarcoma.
CASC2,gastric cancer,CASC2 might serve as a tumor suppressor lncRNA that  suppressed cell proliferation by inactivation of MAPK pathway.
HNF1A-AS1,osteosarcoma,Upregulation of lncRNA HNF1A-AS1 promotes cell proliferation and metastasis in osteosarcoma through activation of the Wnt/β1-catenin signaling pathway.
IRAIN,pancreatic cancer,Long non-coding RNA IRAIN suppresses apoptosis and promotes proliferation by binding to LSD1 and EZH2 in pancreatic cancer
GACAT3,gastric cancer,Novel long non-coding RNA GACAT3 promotes gastric cancer cell proliferation through the IL-6/STAT3 signaling pathway
SPRY4-IT1,cervical cancer,"LncRNA SPRY4-IT1 may be a novel molecule involved in cervical cancer progression, which  may be of use as both a potential predictor and therapeutic target."
PCBP2-OT1,tongue squamous cell carcinoma,Long noncoding RNA TUC338 overexpression leads to enhanced proliferation and reduced apoptosis in TSCC.
CRNDE,gallbladder cancer,Long non-coding RNA CRNDE promotes gallbladder carcinoma carcinogenesis
TUG1,colon cancer,Overexpression of Long Non-Coding RNA TUG1 Promotes Colon Cancer Progression.
H19,cervical cancer,H19 promotes  both anchorage-specific and -independent growth of cervical cancer cell lines and may serve as a potential target for cancer diagnosis and therapy.
LINC00312,bladder cancer,LINC00312 inhibited BC cell invasion and metastasis through mediating miR-197-3p.
GAS5,non-small cell lung cancer,Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer.
PANDAR,colorectal cancer,The high expression of long non-coding RNA PANDAR indicates a poor prognosis for  colorectal cancer and promotes metastasis by EMT pathway.
UCA1,breast cancer,Long non-coding RNA UCA1 enhances tamoxifen resistance in breast cancer cells through a miR-18a-HIF1α feedback regulatory loop.
AFAP1-AS1,pancreatic ductal adenocarcinoma,"High AFAP1-AS1, UCA1 and low ENSG00000218510 expression were correlated with several tumorigenesis related pathways."
UCA1,pancreatic ductal adenocarcinoma,"High AFAP1-AS1, UCA1 and low ENSG00000218510 expression were correlated with several tumorigenesis related pathways."
LINC00339,pancreatic ductal adenocarcinoma,"High AFAP1-AS1, UCA1 and low ENSG00000218510 expression were correlated with several tumorigenesis related pathways."
H19,pneumoconiosis,Polymorphisms in Long Noncoding RNA H19 Contribute to the Protective Effects of Coal Workers' Pneumoconiosis in a Chinese Population.
LINC00520,breast cancer,"LINC00520 is induced by Src, STAT3, and PI3K and plays a functional role in breast cancer."
NR_026689,ovarian cancer,Knockdown of long noncoding RNA NR_026689 inhibits proliferation and invasion and increases apoptosis in ovarian carcinoma HO-8910PM cells.
HIF-2A,osteosarcoma,HIF-2A and HIF2PUT upregulation may be a common feature in human osteosarcomas with aggressive potency.
SPRY4-IT1,colorectal cancer,Long noncoding RNA SPRY4-IT1 promotes malignant development of colorectal cancer  by targeting epithelial-mesenchymal transition.
XIST,gastric cancer,lncRNA XIST is up-regulated and is associated with aggressive tumor phenotypes and patient survival in gastric cancer
Chaer,cardiac hypertrophy,The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy.
CYTOR,breast cancer,CYTOR plays a role in breast cancer.
RNCR3,diabetes mellitus,RNCR3 knockdown may be a promising strategy for the prevention of diabetes mellitus-induced retinal neurodegeneration.
NKILA,tongue squamous cell carcinoma,Long non-coding RNA NKILA inhibits migration and invasion of tongue squamous cell carcinoma cells via suppressing epithelial-mesenchymal transition.
HOTAIR,ischemic stroke,Long non-coding RNA HOTAIR promotes ischemic infarct induced by hypoxia through up-regulating the expression of NOX2.
NEAT1,ovarian cancer,NEAT1 has a potential to function as a clinical biomarker for predicting disease invasiveness and prognosis of patients with OC.
LINC-ROR,gastric cancer,LncRNA ROR was associated with core stemness transcriptional factors and the pluripotent state of GCSCs
uc009yby.1,renal cell carcinoma,LncRNA uc009yby.1 promotes renal cell proliferation and is associated with poor survival in patients with clear cell renal cell carcinomas.
AC145110.1,breast cancer,LncRNAs might be involved in breast tumorigenesis through the modulation of gene expression in multiple pathologic pathways.
RP1-13P20.6,colorectal cancer,LncRNA-RP1-13P20.6 is a potential biomarker for CRC.
H19,gastric cancer,"Serum H19 and LINC00152 may serve as potential biomarkers for diagnosis of GC, particularly for those with H. pylori infection."
CYTOR,gastric cancer,"Serum H19 and LINC00152 may serve as potential biomarkers for diagnosis of GC, particularly for those with H. pylori infection."
LEF1-AS1,colorectal cancer,NR_029373 and NR_034119 are potential biomarkers for CRC prognosis prediction.
LINC00460,colorectal cancer,NR_029373 and NR_034119 are potential biomarkers for CRC prognosis prediction.
MALAT1,retinal neurodegeneration,Long non-coding RNA MALAT1 regulates retinal neurodegeneration through CREB signaling.
TINCR,bladder cancer,TINCR may be the potential therapeutic target for treating bladder urothelial carcinoma.
MALAT1,tongue squamous cell carcinoma,Long non-coding RNA MALAT-1 modulates metastatic potential of tongue squamous cell carcinomas partially through the regulation of small proline rich proteins.
MALAT1,nasopharyngeal carcinoma,RBM24 suppresses cancer progression by upregulating miR 25 to target MALAT1 in nasopharyngeal carcinoma.
TDRG1,esophageal squamous cell carcinoma,LincRNA-NR_024015 may be a useful marker for the prediction of the biological behavior of ESCC.
AFAP1-AS1,colorectal cancer,Long non-coding RNA AFAP1-AS1 facilitates tumor growth and promotes metastasis in colorectal cancer.
FENDRR,non-small cell lung cancer,"Loss of long noncoding RNA FOXF1-AS1 regulates epithelial-mesenchymal transition, stemness and metastasis of non-small cell lung cancer cells."
HOXC-AS1,atherosclerosis,Induction of cholesterol accumulation by Ox-LDL could be partly suppressed by overexpression of HOXC-AS1.
ZFAS1,hepatocellular carcinoma,ZNFX1-AS1 plays a vital role in HCC progression via regulating the methylation of miR-9 and may be a potential tumor suppressor.
HOTAIR,cervical cancer,HOTAIR plays  an important oncogenic role in cervical cancer and might serve as a marker for cervical cancer prognosis and a potential target for therapeutic intervention.
CCAT1,lung adenocarcinoma,Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells.
PCAT14,prostate cancer,PCAT14 is highly expressed in low grade disease and loss of PCAT14 predicts for disease aggressiveness and recurrence.
LOC100505976,laryngeal squamous cell carcinoma,LOC100505976 might play pivotal roles in the tumorigenesis of LSCC.
XLOC_l2_010636,laryngeal squamous cell carcinoma,XLOC_l2_010636 might play pivotal roles in the tumorigenesis of LSCC.
MALAT1,ovarian cancer,"MALAT1 is a potential biomarker for tumor growth and metastasis, as well as a promising therapeutic target in ovarian cancer, facilitating further ovarian cancer research."
MALAT1,melanoma,Long non-coding RNA MALAT1 acts as a competing endogenous RNA to promote malignant melanoma growth and metastasis by sponging miR-22.
UCA1,oral squamous cell carcinoma,Long non-coding RNA UCA1 contributes to the progression of oral squamous cell carcinoma via regulating WNT/β1-catenin signaling pathway.
CCAT2,prostate cancer,The up-regulation of long non-coding RNA CCAT2 indicates a poor prognosis for prostate cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
CDKN2B-AS1,nasopharyngeal carcinoma,"LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer  progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells."
NEAT1,glioma,"NEAT1 knockdown inhibited GSC cell proliferation, migration and invasion and promoted GSC apoptosis."
lncRNA-ATB,pneumoconiosis,Elevated lncRNA-ATB was associated with CWP risk and may serve as a potential biomarker for CWP.
LINC01138,prostate cancer,LINC01138 promoted the proliferation and inhibited apoptosis of PCa.
SUZ12P1,prostate cancer,SUZ12P1 promoted the proliferation and inhibited apoptosis of PCa.
NEAT1,breast cancer,The dysregulation of the BRCA1/NEAT1/miR-129-5p/WNT4 signaling axis is involved in promoting breast tumorigenesis.
91H,osteosarcoma,91H may be a novel biomarker for risk prognostication and  also provide a clue to the molecular etiology of osteosarcoma.
SLC25A25-AS1,colorectal cancer,"Decreased expression of LncRNA SLC25A25-AS1 promotes proliferation, chemoresistance, and EMT in colorectal cancer cells."
HOTAIR,large B-Cell lymphoma,"HOTAIR expression could be one of possible mechanisms for inducing H3K27me3 via EZH2-related PRC2 activation, and induced H3K27me3 may be strongly related to aggressive DLBCLs which show poor patient outcome."
HOTAIR,papillary thyroid carcinoma,HOTAIR acts as a PTC oncogene via promoting tumorigenic properties of PTC cells.
H19,glioma,Long non-coding RNA H19 regulates glioma angiogenesis and the biological behavior of glioma-associated endothelial cells by inhibiting microRNA-29a.
SNHG20,colorectal cancer,Dysregulation of SNHG20 participates in CRC progression and may serve as a potential therapeutic target in CRC patients.
HOTAIR,laryngeal squamous cell carcinoma,"Suppressing HOTAIR expression stimulated EZH2 expressing, promoted the proliferation of AMC-HN8 cells, and increased the sensitivity to cis-platinum of the LSCC cells."
H19,breast cancer,Plasma H19 may serve as a potential biomarker for BC early screening  and prognosis monitor.
UCA1,endometrial cancer,The UCA1 plays an important role in the metastasis of EC and may serve as a novel molecular marker  to predict the aggressive tumor progression and unfavorable prognosis of EC patients.
XIST,B-cell acute lymphoblastic leukemia,"XIST may play important roles in the development of B-ALL, serving as a potential therapeutic target."
MIR22HG,ovarian cancer,C17orf91 was a potential prognostic marker and functioned as an oncogene in ovarian cancer.
SNHG6,hepatocellular carcinoma,"The long non-coding RNA, SNHG6-003, functions as a competing endogenous RNA to promote the progression of hepatocellular carcinoma."
UFC1,osteoarthritis,Long Noncoding RNA UFC1 Promotes Proliferation of Chondrocyte in Osteoarthritis by Acting as a Sponge for miR-34a.
MALAT1,renal cell carcinoma,MALAT1 could function as potential prognostic markers in RCC. MALAT1 could also display high accuracy for RCC diagnosis.
MIAT,chronic lymphocytic leukemia,MIAT constitutes a regulatory loop with OCT4 in malignant mature B cell
PCAT1,prostate cancer,PCAT1 promotes prostate cancer cell proliferation and tumor growth in vitro and in vivo.
MALAT1,hepatocellular carcinoma,There is a HIF-2α-MALAT1-miR-216b axis regulating MDR of HCC cells via modulating autophagy.
RBM5-AS1/LUST,colon cancer,RBM5-AS1 activity is critical for the functional enablement of colon cancer stem-like cells.
NONRATT021972,diabetic cardiac autonomic neuropathy,Inhibition of NONRATT021972 may serve as a novel therapeutic strategy for preventing the development of DCAN.
linc-223,acute myeloid leukemia,LncRNA linc-223 may have an important role in myeloid differentiation and leukemogenesis
SNHG1,neuroblastoma,SNHG1 is up-regulated by MYCN amplification and could be a potential prognostic biomarker for high-risk NB intervention.
BANCR,bladder cancer,Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer.
MFI2,osteosarcoma,Overexpression of long non-coding RNA MFI2 promotes cell proliferation and suppresses apoptosis in human osteosarcoma.
POIR,periodontitis,POIR has potential as a therapeutic target in mesenchymal stem cells during inflammation.
MALAT1,osteosarcoma,The expression of MALAT1 is high in osteosarcoma and correlates with tumor metastasis. MALAT1 promotes invasion and metastasis of osteosarcoma cells likely thought the Wnt/β1-catenin signal pathway.
LOC729966,papillary thyroid carcinoma,NR_036575.1 could be applied as a potential biomarker and a novel therapeutic target for PTC patients.
TUG1,atherosclerosis,Tanshinol suppresses endothelial cells apoptosis in mice with atherosclerosis via lncRNA TUG1 up-regulating the expression of miR-26a.
CDKN2B-AS1,thyroid cancer,Long non-coding RNA ANRIL promotes the invasion and metastasis of thyroid cancer  cells through TGF-β1/Smad signaling pathway.
DUXAP8,gastric cancer,The pseudogene derived long noncoding RNA DUXAP8 promotes gastric cancer cell proliferation and migration via epigenetically silencing PLEKHO1 expression.
CHRF,silicosis,The CHRF-miR-489-MyD88 Smad3 signaling axis exerts key functions in silica-induced pulmonary fibrosis and may represent  a therapeutic target for silicosis.
PVT1,diabetic kidney disease,"Variants in the plasmacytoma variant translocation (PVT1) gene were strongly associated with DKD in the Pima Indians, a group with the highest prevalence of type 2 diabetes in the world."
XIST,non-small cell lung cancer,Long noncoding RNA XIST acts as an oncogene in non small cell lung cancer by epigenetically repressing KLF2 expression.
n375709,nasopharyngeal carcinoma,LncRNA n375709 was identified to be involved in the regulation of NPC paclitaxel resistance.
HULC,colorectal cancer,Long noncoding RNA HULC promotes colorectal carcinoma progression through epigenetically repressing NKD2 expression.
PVT1,hepatocellular carcinoma,The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis.
MIR7-3HG,hepatocellular carcinoma,The long noncoding RNAs PVT1 and uc002mbe.2 in sera provide a new supplementary method for hepatocellular carcinoma diagnosis.
TCL6,renal cell carcinoma,Decreased TCL6 expression may be an independent adverse prognostic factor in ccRCC patients.
GAS5-AS1,non-small cell lung cancer,Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer.
RBMY2FP,hepatocellular carcinoma,Long non-coding RNA RBMY2FP promotes proliferation of male hepatocellular carcinoma by directing DNA methylation and activating RBMY1A1 via DNMT1.
RSU1P2,cervical cancer,LncRNA RSU1P2 contributes to tumorigenesis by acting as a ceRNA against let-7a in cervical cancer cells.
MELOE,melanoma,"Within the MELOE family, IRES-dependent antigens represent the best T cell targets for immunotherapy of melanoma."
MALAT1,gastric cancer,The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis.
TUG1,non-small cell lung cancer,Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2.
LINC01089,breast cancer,LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer.
HOTAIR,ovarian cancer,The upregulation of HOTAIR contributed to the malignant progression of ovarian cancer cells.
PVT1,asthma,Targeting PVT1 might be effective in reducing airway remodeling in asthmatic patients.
NEAT1,systemic lupus erythematosus,The increased NEAT1 expression may be a potential contributor to the  elevated production of a number of cytokines and chemokines in SLE patients.
MEG3,endometrial cancer,LncRNA-MEG3 inhibits cell proliferation of endometrial carcinoma by repressing Notch signaling.
CCAT2,small cell lung cancer,LncRNA CCAT2 predicts poor prognosis and regulates growth and metastasis in small cell lung cancer.
BANCR,esophageal squamous cell carcinoma,Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
TMSB4,osteoarthritis,The TMSB4 Pseudogene LncRNA Functions as a Competing Endogenous RNA to Promote Cartilage Degradation in Human Osteoarthritis.
P2RX7-V3,uveal melanoma,P2RX7-V3 that plays a crucial role in UM tumorigenesis and may serve as a useful biomarker in the diagnosis and prognosis treatment of UM in the future.
HOTAIR,cervical cancer,"Functional SNP rs920778 regulates HOTAIR expression, and may ultimately influence the predisposition for cervical cance"
GAS5,gastric cancer,GAS5 is downregulated in gastric cancer cells by promoter hypermethylation and regulates adriamycin sensitivity
MALAT1,breast cancer,"MALAT1 upregulation plays an important rolein BC development, and serum MALAT1 level may be a potential tumor marker for BC diagnosis."
BANCR,papillary thyroid carcinoma,BANCR inhibits tumorigenesis in PTC and that BANCR levels may be used as a novel prognostic marker.
XIST,nasopharyngeal carcinoma,Long non-coding RNA XIST exerts oncogenic functions in human nasopharyngeal carcinoma by targeting miR-34a-5p.
ZFAS1,colorectal cancer,Upregulation of long noncoding RNA ZFAS1 predicts poor prognosis and prompts invasion and metastasis in colorectal cancer.
CDKN2B-AS1,melanoma,ANRIL lncRNA triggers efficient therapeutic efficacy by reprogramming the aberrant INK4-hub in melanoma.
SPRY4-IT1,glioma,Long noncoding RNA SPRY4-IT1 is a prognostic factor for poor overall survival and has an oncogenic role in glioma.
SBF2-AS1,non-small cell lung cancer,Over-expression of lncRNA SBF2-AS1 is associated with advanced tumor progression  and poor prognosis in patients with non-small cell lung cancer.
RPLP0P2,lung adenocarcinoma,Low expression lncRNA RPLP0P2 is associated with poor prognosis and decreased cell proliferation and adhesion ability in lung adenocarcinoma.
BCAR4,osteosarcoma,Long noncoding RNA BCAR4 promotes osteosarcoma progression through activating GLI2-dependent gene transcription.
TUG1,bladder cancer,Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
HOTAIR,lung adenocarcinoma,The HOTAIR/miR-326/SP1 pathway regulates chemoresistance of LAD cells.
AK001094,gastric cancer,The five-lncRNA signature may have a good clinical applicability for determining the diagnosis and predicting the prognosis of GC.
AK024171,gastric cancer,The five-lncRNA signature may have a good clinical applicability for determining the diagnosis and predicting the prognosis of GC.
AK093735,gastric cancer,The five-lncRNA signature may have a good clinical applicability for determining the diagnosis and predicting the prognosis of GC.
BC003519,gastric cancer,The five-lncRNA signature may have a good clinical applicability for determining the diagnosis and predicting the prognosis of GC.
NR_003573,gastric cancer,The five-lncRNA signature may have a good clinical applicability for determining the diagnosis and predicting the prognosis of GC.
MALAT1,osteosarcoma,MALAT1 promotes osteosarcoma development by targeting TGFA via MIR376A.
PCAT6,lung cancer,PCAT6 could play  an oncogenic role in lung cancer progression and may serve as a biomarker for prognosis of lung cancer patients.
SPRY4-IT1,esophageal squamous cell carcinoma,"SPRY4-IT1 is a vital regulator in ESCC progression, and the SPRY4-IT1/ZNF703 axis might provide novel clues for future ESCC therapy."
PICSAR,cutaneous squamous cell carcinoma,This long noncoding RNA may serve as a useful diagnostic marker and therapeutic target for cutaneous squamous cell carcinoma.
GCASPC,gallbladder cancer,"GCASPC overexpression suppressed cell proliferation in vitro and in vivo, whereas GCASPC silencing had opposite effects."
uc.63,breast cancer,Our results reveal an important role of uc.63 in promoting breast cancer cells survival and offer the prospect to identify a signature associated with poor prognosis.
MALAT1,epithelial ovarian cancer,The levels of plasma MALAT1 may act as a valuable biomarker for the diagnosis of metastasis.
NEAT1,leukemia,Overexpression of lncRNA NEAT1 mitigates multidrug resistance by inhibiting ABCG2 in leukemia.
HOTAIR,glioma,MiR-148b-3p inhibits malignant biological behaviors of glioma cells by directly targeting HOTAIR.
GAS5,melanoma,LncRNA GAS5 is a critical regulator of metastasis phenotype of melanoma cells and inhibits tumor growth in vivo.
AK126698,non-small cell lung cancer,Long noncoding RNA AK126698 inhibits proliferation and migration of non-small cell lung cancer cells by targeting Frizzled-8 and suppressing Wnt/β1-catenin signaling pathway.
LINC01133,colorectal cancer,Long non-coding RNA LINC01133 inhibits epithelial mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6.
LINC00261,gastric cancer,Decreased expression of the long noncoding RNA LINC00261 indicate poor prognosis  in gastric cancer and suppress gastric cancer metastasis by affecting the epithelial-mesenchymal transition.
MIR31HG,bladder cancer,MIR31HG may function as a cancer-suppressor gene to participate in the bladder cancer carcinogenesis and development.
GAS5,hypertension,This study identifiedGAS5 as a critical regulator in hypertension and demonstrated the potential of gene therapy and drug development for treating hypertension.
MEG3,hepatocellular carcinoma,"MEG3 inhibits cell proliferation and induces apoptosis, partially via the activation of the ER stress and p53 pathway,"
CCAT1,endometrial cancer,CARLo-5 was identified as a pro-oncogeniclncRNA that may play an important role in EC progression and represent a prognostic marker for EC.
CASC9,esophageal cancer,CASC9 is significantly upregulated in ESCC tissues and may represent a new marker of poor prognosis and a potential therapeutic target for esophageal cancer intervention.
MALAT1,non-small cell lung cancer,"MALAT1 significantly increased the migration, invasion and tumorigenesis in vivo, which suggests its important role in the bone metastasis of NSCLC."
UCA1,breast cancer,LncRNA UCA1 promotes epithelial-mesenchymal transition (EMT) of breast cancer cells via enhancing Wnt/beta-catenin signaling pathway.
uc004cov.4,hypertrophic cardiomyopathy,The specific mitochondrial long noncoding RNAs uc004cov.4 and uc022bqu.1 were upregulated in patients with HOCM and they were also able to identify HOCM and could be developed as useful clinical biomarkers in the future.
uc022bqu.1,hypertrophic cardiomyopathy,The specific mitochondrial long noncoding RNAs uc004cov.4 and uc022bqu.1 were upregulated in patients with HOCM and they were also able to identify HOCM and could be developed as useful clinical biomarkers in the future.
TUG1,colorectal cancer,Long non-coding RNA TUG1 promotes colorectal cancer metastasis via EMT pathway
MALAT1,gallbladder cancer,Inhibition of MALAT1 expression may be to a novel therapeutic strategy for gallbladder cancer.
BC087858,non-small cell lung cancer,LncRNA BC087858 could promote cells invasion and induce non-T790M mutation acquired resistance to EGFR-TKIs by activating PI3K/AKT and MEK/ERK pathways and EMT via up- regulating ZEB1 and Snail in NSCLC.
GAS5,colorectal cancer,GAS5 and Yiya were promising prognostic biomarkers of liver metastases for early stage CRC patients.
LINC00538,colorectal cancer,GAS5 and Yiya were promising prognostic biomarkers of liver metastases for early stage CRC patients.
CLMAT3,colorectal cancer,Reducing lncRNA-CLMAT3 inhibits colorectal cancer cell proliferation by affecting cell cycle components.
SPRY4-IT1,colorectal cancer,"SPRY4-IT1 could act as a functional oncogene in CRC, as well as a potential therapeutic target to inhibit  CRC metastasis."
MIAT,Alzheimer's disease,"We show that MIAT knockdown leads to cerebral microvascular degeneration, progressive neuronal loss and neurodegeneration, and  behavioral deficits in a CNS neurovascular disorder, Alzheimer's disease."
UCA1,melanoma,"LncRNA UCA1-miR-507-FOXM1 axis is involved in cell proliferation, invasion and G0/G1 cell cycle arrest in melanoma."
HOTAIR,breast cancer,"The effective chemopreventive effect of Dp on breast carcinogenesis, in which down-regulation of HOTAIR plays a critical role."
NEAT1,bladder cancer,NEAT1 may play oncogenic roles and can  be used as a therapeutic target for treating human bladder cancer. 
CRNDE,medulloblastoma,Long non-coding RNA CRNDE promotes tumor growth in medulloblastoma
FER1L4,endometrial cancer,LncRNA FER1L4 suppresses cancer cell proliferation and cycle by regulating PTEN expression in endometrial carcinoma.
RMST,breast cancer,RMST was involved in breast cancer
HOTAIR,breast cancer,"The transcriptional regulation of HOTAIR, identifies HOTAIR and its regulators as novel biomarkers of patient response to endocrine therapy and corroborates the importance of transcriptional enhancers in cancer."
C6orf176-TV1,non-small cell lung cancer,The expression of C6orf176-TV1 or C6orf176-TV2 is down regulated in NSCLC and it is correlated with the grade of differentiation. It may act as a diagnosis indicator for NSCLC patients
C6orf176-TV2,non-small cell lung cancer,The expression of C6orf176-TV1 or C6orf176-TV2 is down regulated in NSCLC and it is correlated with the grade of differentiation. It may act as a diagnosis indicator for NSCLC patients
MALAT1,pancreatic cancer,Long Noncoding RNA MALAT1 Promotes Aggressive Pancreatic Cancer Proliferation and Metastasis via the Stimulation of Autophagy.
PVT1,renal carcinoma,Our study discloses the role of  PVT1 as a novel prognostic factor and as a molecular target for novel therapeutic interventions in renal carcinoma.
H19,glioma,"H19 plays an important role in the development of TMZ resistance, and may represent a novel therapeutic target for TMZ-resistant gliomas."
TUG1,glioma,This study revealed a new TUG1/miR-26a/PTEN regulatory mechanism and provided a further understanding of the tumor-suppressive role of TUG1 in glioma development.
H19,bladder cancer,"LncRNA H19 and circRNA MYLK could bind competitively with miRNA-29a-3p increasing target gene DNMT3B, VEGFA and ITGB1 expressions."
RP11-359E19.2,bladder cancer,"The nearby genes pattern displayed that overexpressing ADAM2 and C8orf4 are cis-regulated by lncRNA RP11-359E19.2, involving in progression of bladder cancer."
BC041488,bladder cancer,LncRNA BC041488 could trans-regulate CDK1 mRNA expression through SRF transcription factor.
MALAT1,pulmonary arterial hypertension,Functional polymorphism of lncRNA MALAT1 contributes to pulmonary arterial hypertension susceptibility in Chinese people.
TUG1,hepatoblastoma,Targeting long non-coding RNA-TUG1 inhibits tumor growth and angiogenesis in hepatoblastoma.
SOX2-OT,colorectal cancer,Enhanced expression of long non-coding RNA Sox2ot promoted cell proliferation and motility in colorectal cancer.
MALAT1,tongue squamous cell carcinoma,Upregulated MALAT1 in TSCC promoted EMT and inhibited cell apoptosis by modulating Wnt/β1-catenin signaling pathway.
LINC00052,hepatocellular carcinoma,LINC00052 regulates the expression of NTRK3 by miR-128 and miR-485-3p to strengthen HCC cells invasion and migration.
NEAT1,non-small cell lung cancer,Long non-coding RNA NEAT1 promotes non-small cell lung cancer progression through regulation of miR-377-3p-E2F3 pathway.
HOTTIP,osteosarcoma,Overexpression of long non-coding RNA HOTTIP increases chemoresistance of osteosarcoma cell by activating the Wnt/β1-catenin pathway.
HOTTIP,non-small cell lung cancer,"HOTTIP functions as an oncogene by regulating HOXA13 in NSCLC, which may represent a new biomarker and a potential therapeutic target for NSCLC intervention."
CCAT2,hepatocellular carcinoma,"Long non-coding RNA CCAT2 functions as an oncogene in hepatocellular carcinoma, regulating cellular proliferation, migration and apoptosis."
MINCR,gallbladder cancer,MINCR could potentially be a therapeutic target as well as a prognostic marker in GBC.
TUG1,glioblastoma,"TUG1 enhances tumor-induced angiogenesis and VEGF expression through inhibiting miR 299. Also, the inhibition of TUG1 could provide a novel therapeutic target for glioblastoma treatment."
SOCS2-AS1,prostate cancer,SOCS2-AS1 plays an important role in the development of castration-resistant prostate cancer by repressing apoptosis.
TUG1,B-cell neoplasms,TUG1 is a recently identified oncogenic lncRNA
TUG1,oesophageal squamous cell carcinoma,TUG1 is a recently identified oncogenic lncRNA
TUG1,bladder cancer,TUG1 is a recently identified oncogenic lncRNA
TUG1,hepatocellular carcinoma,TUG1 is a recently identified oncogenic lncRNA
TUG1,osteosarcoma,TUG1 is a recently identified oncogenic lncRNA
LOC100130476,esophageal squamous cell carcinoma,LOC100130476 is down-regulated in ESCC at least partly by hypermethylation of CpG sites in exon 1 and its hypermethylation may have prognostic implications for ESCC patients.
BACE1-AS,Alzheimer's disease,BACE1-AS levels are up-regulated in AD brains where BACE1-AS acts by stabilizing BACE1 mRNA thereby increasing BACE1 protein content and Aβ142  formation
NEAT1_2,amyotrophic lateral sclerosis,In Frontotemporal dementia and Amyotrophic lateral sclerosis the lncRNAs NEAT1_2 and MALAT1 co-localize at nuclear paraspeckles with TDP-43 and FUS proteins and their binding to TDP-43 is markedly increased in affected brains.
MALAT1,amyotrophic lateral sclerosis,In Frontotemporal dementia and Amyotrophic lateral sclerosis the lncRNAs NEAT1_2 and MALAT1 co-localize at nuclear paraspeckles with TDP-43 and FUS proteins and their binding to TDP-43 is markedly increased in affected brains.
UCHL1-AS1,Parkinson's disease,In Parkinson's Disease the lncRNA UCHL1-AS1 acts by directly promoting translation of UCHL1 protein leading to perturbation of the ubiquitin-proteasome  system
HTT-AS,Huntington's disease,"Different lncRNAs, such as HTT-AS, BDNF-AS and HAR1, were found to be dysregulated in their expression also in Huntington's Disease."
BDNF-AS,Huntington's disease,"Different lncRNAs, such as HTT-AS, BDNF-AS and HAR1, were found to be dysregulated in their expression also in Huntington's Disease."
HAR1,Huntington's disease,"Different lncRNAs, such as HTT-AS, BDNF-AS and HAR1, were found to be dysregulated in their expression also in Huntington's Disease."
FMR1-AS1,fragile X syndrome,"FMR1-AS1 is expressed in peripheral blood leukocytes, suggesting these lncRNAs may represent biomarkers for FXS/FXTAS early detection and therapy."
FMR6,fragile X syndrome,"FMR6 is expressed in peripheral blood leukocytes, suggesting these lncRNAs may represent biomarkers for FXS/FXTAS early detection and therapy."
SCAANT1-AS,spinocerebellar ataxia,SCAANT1-AS plays a important role in spinocerebellar ataxia 7 and 8
ATXN8OS,spinocerebellar ataxia,ATXN8OS plays a important role in spinocerebellar ataxia 7 and 8
CAT104,breast cancer,"Further study showed the three-lncRNA signature was not only pervasive in different breast cancer stages, subtypes and  age groups, but also provides more accurate prognostic information than some widely known biomarkers."
LINC01234,breast cancer,"Further study showed the three-lncRNA signature was not only pervasive in different breast cancer stages, subtypes and  age groups, but also provides more accurate prognostic information than some widely known biomarkers."
STXBP5-AS1,breast cancer,"Further study showed the three-lncRNA signature was not only pervasive in different breast cancer stages, subtypes and  age groups, but also provides more accurate prognostic information than some widely known biomarkers."
MEG3,lung adenocarcinoma,MEG3 may be underlying therapeutic targets for LUAD functioning as ceRNAs for regulation of miRNA-mRNA.
MIAT,lung adenocarcinoma,MIAT may be underlying therapeutic targets for LUAD functioning as ceRNAs for regulation of miRNA-mRNA.
LINC00115,lung adenocarcinoma,LINC00115 may be underlying therapeutic targets for LUAD functioning as ceRNAs for regulation of miRNA-mRNA.
GAS5,non-small cell lung cancer,GAS5 downregulation is associated with cisplatin resistance in NSCLC. GAS5 can inhibit autophagy and therefore enhance cisplatin sensitivity in  NSCLC cells.
HMlincRNA717,pancreatic cancer,HMlincRNA717 could be a potential prognostic biomarker for pancreatic cancer progression.
MAPT-AS1,Parkinson's disease,"Increased MAPT expression could be associated with disease state, but not with PD neuropathology severity."
UCA1,osteosarcoma,Overexpression of lncRNA UCA1 promotes osteosarcoma progression and correlates with poor prognosis.
TUG1,esophageal squamous cell carcinoma,High TUG1 expression is associated with chemotherapy resistance and poor prognosis in esophageal squamous cell carcinoma.
HAGLR,bladder cancer,High expression of HOXD-AS1 may be involved in the bladder cancer carcinogenesis through inhibiting the phenotypes and activating endogenous cancer-related molecular pathways.
HOTAIR,cervical cancer,The long non-coding RNA HOTAIR increases tumour growth and invasion in cervical cancer by targeting the Notch pathway.
TUG1,renal cell carcinoma,"Downregulation of the long noncoding RNA TUG1 inhibits the proliferation, migration, invasion and promotes apoptosis of renal cell carcinoma."
CAR10,lung cancer,"These results demonstrate the role of CAR10 in environmental lung carcinogenesis, and CAR10-YB-1 represents a potential therapeutic target."
HULC,gastric cancer,Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer.
CDKN2B-AS1,ischemic heart failure,"CDKN2B-AS1/ANRIL, HOTAIR and LOC285194/TUSC7 showed similar modulation in peripheral blood mononuclear cells and heart tissue, suggesting a potential role as disease biomarkers."
HOTAIR,ischemic heart failure,"CDKN2B-AS1/ANRIL, HOTAIR and LOC285194/TUSC7 showed similar modulation in peripheral blood mononuclear cells and heart tissue, suggesting a potential role as disease biomarkers."
TUSC7,ischemic heart failure,"CDKN2B-AS1/ANRIL, HOTAIR and LOC285194/TUSC7 showed similar modulation in peripheral blood mononuclear cells and heart tissue, suggesting a potential role as disease biomarkers."
CDKN2B-AS1,colorectal cancer,"ANRIL is associated with the survival rate of patients with colorectal cancer,and affects cell migration and invasion in vitro."
MALAT1,ovarian cancer,"The findings define a major oncogenic role for MALAT1, which may offer an attractive novel target for therapeutic intervention in ovarian cancer."
LINC-ROR,nasopharyngeal carcinoma,"Long non-coding RNA ROR promotes proliferation, migration and chemoresistance of  nasopharyngeal carcinoma."
CDKN2B-AS1,non-small cell lung cancer,Long noncoding RNA ANRIL could be transactivated by cMyc and promote tumor progression of non-small-cell lung cancer.
HOTAIR,hepatocellular carcinoma,"HOTAIR, overexpressed in  HCC and associated with tumor size, could activate autophagy by increasing ATG3 and ATG7 expression, promoting HCC cell proliferation."
LINC00342,non-small cell lung cancer,LINC00342  which is significantly up-regulated in NSCLC and could be a prognostic biomarker.
HOTAIR,colon cancer,"HOTAIR plays an important role in the tumorigenesis, development and metastasis of colon cancer. HOTAIR may act as an oncogene and represents a new molecular target for the treatment of colon cancer."
MALAT1,lung adenocarcinoma,LncRNA MALAT1 exerts oncogenic functions in lung adenocarcinoma by targeting miR-204.
CDKN2B-AS1,colorectal cancer,Downregulation of long non-coding RNA ANRIL suppresses lymphangiogenesis and lymphatic metastasis in colorectal cancer.
HULC,hepatocellular carcinoma,LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR 200a-3p/ZEB1 signaling pathway.
CCAT2,ovarian cancer,The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
SPRY4-IT1,hepatocellular carcinoma,SPRY4-IT1 plays a critical role in HCC tumorigenesis and may be considered as a potential diagnostic indicator in HCC.
HOTAIR,glioma,"Downregulation of HOTAIR expression effectively promoted the expression of PDCD4, thereby inhibiting the proliferation, invasion and in vivo tumorigenicity of human GSCs."
BCYRN1,breast cancer,BC200 may serve as a prognostic marker and possible target for attenuating deregulated cell proliferation in estrogen dependent breast cancer.
LINC00628,gastric cancer,"LINC00628 functions as a GC suppressor through suppressing proliferation, migration and colony formation of cancer cells."
PVT1,cervical cancer,"PVT1 is not only an important prognostic marker, but also a potential therapy target for cervical cancer."
NEAT1,non-small cell lung cancer,NEAT1 may act as a competing endogenous lncRNA to upregulate EGCG-induced CTR1 by sponging hsa-mir 98-5p in NSCLC.
RP11-838N2.4,glioblastoma,Characterization of lncRNA RP11-838N2.4 could contribute to strategies for enhancing the efficacy of TMZ.
uc.167,ventricular septal defects,uc.167 contributes to the development potential of VSD and may constitute a potential therapeutic target in this disease.
ATB,glioma,Long non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a.
UCA1,esophageal squamous cell carcinoma,LncRNA UCA1 inhibits esophageal squamous-cell carcinoma growth by regulating the  Wnt signaling pathway.
UNMIBC,bladder cancer,LncRNA-UNMIBC can facilitate tumor growth and may act as a negative prognostic factor of recurrence.
HIF1A-AS2,glioblastoma,The Long Non-coding RNA HIF1A-AS2 Facilitates the Maintenance of Mesenchymal Glioblastoma Stem-like Cells in Hypoxic Niches.
TUG1,gastric cancer,LncRNA-TUG1 shows an up-regulated expression in GC tissue and that bears a correlation with clinicopathological features of malignant tumor.
MDC1-AS1,glioma,MDC1-AS may serve as a potential biomarker and therapeutic target for glioma.
AFAP1-AS1,colorectal cancer,Overexpression of lncRNA AFAP1-AS1 correlates with poor prognosis and promotes tumorigenesis in colorectal cancer.
LINC00673,pancreatic ductal adenocarcinoma,The PDAC risk variant of LINC00673 is targeted by miR 1231 to promote PDAC growth.
MALAT1,gastric cancer,Overexpressed MALAT1 promotes invasion and metastasis of gastric cancer cells via increasing EGFL7 expression.
GAPLINC,colorectal cancer,"The increased expression of GAPLINC was found to be positively correlated with larger tumor size, advanced tumor stage (T stage), advanced node stage (N stage), increased death, and shorter survival of patients with CRC by in situ hybridization analysis."
HULC,osteosarcoma,"Elevated HULC expression was associated with poor clinical outcomes among the OS patients, which suggests that HULC could be a potential prognostic biomarker in OS."
SPRY4-IT1,esophageal squamous cell carcinoma,Upregulation of long noncoding RNA SPRY4-IT1 promotes metastasis of esophageal squamous cell carcinoma via induction of epithelial mesenchymal transition.
CASC8,lung cancer,"LncRNA CASC8 rs10505477 could serve as a possible risk marker for diagnosing lung cancer, and could be used to forecast the response and toxicity of platinum based treatment in lung cancer patients."
CPS1-IT1,hepatocellular carcinoma,LncRNA CPS1-IT1 acts as a tumor suppressor in HCC by reducing HIF-1α activation and suppressing EMT.
XIST,breast cancer,Our findings elucidate the tumor suppressor role of XIST in breast cancer and provide the molecular basis of XIST in downregulating AKT activation.
H19,esophageal squamous cell carcinoma,"H19 acts as an oncogene and promotes ESCC cell proliferation and metastasis, which may infer H19 as a marker of poor prognosis and, thus, a potential therapeutic target for treating ESCC patients."
ZFAS1,gastric cancer,Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression.
HOTAIR,gastric cancer,HOTAIR has been demonstrated having oncogene activities
HULC,gastric cancer,HULC has been demonstrated having oncogene activities
CYTOR,gastric cancer,CYTOR has been demonstrated having oncogene activities
MALAT2,gastric cancer,MALAT2 has been demonstrated having oncogene activities
H19,gastric cancer,H19 has been demonstrated having oncogene activities
GHET1,gastric cancer,GHET1 has been demonstrated having oncogene activities
GACAT3,gastric cancer,GACAT3 has been demonstrated having oncogene activities
LEIGC,gastric cancer,LEIGC has been thought as tumor suppressor
GAS5,gastric cancer,GAS5 has been thought as tumor suppressor
FER1L4,gastric cancer,FER1L4 has been thought as tumor suppressor
lnc-beta-Catm,hepatocellular carcinoma,"The expression of lnc-beta-Catm, EZH2 and Wnt-beta-catenin targets is positively correlated with cancer severity and prognosis of people with HCC."
SPRY4-IT1,melanoma,PRY4-IT1 may be a potential prognostic marker and a potential therapeutic target.
PVT1,cervical cancer,The lncRNA PVT1 Contributes to the Cervical Cancer Phenotype and Associates with  Poor Patient Prognosis.
HOTAIR,cervical cancer,Analysis of the association of HOTAIR single nucleotide polymorphism (rs920778) and risk of cervical cancer.
APOC1P1-3,breast cancer,Overexpression of APOC1P1-3 can inhibit breast cancer apoptosis.
MALAT1,ovarian cancer,"MALAT-1 promotes the growth and migration of ovarian cancer cells, suggesting that MALAT-1 may be an important contributor to ovarian cancer development."
PAX8-AS1,cervical cancer,Expression quantitative trait loci in long non-coding RNA PAX8-AS1 are associated with decreased risk of cervical cancer.
lnc-CC3,cervical cancer,"Overexpression of lnc-CC3 promoted migration and invasion by SiHa cervical cancer cells in vitro and in vivo, increased Slug expression, and reduced the expression of the epithelial cell"
AK021595,lung cancer,AK021595 may be candidate prognostic biomarkers for lung cancer patients.
BC030759,lung cancer,BC030759 may be candidate prognostic biomarkers for lung cancer patients.
AK000053,lung cancer,AK000053 may be candidate prognostic biomarkers for lung cancer patients.
AK124307,lung cancer,AK124307 may be candidate prognostic biomarkers for lung cancer patients.
BC020384,lung cancer,BC020384 may be candidate prognostic biomarkers for lung cancer patients.
AK022024,lung cancer,AK022024 may be candidate prognostic biomarkers for lung cancer patients.
CR615992,lung cancer,CR615992 may be candidate prognostic biomarkers for lung cancer patients.
AF085995,lung cancer,AF085995 may be candidate prognostic biomarkers for lung cancer patients.
CASC2,renal cell carcinoma,CASC2 may be considered a novel target for the diagnosis and treatment of RCC.
NEAT1,Huntington's disease,NEAT1 upregulation in HD contributes to the neuroprotective mechanism against neuronal  injury rather than the pathological process underlying neurodegeneration in HD.
CCAT2,oral squamous cell carcinoma,Up-regulation of CCAT2 expression in tumor tissue might act as an oncogene  and promote the development of OSCC.
ZNF582-AS1,colorectal cancer,ZNF582-AS1 may be a novel tumor-suppressive lncRNA.
UCA1,hepatocellular carcinoma,The possible role of lncRNA-UCA1 is a promising diagnostic and a prognostic marker as well as potential therapeutic target in HCC.
PAUPAR,uveal melanoma,The role of this lncRNA is a novel therapeutic target in cancer prevention and treatment.
LINC00673,pancreatic cancer,"A long intergenic noncoding RNA (lincRNA), LINC00673, is a potential tumor suppressor whose germline variation is associated with pancreatic cancer risk."
CCAT1,lung cancer,This epigenetic silencing of miR-218 by CCAT1 induces an altered cell cycle transition through BMI1 and provides a new mechanism for CSE-induced lung carcinogenesis.
SNHG15,hepatocellular carcinoma,LncRNA SNHG15 may serve as an efficient clinical biomarker and a therapeutic target for HCC patients.
LINC00673,melanoma,The lncRNA SLNCR1 Mediates Melanoma Invasion through a Conserved SRA1-like Region.
PANDAR,bladder cancer,Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer.
LUCAT1,non-small cell lung cancer,Long noncoding RNA LUCAT1 is associated with poor prognosis in human non-small cell lung cancer and affects cell proliferation via regulating p21 and  p57 expression.
CASC2,colorectal cancer,CASC2 as a ceRNA plays an important role in CRC pathogenesis and may serve as a potential target for cancer diagnosis and treatment.
BCAR4,colorectal cancer,"One lncRNA, BCAR4, could be potential candidates to detect colorectal cancer."
MALAT1,breast cancer,The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial-Mesenchymal Transition in Breast Cancer.
AGAP2-AS1,non-small cell lung cancer,AGAP2-AS1 may act as an oncogene by repressing tumor-suppressor LATS2 and KLF2 transcription.
SOX2-OT,retinal neurodegeneration,Sox2OT knockdown plays a neuroprotective role in diabetes-related retinal neurodegeneration in vivo.
LOC100130476,gastric cardia adenocarcinoma,Aberrant methylation of LOC100130476 in peripheral white blood cells and GCA tissues may be used as a potential valuable biomarker in GCA diagnosis and prognosis.
LINC00426,primary Sjögren's syndrome,LINC00426 was significantly upregulated in pSS
ENST00000455309,primary Sjögren's syndrome,ENST00000455309 was significantly upregulated in pSS
n336161,primary Sjögren's syndrome,n336161 was significantly upregulated in pSS
NR_002712,primary Sjögren's syndrome,NR_002712 was significantly upregulated in pSS
LINC02384,primary Sjögren's syndrome,LINC02384 was significantly upregulated in pSS
Lnc-UTS2D-1:1,primary Sjögren's syndrome,Lnc-UTS2D-1:1 was significantly upregulated in pSS
n340599,primary Sjögren's syndrome,n340599 was significantly upregulated in pSS
TCONS_l2_00014794,primary Sjögren's syndrome,TCONS_l2_00014794 was significantly upregulated in pSS
CYTOR,renal cell carcinoma,Linc00152 is a novel molecule involved in ccRCC progression as well as a potential prognostic  biomarker and therapeutic target.
HOTAIR,lung cancer,MiR-326 regulates cell proliferation and migration in lung cancer by targeting Phox2a and is regulated by HOTAIR.
H19,osteosarcoma,MiR-141 modulates osteoblastic cell proliferation by regulating the target gene of lncRNA H19 and lncRNA H19-derived miR-675.
lnc-ZNF354A-1,ankylosing spondylitis,lnc-ZNF354A-1 may be involved in the abnormal osteogenic differentiation of ASMSC.
lnc-LIN54-1,ankylosing spondylitis,lnc-LIN54-1 may be involved in the abnormal osteogenic differentiation of ASMSC.
lnc-FRG2C-3,ankylosing spondylitis,lnc-FRG2C-3 may be involved in the abnormal osteogenic differentiation of ASMSC.
lnc-USP50-2,ankylosing spondylitis,lnc-USP50-2 may be involved in the abnormal osteogenic differentiation of ASMSC.
ATB,prostate cancer,Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
MALAT1,breast cancer,MALAT1 is a predictive biomarker and a therapeutic target.
RMEL3,melanoma,"RMEL3 is required for MAPK and PI3K signaling, and its knockdown decrease BRAFV600E melanoma cell survival and proliferation."
UCA1,liver cancer,Double mutant P53 (N340Q/L344R) promotes hepatocarcinogenesis through upregulation of Pim1 mediated by PKM2 and LncRNA CUDR.
HOTAIR,ovarian cancer,HOTAIR variants could be a useful biomarker for the predisposition to EOC and for the early diagnosis of the disease.
ZNRD1-AS1,lung cancer,"Strong evidence for LncRNA ZNRD1-AS1, and its functional Cis-eQTL locus contributing more to the susceptibility of lung cancer."
MEG3,breast cancer,"Downregulated long non-coding RNA MEG3 in breast cancer regulates proliferation, migration and invasion by depending on p53's transcriptional activity."
SAMMSON,melanoma,Targeting the lncRNA SAMMSON Reveals Metabolic Vulnerability in Melanoma.
HOTAIR,colorectal cancer,"The role of the HOTAIR in CRC progression is associated with the acquisition of stemness, with the potential mechanism of gene silencing by binding to PRC2 and LSD1"
MALAT1,colorectal cancer,"The down-regulation of MALAT1 by resveratrol could decrease the nuclear localization of β‐catenin and attenuate Wnt/β‐catenin signaling, thereby inhibiting CRC invasion and metastasis "
LOC285194,colorectal cancer,LOC285194 was shown to be a potential inhibitor and the signal pathway should be further characterized.
uc.388,colorectal cancer,uc.388 was shown to be a potential inhibitor and the signal pathway should be further characterized .
MEG3,testicular germ cell tumor,Re-expression of Meg3 may be an attractive strategy for TGCT therapy.
TUSC7,non-small cell lung cancer,"TUSC7 was a potential biomarker for NSCLC prognosis, and the dysregulation of TUSC7 may play an important role in the NSCLC progression."
uc.338,hepatocellular carcinoma,The oncogenic activity of uc.338 is partially due to its repression of p21. uc.338 may be a potential target for HCC therapy.
SBF2-AS1,non-small cell lung cancer,SBF2-AS1 may serve as a novel biomarker and potential therapeutic target for NSCLC patients.
LOC100507661,thyroid cancer,LOC100507661 expression is elevated in human thyroid cancer and may play a critical role in thyroid carcinogenesis.
AL049437,Parkinson's disease,LncRNA AL049437 likely contributed to the risk of PD
AK021630,Parkinson's disease,LncRNA AK021630 likely inhibited the occurrence of PD
NEAT1,breast cancer,NEAT1 is Required for Survival of Breast Cancer Cells Through FUS and miR-548.
GClnc1,gastric cancer,GClnc1 is an oncogenic lncRNA in human gastric cancer.
HOTAIRM1,acute promyelocytic leukemia,"The reduced PU.1 expression, rather than PML-RARα itself, results in the low expression of HOTAIRM1 in APL cells"
HOTTIP,gastric cancer,Oncogenic function of the homeobox A13-long noncoding RNA HOTTIP-insulin growth factor-binding protein 3 axis in human gastric cancer.
BCYRN1,esophageal squamous cell carcinoma,High expression of BC200 reflects poor prognosis and could serve as a novel predictive marker for ESCC patients who received radical resection.
LINC00473,non-small cell lung cancer,"LINC00473 expression potentially serves as a robust biomarker for tumor LKB1 functional status that can be integrated into clinical trials for patient selection and treatment evaluation, and implicates LINC00473 as a therapeutic target for LKB1-inactivated NSCLC."
AK033210,bronchopulmonary dysplasia,"A downregulated lncRNA, namely AK033210, associated with tenascin C may be involved in the pathogenesis of BPD."
MALAT1,glioma,The current study indicated a promoting role of MALAT1 in the development of glioma cell.
CCAT1,gastric cancer,"Enforced expression of CCAT1 exerts potent tumorigenic effects by promoting cell proliferation, invasion and migration."
CCAT1,colorectal cancer,"Enforced expression of CCAT1 exerts potent tumorigenic effects by promoting cell proliferation, invasion and migration."
CCAT1,hepatocellular carcinoma,"Enforced expression of CCAT1 exerts potent tumorigenic effects by promoting cell proliferation, invasion and migration."
SNHG1,hepatocellular carcinoma,SNHG1 may be considered as a prognostic biomarker and therapeutic target for HCC.
GHET1,colorectal cancer,Knockdown of Long Noncoding RNA GHET1 Inhibits Cell Proliferation and Invasion of Colorectal Cancer.
LOC572558,bladder cancer,LOC572558 may serve as a promising new diagnostic marker and therapeutic target in bladder cancer.
HOTAIR,diffuse large B-cell lymphoma,"HOTAIR may be regarded as a novel indicator of poor prognosis, and may serve as a potential target for gene therapy in the treatment of DLBCL."
CDKN2B-AS1,gastric cancer,"Knockdown of lncRNA ANRIL in gastric cancer cells inhibits the development of MDR, suggesting an efficacious target for reversing MDR in gastric cancer therapy."
uc.48+,type 2 diabetes mellitus,LncRNA uc.48+ siRNA improved diabetic sympathetic neuropathy in type 2 diabetic rats through regulating the expression of P2X7 and ERK signaling in SCG.
lncARSR,renal cell carcinoma,LncARSR may serve as a predictor and a potential therapeutic target for sunitinib resistance.
HOTAIR,breast cancer,Plasma HOTAIR may serve as a potential biomarker for breast cancer diagnosis.
LINP1,breast cancer,"Blocking LINP1, which is regulated by p53 and epidermal growth factor receptor (EGFR) signaling, increases the sensitivity of the tumor-cell response to radiotherapy in breast cancer."
HOTTIP,gastric cancer,HOTTIP and HOXA13 play important roles in gastric cancer progression and provide a new insight into therapeutic treatment for the disease.
AB073614,glioma,Increased lncRNA AB073614 expression may be identified as a poor prognostic biomarker in gliomas.
AB073614,ovarian cancer,LncRNA AB073614 characterized as a new candidate lncRNA promotes the development of ovarian cancer.
HOTTIP,gastric cancer,Overexpression of long noncoding RNA HOTTIP promotes tumor invasion and predicts  poor prognosis in gastric cancer.
CDKN2B-AS1,breast cancer,CDKN2B-AS1 plays a important role in breast cancer.
XIST,hepatocellular carcinoma,MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST.
MIAT,prostate cancer,Long noncoding RNAs can be exploited as new biomarkers and therapeutic targets for NEPC(neuroendocrine prostate cancer)
CDKN2B-AS1,ovarian cancer,ANRIL promotes EOC(epithelial ovarian cancer) progression and is a potential  prognostic biomarker.
NEAT1,gastric cancer,LncRNA NEAT1 plays an important role on gastric cancer tumorigenesis and progression and may act as a potential biomarker for therapeutic strategy and prognostic prediction.
H19,thyroid cancer,Long noncoding RNA H19 competitively binds miR 17-5p to regulate YES1 expression in thyroid cancer.
H19,bladder cancer,Genetic variants in lncRNA H19 are associated with the risk of bladder cancer in a Chinese population.
ATB,keloid,Knockdown of lncRNA-ATB suppresses autocrine secretion of TGF-β12 by targeting ZNF217 via miR-200c in keloid fibroblasts.
HNF1A-AS1,hepatocellular carcinoma,"We identified HNF1A-AS1-miR-30b axis as a key regulator in hepatocarcinogenesis,  which may be promising biomarkers and therapeutic targets in the future."
LOC101926975,Hirschsprung's disease,LOC101926975 can distinguish HSCR from the normal ones.
NEAT1,ovarian cancer,"LncRNA NEAT1, whose expression was collaboratively controlled by HuR and miR-124-3p, could regulate ovarian carcinogenesis and may serve as a potential target for antineoplastic therapies."
RP4-799P18.3,ovarian cancer,The lncRNA signature may have important implications for outcome prediction and therapy decisions.
PTPRD-AS1,ovarian cancer,The lncRNA signature may have important implications for outcome prediction and therapy decisions.
RP11-57P19.1,ovarian cancer,The lncRNA signature may have important implications for outcome prediction and therapy decisions.
RP11-307C12.11,ovarian cancer,The lncRNA signature may have important implications for outcome prediction and therapy decisions.
RP11-254I22.1,ovarian cancer,The lncRNA signature may have important implications for outcome prediction and therapy decisions.
RP11-80H5.7,ovarian cancer,The lncRNA signature may have important implications for outcome prediction and therapy decisions.
RP1-223E5.4,ovarian cancer,The lncRNA signature may have important implications for outcome prediction and therapy decisions.
GACAT3,ovarian cancer,The lncRNA signature may have important implications for outcome prediction and therapy decisions.
H19,gallbladder cancer,Upregulation of H19 indicates a poor prognosis in gallbladder carcinoma and promotes epithelial-mesenchymal transition.
LINC-ROR,colon cancer,Overexpression of lincRNA-ROR combined with depletion of miR-145 may exert crucial impact on colon cancer prognosis evaluation and treatment.
HOTAIR,colorectal cancer,The HOTAIR expression in CD133(+)CSCs could serve as a potential  anti-cancer regimen to inhibit the invasiveness and metastasis of CRC CSCs.
FTX,hepatocellular carcinoma,lnc-FTX may act as a tumor suppressor in HCC through physically binding miR-374a and MCM2.
SNHG5,gastric cancer,SNHG5 may be a novel therapeutic target for the treatment of GC
HOTTIP,prostate cancer,"Down-regulation of HOTTIP and HOXA13 was associated with cell growth and cell cycle, and exerts tumor-suppressive functions in the genesis and progression of prostate cancer, providing a potential attractive therapeutic approach for this malignancy."
HOTAIR,temporomandibular joint osteoarthritis,Upregulation of lncRNA HOTAIR contributes to IL-1β1 induced MMP overexpression and chondrocytes apoptosis in temporomandibular joint osteoarthritis.
LOC100287225,colorectal cancer,LOC100287225 misregulation could be a potential target for gene therapy in colorectal cancer.
HOTTIP,pancreatic ductal adenocarcinoma,HOTTIP has been shown to influence the malignant behavior of PDAC cells.
MALAT1,pancreatic ductal adenocarcinoma,MALAT1 has been shown to influence the malignant behavior of PDAC cells.
CRNDE,glioma,CRNDE Promotes Malignant Progression of Glioma by Attenuating miR-384/PIWIL4/STAT3 Axis.
SAMMSON,melanoma,SAMMSON is expressed in the majority of human melanomas and promotes cell growth  and survival.
UCA1,gastric cancer,UCA1 might provide a new potential therapeutic target and stratagem for gastric cancer.
SNHG20,hepatocellular carcinoma,"SNHG20, up-regulated in patients with HCC, may serve as an independent prognostic predictor for HCC patients."
Z38,breast cancer,"The newly found lncRNA Z38, which plays important roles in breast cancer, may act as a candidate biomarker and therapeutic target in carcinomas."
BANCR,osteosarcoma,BANCR may act as a tumor promoter in osteosarcoma and could serve as a potential therapeutic target for this disease.
TMEVPG1,primary immune thrombocytopenia,"TMEVPG1 could promote IFNG transcription, and IFNG over-expression negative  feedback regulated on TMEVPG1 expression, which resulted in decreased TMEVPG1 in  ITP patients."
PICSAR,cutaneous squamous cell carcinoma,These results also identify PICSAR as a biomarker and putative therapeutic target in cSCC.
UCA1,colorectal cancer,UCA1 and CREB1 are potential new oncogenes and prognostic factors for CRC.
HULC,diffuse large B-cell lymphoma,HULC could represent a novel indicator of poor prognosis and may be served as a potential target for the diagnosis and gene therapy of DLBCL.
CDKN2B-AS1,glaucoma,CDKN2B-AS1 plays a important role in Glaucoma
MALAT1,proliferative vitreoretinopathy,MALAT1 plays a important role in proliferative vitreoretinopathy
MIAT,diabetic retinopathy,MIAT plays a important role in diabeticretinopathy
BANCR,retinoblastoma,BANCR plays a important role in retinoblastoma
MEG3,retinoblastoma,MEG3 plays a important role in retinoblastoma
LINC-ROR,unveal melanoma,LINC-ROR plays a important role in unveal melanoma
CRNDE-h,colorectal cancer,"LncRNA CRNDE-h is associated with adverse clinical characteristics and poor prognosis, which suggests that it might play an important role in CRC development and progression and might have clinical potential as a useful prognostic predictor."
HOTAIR,ovarian cancer,An NF-KB-HOTAIR axis drives a positive feedback loop cascade during DDR and contributes to cellular senescence and chemotherapy resistance in ovarian and other cancers.
H19,nasopharyngeal carcinoma,Long noncoding RNA H19 regulates EZH2 expression by interacting with miR-630 and  promotes cell invasion in nasopharyngeal carcinoma.
LINC00668,gastric cancer,E2F1-induced upregulation of long noncoding RNA LINC00668 predicts a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically silencing of CKIs.
ENST00000436681,congenital heart defect,The lncRNA aberrantly expressed in the plasma of pregnant women with typical fetal CHD may play a key role in the development of CHD and may be used as novel biomarkers for prenatal diagnosis of fetal CHD.
H19,congenital heart defect,The lncRNA aberrantly expressed in the plasma of pregnant women with typical fetal CHD may play a key role in the development of CHD and may be used as novel biomarkers for prenatal diagnosis of fetal CHD.
AA584040,congenital heart defect,The lncRNA aberrantly expressed in the plasma of pregnant women with typical fetal CHD may play a key role in the development of CHD and may be used as novel biomarkers for prenatal diagnosis of fetal CHD.
AA709223,congenital heart defect,The lncRNA aberrantly expressed in the plasma of pregnant women with typical fetal CHD may play a key role in the development of CHD and may be used as novel biomarkers for prenatal diagnosis of fetal CHD.
BX478947,congenital heart defect,The lncRNA aberrantly expressed in the plasma of pregnant women with typical fetal CHD may play a key role in the development of CHD and may be used as novel biomarkers for prenatal diagnosis of fetal CHD.
PCAT1,hepatocellular carcinoma,"Upregulation of long non coding RNA PCAT-1 contributes to cell proliferation, migration and apoptosis in hepatocellular carcinoma."
MIR100HG,cervical cancer,MIR100HG and AC024560.2 may be a potential biomarkers of PLNM and these lncRNAs may provide broader perspective for combating cervical cancer metastasis.
AC024560.2,cervical cancer,MIR100HG and AC024560.2 may be a potential biomarkers of PLNM and these lncRNAs may provide broader perspective for combating cervical cancer metastasis.
NONHSAT104436,esophageal squamous cell carcinoma,NONHSAT104436 might play a very important part in ESCC tumor progression.
CTD903,colorectal cancer,"LncRNA-CTD903 acts as a tumor suppressor in CRC and can inhibit cell invasion and migration through repressing  Wnt/β1-catenin signaling, which plays important roles in EMT and CRC metastasis."
lnc13,celiac disease,The long noncoding RNA lnc13 associated with susceptibility to celiac disease
NEAT1,multiple sclerosis,The lncRNA may be involved in MS pathogenesis.
TUG1,multiple sclerosis,The lncRNA may be involved in MS pathogenesis.
RN7SK,multiple sclerosis,The lncRNA may be involved in MS pathogenesis.
GAS5,breast cancer,This work identifies GAS5 as a novel prognostic marker and candidate drug target for HER2-positive breast cancer.
POU6F2-AS2,oesophageal squamous cell carcinoma,Long noncoding RNA POU6F2-AS2 is associated with oesophageal squamous cell carcinoma.
C2dat1,ischemic brain injury,"A novel I/R-induced lncRNA C2dat1 that modulates the expression of CaMKIIdelta to impact neuronal survival, and may be a potential target for therapeutic intervention of ischemic brain injury."
HOTAIR,pancreatic cancer,Salivary HOTAIR and PVT1 show potential as novel non-invasive biomarkers for detecting PC.
PVT1,pancreatic cancer,Salivary HOTAIR and PVT1 show potential as novel non-invasive biomarkers for detecting PC.
ATB,hepatocellular carcinoma,UTMD-mediated siRNA transfection against lncRNA-ATB may be a promising therapy for HCC metastasis.
H19,colorectal cancer,"rs2839698 in H19 was associated with elevated risk of colorectal cancer, which may be a potential biomarker for predicting colorectal cancer susceptibility."
CDKN2B-AS1,gastric cancer,ANRIL knockdown blocks the effects of TET2 on gastric cancer cell proliferation and colony formation.
MIR503HG,choriocarcinoma,"LincRNAs MIR503HG and LINC00629 impaired migration and invasion capacities in a choriocarcinoma in  vitro model, indicating a potential role in human reproduction and tumorigenesis."
LINC00629,choriocarcinoma,"LincRNAs MIR503HG and LINC00629 impaired migration and invasion capacities in a choriocarcinoma in  vitro model, indicating a potential role in human reproduction and tumorigenesis."
CILinc01,osteoarthritis,"The inflammatory response in human OA chondrocytes is associated with widespread changes in the profile of lncRNAs, including PACER, CILinc01, and CILinc02."
CILinc02,osteoarthritis,"The inflammatory response in human OA chondrocytes is associated with widespread changes in the profile of lncRNAs, including PACER, CILinc01, and CILinc02."
PACERR,osteoarthritis,"The inflammatory response in human OA chondrocytes is associated with widespread changes in the profile of lncRNAs, including PACER, CILinc01, and CILinc02."
FGFR3-AS1,osteosarcoma,Long noncoding RNA FGFR3-AS1 promotes osteosarcoma growth through regulating its  natural antisense transcript FGFR3.
H19,Parkinson's disease,H19 may be used in monitoring disease progression and it may serve as potential new targets for novel therapeutic approaches.
MALAT1,Parkinson's disease,MALAT1 may be used in monitoring disease progression and it may serve as potential new targets for novel therapeutic approaches.
SNHG1,Parkinson's disease,SNHG1 may be used in monitoring disease progression and it may serve as potential new targets for novel therapeutic approaches.
NEAT1,Parkinson's disease,NEAT1 may be used in monitoring disease progression and it may serve as potential new targets for novel therapeutic approaches.
MALAT1,proliferative vitreoretinopathy,LncRNA MALAT1 is involved in TGFβ11 induced EMT of human RPE cells and provides new understandings for the pathogenesis of PVR.
HIF1A-AS2,bladder cancer,Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
CCAT2,bladder cancer,ShRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells.
MALAT1,esophageal squamous cell carcinoma,"MALAT1 promotes the initiation and progression of ESCC, suggesting that inhibition of MALAT1 might be a potential target for treatment of ESCC."
CASC11,colorectal cancer,The novel lncRNA CASC11 may serve as a candidate diagnostic biomarker and a promising therapeutic target for CRC.
TINCR,colorectal cancer,Loss of TINCR expression promotes proliferation and metastasis in CRC and it could be considered as a potential cancer suppressor gene.
UCA1,hepatocellular carcinoma,HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting  EZH2 and repressing p27Kip1/CDK2 signaling.
SAMMSON,melanoma,Silencing of the lineage addiction oncogene SAMMSON disrupts vital mitochondrial functions in a cancer-cell-specific manner
TUSC7,hepatocellular carcinoma,"TUSC7 suppresses EMT through the TUSC7-miR-10a-EphA4 axis, which may be a potential target for therapeutic intervention in HCC."
HOTAIR,hepatocellular carcinoma,Long non-coding RNA HOTAIR is a marker for hepatocellular carcinoma progression and tumor recurrence.
MALAT1,lung cancer,MALAT-1 silencing may be an effective therapeutic approach against tumors.
MALAT1,bladder cancer,MALAT-1 silencing may be an effective therapeutic approach against tumors.
MALAT1,hepatocellular carcinoma,MALAT-1 silencing may be an effective therapeutic approach against tumors.
FTX,hepatocellular carcinoma,FTX may serve as a novel prognostic biomarker and therapeutic target for HCC.
MEG3,hepatocellular carcinoma,Armored long non-coding RNA MEG3 targeting EGFR based on recombinant MS2 bacteriophage virus-like particles against hepatocellular carcinoma.
H19,colorectal cancer,Long noncoding RNA H19 indicates a poor prognosis of colorectal cancer and promotes tumor growth by recruiting and binding to eIF4A3.
DANCR,osteosarcoma,ANCR might be an oncogenic lncRNA that promoted proliferation of osteosarcoma.
CCAT2,cervical cancer,LncRNA CCAT2 promoted the proliferation and survival of cervical cancer cells.
H19,glioma,Suppressing H19 Modulates Tumorigenicity and Stemness in U251 and U87MG Glioma Cells.
HULC,atherosclerosis,HULC-miR-9 pathway may be a potential target for treating atherosclerosis.
EPB41L4A-AS2,breast cancer,The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors.
EPB41L4A-AS2,kidney cancer,The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors.
EPB41L4A-AS2,lung cancer,The long non-coding RNA EPB41L4A-AS2 inhibits tumor proliferation and is associated with favorable prognoses in breast cancer and other solid tumors.
HOTAIR,Parkinson's disease,HOTAIR promoted PD induced by MPTP through regulating  LRRK2 expression could add our understanding of the molecular mechanisms in PD. 
TUG1,prostate cancer,TUG1 plays an important role in prostate cancer.
CTB-89H12.4,prostate cancer,CTB-89H12.4 plays an important role in prostate cancer.
ucoo2kmd.1,colorectal cancer,The overexpression oflncRNA-uc002kmd.1 enhanced cell proliferation in CRC.
SARCC,renal cell carcinoma,Differential regulation of LncRNA-SARCC suppresses VHL-mutant RCC cell proliferation yet promotes VHL-normal RCC cell proliferation via modulating androgen receptor/HIF-2α/C-MYC axis under hypoxia.
PVT1,diabetes mellitus,Autophagy ameliorates cognitive impairment through activation of PVT1 and apoptosis in diabetes mice.
SRA,breast cancer,SRA genetic variants may contribute to BC risk and have apparent interaction with reproductive factors in BC progression.
EVI1,hepatocellular carcinoma,EVI1 is frequently up-regulated and regulates a cluster of lncRNAs in HBV related hepatocellular carcinoma (HCC).
HOTAIR,osteosarcoma,Genetic variants of lncRNA HOTAIR contribute to the risk of osteosarcoma.
PCA3,prostate cancer,PCA3 was the first lncRNA identified in prostate cancer and has been shown to be expressed in a majority of prostate cancer cases.
CBR3-AS1,prostate cancer,"Other lncRNAs are known to interact directly with the androgen receptor pathway including PlncRNA-1, HOTAIR, PRNCR1 and PCGEM1. "
HOTAIR,prostate cancer,"Other lncRNAs are known to interact directly with the androgen receptor pathway including PlncRNA-1, HOTAIR, PRNCR1 and PCGEM1. "
PRNCR1,prostate cancer,"Other lncRNAs are known to interact directly with the androgen receptor pathway including PlncRNA-1, HOTAIR, PRNCR1 and PCGEM1. "
PCGEM1,prostate cancer,"Other lncRNAs are known to interact directly with the androgen receptor pathway including PlncRNA-1, HOTAIR, PRNCR1 and PCGEM1. "
MALAT1,retinal neurodegeneration,MALAT1 might regulate the development of retinal neurodegeneration through CREB signaling.
HOTAIR,colon cancer,MiR-125a-5p decreases after long non coding RNA HOTAIR knockdown to promote cancer cell apoptosis by releasing caspase 2.
PCA3,prostate cancer,PCA3 long noncoding RNA modulates the expression of key cancer-related genes in LNCaP prostate cancer cells.
TCONS_00003876,breast cancer,TCONS_00003876 might play a role in HER2-positive breast cancer.
lnc-HOXC4-3:1,breast cancer,lnc-HOXC4-3:1 might play a role in HER2-positive breast cancer.
lnc-TEAD4-1:1,breast cancer,lnc-TEAD4-1:1 might play a role in HER2-positive breast cancer.
MIAT,dilated cardiomyopathy,MIAT is a specific biomarker of CCC.
RGMB-AS1,lung adenocarcinoma,LncRNA RGMB-AS1 may play an important role in lung adenocarcinoma and may serve as a potential therapeutic target.
UCA1,acute myocardial infarction,The circulating UCA1 could be used as a promising novel biomarker for the diagnosis and/or prognosis of AMI.
MALAT1,non-small cell lung cancer,MALAT1 can serve as a convenient tool for early NSCLC diagnosis.
CDKN2B-AS1,hypertension,Polymorphisms in the long non-codingRNA CDKN2B-AS1 may contribute to higher systolic blood pressure levels in hypertensive patients.
HOTAIR,glioblastoma,HOTAIR plays an important role in glioblastoma
NORAD,breast cancer,"LINC00657 knockout significantly suppresses tumor cell growth and proliferation, suggesting that it  plays an oncogenic role."
GAS8-AS1,papillary thyroid carcinoma,LncRNA GAS8-AS1 and LPAR4 as potential diagnostics and therapeutic targets.
MALAT1,glioma,The tumor-suppressive role of MALAT1 in glioma by attenuating ERK/MAPK-mediated growth and MMP2 mediated invasiveness.
BC012900,ulcerative colitis,The lncRNA may be an integral modulator of intestinal inflammation associated with IBD and represent a novel target for future therapeutics and diagnostic marker development.
LET,esophageal squamous cell carcinoma,Long non-coding RNA-Low Expression in Tumor inhibits the invasion and metastasis of esophageal squamous cell carcinoma by regulating p53 expression.
UCA1,renal cell carcinoma,"UCA1 may be consider as a promising biomarker for diagnosis, and a therapeutic target in RCC."
HOTAIR,gastric cancer,HOTAIR was significantly correlated with tumor size and lymphatic metastasis (p<0.05)
UCA1,gastric cancer,"UCA1 was significantly correlated with tumor size, TNM stage and lymphatic metastasis (p<0.05)"
MALAT1,hepatic steatosis,MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability.
DQ786243,colorectal cancer,LncRNA DQ786243 contributes to proliferation and metastasis of colorectal cancer  both in vitro and in vivo
TRIM52-AS1,renal cell carcinoma,Downregulation of long non-coding RNA TRIM52-AS1 functions as a tumor suppressor in renal cell carcinoma.
MEG3,colorectal cancer,Genetic variants in MEG3 may contribute to the development and risk of colorectal cancer.
H19,gastric cancer,Long Noncoding RNA H19-Derived miR 675 Enhances Proliferation and Invasion via RUNX1 in Gastric Cancer Cells.
LINC00636,breast cancer,LINC00636 provides useful information for exploring candidate therapeutic targets and new molecular biomarkers for HER-2-enriched subtype breast cancer.
LINC01405,breast cancer,LINC01405 provides useful information for exploring candidate therapeutic targets and new molecular biomarkers for HER-2-enriched subtype breast cancer.
ADARB2-AS1,breast cancer,ADARB2-AS1 provides useful information for exploring candidate therapeutic targets and new molecular biomarkers for HER-2-enriched subtype breast cancer.
ST8SIA6-AS1,breast cancer,ST8SIA6-AS1 provides useful information for exploring candidate therapeutic targets and new molecular biomarkers for HER-2-enriched subtype breast cancer.
LINC00511,breast cancer,LINC00511 provides useful information for exploring candidate therapeutic targets and new molecular biomarkers for HER-2-enriched subtype breast cancer.
DPP10-AS1,breast cancer,DPP10-AS1 provides useful information for exploring candidate therapeutic targets and new molecular biomarkers for HER-2-enriched subtype breast cancer.
PVT1,lung squamous cell carcinoma,"Its targets and regulators, may play crucial roles in the progress of LUSC."
TERC,lung squamous cell carcinoma,"Its targets and regulators, may play crucial roles in the progress of LUSC."
PANDAR,breast cancer,LncRNA PANDAR regulates the G1/S transition of breast cancer cells by suppressing p16(INK4A) expression.
MALAT1,breast cancer,MALAT1 regulated migration and invasion of breast cancer cells via affecting cdc42 through binding miR-1 competitively.
PVT1,gastric cancer,PVT1 might serve as a promising biomarker early detection and prognosis prediction of gastric cancer.
CYP4B1-PS1,diabetic nephropathy,A novel long non-coding RNA CYP4B1 PS1-001 regulates proliferation and fibrosis in diabetic nephropathy.
CCAT1,acute myeloid leukemia,The manipulation of CCAT1 expression could serve as a potential strategy in AML therapy.
HIF1A-AS2,breast cancer,HIF1A-AS2 and AK124454 promoted cell proliferation and invasion in TNBC cells and contributed there to paclitaxel resistance.
AK124454,breast cancer,HIF1A-AS2 and AK124454 promoted cell proliferation and invasion in TNBC cells and contributed there to paclitaxel resistance.
BC088254,myocardial hypertrophy,lncRNA BC088254 may have a certain role in myocardial hypertrophy induced by TAC 
LCAL6,lung adenocarcinoma,The lung cancer associated lncRNA 6 (LCAL6) was significantly unregulated and predicted survival in LUAD.
MALAT1,breast cancer,MiR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation.
MALAT1,breast cancer,Aberrant KDM5B expression promotes aggressive breast cancer through MALAT1 overexpression and downregulation of has miR-448.
TUG1,gastric cancer,"TUG1, as a regulator of proliferation, may serve as a candidate prognostic biomarker and target for new therapies in human GC."
NEAT1,gastric adenocarcinoma,Expression of NEAT1 lncRNA was enhanced in GACs; and NEAT1 may influence GAC progression by promoting tumor growth.
RP11-434D9.1,breast cancer,RP11-434D9.1 is correlated with TNBC occurrence
LINC00052,breast cancer,LINC00052 is correlated with TNBC occurrence
BC016831,breast cancer,BC016831 is correlated with TNBC occurrence
IGKV,breast cancer,IGKV is correlated with TNBC occurrence
MALAT1,renal cell carcinoma,MALAT-1 can be used to predict unfavorable prognoses for RCC.
PVT1,non-small cell lung cancer,PVT1/EZH2/LATS2 interactions might serve as new target for lung adenocarcinoma diagnosis and therapy.
NONHSAT040387,atrial fibrillation,NONHSAT040387 plays an important role in AF
NONHSAT098586,atrial fibrillation,NONHSAT098586 plays an important role in AF
NR_026689,lung cancer,LncRNA NR_026689 may be a potential early biomarker for lung cancer and is associated with lung carcinogenesis induced by NNK
CBR3-AS1,hepatocellular carcinoma,PlncRNA-1 may serve as an oncogene in HCC progression and represent a valuable prognostic marker and potential therapeutic target for HCC.
lnc-LAMC2-1:1,colorectal cancer,rs2147578 in lnc-LAMC2-1:1 might be a genetic modifier for the development of CRC.
LINC-ROR,pancreatic cancer,"linc-ROR acts as an important regulator of ZEB1, can promote invasion and metastasis in PC, and may represent a novel therapeutic target."
PANDAR,gastric cancer,PANDAR may be a potential novel biomarker that predicts prognosis in gastric cancer.
MEG3,metabolic syndrome,"Pioglitazone up-regulated MEG3 expression to protect EPCs via decreasing miR-140-5p expression and increasing HDAC7 expression in MetS, which may be a novel therapeutic target for preventing  and treating MetS."
MIF-AS1,nephrolithiasis,The MIF-AS rs755622 polymorphism may have a crucial role in the development of nephrolithiasis.
AB209630,hypopharyngeal squamous cell carcinoma,"AB209630, a long non-coding RNA decreased expression in hypopharyngeal squamous cell carcinoma, influences proliferation, invasion, metastasis, and survival."
HULC,glioma,HULC long noncoding RNA silencing suppresses angiogenesis by regulating ESM-1 via the PI3K/Akt/mTOR signaling pathway in human gliomas.
BCYRN1,ovarian cancer,BC200 appears to serve a role in the mediation of carboplatin-induced ovarian cancer cell death.
AFAP1-AS1,hepatocellular carcinoma,Long noncoding RNA AFAP1-AS1 indicates a poor prognosis of hepatocellular carcinoma and promotes cell proliferation and invasion via upregulation of the RhoA/Rac2 signaling.
PVT1,breast cancer,"PVT1 leads to increased premalignant features, and ultimately to tumor formation."
PVT1,breast cancer,"PVT1 leads to increased premalignant features, and ultimately to tumor formation."
MALAT1,colorectal cancer,Long non-coding RNA MALAT1 increases AKAP-9 expression by promoting SRPK1-catalyzed SRSF1 phosphorylation in colorectal cancer cells.
H19,breast cancer,Genetic Polymorphisms in Long Noncoding RNA H19 Are Associated With Susceptibility to Breast Cancer in Chinese Population.
MEG3,tongue squamous cell carcinoma,MEG3 emerges as an independent prognostic factor for poor clinical outcomes in TSCC patients
AK021954,atherosclerosis,LncRNA AK021954 gene and FGF18 involved in baicalein inhibiting the proliferation of VSMCs. It may provide a promising method in treatment of atherosclerosis.
UCA1,colon cancer,Plasma UCA1 may serve as a potential biomarker for early diagnosis and disease monitoring of colon cancer patients.
PVT1,ovarian cancer,Overexpression of LncRNA PVT1 in ovarian cancer promotes cisplatin resistance by regulating apoptotic pathways.
AK123072,gastric cancer,Hypoxia/lncRNA-AK123072/EGFR pathway in gastric cancer pathogenesis and this might help in the development of new therapeutics in clinics.
MALAT1,non-small cell lung cancer,MALAT1 is an oncogenic long non-coding RNA associated with tumor invasion in non-small cell lung cancer regulated by DNA methylation.
SPRY4-IT1,esophageal squamous cell carcinoma,"Long noncoding RNA SPRY4-IT1 promotes esophageal squamous cell carcinoma cell proliferation, invasion, and epithelial mesenchymal transition."
LINC01852,non-small cell lung cancer,ENST00000434223 may be a potential biomarker and a therapeutic target of NSCLC.
LET,renal cell carcinoma,LET can be a promising new class of biomarkers for tumour diagnosis
PVT1,renal cell carcinoma,PVT1 can be a promising new class of biomarkers for tumour diagnosis
PANDAR,renal cell carcinoma,PANDAR can be a promising new class of biomarkers for tumour diagnosis
PTENP1,renal cell carcinoma,PTENP1 can be a promising new class of biomarkers for tumour diagnosis
LINC00963,renal cell carcinoma,LINC00963 can be a promising new class of biomarkers for tumour diagnosis
KRT7-AS,gastric cancer,"KRT7-AS promotes GC, at least in part, by increasing KRT7 expression."
H19,laryngeal squamous cell carcinoma,The lncRNA H19 promoted LSCC progression via miR-148a-3p and DNMT1.
SLC26A4-AS1,cardiac hypertrophy,The lncRNA played an important role in the CH
RP11-344E13.3,cardiac hypertrophy,The lncRNA played an important role in the CH
MAGI1-IT1,cardiac hypertrophy,The lncRNA played an important role in the CH
LncPPARdelta,coronary artery disease,"LncPPARdelta, especially combined with risk factors, can be a good biomarker for CAD."
MALAT1,gastric cancer,MALAT1 long ncRNA promotes gastric cancer metastasis by suppressing PCDH10.
KCNQ1OT1,colorectal cancer,β1-catenin signaling may contribute to development of colorectal cancer by functioning as a novel lncRNA regulatory factor via direct targeting of KCNQ1OT1.
HOTAIR,endometrial cancer,HOTAIR expression could serve as an independent prognostic factor in EC.
UCA1,ovarian cancer,"UCA1 is a new prognostic biomarker for EOC, establishing a novel connection among UCA1, miR-485-5p, and MMP14 in EOC metastasis."
NONRATT021972,diabetes mellitus,Inhibition of it may serve as a novel therapeutic strategy for diabetes complicated with nervous inflammatory diseases.
OR3A4,gastric cancer,Long noncoding RNA OR3A4 promotes metastasis and tumorigenicity in gastric cancer.
GAS5,breast cancer,"The GAS5 lncRNA HREM sequence alone is sufficient to induce apoptosis in breast cancer cells, including triple-negative breast cancer cells."
SOX2-OT,esophageal squamous cell carcinoma,Down-Regulatory Effects of miR-211 on Long Non-Coding RNA SOX2OT and SOX2 Genes in Esophageal Squamous Cell Carcinoma.
CASC15,basal cell carcinoma,The lncRNA may play a role in the molecular pathogenesis of BCC
CDKN2B-AS1,basal cell carcinoma,The lncRNA may play a role in the molecular pathogenesis of BCC
SCHLAP1,bladder cancer,SChLAP1 plays oncogenic roles and can be used as a therapeutic target for treating human bladder cancer.
RP11-181G12.2,lung adenocarcinoma,RP11-181G12.2 may play a key role in tumor development.
RP11-89K21,lung adenocarcinoma,RP11-89K21 may play a key role in tumor development.
OTTHUMT00000387022,coronary artery disease,OTTHUMT00000387022 is a novel and specific biomarker of CAD.
TUG1,colorectal cancer,The long non-coding RNA TUG1 indicates a poor prognosis for colorectal cancer and promotes metastasis by affecting epithelial mesenchymal transition.
KRT18P55,gastric cancer,"Upregulated KRT18P55 was a novel biomarker for the progression of GC, especially for the intestinal type."
MALAT1,cervical cancer,"Human MALAT-1 long non-coding RNA is overexpressed in cervical cancer metastasis  and promotes cell proliferation, invasion and migration."
UCA1,ovarian cancer,UCA1 may serve as an indicator of response to chemotherapy and prognosis of ovarian cancer and UCA1 may play an important role in the progression of ovarian cancer.
MEG3,pancreatic cancer,fenofibrate inhibited pancreatic cancer cells proliferation via activation of p53 mediated by upregulation of MEG3.
MALAT1,pancreatic cancer,"EZH2 promotes cell migration and invasion but not alters cell proliferation by suppressing E-cadherin, partly through association with MALAT-1 in pancreatic cancer."
FEZF1-AS1,colorectal cancer,"The dysregulation of FEZF1-AS1 participates in colorectal tumorigenesis and progression, which might be achieved, at least in part, through FEZF1 induction."
MALAT1,neuroblastoma,"Up-regulation of MALAT1 expression in human neuroblastoma cells under hypoxic conditions increases FGF2 expression and promotes vasculature formation, and therefore plays an important role in tumor-driven angiogenesis."
lncRNA-ATB,renal cell carcinoma,High expression of long non-coding RNA lncRNA-ATB is correlated with metastases and promotes cell migration and invasion in renal cell carcinoma.
GAS5,melanoma,Lentiviral-mediated overexpression of long non-coding RNA GAS5 reduces invasion by mediating MMP2 expression and activity in human melanoma cells. 
SOX2-OT,lung cancer,Our findings support a potential oncogenic role for SOX2OT in non-small cell lung cancer tumor genesis and SOX2OT seems a promising therapeutic candidate for NSCLC.
MEG3,diabetes mellitus,MEG3 up-regulation may serve as a therapeutic strategy for treating diabetes-related microvascular complications
LINC01133,non-small cell lung cancer,How LINC01133 over-expression confers an oncogenic function in NSCLC that may offer a novel therapy target in this disease.
TINCR,esophageal squamous cell carcinoma,"TINCR promotes proliferation, migration and invasion of ESCC cells, acting as a potential oncogene of ESCC."
HOXA11-AS,glioma,HOXA11-AS could serve as a biomarker for identifying glioma molecular subtypes and as therapeutic target for glioma patients.
HOTAIR,ovarian cancer,"HOTAIR can promote proliferation, migration, and invasion in ovarian SKOV3 cells as a competing endogenous RNA."
FALEC,thyroid cancer,FAL1 may have a role in cell-cycle progression and may be associated with aggressive tumor behavior in PTC.
CCAT1,gastric cancer,"The CCAT1/miR-490/hnRNPA1 axis promotes GC migration, and it may have a possible diagnostic and therapeutic potential in GC."
ENST00000537266,papillary thyroid carcinoma,"LncRNAs(ENST00000426615 and ENST00000537266) might be important regulators of PTC cell proliferation and motility, which might provide new insight into the understanding of PTC pathogenesis."
HAGLROS,papillary thyroid carcinoma,"LncRNAs(ENST00000426615 and ENST00000537266) might be important regulators of PTC cell proliferation and motility, which might provide new insight into the understanding of PTC pathogenesis."
uc.77,idiopathic pulmonary fibrosis,Overexpression of uc.77 or 2700086A05Rik in human lung epithelial cells induced EMT as demonstrated by changes in gene and protein expression of various EMT markers and cell morphology.
2700086A05Rik,idiopathic pulmonary fibrosis,Overexpression of uc.77 or 2700086A05Rik in human lung epithelial cells induced EMT as demonstrated by changes in gene and protein expression of various EMT markers and cell morphology.
MEG3,osteosarcoma,Downregulation of lncRNA MEG3 was associated with poor overall survival of osteosarcoma and lncRNA MEG3 could be a useful biomarker for progression and prognosis of osteosarcoma.
HOTAIR,asthenozoospermia,Low long non-coding RNA HOTAIR expression is associated with down regulation of Nrf2 in the spermatozoa of patients with asthenozoospermia or oligoasthenozoospermia.
CCAT1,colorectal cancer,Combination of HOTAIR and CCAT1 had a higher positive diagnostic rate of CRC than HOTAIR or CCAT1 alone.
HOTAIR,colorectal cancer,Combination of HOTAIR and CCAT1 had a higher positive diagnostic rate of CRC than HOTAIR or CCAT1 alone.
PRNCR1,prostate cancer,PRNCR1 plays an important role in prostate cancer.
PCAT1,prostate cancer,PCAT1 plays an important role in prostate cancer.
PCAT2,prostate cancer,PCAT2 plays an important role in prostate cancer.
NEAT1,laryngeal squamous cell carcinoma,NEAT1 plays an oncogenic role in the tumorigenesis of LSCC and may serve as a potential target for therapeutic intervention.
FGF14-AS2,breast cancer,A novel long non-coding RNA FGF14-AS2 is correlated with progression and prognosis in breast cancer.
AK027294,colorectal cancer,"AK027294 is highly expressed in colorectal cancer and closely correlates with colorectal cells proliferation, migration, and apoptosis."
MEG3,gallbladder cancer,MEG3 can inhibit the proliferation of  GBC cells and promote apoptosis
CDKN2B-AS1,gallbladder cancer,ANRIL can improve the proliferation of gallbladder cells and inhibit apoptosis.
DILC,liver cancer,"Lnc-DILC could be not only a potential prognostic biomarker, but also a possible therapeutic target against LCSCs."
CBR3-AS1,prostate cancer,PlncRNA-1 might warrant further investigation to determine its potential role as a promising therapeutic target in PCa.
HOTTIP,hepatocellular carcinoma,FMiRNA-192 and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma.
RP11-395G23.3,endometrial cancer,RP11-395G23.3 plays an important role in the post transcriptional regulation in EC.
LA16c-313D11.11,endometrial cancer,LA16c-313D11.11 plays an important role in the post transcriptional regulation in EC.
LINC01158,gastric cancer,Linc-POU3F3 could promote the distribution  of Tregs in peripheral blood T cell which caused an enhanced cell proliferation of gastric cancer cells by recruiting TGF beta as well as activating TGF-beta signal pathway.
HOTAIR,sepsis,LncRNA-HOTAIR promotes TNF-α production in cardiomyocytes of LPS induced sepsis mice by activating NF-KB pathway.
GFRA,Hirschsprung's disease,GFRA is a potential diagnostic biomarker of HSCR.
H19,gallbladder cancer,Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
AFAP1-AS1,hepatocellular carcinoma,AFAP1-AS1 is important in HCC development and serves as a therapeutic target of HCC.
HOTAIR,bladder cancer,UE-derived lncRNA HOTAIR may potentially serve as biomarkers and therapeutic targets.
TP73-AS1,esophageal squamous cell carcinoma,Knockdown of long non-coding RNA TP73-AS1 inhibits cell proliferation and induces apoptosis in esophageal squamous cell carcinoma.
CYTOR,gastric cancer,LINC00152 may play contribute to the progression of GC and  may be an effective therapeutic target.
SUMO1P3,bladder cancer,SUMO1P3 plays oncogenic roles in bladder cancer and can be used as a potential prognostic and therapeutic target.
MALAT1,cervical cancer,Down-regulation of MALAT1 inhibits cervical cancer cell invasion and metastasis by inhibition of epithelial-mesenchymal transition.
LOC400891,prostate cancer,Overexpression of long non-coding RNA LOC400891 promotes tumor progression and poor prognosis in prostate cancer.
lnc-MX1-1,prostate cancer,Lnc-MX1-1 may serve as a potential biomarker and therapeutic target for prostate cancer.
LUNAR1,diffuse large B-cell lymphoma,Long noncoding RNA LUNAR1 associates with cell proliferation and predicts a poor prognosis in diffuse large B-cell lymphoma.
LINC00635,lung cancer,"The long non-coding RNA, LINC00635-001, sensitizes EGFR-TKI-resistant human lung cancer cells in vitro by inhibiting Akt activation."
CASC2,lung cancer,Low expression of long noncoding RNA CASC2 indicates a poor prognosis and regulates cell proliferation in non-small cell lung cancer.
BACE1-AS,ovarian cancer,Elevation of lncRNA BACE1-AS expression is a potential mechanism for suppressing human OCSC proliferation and invasion.
TUSC7,osteosarcoma,TUSC7 could be a potential tumor suppressor in osteosarcoma.
HOTAIR,bladder transitional cell carcinoma,Long noncoding RNA HOTAIR is a prognostic biomarker and inhibits chemosensitivity to doxorubicin in bladder transitional cell carcinoma.
H19,gastric cancer,H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.
PCAT1,lung cancer,Long non-coding RNA PCAT-1 overexpression promotes proliferation and metastasis  in non-small cell lung cancer cells.
UPAT,colon cancer,UPAT and UHRF1 may be promising molecular targets for the therapy of colon cancer.
UHRF1,colon cancer,UPAT and UHRF1 may be promising molecular targets for the therapy of colon cancer.
NONHSAT123350,renal clear cell carcinoma,NONHSAT123350 could be involved in the pathogenesis of RCCC and its expression level was closely related to disease-free survival (DFS)  and overall survival (OS) in patients without distant metastasis.
MHRT,acute myocardial infarction,The plasma concentration of MHRT may serve as a biomarker for myocardial infarction diagnosis in humans AMI.
BANCR,hepatocellular carcinoma,BANCR may contribute to HCC initiation and progression and would be used as not only a novel prognostic marker but also  a potential therapeutic target for this disease.
HNF1A-AS1,nasopharyngeal carcinoma,Long non-coding RNA HNF1A-AS is upregulated and promotes cell proliferation and metastasis in nasopharyngeal carcinoma.
AFAP1-AS1,esophageal squamous cell carcinoma,High expression of long non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
NUTF2P3,pancreatic cancer,lncRNA-NUTF2P3-001 and miR-3923 can be applied as novel predictors and therapeutic targets for pancreatic cancer.
CCAT1,colorectal cancer,CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer.
TUG1,glioma,LncRNA TUG1 acts as a tumor suppressor in human glioma by promoting cell apoptosis.
NONRATT021972,type 2 diabetes mellitus,NONRATT021972 siRNA treatment may suppress the upregulated expression and activation of the P2X3 receptor and reduce the hyperalgesia potentiated by the pro-inflammatory cytokine TNF-α in T2DM rats.
PCNA-AS1,gastric cancer,IncRNA-PCNA-AS1 may participate in the gastric cancer carcinogenesis and development and may serve as a new biomarker for patients with gastric cancer.
HOTTIP,lung cancer,HOTTIP may be potentialnclinical biomarkers to predict lung cancernrisk and platinum-based chemotherapynresponse.
CCAT2,lung cancer,CCAT2 may be potentialnclinical biomarkers to predict lung cancernrisk and platinum-based chemotherapynresponse.
H19,lung cancer,H19 may be potentialnclinical biomarkers to predict lung cancernrisk and platinum-based chemotherapynresponse.
HOTAIR,lung cancer,HOTAIR may be potentialnclinical biomarkers to predict lung cancernrisk and platinum-based chemotherapynresponse.
MALAT1,lung cancer,MALAT1 may be potentialnclinical biomarkers to predict lung cancernrisk and platinum-based chemotherapynresponse.
CDKN2B-AS1,lung cancer,CDKN2B-AS1 may be potentialnclinical biomarkers to predict lung cancernrisk and platinum-based chemotherapynresponse.
SCHLAP1,prostate cancer,Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer.
CCAT2,cervical squamous cell cancer,Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients.
UCA1,gastric cancer,Plasma UCA1 levels could be a promising candidate of noninvasive biomarker for GC early diagnosis.
MALAT1,pre-eclampsia,Under-expression of MALAT-1 during early placentation may be involved in the pathogenesis of preeclampsia.
H19,non-small cell lung cancer,C-Myc-activated long non-coding RNAH19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
IRAIN,non-small cell lung cancer,"These data identify IRAIN as a novel promoting gene, which plays a vital role in tumorigenesis of NSCLC."
CTD-2541M15,gastric cancer,CTD-2541M15 may be associated with the progression and development of GC
UCA1,gastric cancer,UCA1 may be associated with the progression and development of GC
MEG3,gastric cancer,MEG3 may be associated with the progression and development of GC
HOTAIR,nasopharyngeal carcinoma,Long noncoding RNA HOTAIR mediated angiogenesis in nasopharyngeal carcinoma by direct and indirect signaling pathways.
HOTTIP,hepatocellular carcinoma,The miR-192/-204-HOTTIP axis might be an important molecular pathway during hepatic cell tumorigenesis.
LOC389641,pancreatic ductal adenocarcinoma,LOC389641 promotes PDAC progression and increases cell invasion by regulating E cadherin with the possible involvement of TNFRSF10A.
CDKN2B-AS1,colorectal cancer,ANRIL positively regulates the proliferation of HCT116 cells in two- and three-dimensional culture in a p15/p16-pRB pathway-independent manner.
HOTAIR,small cell lung cancer,HOTAIR mediates chemoresistance of SCLC  by regulating HOXA1 methylation and could be utilized as a potential target for new adjuvant therapies against chemoresistance.
GAS5,hepatocellular carcinoma,Decreased expression of long non-coding RNA GAS5 indicates a poor prognosis and promotes cell proliferation and invasion in hepatocellular carcinoma by regulating vimentin.
MIAT,myocardial infarction,MIAT plays an impoetant role in myocardial infarction 
Gm15577,medulloblastoma,"Gm15577 may modulate cerebellar granule cell proliferation and differentiation by targeting Negr1, and their dysfunctions or abnormal expression may be related to tumorigenesis of medulloblastoma."
MALAT1,breast cancer,"MALAT1 represents an exciting therapeutic target, and MALAT1 ASOs represent a potential therapy for inhibiting  breast cancer progression."
MALAT1,liver fibrosis,MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis.
BALR-6,B-lymphoblastic leukemia,BALR-6 regulates cell growth and cell survival in B-lymphoblastic leukemia.
LINC01207,lung adenocarcinoma,The long noncoding RNA LINC01207 promotes proliferation of lung adenocarcinoma.
H19,glioma,"H19 derived microRNA-675 may regulate giloma cell proliferation and migration through CDK6, and predict a poor prognosis of glioma patients."
MIR31HG,gastric cancer,Decreased long noncoding RNA MIR31HG is correlated with poor prognosis and contributes to cell proliferation in gastric cancer.
uc.48+,diabetic neuropathic pain,LncRNA uc.48+ is involved in diabetic neuropathic pain mediated by the P2X3 receptor in the dorsal root ganglia.
HOTTIP,colorectal cancer,HOTTIP is involved in the progression of CRC and may provide evidence for HOTTIP being a target for therapy of this disease.
HOTAIRM1,pancreatic ductal adenocarcinoma,HOTAIRM1 may provide new potential molecular markers for diagnosis and treatment of PDAC.
MALAT1,breast cancer,MALAT1 may be a target for TNBC therapy.
MEG3,glioma,Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas.
GAS5,type 2 diabetes mellitus,LncRNA GAS5 levels are correlated to prevalence of T2DM.
uc001ncr,hepatocellular carcinoma,The serum expression of uc001ncr and AX800134 has potential as novel potential biomarker for the diagnosis of HCC
AX800134,hepatocellular carcinoma,The serum expression of uc001ncr and AX800134 has potential as novel potential biomarker for the diagnosis of HCC
C5T1,rheumatoid arthritis,"The identification of a novel lncRNA C5T1lncRNA that is fully located in the associated region and influences transcript levels of C5, a gene previously linked to RA pathogenesis."
ICR,hepatocellular carcinoma,"ICR specifically regulates CSC properties of ICAM-1(+)HCC cells and that ICR contributes to PVTT development. Therefore, ICR may be a promising target for HCC therapy."
ICAM-1,hepatocellular carcinoma,"ICR specifically regulates CSC properties of ICAM-1(+)HCC cells and that ICR contributes to PVTT development. Therefore, ICR may be a promising target for HCC therapy."
H19,non-small cell lung cancer,C-Myc-regulated long non-coding RNA H19 indicates a poor prognosis and affects cell proliferation in non-small cell lung cancer.
GAS5,breast cancer,Plasma lncRNA GAS5 may have the potential to assess the surgical effects and prognosis for BC patients.
SNHG15,gastric cancer,Elevated lncRNA SNHG15 could be identified as a poor prognostic biomarker in GC and regulate cell invasion.
MEG3,retinoblastoma,MEG3 was a tumor suppressor by negatively regulating the activity of the Wnt/β1-catenin pathway in the progression of retinoblastoma and might serve as a prognostic biomarker and molecular therapeutic target.
HOTAIR,lung adenocarcinoma,HOTAIR inhibition may represent a promising therapeutic option for suppressing lung ADC progression.
UCA1,non-small cell lung cancer,"UCA1 functions as an oncogene in NSCLC, acting mechanistically by upregulating ERBB4 in part through 'spongeing' miR-193a-3p."
FMR6,fragile X-associated premature ovarian insufficiency,FMR6 may play a role in the pathogenesis of fragile X-associated premature ovarian insufficiency.
XLOC_011402,polycystic ovary syndrome,XLOC_011402 may contribute to the occurrence of PCOS and affect oocyte development.
ENST00000454271,polycystic ovary syndrome,ENST00000454271 may contribute to the occurrence of PCOS and affect oocyte development.
ENST00000433673,polycystic ovary syndrome,ENST00000433673 may contribute to the occurrence of PCOS and affect oocyte development.
LINC01828,polycystic ovary syndrome,LINC01828 may contribute to the occurrence of PCOS and affect oocyte development.
ENST00000432431,polycystic ovary syndrome,ENST00000432431 may contribute to the occurrence of PCOS and affect oocyte development.
MALAT1,glioma,"MALAT1 plays an important role in regulating the expression of stemness markers and proliferation of SHG139S, and provide a new research direction to target the progression of GSCs."
lncRNA-HIF2PUT,colorectal cancer,LncRNA-HIF2PUT may be a regulator of HIF-2α and a mediator of CSCs in 
MEG3,hepatocellular carcinoma,ILF3 may participate in the anticancer regulation of MEG3 by interacting with MEG3.
FENDRR,lung cancer,FENDRR may serve as a new biomarker for diagnosis of XWLC or a novel therapeutic target
SGO1-AS1,lung cancer,SGO1-AS1 may serve as a new biomarker for diagnosis of XWLC or a novel therapeutic target
NR_024118,rheumatoid arthritis,Shikonin has disease modifying activity that is attributable to the inhibition of inflammatory response via lncRNA-NR024118.
XIST,breast cancer,XIST and 53BP1 may be predictive biomarkers in BRCA1-like breast cancer
53BP1,breast cancer,XIST and 53BP1 may be predictive biomarkers in BRCA1-like breast cancer
LINC-ROR,pancreatic cancer,ROR is a potential novel prognostic marker to predict the clinical outcome of pancreatic cancer patients after surgery and may be a rational target for therapy.
IFNG-AS1,Hashimoto's thyroiditis,Enhanced expression of lncRNA-IFNG-AS1 contributes to Th1 cell response in HT patients and may be involved in the pathogenesis of HT.
GAS5,breast cancer,GAS5 is a pivotal tumor suppressor long noncoding RNA in human cancers.
GAS5,prostate cancer,GAS5 is a pivotal tumor suppressor long noncoding RNA in human cancers.
GAS5,lung cancer,GAS5 is a pivotal tumor suppressor long noncoding RNA in human cancers.
GAS5,colorectal cancer,GAS5 is a pivotal tumor suppressor long noncoding RNA in human cancers.
RP11-284N8.3.1,ovarian cancer,RP11-284N8.3.1 is a candidate biomarker for the prognosis of patients with OV and may enable a more accurate prediction of survival.
AC104699.1.1,ovarian cancer,AC104699.1.1 is a candidate biomarker for the prognosis of patients with OV and may enable a more accurate prediction of survival.
NONRATT021972,myocardial ischemic injury,LncRNA NONRATT021972 involved the pathophysiologic processes mediated by P2X7 receptors in stellate ganglia after myocardial ischemic injury.
FTX,colorectal cancer,Long non-coding RNA FTX may be a potential biomarker for predicting the survival  of colorectal cancer patients and might be a molecular target for treatment of human colorectal cancer.
HOTAIR,acute myeloid leukemia,Overexpression of long non-coding RNA HOTAIR predicts a poor prognosis in patients with acute myeloid leukemia.
DSCAM-AS1,breast cancer,DSCAM-AS1 plays an important role in breast cancer
MALAT1,glioma,"Knockdown of MALAT1 resulted in the increased permeability of BTB, which might contribute to establishing potential therapeutic strategies for human gliomas."
AC002454.1,endometriosis,AC002454.1 might induce cell cycle disorder by regulating CDK6 to participate in the pathogenesis of endometriosis.
CDKN2B-AS1,coronary artery disease,The newly identified TNF-α-NF-KB-ANRIL/YY1-IL6/8 pathway enhances understanding of the etiology of CAD and provides potential therapeutic target for treatment of CAD.
DANCR,colorectal cancer,Over-expression of lncRNA DANCR is associated with advanced tumor progression and poor prognosis in patients with colorectal cancer.
HOTTIP,colorectal cancer,lncRNA HOTTIP overexpression maybe serves as an unfavorable prognosis predictor for CRC patients.
HOTTIP,osteosarcoma,Long non-coding RNA HOTTIP is up regulated and associated with poor prognosis in patients with osteosarcoma.
MALAT1,gastric cancer,JMJD1A-MALAT1-MAPK signaling might participate in the JMJD1A-induced cell proliferation of gastric cancer.
AK056155,Loeys-Dietz syndrome,"AK056155 involved in the development of Loeys-Dietz syndrome through AKT/PI3K signaling pathway, it may provide a promising target gene to prevent LDS develop in to aortic aneurysm."
H19,ovarian cancer,LncRNAH19 plays an important role in OC cell proliferation and contributes to a better understanding of the importance of dysregulated lncRNAs in OC progression.
MALAT1,hepatocellular carcinoma,"The plasma MALAT1 level is associated with liver damage, and has clinical utility for predicting development of HCC."
BX647187,prostate cancer,Hec1 is consistently overexpressed in human PCa and Hec1 is closely linked with human PCa progression through the meditator LncRNA BX647187
NONHSAT037832,papillary thyroid carcinoma,Downregulation of long noncoding RNA NONHSAT037832 in papillary thyroid carcinoma and its clinical significance.
MEG3,prostate cancer,Long Non-Coding RNA MEG3 Inhibits Cell Proliferation and Induces Apoptosis in Prostate Cancer.
NEAT1,esophageal squamous cell carcinoma,Up regulation of the long non-coding RNANEAT1 promotes esophageal squamous cell carcinoma cell progression and correlates with poor prognosis.
lnc-ZNF180-2,renal clear cell carcinoma,The long non-coding RNA lnc-ZNF180-2 is a prognostic biomarker in patients with clear cell renal cell carcinoma.
MEG3,diabetes mellitus,MEG3 may be a potential target and therapeutic strategy for diabetes.
linc-ITGB1,breast cancer,Long non-coding RNA linc-ITGB1 promotes cell migration and invasion in human breast cancer.
BCYRN1,Alzheimer's disease,Overexpression of BC200 RNA leads to inadequate RNA delivery to the synapses and results in neurodegenerative processes of Alzheimer's disease and neoplastic changes in various groups of tissues.
PCA3,prostate cancer,This gene has been mainly exploited as an accurate diagnostic urine biomarker for Pca detection.
HOTAIR,head and neck squamous cell carcinoma,HOTAIR inhibition could be developed as a new therapeutic in HNSCC treatments.
NEAT1,glioma,This study supports NEAT1 as a potential prognostic predictor with its high expression in cancer tissues and its association with carcinogenesis and progression in glioma.
HOTAIR,breast cancer,HOTAIR plays a role as an oncogenic molecule in breast cancer
MALAT1,osteosarcoma,Long noncoding RNA MALAT1 as a potential therapeutic target in osteosarcoma.
MEG3,cervical cancer,Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21.
RUNX1-IT1,gastric cancer,C21orF96 is an oncogenic lncRNA that promotes tumor progression and plays a pivotal role in the development of gastric cancer.
TSIX,systemic sclerosis,Long non-coding RNA TSIX is upregulated in scleroderma dermal fibroblasts and controls collagen mRNA stabilization.
LINC00472,breast cancer,"LINC00472 is functionally a tumor suppressor, and that assessing its expression in breast tumors may have clinical implications in breast cancer management."
CRNDE,ovarian cancer,CRNDE is a potential marker of poor prognosis in women with ovarian carcinomas
LINC00917,intervertebral disc degeneration,LINC00917 might play important roles in the development of IDD
CTD-2246P4.1,intervertebral disc degeneration,CTD-2246P4.1 might play important roles in the development of IDD
CTC-523E23.5,intervertebral disc degeneration,CTC-523E23.5 might play important roles in the development of IDD
RP4-639J15.1,intervertebral disc degeneration,RP4-639J15.1 might play important roles in the development of IDD
RP11-363G2.4,intervertebral disc degeneration,RP11-363G2.4 might play important roles in the development of IDD
AK024171,intervertebral disc degeneration,AK024171 might play important roles in the development of IDD
MIR132,intervertebral disc degeneration,MIR132 might play important roles in the development of IDD
RP11-38F22.1,intervertebral disc degeneration,RP11-38F22.1 might play important roles in the development of IDD
MVIH,breast cancer,Long non-coding RNA MVIH is associated with poor prognosis and malignant biological behavior in breast cancer.
NEAT1,colorectal cancer,Whole blood NEAT1 expression is a novel diagnostic and prognostic biomarker of overall survival in colorectal cancer.
HOTAIR,prostate cancer,"LncRNA HOTAIR is highly expressed in prostate cancer, which is associated with the growth and invasiveness of prostate cancer cells."
lncRNA-n336928,bladder cancer,"High expression of lncRNA-n336928 is associated with the progression of bladder cancer, and that lncRNA-n336928 might  serve as a biomarker for prognosis of bladder cancer."
UCA1,hepatocellular carcinoma,LncRNA-UCA1 and lncRNA-WRAP53 upregulation may serve as novel serum biomarkers for HCC diagnosis and prognosis.
WRAP53,hepatocellular carcinoma,LncRNA-WRAP53 was significant independent prognostic markers in relapse-free survival.
GAS5,breast cancer,"Notch-1, which identified the most relevant lncRNA GAS5 in breast cancer, promotes breast cancer cells proliferation by regulating LncRNA GAS5."
HEIH,hepatocellular carcinoma,HEIH plays an important role in the invasion of hepatocellular carcinoma cell.
HULC,hepatocellular carcinoma,HULC could promote proliferation of hepatoma cells.
UCA1,prostate cancer,Long non-coding RNA UCA1 contributes to the progression of prostate cancer and regulates proliferation through KLF4 KRT6/13 signaling pathway.
HOTAIR,colorectal cancer,Knockdown of long non-coding RNA HOTAIR inhibits proliferation and invasiveness and improves radiosensitivity in colorectal cancer.
MIR31HG,pancreatic ductal adenocarcinoma,"MIR31HG functions as an oncogenic lncRNA that promotes tumor progression, and miR-193b targets not only protein-coding genes but also the lncRNA, MIR31HG."
BC032469,gastric cancer,"Long noncoding RNA BC032469, a novel competing endogenous RNA, upregulates hTERT expression by sponging miR-1207-5p and promotes proliferation in gastric cancer."
GAS5,bladder cancer,"GAS5 was able to suppress bladder cancer cell proliferation, at least partially, by suppressing the expression of CCL1."
HOTAIR,breast cancer,"Genetic variant rs920778 in HOTAIR significantly increased the risk of BC, and it may have apparent interaction with reproductive factors in the progression on BC."
PVT1,acute promyelocytic leukemia,Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia.
UCA1,bladder cancer,LncRNA-UCA1 might act as a promising therapeutic target for the invasion and metastasis of bladder cancer.
MEG8,temple syndrome,The differentially methylated region of MEG8 is hypermethylated in patients with Temple syndrome.
HULC,liver cancer,HULC promotes tumor angiogenesis in liver cancer through miR 107/E2F1/SPHK1 signaling.
LINC01419,hepatocellular carcinoma,LINC01419 and AK021443 regulate cell cycle genes
AK021443,hepatocellular carcinoma,LINC01419 and AK021443 regulate cell cycle genes
AF070632,hepatocellular carcinoma,"AF070632 is associated with cofactor binding, oxidation-reduction and carboxylic acid catabolic process."
CYTOR,hepatocellular carcinoma,LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway
PICSAR,testicular embryonal carcinoma,Downregulation of miR-320a/383-sponge like long non-coding RNA NLC1-C (narcolepsy candidate-region 1 genes) is associated with male infertility and promotes testicular embryonal carcinoma cell proliferation.
CYTOR,gastric cancer,Linc00152 could promote tumor growth through EGFR-mediated PI3K/AKT pathway which may serve as potential targets for therapy in the future.
LOWEG,gastric cancer,A novel long noncoding RNA-LOWEG is low expressed in gastric cancer and acts as a tumor suppressor by inhibiting cell invasion.
PRNCR1,colorectal cancer,PRNCR1 promotes the proliferation of CRC cells and is a potential oncogene of CRC.
HOTAIR,cervical cancer,Propofol promotes cell apoptosis via inhibiting HOTAIR mediated mTOR pathway in cervical cancer.
MALAT1,oral squamous cell carcinoma,MALAT1 is an important prognostic factor and therapeutic target for OSCC.
HOTAIR,ovarian cancer,Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β1-catenin pathway in human ovarian cancer.
PVT1,bladder cancer,Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells.
MALAT1,prostate cancer,MALAT1 may be a crucial RNA cofactor of EZH2 and that theEZH2-MALAT1 association may provide a new avenue for development new strategies for treatment of CRPC
UCA1,liver cancer,Long noncoding RNA CUDR will help in the development of new liver cancer therapeutic and diagnostic approaches.
MALAT1,diabetes mellitus,Down-regulation of lncRNA MALAT1 reduces cardiomyocyte apoptosis and improves left ventricular function in diabetic rats.
GAS5,endometrial cancer,GAS5 plasmid may reverse this regulation effect in endometrial cancer cells.
ZFAS1,colorectal cancer,Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer.
GAS5,ovarian cancer,"GAS5 inhibits EOC cell  proliferation, migration and invasion, and promotes cell apoptosis. GAS5 can serve as a novel therapeutic target in patients with EOC."
PCA3,prostate cancer,PCA3 can use as a tumor marker for PCa and may be an attractive novel therapeutic target for the diagnosis and treatment of PCa.
PCATs,prostate cancer,PCATs can use as a tumor marker for PCa and may be an attractive novel therapeutic target for the diagnosis and treatment of PCa.
SCHLAP1,prostate cancer,SCHLAP1 can use as a tumor marker for PCa and may be an attractive novel therapeutic target for the diagnosis and treatment of PCa.
SPRY4-IT1,prostate cancer,SPRY4-IT1 can use as a tumor marker for PCa and may be an attractive novel therapeutic target for the diagnosis and treatment of PCa.
TRPM2-AS,prostate cancer,TRPM2-AS can use as a tumor marker for PCa and may be an attractive novel therapeutic target for the diagnosis and treatment of PCa.
TUG1,osteosarcoma,Upregulation of long non-coding RNA TUG1 correlates with poor prognosis and disease status in osteosarcoma.
CPS1-IT1,intrahepatic cholangiocarcinoma,CPS1 and CPS1-IT1 may be potential prognostic indicators for patients with ICC.
HOTAIR,ovarian cancer,HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer.
MALAT1,esophageal squamous cell carcinoma,"MALAT-1 knockdown induced a decrease in proliferation enhanced apoptosis, inhibited migration/invasion, and reduced colony formation and led to cell cycle arrest at  the G2/M phase."
CECR7,hepatocellular carcinoma,CECR7 was found to be significantly associated with overall survival
LINC00346,hepatocellular carcinoma,LINC00346 was found to be significantly associated with overall survival
MAPKAPK5-AS1,hepatocellular carcinoma,MAPKAPK5-AS1 was found to be significantly associated with overall survival
LOC338651,hepatocellular carcinoma,LOC338651 was found to be significantly associated with overall survival
FLJ90757,hepatocellular carcinoma,FLJ90757 was found to be significantly associated with overall survival
LOC283663,hepatocellular carcinoma,LOC283663 was found to be significantly associated with overall survival
PVT1,non-small cell lung cancer,Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer
ATB,colon cancer,LncRNA-ATB mediated E-cadherin repression promotes the progression of colon cancer and predicts poor prognosis.
SNHG12,osteosarcoma,Long non-coding RNA small nucleolar RNA host gene 12 (SNHG12) promotes cell proliferation and migration by upregulating angiomotin gene expression in human osteosarcoma cells.
TRPM2-AS,prostate cancer,The long non-coding RNA (ncRNA) TRPM2 AS is a key regulator of survival in prostate cancer
MALAT1,nasopharyngeal carcinoma,"MALAT1 regulated CSC activity and radioresistance by modulating miR 1/slug axis, which indicated that MALAT1 could act as a therapeutic target for NPC patients."
H19,non-small cell lung cancer,"H19 is involved in the oncogenesis of NSCLC, and H19 may  be a potential diagnostic and target for new therapies in patients with NSCLC."
GAS5,head and neck cancer,Circulating GAS5 could be a biomarker in predicting treatment response in HNC patients.
HOTAIR,pancreatic ductal adenocarcinoma,"HOTAIR can affect the radiosensitivity of PDAC cells partly via regulating the expression of WIF-1, and HOTAIR-WIF-1 axis is a potential target for PDAC radiotherapy."
ATB,pancreatic cancer,LncRNA-ATB may play a critical role in pancreatic cancer progression and prognosis and may serve as a potential prognostic biomarker in pancreatic cancer patients.
MEG3,non-small cell lung cancer,Meg3 and miR-3163 may coordinate suppression of translation of Skp2 mRNA in NSCLC cells to inhibit NSCLC cell growth.
MIR100HG,neuroblastoma,"Identification of linc-NeD125, a novel long non coding RNA that hosts miR-125b-1 and negatively controls proliferation of human neuroblastoma cells."
PACERR,osteosarcoma,PACER promotes proliferation and metastasis of osteosarcoma cells by activating the COX-2 gene and its own expression was influenced by DNA methylation.
MALAT1,diabetic cardiomyopathy,Involvement of long noncoding RNA MALAT1 in the pathogenesis of diabetic cardiomyopathy.
HNF1A-AS1,gastric cancer,"lncRNA HNF1A-AS1 may be a regulator of GC, and thus, it may have potential as a novel biomarker and treatment target for this type of cancer."
HOTAIR,bladder cancer,Long non-coding RNA HOTAIR regulates cyclin J via inhibition of microRNA-205 expression in bladder cancer.
CCAT1,breast cancer,Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer.
SPRY4-IT1,glioma,Knockdown of SPRY4-IT1 could inhibit epithelial mesenchymal transition (EMT) phenotype in glioma cells
UCA1,breast cancer,Macrophage could promote invasiveness of breast cancer cells by enhancing expression of lncRNA UCA1.
FOXC2-AS1,osteosarcoma,FOXC2-AS1 may play a critical role in doxorubicin resistance of OS by interacting with important genes
FENDRR,osteosarcoma,FENDRR may play a critical role in doxorubicin resistance of OS by interacting with important genes
AFAP1-AS1,non-small cell lung cancer,LncRNA AFAP1-AS1 was up-regulated in NSCLC tissues and it could be an independent prognostic indicator for NSCLC patients.
WT1-AS,hepatocellular carcinoma,WT1-AS may function as a tumor suppressor in HCC by reversing the oncogenic effects of WT1.
MCHR2-AS1,psychiatric disease,MCHR2-AS1 plays an important role in psychiatric patients
MALAT1,renal clear cell carcinoma,The inhibition of MALAT1 expression may be a promising strategy for KIRC therapy.
TDRG1,aplastic anemia,FGF1 induces the proliferation of BMSCs in patients with AA via promoting acetylation in lncRNA of the TDRG1 gene promoter.
PVT1,hematological malignancies,The fusion genes involving lincRNAs potentially play as-yet-unknown oncogenic functional roles.
CCDC26,hematological malignancies,The fusion genes involving lincRNAs potentially play as-yet-unknown oncogenic functional roles.
HOTAIR,bladder cancer,"HOTAIR expression has prognostic value for bladder cancer progression, recurrence, and survival and suggest that HOTAIR  plays active roles in modulating the cancer epigenome, becoming an interesting candidate as a target for cancer diagnosis and therapy."
SPRY4-IT1,non-small cell lung cancer,"Circulating SPRY4-IT1, ANRIL, and NEAT might serve as a predictor for the early warning of non-small-cell lung cancer."
CDKN2B-AS1,non-small cell lung cancer,"Circulating SPRY4-IT1, ANRIL, and NEAT might serve as a predictor for the early warning of non-small-cell lung cancer."
NEAT1,non-small cell lung cancer,"Circulating SPRY4-IT1, ANRIL, and NEAT might serve as a predictor for the early warning of non-small-cell lung cancer."
lncTCF7,hepatocellular carcinoma,"Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition."
NONHSAG011351,type 1 diabetes mellitus,"ERBB3 whose locus associated lncRNA (NONHSAG011351) was found to be expressed in human islets, may constitute novel targets to prevent β1-cell destruction in T1D."
WT1-AS,gastric cancer,Decreased expression of long non-coding RNA WT1-AS promotes cell proliferation and invasion in gastric cancer.
CDKN2B-AS1,bladder cancer,ANRIL possibly serves as anoncogene in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic apoptosis pathway.
ENST00000438550,nasopharyngeal carcinoma,ENST00000438550 expression was demonstrated to be significantly correlated with NPC disease progression.
FAM30A,gallbladder cancer,KIAA0125 promoted the migration and invasion of GBC cells and could serve as a potential therapeutic target in advanced GBC.
HOTTIP,pancreatic cancer,Increased HOTTIP-005 and RP11-567G11.1 expression were poor prognostic factors for patients with PC
RP11-567G11.1,pancreatic cancer,Increased HOTTIP-005 and RP11-567G11.1 expression were poor prognostic factors for patients with PC
GAS5,liver fibrosis,"GAS5 increased the level of p27 protein by functioning as a competing endogenous RNA for miR-222, thereby inhibiting the activation and proliferation of HSCs."
MEG3,hepatocellular carcinoma,MEG3 functions as a tumor suppressor in hepatoma cells through interacting with p53 protein to activate p53-mediated transcriptional activity and influence the expression of partial p53 target genes.
CCAT2,breast cancer,Long noncoding RNA CCAT2 promotes breast tumor growth by regulating the Wnt signaling pathway.
TMEVPG1,Sjögren syndrome,Upregulation of long noncoding RNA TMEVPG1 enhances T helper type 1 cell response in patients with Sjögren's syndrome.
SNHG5,melanoma,"Serum long non-coding RNA, snoRNA host gene 5 level as a new tumor marker of malignant melanoma."
UCA1,breast cancer,Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR-143.
HOTAIRM1,acute myeloid leukemia,"The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature."
CCAT1,hepatocellular carcinoma,CARLo-5 promotes proliferation and metastasis of HCC and potentially emerged as a novel therapeutic target.
HOXA11-AS,ovarian cancer,"HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer."
PVT1,thyroid cancer,Long noncoding RNA PVT1 modulates thyroid cancer cell proliferation by recruiting EZH2 and regulating thyroid-stimulating hormone receptor (TSHR).
LINC01016,breast cancer,"LINC01016 and LINC00160 are direct transcriptional targets of ERα, correlate with Erα expression in clinical samples, and show prognostic significance in relation to breast cancer survival."
LINC00160,breast cancer,"LINC01016 and LINC00160 are direct transcriptional targets of ERα, correlate with Erα expression in clinical samples, and show prognostic significance in relation to breast cancer survival."
lncRNA-Hh,breast cancer,"LncRNA-Hh silence in Twist-positive breast cells attenuates the activated Shh-GLI1 signaling and decreases the CSC-associated SOX and OCT4 levels, thus reduces the MFE and tumorigenesis of transplanted tumor."
lncRNA-DLEU1,breast cancer,LncRNA-DLEU1 was highly expressed in the MCF-7 cells in breast cancer
H19,embryonal carcinoma,H19 oncogenicity in hEC cells is mediated through the regulation of the pluripotency state.
HOTAIR,prostate cancer,LncRNA HOTAIR Enhances the Androgen Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer.
TP73-AS1,multiple myeloma,KIAA0495 methylation appeared unimportant in the pathogenesis or progression of myeloma.
SOX2-OT,breast cancer,SOX2-OT can be used as a potential cancer biomarker
PTPRG-AS1,breast cancer,PTPRG-AS1 can be used as a potential cancer biomarker
RASSF1-AS1,breast cancer,RASSF1-AS1 can be used as a potential cancer biomarker
CDKN2B-AS1,breast cancer,CDKN2B-AS1 can be used as a potential cancer biomarker
CDKN2B-AS1,non-small cell lung cancer,Long Noncoding RNA ANRIL Regulates Proliferation of Non-small Cell Lung Cancer and Cervical Cancer Cells.
CDKN2B-AS1,cervical cancer,Long Noncoding RNA ANRIL Regulates Proliferation of Non-small Cell Lung Cancer and Cervical Cancer Cells.
FOXC2-AS1,osteosarcoma,LncRNA ODRUL may act as a pro-doxorubicin-resistant molecule through inducing the expression of the classical multidrug resistance-related ABCB1 gene in osteosarcoma cells 
MALAT1,esophageal squamous cell carcinoma,MALAT1 expression may serve as a predictive marker for middle thoracic ESCC patients who have been received radical resection.
GAS5,hepatocellular carcinoma,Long noncoding RNA GAS5 suppresses the migration and invasion of hepatocellular carcinoma cells via miR-21.
MALAT1,cervical cancer,High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion.
RP11-397D12.4,non-small cell lung cancer,"RP11-397D12.4, AC007403.1,and ERICH1 AS1 may be potential biomarkers for predicting the tumorigenesis of NSCLC in the future"
AC007403.1,non-small cell lung cancer,"RP11-397D12.4, AC007403.1,and ERICH1 AS1 may be potential biomarkers for predicting the tumorigenesis of NSCLC in the future"
ERICH1-AS1,non-small cell lung cancer,"RP11-397D12.4, AC007403.1,and ERICH1 AS1 may be potential biomarkers for predicting the tumorigenesis of NSCLC in the future"
DBH-AS1,hepatocellular carcinoma,HBx-related long non-coding RNA DBH AS1 promotes cell proliferation and survival  by activating MAPK signaling in hepatocellular carcinoma.
HOXA-AS2,gastric cancer,Long noncoding RNA HOXA-AS2 promotes gastric cancer proliferation by epigenetically silencing P21/PLK3/DDIT3 expression.
HOTAIR,gastric cancer,SNP rs4759314 of HOTAIR acts as a potential biomarker for predicting gastric cancer
UCA1,lung cancer,Upregulated lncRNA-UCA1 contributes to progression of lung cancer and is closely  related to clinical diagnosis as a predictive biomarker in plasma.
NBAT1,breast cancer,NBAT1 suppresses breast cancer metastasis by regulating DKK1 via PRC2.
H19,liver cancer,miR675 upregulates long noncoding RNA H19 through activating EGR1 in human liver cancer.
SNHG3,hepatocellular carcinoma,SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma.
UCA1,bladder cancer,Long non-coding RNA UCA1 promotes glutamine metabolism by targeting miR-16 in human bladder cancer.
GAS5,glioma,the introduction of GAS5 by plasmid transfection increased the expression of tumor suppressor Bcl-2 modifying factor (bmf) and Plexin C1 via directly targeting and reducing the expression of miR-222.
HOTAIR,breast cancer,LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer.
LOC554202,colorectal cancer,Loc554202 may play an important role in the progression of CRC and could be a candidate prognostic biomarker or a target for  new cancer therapies.
HULC,hepatocellular carcinoma,Both plasma levels of HULC and Linc00152 achieve a fine diagnostic accuracy in diagnosing ontogenesis and metastasis of HCC and may act as novel biomarkers for HCC.
CYTOR,hepatocellular carcinoma,Both plasma levels of HULC and Linc00152 achieve a fine diagnostic accuracy in diagnosing ontogenesis and metastasis of HCC and may act as novel biomarkers for HCC.
H19,breast cancer,H19 non coding RNA-derived miR-675 enhances tumorigenesis and metastasis of breast cancer cells by downregulating c-Cbl and Cbl-b.
MALAT1,hepatocellular carcinoma,Sp1 cooperates with Sp3 to upregulate MALAT1 expression in human hepatocellular carcinoma.
MINCR,Burkitt lymphoma,MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cells.
TUSC7,acute myeloid leukemia,Overexpression of the LSAMP and TUSC7 genes in acute myeloid leukemia following microdeletion/duplication of chromosome 3.
HOTAIR,ovarian cancer,Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β1-catenin pathway in human ovarian cancer.
PCGEM1,osteoarthritis,PCGEM1 stimulates proliferation of osteoarthritic synoviocytes by acting as a sponge for miR-770.
XIST,non-small cell lung cancer,Increased serum XIST and HIF1A-AS1 could be used as a predictive biomarker for NSCLC screening
HIF1A-AS1,non-small cell lung cancer,Increased serum XIST and HIF1A-AS1 could be used as a predictive biomarker for NSCLC screening
HOTAIR,lung cancer,Radiotherapy induced Lewis lung cancer cell apoptosis via inactivating β1-catenin mediated by upregulated HOTAIR.
TUG1,hepatocellular carcinoma,Long non-coding RNA TUG1 is up regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2.
GAS5,lung adenocarcinoma,GAS5 plays critical roles in lung adenocarcinoma.
LINC00982,gastric cancer,Upregulated expression of long non coding RNA LINC00982 regulates cell proliferation and its clinical relevance in patients with gastric cancer.
NALT1,acute lymphoblastic leukemia,LncRNA NALT interaction with NOTCH1 promoted cell proliferation in pediatric T cell acute lymphoblastic leukemia.
ZNRD1-AS1,cervical cancer,Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence cervical cancer development.
LINC01617,colorectal cancer,LINC01617 might be the potential biomarker for the tumorigenesis prediction of CRC in the future.
LOC152578,colorectal cancer,LOC152578 might be the potential biomarker for the tumorigenesis prediction of CRC in the future.
LINC01507,colorectal cancer,LINC01507 might be the potential biomarker for the tumorigenesis prediction of CRC in the future.
HOTAIR,gastric adenocarcinoma,HOTAIR is a predictive and prognostic biomarker for patients with advanced gastric adenocarcinoma receiving fluorouracil and platinum combination chemotherapy.
RP11-457M11.2,lung adenocarcinoma,RP11-457M11.2 could serve as a biomarker for diagnosis
HOTAIR,breast cancer,HOTAIR plays an important roles in breast tumourigenesis
H19,breast cancer,H19 plays an important roles in breast tumourigenesis
KCNQ1OT1,breast cancer,KCNQ1OT1 plays an important roles in breast tumourigenesis
BANCR,papillary thyroid carcinoma,BANCR may contribute to the tumorigenesis of PTC through regulation of cyclin D1 and TSHR
LSINCT5,chronic heart failure,Increased B-type-natriuretic peptide promotes myocardial cell apoptosis via the B-type-natriuretic peptide/long non coding RNA LSINCT5/caspase-1/interleukin 1β1 signaling pathway.
MEG3,hepatocellular carcinoma,Dendrosomal curcumin increases expression of the long non-coding RNA gene MEG3 via up-regulation of epi-miRs in hepatocellular cancer.
TUG1,bladder cancer,Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells.
n336934,Alzheimer's disease,Upregulated lncRNA n336934 is linked to cholesterol homeostasis.
LINC01616,Alzheimer's disease,LncRNA n341006 is associated with protein ubiquitination pathway
HULC,hepatocellular carcinoma,"Knockdown of Sp transcription factors and HULC by RNAi showed that they play important roles in HCC cell proliferation, survival and migration."
NEAT1,colorectal cancer,NEAT1 may serve as an indicator of tumor recurrence and prognosis of colorectal cancer.
MALAT1,cervical cancer,Long non-coding RNA MALAT1 modulates radiosensitivity of HR-HPV+ cervical cancer  via sponging miR-145.
LINC00675,pancreatic ductal adenocarcinoma,Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
LOXL1-AS1,exfoliation syndrome,Dysregulation of its expression by genetic risk variants plays a key role in XFS pathogenesis.
FER1L4,gastric cancer,The lncRNA FER1L4 acts as a competing endogenous RNA (ceRNA) to regulate the expression of PTEN by taking up miR-106a-5p in gastric cancer.
SPRY4-IT1,lung cancer,Over expression of SPRY4-IT1 enhanced the invasion and migration of  A549 cells.
AB073614,ovarian cancer,A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer.
BANCR,colorectal cancer,Fentanyl inhibits the invasion and migration of colorectal cancer cells via inhibiting the negative regulation of Ets-1 on BANCR.
LUADT1,lung adenocarcinoma,"LUADT1 is an oncogenic lncRNA that regulates LUAD progression, suggesting that dysregulated lncRNAs may serve as key regulatory factors in LUAD progression."
GAPLINC,gastric cancer,Long Noncoding RNA GAPLINC Regulates CD44-Dependent Cell Invasiveness and Associates with Poor Prognosis of Gastric Cancer.
MEG3,pituitary adenoma,MEG3 is a lncRNA tumor suppressor in the pituitary and its inactivation contributes to NFA development
MALAT1,congenital microtia,LncRNA of MALAT1 may play important roles in the development of the external ear.
PCAT5,prostate cancer,"PCAT5 is a novel oncogenic lncRNA in ERG-positive prostate cancers, with implications for defining CRPC biomarkers and new therapeutic interventions."
ABHD11-AS1,gastric cancer,Gastric juice ABHD11-AS1 may be a potential biomarker in the screening of gastric cancer.
GAS5,gastric cancer,GAS5 plays in the molecular etiology of GC and suggest a potential of GAS5 as a new therapeutic target for GC treatment.
FTH1P3,oral squamous cell carcinoma,"LncRNAs FTH1P3, PDIA3F and GTF2IRD2P1 may responsible for progression and metastasis of OSCC via targeting MMP1, MMP3, MMP9, PLAU and IL8 which are key regulators of tumorigenesis."
PDIA3F,oral squamous cell carcinoma,"LncRNAs FTH1P3, PDIA3F and GTF2IRD2P1 may responsible for progression and metastasis of OSCC via targeting MMP1, MMP3, MMP9, PLAU and IL8 which are key regulators of tumorigenesis."
GTF2IRD2P1,oral squamous cell carcinoma,"LncRNAs FTH1P3, PDIA3F and GTF2IRD2P1 may responsible for progression and metastasis of OSCC via targeting MMP1, MMP3, MMP9, PLAU and  IL8 which are key regulators of tumorigenesis."
MALAT1,breast cancer,Hsa-miR-1 suppresses breast cancer development by down-regulating K-ras and long non-coding RNA MALAT1.
H19,glioblastoma,H19 plays an important role in tumorigenicity and stemness of glioblastoma and thus could be a therapeutic target for treatment of glioblastoma in the future.
PTCSC3,papillary thyroid carcinoma,PTCSC3 impacts PTC predisposition and carcinogenesis through the S100A4 pathway.
H19,hepatocellular carcinoma,The lncRNA H19 is a putative therapeutic target in hepatocellular carcinoma.
EGFR-AS1,hepatocellular carcinoma,"The inhibition of EGFR-AS1 in HCC cells significantly impeded cell proliferation and  invasion in vivo, which might provide a potential possibility for targeted therapy of HCC."
HOTTIP,lung cancer,LncRNA HOTTIP contributes to tumor growth in vivo and in vitro and inhibits cell apoptosis in lung cancer.
MALAT1,non-small cell lung cancer,"MALAT1 expression by regulation of TDP 43 controls cellular growth, migration, and invasion of NSCLCs."
HOTAIR,acute myeloid leukemia,HOTAIR is upregulated in acute myeloid leukemia and that indicates a poor prognosis.
sONE,hypertension,L.barbarum L. had anti-hypertensive effect and might lower blood pressure by suppressing the expression of lncRNA sONE in BHR model
AP001631.9,gastric cancer,LncRNA-AP001631.9 plays critical roles in gastric cancer progression and can serve as a potential new target for the treatment of gastric cancer.
MALAT1,bladder cancer,MALAT1 might serve as a potential prognostic biomarker for various cancers.
MALAT1,colorectal cancer,MALAT1 might serve as a potential prognostic biomarker for various cancers.
MALAT1,kidney cancer,MALAT1 might serve as a potential prognostic biomarker for various cancers.
MEG3,gastric cancer,Long non-coding RNA MEG3 functions as acompeting endogenous RNA to regulate gastric cancer progression.
SNHG1,astrocytoma,The upregulation of ENST00000545440 and NR_002809 was associated with advanced clinical stages of astrocytoma.
LINC01089,astrocytoma,The upregulation of ENST00000545440 and NR_002809 was associated with advanced clinical stages of astrocytoma.
BC002811,astrocytoma,"The low expression of BC002811 or XLOC_010967, or the high expression of NR_002809 was significantly associated with poor patient survival."
XLOC_010967,astrocytoma,"The low expression of BC002811 or XLOC_010967, or the high expression of NR_002809 was significantly associated with poor patient survival."
HOTAIR,breast cancer,LncRNA HOTAIR displayed molecular profiles indistinguishable from invasive breast cancer.
BANCR,gastric cancer,BANCR promoting gastric cancer cells proliferation via regulation of NF-KB1.
AFAP1-AS1,nasopharyngeal carcinoma,AFAP1-AS1 might be a potential novel marker that can predict cancer patient prognosis and as a potential therapeutic target for NPC.
AFAP1-AS1,lung cancer,"AFAP1-AS1, a long noncoding RNA upregulated in lung cancer and promotes invasion and metastasis."
LET,nasopharyngeal carcinoma,"Long noncoding RNA-LET, which is repressed by EZH2, inhibits cell proliferation and induces apoptosis of nasopharyngeal carcinoma cell."
NEAT1,glioma,Long noncoding RNA NEAT1 promotes glioma pathogenesis by regulating miR-449b-5p/c-Met axis.
MALAT1,cervical cancer,MALAT1-miR-124-RBG2 axis is involved in growth and invasion of HR-HPV-positive cervical cancer cells.
MALAT1,proliferative vitreoretinopathy,MALAT1 is a potential prognostic indicator and a target for the diagnosis and gene therapy for PVR diseases.
SPRY4-IT1,gastric cancer,Low expression of SPRY4-IT1 is involved in progression and metastasis of gastric cancer and may represent a novel biomarker of poor prognosis in patients with gastric cancer.
UCA1,colorectal cancer,UCA1 is associated with tumor proliferation and metastasis and predicts poor prognosis in colorectal cancer.
CYTOR,gastric cancer,"Long non-coding RNA Linc00152 is involved in cell cycle arrest, apoptosis, epithelial to mesenchymal transition, cell migration and invasion in gastric cancer."
MEG3,gastric cancer,"MiR-141 could be interacting with MEG3 and targeting E2F3, and these factors may play important anti-tumor effects in GC pathogenesis and provide therapeutic targets in the clinics."
CRNDE,glioma,CRNDE affects the malignant biological characteristics of human glioma stem cells by negatively regulating miR-186.
CCAT1,hepatocellular carcinoma,"CCAT1, acting as a potential biomarker in predicting the prognosis of HCC, is regulated by c-Myc."
FER1L4,colon cancer,FER1L4 is predictive of poor prognosis in colon cancer and may play a crucial role in cancer prevention and treatment.
MEG3,renal cell carcinoma,MEG3 induces the apoptosis of RCC cells possibly by activating the mitochondrial pathway.
TUNAR,breast cancer,Long noncoding RNA linc00617 exhibits oncogenic activity in breast cancer
PRNCR1,gastric cancer,SNPs in the lncRNA PRNCR1 may be a biomarker for the etiology of GC.
H19,bladder cancer,H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activation.
ZMAT1,gastric cancer,ZMAT1 transcript variant 2 is a potential diagnostic factor in patients with gastric cancer.
CCAT1,hepatocellular carcinoma,CCAT1 promotes hepatocellular carcinoma cell proliferation and invasion.
NEAT1,hepatocellular carcinoma,NEAT1 acts as a pivotal player in tumorigenesis and metastasis of hepatocellular carcinoma.
MALAT1,breast cancer,MALAT1 is a novel regulator of EMT in breast cancer and may be a potential therapeutic target for breast cancer metastasis
HOTAIR,gastric cancer,Long non-coding RNA HOTAIR promotes HLA-G expression via inhibiting miR-152 in gastric cancer cells.
HOTAIR,glioma,Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326.
HULC,hepatocellular carcinoma,MiR-203 played tumor suppressive roles by downregulating ADAM9 and HULC and indicated its potential application in cancer treatment.
LINC00313,lung cancer,LINC00313 could be a biomarker for lung cancer
TCONS_00068220,gastric cancer,lncRNA TCONS_00068220 may play a role in gastric cancer.
HOTAIR,liver cancer,LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2.
H19,esophageal cancer,H19 has a significant role in the development of EC and may serve as a potential prognostic marker and therapeutic target for EC.
RP11-119F7.4,gastric cancer,LncRNA RP11-119F7.4 may be involved in carcinogenesis and may prove useful as a biomarker for diagnosis and prognostic significance in patients with gastric cancer.
H19,bladder cancer,YAP1 and H19 expression levels were detected and correlated with clinical and pathologic grades.
GAS5,hepatocellular carcinoma,GAS5 may act as a proto-oncogene in HCC
UCA1,bladder cancer,UCA1 plays an important role in bladder cancer
UCA1,non-small cell lung cancer,Long non-coding RNA UCA1 induces non-T790M acquired resistance to EGFR-TKIs by activating the AKT/mTOR pathway in EGFR-mutant non-small cell lung cancer.
AOC4P,hepatocellular carcinoma,Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
H19,gastric cancer,"H19 and miR-141 could compete with each other and affect their target genes in gastric cancer,"
EGOT,breast cancer,EGOT may play an important role in breast cancer progression and prognosis and may serve as a new potential prognostic target in breast cancer patients.
TARID,kidney clear cell sarcoma,TARID plays an important role in CCSK
ZEB2-AS1,bladder cancer,CAFs induces EMT and invasion of human UBC cells through the TGFβ11-ZEB2NAT-ZEB2 axis.
HOTAIR,cervical cancer,"Our study depicts one of the causal mechanisms of cervical carcinogenesis by HPV16 E7, through modulation of HOTAIR expression and function."
lncRNA-CD244,tuberculosis infection,Long noncoding RNA derived from CD244 signaling epigenetically controls CD8+ T-cell immune responses in tuberculosis infection.
NEAT1,HIV,The presence of NEAT1 in plasma is a potential biomarker of HIV-1 infection.
MALAT1,HIV,MALAT1 may interact with HIV-1 in vivo
UCA1,bladder cancer,UCA1 may be a biomarker for bladder cancer diagnosis.
MALAT1,lung cancer,MALAT1 as a biomarker to screen lung cancer may represent a host response to lung cancer.
lncRNA-AK058003,breast cancer,"Unregulated lncRNA-AK058003 in breast cancer cells promotes cancer cell proliferation, invasion and metastasis via the  regulation of SNCG expression."
SOX2-OT,esophageal squamous cell carcinoma,SOX2-OT plays an important role during development and tumorigenesis
SOX2-OT,lung squamous cell carcinoma,SOX2-OT plays an important role during development and tumorigenesis
SOX2-OT,breast cancer,SOX2-OT plays an important role during development and tumorigenesis
H19,hepatocellular carcinoma,H19 and UCA1 were both demonstrated  to be risk factors of HCC disease-free survival in multivariate Cox model
UCA1,hepatocellular carcinoma,H19 and UCA1 were both demonstrated  to be risk factors of HCC disease-free survival in multivariate Cox model
HULC,hepatocellular carcinoma,HULC had a significant association with vascular invasion
HOTAIR,gastric cancer,HOTAIR acts as an EMT regulator and may be a candidate prognostic biomarker and a target for new therapies in GC patients.
H19,glioma,The lncRNA may play an important role in glioma recurrence
CRNDE,glioma,The lncRNA may play an important role in glioma recurrence
HOTAIRM1,glioma,The lncRNA may play an important role in glioma recurrence
AC016745.3,glioma,The lncRNA may play an important role in glioma recurrence
XLOC_001711,glioma,The lncRNA may play an important role in glioma recurrence
RP11-128A17.1,glioma,The lncRNA may play an important role in glioma recurrence
HOTAIR,ovarian cancer,"HOTAIR can promote proliferation, migration, and invasion in ovarian SKOV3 cells as a competing endogenous RNA."
HOTAIR,glioblastoma,"The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation."
HOTAIR,cervical cancer,"HOTAIR may be a predictor of poor prognosis in four of the main estrogen-dependent tumors, especially in cervical, ovarian, and endometrial cancer patients without preoperative treatment in Asian populations."
HOTAIR,ovarian cancer,"HOTAIR may be a predictor of poor prognosis in four of the main estrogen-dependent tumors, especially in cervical, ovarian, and endometrial cancer patients without preoperative treatment in Asian populations."
HOTAIR,endometrial cancer,"HOTAIR may be a predictor of poor prognosis in four of the main estrogen-dependent tumors, especially in cervical, ovarian, and endometrial cancer patients without preoperative treatment in Asian populations."
LK4P2,hepatocellular carcinoma,The lncRNA may participate in regulating HBV related HCC
CASC15,neuroblastoma,"CASC15-S is a mediator of neural growth and differentiation, which impacts neuroblastoma initiation and progression."
TCONS_l2_00001418,prostate cancer,The lincRNA can be a candidate biomarker for Pca diagnosis and prognosis
TCONS_l2_00008237,prostate cancer,The lincRNA can be a candidate biomarker for Pca diagnosis and prognosis
TCONS_l2_00011130,prostate cancer,The lincRNA can be a candidate biomarker for Pca diagnosis and prognosis
TCONS_l2_00013175,prostate cancer,The lincRNA can be a candidate biomarker for Pca diagnosis and prognosis
TCONS_l2_00022611,prostate cancer,The lincRNA can be a candidate biomarker for Pca diagnosis and prognosis
TCONS_l2_00022670,prostate cancer,The lincRNA can be a candidate biomarker for Pca diagnosis and prognosis
linc-PXN-1,prostate cancer,The lincRNA can be a candidate biomarker for Pca diagnosis and prognosis
PCAT1,hepatocellular carcinoma,PCAT-1 up-regulation may serve as a novel biomarker of poor prognosis in HCC patients.
SOX2-OT,hepatocellular carcinoma,"LncRNA Sox2ot played crucial roles in promoting HCC cell migration and invasion, and might represent a novel prognostic biomarker for HCC."
HA117,Hirschsprung's disease,"LncRNA HA117 may have an anti-differentiation function, and play a pivotal role in the progression of HSCR."
PVT1,ovarian cancer,Carboplatin-docetaxel-induced activity against ovarian cancer is dependent on up-regulated lncRNA PVT1.
NBAT1,renal clear cell carcinoma,Decreased expression of long non-coding RNA NBAT-1 is associated with poor prognosis in patients with clear cell renal cell carcinoma.
H19,gastric cancer,"Plasma H19 could serve as a potential biomarker for diagnosis of GC, in particular for early tumor screening."
MEG3,osteoarthritis,MEG3 may be involved in OA development through the regulation of angiogenesis.
H19,endometriosis,H19 lncRNA alters stromal cell growth via IGF signaling in the endometrium of women with endometriosis.
HOTAIR,non-small cell lung cancer,"Under hypoxic conditions, HOTAIR enhanced cancer cell proliferation, migration, and invasion."
PCA3,prostate cancer,PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3.
XR_250621.1,breast cancer,XR_250621.1 can be a potential therapeutic target for breast cancer
NONHSAT125629,breast cancer,NONHSAT125629 can be a potential therapeutic target for breast cancer
ZFAS1,hepatocellular carcinoma,Our results establish a function for ZFAS1 in metastatic progression and suggest its candidacy as a new prognostic biomarker and target for clinical management of HCC.
H19,colorectal cancer,The lncRNA H19 promotes epithelial to mesenchymal transition by functioning as miRNA sponges in colorectal cancer.
CCAT1,colorectal cancer,"CCAT1 plays an important role in the genesis, development, invasion and metastasis; it mediates the EMT process of colorectal cancer; and it's expected to be a new marker and treatment target in colorectal diagnosis and treatment."
HIF1A-AS1,thoracoabdominal aorta aneurysm,"HIF1a-AS1 was overexpressed in the TAAA and the interaction between HIF1a-AS1 and apoptotic proteins plays a key role in the proliferation and apoptosis of VSMCs in vitro, which may contribute to the pathogenesis of TAAA."
MEG3,non-small cell lung cancer,Meg3 may have a crucial role in the development of cisplatin resistance in non-small cell lung cancer.
HOTTIP,tongue squamous cell carcinoma,Long non-coding RNA HOTTIP is correlated with progression and prognosis in tongue squamous cell carcinoma.
RGMB-AS1,non-small cell lung cancer,"LncRNA RGMB-AS1 was upregulated and RGMB was downregulated in NSCLC patients. Both were related to differentiation status, lymph node metastases and TNM stage."
PANDAR,hepatocellular carcinoma,Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
BANCR,gastric cancer,Increased expression of LncRNA BANCR is associated with clinical progression and  poor prognosis in gastric cancer.
HOXA11-AS,uterine cervix carcinoma,"HOXA11-AS might participate in cervix carcinogenesis by regulating HOXA11, which  is involved in regulating biological processes of cervix cancer."
UCA1,acute myeloid leukemia,UCA1 sustains proliferation of AML cells by repressing the expression of the cell cycle regulator p27kip1.
DLX6-AS1,lung adenocarcinoma,High DLX6-AS1 expression levels were significantly associated with both histological differentiation and TNM stage.
CLMAT3,colorectal cancer,LncRNA-CLMAT3 over-expression was significantly associated with CLM and was an independent predictor of poor survival for patients with CRC.
CDKN2B-AS1,hepatocellular carcinoma,LncRNA ANRIL may serve as an efficient clinical biomarker and a therapeutic target for HCC patients.
HULC,osteosarcoma,"HULC is a novel molecule involved in osteosarcoma progression, which may provide a new marker of poor prognosis and a  potential therapeutic target for osteosarcoma intervention."
AK094457,hypertension,Notoginsenoside R1 reduces blood pressure in spontaneously hypertensive rats through a long non-coding RNA AK094457.
AF339813,pancreatic cancer,NUF2 is consistently overexpressed in human PC and NUF2 is closely  linked with human PC progression through the meditator LncRNA AF339813
PVT1,cardiac hypertrophy,PVT1 was essential for the maintenance of cell size of cardiomyocytes and might play a role in the regulation of cardiac hypertrophy.
XLOC_010235,gastric cancer,"XLOC_010235 can be identified as novel, poor prognostic biomarkers in GC."
RP11-789C1.1,gastric cancer,"RP11-789C1.1 can be identified as novel, poor prognostic biomarkers in GC."
APTR,liver fibrosis,Long non-coding RNA APTR promotes the activation of hepatic stellate cells and the progression of liver fibrosis.
HOTTIP,Hirschsprung's disease,"Aberrant reduction of HOTTIP and HOXA13, which have a bidirectional regulatory loop, may play an important role in the pathogenesis of HSCR."
HOTAIR,oral squamous cell carcinoma,"HOTAIR was highly expressed in OSCC tissues and facilitated the growth of OSCC cells, thus probably being an eligible molecular marker for OSCC diagnosis and prognosis determination."
HOTAIR,breast cancer,Circulating DNA of HOTAIR in serum is a novel biomarker for breast cancer
HOTAIR,hepatocellular carcinoma,"HOTAIR silence activates P16(Ink4a) and P14(ARF) signaling by enhancing miR-218 expression and suppressing Bmi-1 expression, resulting in the suppression of tumorigenesis in HCC."
CASC15,melanoma,CASC15 levels correlated  with known gene signatures corresponding to melanoma proliferative and invasive phenotypes.
BCAR4,breast cancer,LncRNA BCAR4 wires up signaling transduction in breast cancer
MIAT,schizophrenia,LncRNA MIAT was a novel susceptibility gene for paranoid schizophrenia in the Chinese Han population
MEG3,thyroid cancer,Long non-coding RNA MEG3 suppresses migration and invasion of thyroid carcinoma by targeting of Rac1.
LINC00993,breast cancer,LINC00993 may be involved in the development and/or progression of TNBC.
CCAL,colorectal cancer,CCAL is a crucial oncogenic regulator involved in CRC tumorigenesis and progression.
HOTAIR,urothelial cancer,"HOTAIR overexpression may affect differentiation state and aggressiveness of UC cells, but in a cell-type dependent manner."
LINC0949,systemic lupus erythematosus,"Linc0949 could be a potential biomarker for diagnosis, disease activity and therapeutic response in SLE."
MEG3,lung adenocarcinoma,MEG3 may represent a new marker of poor response to cisplatin and could be a potential therapeutic target for LAD chemotherapy.
ATB,gastric cancer,"LncRNA-ATB plays an important role in EMT to promote invasion and metastasis through the TGF-β1/miR-200s/ZEB axis, resulting in a poor prognosis in  GC."
HOTAIR,acute myeloid leukemia,HOTAIR plays an important oncogenic role in AML and might serve as a marker for AML prognosis and a potential target for therapeutic intervention.
SPRY4-IT1,bladder cancer,"lncRNA SPRY4-IT1 is a novel molecule involved in bladder cancer progression, which provide a potential prognostic biomarker and therapeutic target."
AI364715,gastric cancer,AI364715 may be a potential biomarker for the diagnosis of gastric cancer
NEAT1,chronic lymphocytic leukemia,LncRNAs NEAT1 and lincRNA-p21 are identified as novel elements of the p53-dependent DNA damage response machinery in CLL and lymphoma.
HOTAIR,esophageal squamous cell carcinoma,HOTAIR expression may serve as a candidate positive marker to predict the prognosis of patients with carcinoma of  digestive system.
HOTAIR,gastric cancer,HOTAIR expression may serve as a candidate positive marker to predict the prognosis of patients with carcinoma of  digestive system.
UCA1,ovarian cancer,"UCA1 can improve the cell migration, invasion and induce cisplatin resistance."
CDKN2B-AS1,hepatocellular carcinoma,"LncRNA ANRIL, as a growth regulator, may serve as a new biomarker and target for therapy in HCC."
CDKN2B-AS1,lung cancer,ANRIL is an lncRNA responsible in anti-tumorigenesis caused by PLD inhibition and combined incorporation of ANRIL into PLD inhibition-induce
DANCR,hepatocellular carcinoma,Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma  by derepression of CTNNB1
BANCR,lung cancer,Knockdown of BANCR expression promoted cell viability surviving from radiation.
GAS5,gastric cancer,"LncRNA GAS5 down-regulation reduced the YBX1 protein level, which decreased YBX1-transactivated p21 expression and abolished G1 phase cell cycle arrest in stomach cancer."
PVT1,gastric cancer,"Overexpression of LncRNA PVT1 in gastric carcinoma promotes the development of MDR, suggesting an efficacious target for reversing MDR in gastric cancer therapy."
HULC,liver cirrhosis,LncRNA HULC affects the differentiation of Treg in HBV-related liver cirrhosis.
H19,gastric cancer,LncRNA H19 SNPs may contribute to susceptibility to GC.
PCAT1,bladder cancer,PCAT-1 plays oncogenic roles and can be used as a therapeutic target for treating human bladder cancer.
RP11-445H22.4,breast cancer,LncRNA RP11-445H22.4 may be a new potential biomarker of breast cancer.
CCDC26,acute myeloid leukemia,CCDC26 controls growth of myeloid leukemia cells through regulation of KIT expression.
BANCR,colorectal cancer,"Down-regulation of BANCR contributes to the proliferation of colorectal cancer cells, at least in part, through the regulation of p21 protein."
HOTAIR,breast cancer,Estrogen promoted HOTAIR through its receptor GPER and estrogen-induced breast cancer cell migration was reversed by deleting HOTAIR in TN breast cancer cells MDA-MB-231and BT549.
AFAP1-AS1,pancreatic ductal adenocarcinoma,AFAP1-AS1 is a potential novel prognostic marker to predict the clinical outcome of PDAC patients after surgery and may be a rational target for therapy.
GAS5,lung adenocarcinoma,"GAS5 LncRNA may represent a potential biomarker for the diagnosis of lung adenocarcinoma and that GAS5 might  play a novel role in the development of the resistance to gefitinib, which could be reversed by overexpressing GAS5."
CCEPR,cervical cancer,CCHE1 plays a pivotal role in cervical cancer cell proliferation via increasing PCNA expression and serves as a potential prognostic biomarker and therapeutic target in human cervical cancer.
CCAT2,esophageal squamous cell carcinoma,CCAT2 may be a prognostic biomarker and therapeutic target for ESCC.
HOTTIP,pancreatic cancer,"The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration."
HOTAIR,pancreatic cancer,LncRNA HOTAIR regulates strikingly different sets of genes in Panc1 cells and in pancreatic tumors.
LINC00261,pancreatic cancer,LINC00261 plays an important role in pancreatic cancer
CYTOR,pancreatic cancer,CYTOR plays an important role in pancreatic cancer
HNF1A-AS1,pancreatic cancer,HNF1A-AS1 plays an important role in pancreatic cancer
AFAP1-AS1,pancreatic cancer,AFAP1-AS1 plays an important role in pancreatic cancer
LINC01133,lung squamous cell carcinoma,A novel long noncoding RNA LINC01133 is upregulated in lung squamous cell cancer  and predicts survival.
FRLnc1,gastric cancer,"FRLnc1 knockdown by RNA interference suppressed cell migration in MGC803 and AGS cells, whereas FRLnc1 overexpression promoted cell migration in BGC823 and SGC7901 cells."
UCA1,gastric cancer,UCA1 might serve as a promising biomarker for early  detection and prognosis prediction of gastric cancer.
HOTAIR,oral squamous cell carcinoma,Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma.
ZXF2,lung adenocarcinoma,The high expression of ZXF was closely related to tumor progression through c-Myc related  pathway
HOTAIR,prostate cancer,Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population.
LINC01296,colorectal cancer,Long non-coding RNA LINC01296 is a potential prognostic biomarker in patients with colorectal cancer.
BANCR,retinoblastoma,LncRNA BANCR plays a significant role in retinoblastoma aggressiveness and prognosis and may act as a promising target for therapeutic strategy and prognostic prediction.
linc-ITGB1,gallbladder cancer,Long non-coding RNA Linc-ITGB1 knockdown inhibits cell migration and invasion in  GBC-SD/M and GBC-SD gallbladder cancer cell lines.
PVT1,gastric cancer,Long noncoding RNA PVT1 indicates a poor prognosis of gastric cancer and promotes cell proliferation through epigenetically regulating p15 and p16.
CDKN2B-AS1,lung cancer,Increased expression of the long non-coding RNA ANRIL promotes lung cancer cell metastasis and correlates with poor prognosis.
HOTTIP,pancreatic cancer,"HOTTIP promotes cell proliferation, invasion, and chemoresistance by modulating HOXA13"
MIR4435-2HG,lung cancer,A novel long noncoding RNA AK001796 acts as an oncogene and is involved in cell growth inhibition by resveratrol in lung cancer.
CASC9,esophageal squamous cell carcinoma,ESCCAL-1 is a novel putative onco-lncRNA in esophageal cancer development.
CCAT1,hepatocellular carcinoma,"CCAT1 plays a pivotal role in HCC progression via functioning as let-7 sponge, and implicate the potential application of CCAT1 for the prognosis and treatment of HCC."
HOTAIR,breast cancer,Combined inhibition of EGFR and c-ABL suppresses the growth of triple-negative breast cancer growth through inhibition of HOTAIR.
HULC,esophageal cancer,A long noncoding RNA HULC rs7763881 A/C polymorphism is associated with decreased risk of esophageal cancer.
ATB,breast cancer,LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer.
BCYRN1,non-small cell lung cancer,"BCYRN1, a c-MYC-activated long non-coding RNA, regulates cell metastasis of non-small-cell lung cancer."
UCA1,ovarian cancer,"UCA1 can improve the cell migration, invasion and induce cisplatin resistance."
H19,renal cell carcinoma,LncRNA H19 might be considered as a potential prognostic indicator and a target for gene therapy of ccRCC.
LINC00472,breast cancer,This long non-coding RNA in breast tumors may have prognostic and predictive value in the clinical management of breast cancer.
HNF1A-AS1,lung adenocarcinoma,The long non-coding RNA HNF1A-AS1 regulates proliferation and metastasis in lung adenocarcinoma.
APF,myocardial infarction,APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p.
HOTAIR,liver cancer,PLK1 and HOTAIR Accelerate Proteasomal Degradation of SUZ12 and ZNF198 during Hepatitis B Virus-Induced Liver Carcinogenesis.
NEAT1,non-small cell lung cancer,"NEAT1 might be associated with oncogenesis and progression in NSCLC, and suggests application in molecular targeted therapy."
Lnc_bc060912,lung cancer,"Lnc_bc060912, via PARP1 and NPM1, affects cell apoptosis and may play important roles in tumorigenesis and cancer progression."
H19,breast cancer,"H19 lncRNA may serve as a biomarker for breast cancer diagnosis and progression, and as a valuable target for breast cancer therapy."
CDKN2B-AS1,ovarian cancer,LncRNA ANRIL plays an important role in SOC invasion/metastasis and could represent a novel biomarker for predicting poor survival as well a promising therapeutic target.
lncTCF7,liver cancer,LncTCF7-mediated Wnt signaling primes liver CSC self-renewal and tumor propagation.
SPRY4-IT1,gastric cancer,SPRY4-IT1 plays a critical role in GC tumorigenesis and may represent a novel prognostic marker and potential therapeutic target in patients  with GC.
HOTAIR,ovarian cancer,"HOTAIR may be used in the development of novel treatments for ovarian cancer, particularly those that are resistant to conventional therapies."
HOTAIR,glioblastoma,HOTAIR was required for GBM formation in vivo
LOC728228,lung cancer,"LOC728228 knockdown inhibited cell proliferation, caused G0/G1-phase cell-cycle arrest, reduced cellular migration,  suppressed colony formation in vitro, and inhibited tumor growth in a nude mouse  xenograft model."
SNHG1,non-small cell lung cancer,Noncoding RNA small nucleolar RNA host gene 1 promote cell proliferation in nonsmall cell lung cancer.
CRNDE,glioma,"CRNDE, a long-noncoding RNA, promotes glioma cell growth and invasion through mTOR signaling."
MALAT1,pancreatic cancer,MALAT-1 could promote tumorigenicity of pancreatic cancer cells in vivo
HOTAIR,pre-eclampsia,"OTAIR is probably involved in the onset of preeclampsia by regulating proliferation, invasion and apoptosis of trophoblast cells"
HOTAIR,ovarian cancer,The long non-coding RNA HOTAIR promotes the proliferation of serous ovarian cancer cells through the regulation of cell cycle arrest and apoptosis.
HOTAIR,ovarian cancer,Downregulated lincRNA HOTAIR expression in ovarian cancer stem cells decreases its tumorgeniesis and metastasis by inhibiting epithelial-mesenchymal transition
MALAT1,hyperglycaemia,Long non-coding RNA MALAT1 regulates hyperglycaemia induced inflammatory process  in the endothelial cells.
MALAT1,lung cancer,"Upregulation of MALAT1 was mediated by the transcription factor Sp1 in A549 lung cancer cells, and Sp1 could be therapeutic target for cancer."
MALAT1,glioblastoma,"Knockdown of MALAT1 reduced migration in glioblastoma cells, without effect on proliferation."
H19,coronary artery disease,Common polymorphisms of H19 are associated with the risk and severity of CAD in a Chinese population.
UCA1,gastric cancer,UCA1 plays a potential role in the process  of gastric cancer progression.
lincRNA-BBOX1-2,gastric cancer,lincRNA-BBOX1-2 plays a potential role in the process  of gastric cancer progression.
CR594506,gastric cancer,CR594506 plays a potential role in the process  of gastric cancer progression.
BC015134,gastric cancer,BC015134 plays a potential role in the process  of gastric cancer progression.
TUSC7,gastric cancer,TUSC7 is a p53-regulated tumour suppressor that acts in part by repressing miR-23b and that  TUSC7 may be a key regulatory hub in GC.
AK022798,gastric cancer,Notch 1 promotes cisplatin-resistant gastric cancer formation by upregulating lncRNA AK022798 expression.
HIF1A-AS1,cardiovascular disease,"LncRNA HIF1A-AS1 may play an important role in the pathogenesis of  CVD, and provide a novel molecular mechanism of clopidogrel for treatment of CVD."
UCA1,hepatocellular carcinoma,Upregulated lncRNA-UCA1 contributes to progression of hepatocellular carcinoma through inhibition of miR-216b and activation of FGFR1/ERK signaling pathway.
NKILA,breast cancer,Low NKILA expression is associated with breast cancer metastasis and poor patient prognosis.
H19,ovarian cancer,"LncRNAs H19, LSINCT5, and XIST have a close relationship to the development  of ovarian cancer occurrence, growth, invasion, and metastasis, and they can promote ovarian cancer cell proliferation."
LSINCT5,ovarian cancer,"LncRNAs H19, LSINCT5, and XIST have a close relationship to the development  of ovarian cancer occurrence, growth, invasion, and metastasis, and they can promote ovarian cancer cell proliferation."
XIST,ovarian cancer,"LncRNAs H19, LSINCT5, and XIST have a close relationship to the development  of ovarian cancer occurrence, growth, invasion, and metastasis, and they can promote ovarian cancer cell proliferation."
LET,cervical cancer,Low expression of long non-coding RNA LET inhibits carcinogenesis of cervical cancer.
CCAT2,gastric cancer,Long non-coding RNA CCAT2 is up-regulated in gastric cancer and associated with poor prognosis.
BLACAT1,gastric cancer,Long noncoding RNA linc-UBC1 is negative prognostic factor and exhibits tumor pro-oncogenic activity in gastric cancer.
MEG3,multiple myeloma,LncRNA MEG3 expression as a potential biomarker for identifying patients with MM and as a potential therapeutic target in MM.
lncRNA-ATB,colorectal cancer,"A long noncoding RNA, lncRNA-ATB, is involved in the progression and prognosis of colorectal cancer."
BOK-AS1,esophageal squamous cell carcinoma,"LncRNA BOKAS was up-regulated following radiation and promoted WISP1 expression and resultant radioresistance, and WISP1 is a potential target to overcome radioresistance in ESCC"
PCGEM1,prostate cancer,The clinical expression profile of PCGEM1 implicates it in the early stages of PCa warranting further research in this direction.
SPRY4-IT1,breast cancer,The long noncoding RNA SPRY4-IT1 increases the proliferation of human breast cancer cells by upregulating ZNF703 expression.
Arid2-IR,renal inflammatory disease,Arid2-IR is a novel lncRNA that functions to promote NF-KB-dependent renal inflammation.
BANCR,melanoma,Long non-coding RNA BANCR promotes proliferation in malignant melanoma by regulating MAPK pathway activation.
LNC00964-3,colorectal cancer,"PiR-015551 may be generated from LNC00964-3, which may be involved in the development of CRC."
HOTAIR,breast cancer,HOTAIR appears to be a marker for lymphatic metastases rather than hematogenous metastases in ER-negative patients.
HOTAIR,breast cancer,HOTAIR is associated with early metastasis and expression of the known predictor of metastatic progression
PCAT1,esophageal squamous cell carcinoma,High expression of PCAT-1 might reflect poor prognosis of ESCC and indicate a potential diagnostic target in ESCC patients.
HOTAIR,osteosarcoma,Overexpression of Long Non-Coding RNA HOTAIR Promotes Tumor Growth and Metastasis in Human Osteosarcoma.
TINCR,gastric cancer,TINCR contributes to the oncogenic potential of GC and may constitute a potential therapeutic target in this disease.
NRON,HIV,The lncRNA NRON modulates HIV-1 replication in a NFAT-dependent manner and is differentially regulated by early and late viral proteins.
MALAT2,gastric cancer,MALAT2-activated long noncoding RNA indicates a biomarker of poor prognosis in gastric cancer.
PANDAR,non-small cell lung cancer,Low expression of long noncoding RNA PANDAR predicts a poor prognosis of non-small cell lung cancer and affects cell apoptosis by regulating Bcl-2.
RP11-160H22.5,hepatocellular carcinoma,"RP11-160H22.5, XLOC_014172 and LOC149086 might be the potential biomarker for the tumorigenesis prediction"
XLOC_014172,hepatocellular carcinoma,"RP11-160H22.5, XLOC_014172 and LOC149086 might be the potential biomarker for the tumorigenesis prediction"
LOC149086,hepatocellular carcinoma,"RP11-160H22.5, XLOC_014172 and LOC149086 might be the potential biomarker for the tumorigenesis prediction"
DRAIC,bladder cancer,"DRAIC expression predicts good prognosis in a wide range of malignancies, including bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma"
DRAIC,glioma,"DRAIC expression predicts good prognosis in a wide range of malignancies, including bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma"
DRAIC,lung adenocarcinoma,"DRAIC expression predicts good prognosis in a wide range of malignancies, including bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma"
DRAIC,stomach adenocarcinoma,"DRAIC expression predicts good prognosis in a wide range of malignancies, including bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma"
DRAIC,renal clear cell carcinoma,"DRAIC expression predicts good prognosis in a wide range of malignancies, including bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma"
DRAIC,hepatocellular carcinoma,"DRAIC expression predicts good prognosis in a wide range of malignancies, including bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma"
DRAIC,skin melanoma,"DRAIC expression predicts good prognosis in a wide range of malignancies, including bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma"
PCAT29,bladder cancer,"A second tumor-suppressive lncRNA PCAT29, located 20 kb downstream of DRAIC, is regulated  identically by AR and FOXA1 and also suppresses cellular migration and metastasis."
PCAT29,glioma,"A second tumor-suppressive lncRNA PCAT29, located 20 kb downstream of DRAIC, is regulated  identically by AR and FOXA1 and also suppresses cellular migration and metastasis."
PCAT29,lung adenocarcinoma,"A second tumor-suppressive lncRNA PCAT29, located 20 kb downstream of DRAIC, is regulated  identically by AR and FOXA1 and also suppresses cellular migration and metastasis."
PCAT29,stomach adenocarcinoma,"A second tumor-suppressive lncRNA PCAT29, located 20 kb downstream of DRAIC, is regulated  identically by AR and FOXA1 and also suppresses cellular migration and metastasis."
PCAT29,renal clear cell carcinoma,"A second tumor-suppressive lncRNA PCAT29, located 20 kb downstream of DRAIC, is regulated  identically by AR and FOXA1 and also suppresses cellular migration and metastasis."
PCAT29,hepatocellular carcinoma,"A second tumor-suppressive lncRNA PCAT29, located 20 kb downstream of DRAIC, is regulated  identically by AR and FOXA1 and also suppresses cellular migration and metastasis."
PCAT29,skin melanoma,"A second tumor-suppressive lncRNA PCAT29, located 20 kb downstream of DRAIC, is regulated  identically by AR and FOXA1 and also suppresses cellular migration and metastasis."
SNHG12,endometrial cancer,"Expression inhibition of lncRNA ASLNC04080 in HEC-1-B cells caused repression of  cell proliferation, increased cell apoptosis, and G1 phase arrest."
UCA1,gastric cancer,"Circulating CUDR, LSINCT-5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controls."
LSINCT5,gastric cancer,"Circulating CUDR, LSINCT-5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controls."
PTENP1,gastric cancer,"Circulating CUDR, LSINCT-5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controls."
HIF1A-AS2,gastric cancer,IF1A-AS2 is overexpressed in GC and may play a pivotal role in tumor cell proliferation.
CCAT2,esophageal squamous cell carcinoma,"CCAT2 showed higher diagnostic performance than conventional serum biomarkers, like AFP, CA153, and NSE."
LET,gastric cancer,Down-regulation of long non-coding RNA LET is associated with poor prognosis in gastric cancer.
HMlincRNA717,non-small cell lung cancer,"HMlincRNA717 expression was an independent prognostic factor for patients with NSCLC, which might be a potential prognostic biomarker and therapeutic target for NSCLC."
CCAT1,gastric cancer,CARLo-5 might serve as a pro-oncogenic lncRNA that promotes proliferation of gastric cancer and activates the ERK/MAPK pathway.
PVT1,pancreatic cancer,"The increased expression of lncRNA PVT1 in PDAC was correlated with tumor progression, and PVT1 might be a potential molecular biomarker for predicting the prognosis of patients with PDAC."
RP4-583P15.10,breast cancer,RP4-583P15.10 may regulated breast cancer through influence immune system.
BANCR,lung cancer,Long non-coding RNA BANCR promotes proliferation and migration of lung carcinoma  via MAPK pathways.
DANCR,postmenopausal osteoporosis,DANCR is involved in the pathology of osteoporosis and may be as a biomarker for postmenopausal osteoporosis.
LINC-ROR,glioma,"The reprogramming-related lincRNA-ROR may serve as a novel tumor suppressor gene in glioma, which can inhibit the proliferation of cancer cell and self renewal of GSCs, partly by inhibiting the KLF4 expression."
GAS5,prostate cancer,This lncRNA promotes the apoptosis of prostate cancer cells and its levels decline as prostate cancer cells acquire castrate-resistance
CDKN2B-AS1,esophageal cancer,The chemotherapeutic drug β1-elemene suppressed the proliferation of esophageal carcinoma ECA-109 cells by regulating the inhibition of hTERT expression by lncRNA CDKN2B-AS1.
MEG3,hepatocellular carcinoma,MEG3 acts as a potential biomarker in predicting the prognosis of HCC
HOTAIR,gastric cancer,A functional lncRNA HOTAIR genetic variant contributes to gastric cancer susceptibility.
MEG3,colorectal cancer,Decreased expression of long noncoding RNA MEG3 affects cell proliferation and predicts a poor prognosis in patients with colorectal cancer.
H19,gastric cancer,H19 plays an important role in gastric carcinogenesis
CDKN2B-AS1,gastric cancer,CDKN2B-AS1 plays an important role in gastric carcinogenesis
PVT1,hepatocellular carcinoma,Long non-coding RNA PVT1 is associated with tumor progression and predicts recurrence in hepatocellular carcinoma patients.
HULC,liver cancer,HULC contributes to the perturbations in circadian rhythm of hepatoma cells.
Abhd11os,Huntington's disease,The loss lncRNA Abhd11os likely contribute to striatal vulnerability in HD
PTENP1,hepatocellular carcinoma,"Co-transduction of HCC cells with the SB-BV vector expressing PTENP1 elevated the levels of PTENP1 and PTEN, which suppressed the oncogenic PI3K/AKT pathway, inhibited cell proliferation, migration/invasion as well as induced autophagy and apoptosis"
HOTAIR,breast cancer,"Calycosin is more effective in inhibiting breast cancer growth in comparison with genistein, through its regulation of Akt signaling pathways and HOTAIR expression."
MALAT1,esophageal squamous cell carcinoma,Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
MALAT1,glioma,LncRNA MALAT1 plays an important role on glioma progression and prognosis and may serve as a convictive prognostic biomarker for glioma patients.
HOTAIR,gastric cancer,HOTAIR Long Noncoding RNA Promotes Gastric Cancer Metastasis through Suppression  of Poly r(C)-Binding Protein (PCBP) 1.
SRA,polycystic ovary syndrome,The lncRNA SRA expression is potentially associated with PCOS and it has positive correlation with obesity in PCOS
HIT,breast cancer,"LncRNA-HIT plays a significant role in regulation of EMT and breast cancer invasion and metastasis, and could be a potential therapeutic target in breast cancers."
MALAT1,renal cell carcinoma,Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.
FR0348383,prostate cancer,"FR0348383 transcript in post-DRE urine may be a novel biomarker for detection of PCa with great diagnostic value, especially in the grey zone cohort."
MALAT1,osteosarcoma,"The downregulation of MALAT-1 inhibited cell proliferation, migration, invasion and epithelial mesenchymal transition (EMT) processes in the E2-dose dependent and ER independent ways."
HULC,hepatocellular carcinoma,"HULC functions as an oncogene in hepatoma cells, acting mechanistically by deregulating lipid metabolism through a signaling pathway involving miR-9, PPARA,"
HOTAIR,breast cancer,"The CC genotype  of HOTAIR rs920778 polymorphism might play important roles in genetic susceptibility to BC development and aggressiveness in a Turkish population,"
XIST,glioblastoma,Knockdown of long non-coding RNA XIST exerts tumor-suppressive functions in human glioblastoma stem cells by up-regulating miR 152.
CCAT1,gallbladder cancer,Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p.
MEG3,pancreatic neuroendocrine tumor,The epigenetic activation of lncRNA MEG3 and/or inactivation of c-MET could be therapeutic for treating PNETs and insulinomas.
HOXA-AS3,glioma,Changes of this lncRNA expressions probably drivves malignant transformation.
BCYRN1,glioma,Changes of this lncRNA expressions probably drivves malignant transformation.
CCAT1,gastric cancer,"CCAT1 is up-regulated in gastric cancer, and may serve as a potential bio-marker for early detection and surveillance."
TCONS_00032546,atrial fibrillation,"Dysregulated lncRNAs may play regulatory roles in AF neural remodeling, which may further provide potential therapeutic targets  for prophylaxis and treatment of AF."
TCONS_00026102,atrial fibrillation,"Dysregulated lncRNAs may play regulatory roles in AF neural remodeling, which may further provide potential therapeutic targets for prophylaxis and treatment of AF."
lincRNA-TSPAN8,hepatocellular carcinoma,"LincRNA-TSPAN8 was found highly expressed in high lung metastatic potential HCC cells, while lowly expressed in no or low lung metastatic potential HCC cells"
RP5-1014O16.1,hepatocellular carcinoma,"RP5- 1014O16.1 was highly expressed in high lymphatic metastatic potential HCC cell lines, while lowly expressed in no lymphatic metastatic potential HCC cell lines."
CTBP1-AS,polycystic ovary syndrome,Abnormal CTBP1-AS expression is a risk factor for PCOS and it is a predictor of variability in serum TT level in Chinese women with PCOS.
LOC285194,pancreatic ductal adenocarcinoma,"Reduced LOC285194 in PDAC tissues was correlated with tumor progression, and lncRNA LOC285194 might be a potential molecular biomarker for predicting the prognosis of patients."
UCA1,esophageal squamous cell carcinoma,Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
HIF1A-AS1,thoracoabdominal aorta aneurysm,"HIF1a-AS1 was overexpressed in the thoracoabdominal aorta aneurysm and the interaction between HIF1a-AS1 and apoptotic proteins plays a key role in  the proliferation and apoptosis of VSMCs in vitro, which may contribute to the pathogenesis of thoracoabdominal aorta aneurysm."
MALAT1,prostate cancer,Reduced Sost expression in the tumor microenvironment may promote bone metastasis by up-regulating MALAT1 in prostate cancer.
CDKN2B-AS1,hepatocellular carcinoma,Long non-coding RNA ANRIL is upregulated in hepatocellular carcinoma and regulates cell proliferation by epigenetic silencing of KLF2
HOTAIR,cervical cancer,HOTAIR enhanced aggressive biological behaviors and induced radio-resistance via inhibiting p21 in cervical cancer.
MALAT1,colon cancer,MALAT-1/Snail pathway plays a critical role in TADC-mediated cancer progression.
MALAT1,esophageal squamous cell carcinoma,"Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells."
LSINCT5,gastric cancer,LSINCT5 may represent a novel prognostic indicator and a target for gene therapy in gastrointestinal cancer
MALAT1,prostate cancer,Urine MALAT-1 is a promising biomarker for predicting prostate cancer risk.
uc.343,osteoarthritis,The lncRNA may be new biomarkers for diagnosis or novel therapeutic targets of OA.
NR_001284,Chronic thromboembolic pulmonary hypertension,"The potential role of lncRNA is in the regulation of central process, including inflammatory response, response to endogenous stimulus and antigen processing and presentation"
HAGLR,neuroblastoma,"HOXD-AS1 controls expression levels of clinically significant protein-coding genes involved in angiogenesis and inflammation, the hallmarks of metastatic cancer."
NBAT1,neuroblastoma,Loss of NBAT-1 contributes to aggressive neuroblastoma by increasing proliferation and impairing differentiation of neuronal precursors.
FOXCUT,basal-like breast cancer,"FOXCUT lncRNA may be functionally involved in the tumor progression of BLBCs through the regulation of its paired mRNA, FOXC1,  demonstrating that FOXCUT may serve as a novel biomarker and therapeutic target in BLBCs."
MDC1-AS1,bladder cancer,MDC1-AS1 may participate in bladder cancer through up-regulation of its antisense tumor-suppressing gene MDC1.
PCGEM1,prostate cancer,"PCGEM1 reprograms the androgen network and the central metabolism in a tumor-specific way, making it a promising target for therapeutic intervention"
LINC01018,hepatocellular carcinoma,SRHC is capable of inhibiting cancer proliferation and is down-regulated in tumors at  least partly by DNA methylation.
CDKN2B-AS1,non-small cell lung cancer,Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression.
uc003wbd,hepatocellular carcinoma,Both lncRNA-uc003wbd and lncRNA-AF085935 are able to be potential biomarkers for HCC and HBV screening.
AF085935,hepatocellular carcinoma,Both lncRNA-uc003wbd and lncRNA-AF085935 are able to be potential biomarkers for HCC and HBV screening.
SCHLAP1,prostate cancer,"SChLAP1 is a novel lncRNA that demonstrates outlier expression in a subset of prostate cancers, promotes tumor cell invasion and metastasis, and associates with lethal disease."
AK058003,gastric cancer,AK058003 is frequently upregulated in GC samples and promotes GC migration and invasion in vivo and in vitro.
LEIGC,gastric cancer,LEIGC is a tumor-suppressing lncRNA in gastric cancer
HOTAIR,lung cancer,The expression of HOTAIR is elevated in lung cancer and correlates with metastasis and poor prognosis
uc002yug.2,esophageal squamous cell carcinoma,LincRNA-uc002yug.2 might involve in AS of RUNX1/AML1 and serve as a predictor for esophageal cancer and prognosis.
MALAT1,pancreatic cancer,Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer.
MALAT1,renal clear cell carcinoma,"LncRNA MALAT1 was a novel molecule involved in ccRCC progression, which provided a potential prognostic biomarker and therapeutic target."
LINC00974,hepatocellular carcinoma,"The combination of Linc00974 and KRT19 may be novel indices for clinical diagnosis of tumor growth and metastasis in HCC, while Linc00974 may become a potential therapeutic target for the prevention of HCC progression."
HOTAIR,gastric cardia adenocarcinoma,HOTAIR may be a useful marker to predict the biological behavior of tumors and potentially a therapeutic target in GCA treatment.
AATBC,bladder cancer,Knockdown of a novel lincRNA AATBC suppresses proliferation and induces apoptosis in bladder cancer.
UBE3A-ATS,Angelman syndrome,Targeting the long non-coding RNA is a therapy for Angelman syndrome
IRAIN,breast cancer,IRAIN lncRNA is a novel imprinted gene that is aberrantly regulated in breast cancer.
HOTAIR,colorectal cancer,HOTAIR may participate in carcinogenesis by regulating protein coding genes involved in special biological process relevant to cancer
lncRNA-422,colorectal cancer,lncRNA-422 may participate in carcinogenesis by regulating protein coding genes involved in special biological process relevant to cancer
SCHLAP1,prostate cancer,SChLAP1 expression is a significantly prognostic for metastatic disease progression of prostate cancer.
UFC1,hepatocellular carcinoma,"The lincRNA-UFC1, a target of microRNA 34a, promotes proliferation and reduces apoptosis in HCC cells to promote growth of xenograft tumors"
HOTAIR,lung cancer,A long noncoding RNA (lncRNA) that is induced by cigarette smoke extract (CSE) and experiments utilizing lncRNAs to integrate inflammation with the epithelial-mesenchymal transition (EMT) in human bronchial epithelial (HBE) cells.
MALAT1,colorectal cancer,MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9.
CASC2,glioma,"CASC2 plays a tumor suppressive role in glioma via negative regulation of miR-21, which may be a novel therapeutic target for treating gliomas."
PCA3,prostate cancer,Long noncoding RNA PCA3 gene promoter region is related to the risk of prostate cancer on Chinese males.
LINC01158,glioma,Linc-POU3F3 may also have a crucial regulatory role in glioma progression.
BC040587,breast cancer,BC040587 expression was correlated with menopausal status and tumor differentiation
HIF2PUT,osteosarcoma,"The lncRNA HIF2PUT may be a novel regulatory factor of osteosarcoma stem cells, which may exert its function partly by controlling HIF-2α expression."
HOTAIR,colorectal cancer,Genetic variants in HOTAIR were associated with risk of colorectal cancer
MALAT1,osteosarcoma,MALAT1 promotes the proliferation and metastasis of osteosarcoma cells 
HOTAIR,osteoarthritis,The lncRNA may be associated with the pathogenesis of OA
GAS5,osteoarthritis,The lncRNA may be associated with the pathogenesis of OA
PMS2L2,osteoarthritis,The lncRNA may be associated with the pathogenesis of OA
RP11-445H22.4,osteoarthritis,The lncRNA may be associated with the pathogenesis of OA
H19,osteoarthritis,The lncRNA may be associated with the pathogenesis of OA
CTD-2574D22.4,osteoarthritis,The lncRNA may be associated with the pathogenesis of OA
HOTAIR,glioblastoma,HOTAIR promotes cell cycle progression in glioma as a result of the binding of its 5' domain to the PRC2 complex
PCAT1,prostate cancer,The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc
HOTTIP,hepatocellular carcinoma,Overexpression of HOTTIP contributes to hepatocarcinogenesis by regulating the expression of its neighbouring protein-coding genes
LOC401317,nasopharyngeal carcinoma,LOC401317 is directly regulated by p53 and exerts antitumor effects in HNE2 nasopharyngeal carcinoma cells.
R05532,colorectal cancer,LncRNA R05532 may be used as the predictive marker of radiosensitivity of colorectal cancer cells in patients with breast cancer
NEAT1,breast cancer,High tumor NEAT1 expression correlates with poor survival
NEAT1,prostate cancer,NEAT1 drives oncogenic growth by altering the epigenetic landscape of target gene promoters to favour transcription
HULC,pancreatic cancer,Long noncoding RNA HULC is a novel biomarker of poor prognosis in patients with pancreatic cancer
HOTAIR,cervical cancer,HOTAIR may represent a novel biomarker for predicting recurrence and prognosis and serve as a promising therapeutic target in cervical cancer
EWSAT1,Ewing sarcoma,EWSAT1 is a downstream target of EWS-FLI1 that facilitates the development of Ewing sarcoma via the repression of  target genes
GHET1,bladder cancer,GHET1 knockdown suppressed the proliferation and invasion of bladder cancer cells in vitro
PVT1,non-small cell lung cancer,Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell  lung cancer
GAS5,cervical cancer,"Knockdown of GAS5 promoted cell proliferation, migration, and invasion"
CYTOR,gastric cancer,CYTOR has the possibility to be applied in gastric cancer diagnosis as a novel blood-based biomarker
ENSG00000261777,prostate cancer,ENSG00000261777 plays an important roles in prostate cancer
2900055J20Rik,left ventricular hypertrophy,2900055J20Rik is a therapeutic target 
Gm14005,left ventricular hypertrophy,Gm14005 is a therapeutic target 
PAN,Kaposi's sarcoma,PAN is a multifunctional regulatory transcript that controls KSHV gene expression in Kaposi's sarcoma
MALAT1,multiple myeloma,MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression.
HOTAIR,cervical cancer,Circulating HOTAIR was commonly upregulated and a potent prognostic marker in cervical cancer
TUG1,esophageal squamous cell carcinoma,TUG1 promotes proliferation and migration of ESCC cells and is a potential oncogene of ESCC
MALAT1,diabetic retinopathy,"MALAT1 knockdown could regulate retinal endothelial cell  proliferation, migration, and tube formation in vitro"
uc.283-plus,glioma,Uc.283-plus lncRNA might have a role in pluripotency of stem cells and in the biology of glioma
SPRY4-IT1,melanoma,SPRY4-IT1 knockdown may induce apoptosis via lipin 2-mediated alterations in lipid metabolism leading to cellular lipotoxicity
HOTAIR,endometrial cancer,Long noncoding RNA HOX transcript antisense intergenic RNA (HOTAIR) as a foe and  novel potential therapeutic target for endometrial carcinoma
SPRY4-IT1,renal clear cell carcinoma,High expression of long non-coding RNA SPRY4-IT1 predicts poor prognosis of clear cell renal cell carcinom
HOTAIR,breast cancer,HOTAIR-mediated regulation of gene expression and growth associated with the basal-like phenotype of breast cancer cells
GAS5,colorectal cancer,Long noncoding RNA GAS5 affects cell proliferation and predicts a poor prognosis  in patients with colorectal cancer
ENST00000480739,pancreatic ductal adenocarcinoma,Downregulated ENST00000480739 in PDAC contributes to tumour metastasis and progression by regulating HIF-1
HOTAIR,breast cancer,Nuclear factor of activated T cells 5 maintained by HOTAIR suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis
SPRY4-IT1,prostate cancer,Knockdown of SPRY4-IT1 in PC3 cells inhibited cell proliferation and invasion and increased cell apoptosis
PTCSC2,papillary thyroid carcinoma,Forced expression of PTCSC2 in the BCPAP cell line affected the expression of a subset of noncoding and coding transcripts with enrichment of genes functionally involved in cell cycle and cancer
HOTAIR,esophageal squamous cell carcinoma,The lncRNA could be potential diagnostic and prognostic biomarkers for ESCC
MGAT3-AS1,acute kidney injury,Circulating long noncoding RNA TapSaki is a predictor of mortality in critically ill patients with acute kidney injury
CERNA2,ovarian cancer,LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b
BANCR,papillary thyroid carcinoma,"BANCR increases PTC cell proliferation, which could activate autophagy"
U79277,breast cancer,The lncRNA may be implicated in breast cancer pathogenesis
AK024118,breast cancer,The lncRNA may be implicated in breast cancer pathogenesis
BC040204,breast cancer,The lncRNA may be implicated in breast cancer pathogenesis
AK000974,breast cancer,The lncRNA may be implicated in breast cancer pathogenesis
RP11-296A18.3,intervertebral disc degeneration,"Up-regulated  RP11-296A18.3 highly likely induced the over expression of FAF1, which eventually promoted the aberrant apoptosis of disc cells"
HOTAIR,gastric cancer,"HOTAIR  is a potential biomarker for identifying patients with peritoneal metastasis, and it is a novel therapeutic target in patients with gastric neoplasia"
GAPLINC,gastric cancer,GAPLINC overexpression defines a subgroup of patients with gastric cancer with very poor survival.
MALAT1,pancreatic cancer,"Elevated expression level of long noncoding RNA MALAT-1 facilitates cell growth, migration and invasion in pancreatic cancer"
AK023096,uterine leiomyomas,The aberrantly expressed lncRNA may contribute to the pathogenesis of uterine leiomyomas
MT1DP,liver cancer,"Tumor suppressor long non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to inhibit FoxA1 in liver cancer cells"
AC138128.1,gastric cancer,LncRNA AC138128.1 might be a novel biomarker for predicting GC
PVT1,gastric cancer,PVT1 is a new biomarker for human gastric cancer and may indicate lymph node invasion
LINC-ROR,breast cancer,LincRNA-RoR and miR-145 regulate invasion in triple-negative breast cancer via targeting ARF6.
AC006050.3,lung squamous cell carcinoma,LncRNA AC006050.3-003 was a valuable biomarker
SNHG14,Prader-Willi syndrome,SNHG14 plays an important role in PWS
NEAT1,acute promyelocytic leukemia,Reduced expression of the nuclear long noncoding RNA NEAT1 may play a role in the myeloid differentiation of APL cells
AC026166.2,laryngeal squamous cell carcinoma,AC026166.2-001 and RP11-169D4.1-001 may act as novel biomarkers in LSCC and may be potential therapeutic targets for LSCC patients
RP11-169D4.1,laryngeal squamous cell carcinoma,AC026166.2-001 and RP11-169D4.1-001 may act as novel biomarkers in LSCC and may be potential therapeutic targets for LSCC patients
LINC00582,endometrial cancer,LincRNA-NR_034037 regulates TSNAX-DISC1 formation programs that tightly regulate EC development
PCA3,prostate cancer,PCA3 is a great biomarker with fairly high specificity and sensitivity
MALAT1,lung cancer brain metastasis,"Increased level of long noncoding RNA MALAT1 promotes lung cancer brain metastasis by inducing EMT, which may be a promising prognosis factor and therapeutic target to treat lung cancer brain metastasis in future"
LET,gallbladder cancer,LncRNA-LET overexpression conferred a proliferative advantage to tumor cells under hypoxic conditions.
H1.3,ovarian cancer,H1.3 overexpression and H19 knockdown synergistically decrease the growth rate of ovarian cancer cells.
MEG3,liver fibrosis,MEG3 may play an important role in stellate cell activation and liver fibrosis progression and act as a novel potential therapeutic target for liver fibrosis.
BC008363,pancreatic ductal adenocarcinoma,LncRNA BC008363 may be a novel biomarker for the prognosis of pancreatic cancer
PCGEM1,prostate cancer,"PCGEM1 inhibited tumor cell proliferation, migration, and invasion, and induced early apoptosis both in vitro."
GAS5,osteoarthritis,GAS5 contributes to the pathogenesis of OA by acting as a negative regulator of miR-21 and thereby regulating cell survival
MALAT1,multiple myeloma,The role of MALAT1 in cellular transformation is pointing toward its potential use as a biomarker and a target for novel therapeutic approaches in multiple myeloma
CCAT1,colon cancer,CCAT1 promotes colon cancer cell proliferation and invasion
LOC285194,esophageal squamous cell carcinoma,"Decreased expression of LOC285194 could serve as a molecular markerto predict the clinical outcome of ESCC patients after surgery, and select patients who would benefit from preoperative CRT"
RCCRT1,renal cell carcinoma,RCCRT1 promoted migration and invasion of RCC and that RCCRT1 may offer a biomarker to verdict prognosis as well as an attractive new target for prognostic and therapeutic intervention for RCC patients in the future.
FENDRR,gastric cancer,FENDRR plays an important role in the progression and metastasis of gastric cancer
XIST,membranous nephropathy,Urinary XIST is a potential biomarker for membranous nephropathy
HOTAIR,renal carcinoma,Suppressed expression of long non-coding RNA HOTAIR inhibits proliferation and tumourigenicity of renal carcinoma cells
LOC283177,diffuse large B-cell lymphoma,LOC283177 plays an important role in DLBCL
CCAT1,non-small cell lung cancer,CARLo-5 may represent a prognostic marker and a potential therapeutic target of NSCLC
lncRNA-FER1L4,gastric cancer,lncRNA-FER1L4 plays an important role in post-transcriptional regulation in cancer
UCA1,urinary bladder,UCA1 can be used as a non-invasive diagnostic biomarker for TCC bladder as an adjunct to cytology in the early diagnosis of primary urinary bladder cancer
NRIR,HCV,"LncRNA-CMPK2 was strongly upregulated in a subset of HCV-infected human livers, suggesting a role in modulation of the IFN response in vivo"
DIRC3,breast cancer,DIRC3 is a potential target of breast cancer
PVT1,breast cancer,PVT1 is a potential target of breast cancer
CCDC26,breast cancer,CCDC26 is a potential target of breast cancer
GAS5,hepatocellular carcinoma,Down-regulation of long non-coding RNA GAS5 is associated with the prognosis of hepatocellular carcinoma
HA117,Hirschsprung's disease,HA117 may be a factor exerting an anti-differentiation or or anti-maturation role in the genesis of HSCR
NCRUPAR,colorectal cancer,Downregulation of a long noncoding RNA-ncRuPAR contributes to tumor inhibition in colorectal cancer
LCAL1,lung cancer,"The most differentially expressed lncRNA, LCAL1, plays a role in cellular proliferation"
ZNRD1-AS1,hepatocellular carcinoma,Expression quantitative trait loci in long non-coding RNA ZNRD1-AS1 influence both HBV infection and hepatocellular carcinoma development
HOTAIR,laryngeal squamous cell carcinoma,"Serum exosomal miR-21 and HOTAIR were significantly correlated with clinical parameters of LSCC, and combined evaluation of their serum expressions may be a valuable biomarker to screen LSCC and might be a promising predicting tool for LSCC patient"
LOC100132354,lung adenocarcinoma,LOC100132354 may play a key role in tumor development
RPLP0P2,lung adenocarcinoma,RPLP0P2 may play a key role in tumor development
RP11-325I22.2,lung adenocarcinoma,RP11-325I22.2 and LOC440905 might play an important role in the mechanism of EGFR exon 19 deletion in lung adenocarcinoma.
LOC440905,lung adenocarcinoma,RP11-325I22.2 and LOC440905 might play an important role in the mechanism of EGFR exon 19 deletion in lung adenocarcinoma.
HOTAIR,atypical teratoid rhabdoid tumor,HOTAIR may play an important role in cancer
MALAT1,endometrioid endometrial carcinoma,MALAT1 contributes to EEC development
LUNAR1,T cell acute lymphoblastic leukemia,"LUNAR1, is required for efficient T-ALL growth in vitro and in vivo due to its ability to enhance IGF1R mRNA expression and sustain IGF1 signaling"
SNAR,colon cancer,A long non-coding RNA snaR contributes to 5-fluorouracil resistance in human colon cancer cells
HOTAIR,breast cancer,"MiR-7, inhibited indirectly by lincRNA HOTAIR, directly inhibits SETDB1 and reverses the EMT of breast cancer stem cells by downregulating the STAT3 pathway"
HOTAIR,gastric adenocarcinoma,"HOTAIR was involved in inhibition of apoptosis and promoted invasiveness, supporting a role for HOTAIR in carcinogenesis and progression of gastric cancer"
AK124939,pulmonary adenocarcinoma,LncRNAs such as AK124939 may be anticancer factors related to the progression of pulmonary adenocarcinoma
91H,colorectal cancer,Up-regulation of 91H promotes tumor metastasis and predicts poor prognosis for patients with colorectal cancer
AF118081,lung cancer,AF118081 knockdown inhibited cell growth and tumor invasion
lnc-MBL2-4:3,tongue squamous cell carcinoma,High level of lnc-MBL2-4:3 was significantly associated with the node positive tongue SCC patients
lnc-STXBP5-1,tongue squamous cell carcinoma,LncRNA deregulation was involved in the pathogenesis of tongue SCC
PVT1,hepatocellular carcinoma,Regulation of the lncRNA-hPVT1/NOP2 pathway may have beneficial effects on the treatment of HCC
MALAT1,non-small cell lung cancer,"Besides tumor histology, prognostic impact of Bcl-2 was also found to depend on MALAT-1 lncRNA expression"
CDKN2B-AS1,acute myocardial infarction,"ANRIL and KCNQ1OT1 improved the prediction of left ventricular dysfunction by a model, including demographic features, clinical parameters, and cardiac biomarkers."
KCNQ1OT1,acute myocardial infarction,"ANRIL and KCNQ1OT1 improved the prediction of left ventricular dysfunction by a model, including demographic features, clinical parameters, and cardiac biomarkers."
SCHLAP1,prostate cancer,The long noncoding RNA SChLAP1 promotes aggressive prostate cancer and antagonizes the SWI/SNF complex
MALAT1,colorectal cancer,High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer
TSLC1-AS1,glioma,LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma
FOXCUT,esophageal squamous cell carcinoma,A novel long non-coding RNA FOXCUT and mRNA FOXC1 pair promote progression and predict poor prognosis in esophageal squamous cell carcinoma
CADM1-AS1,renal clear cell carcinoma,CADM1-AS1 may be a potential biomarker and  therapeutic target in patients with ccRCC
HOTAIR,bladder cancer,Upregulation of the long noncoding RNA HOTAIR predicts recurrence in stage Ta/T1 bladder cancer.
PCAT29,prostate cancer,The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer
CAI2,neuroblastoma,"CAI2 contributes to the paradoxical overexpression of p16 in neuroblastoma, where CAI2 may offer a useful biomarker of high-risk disease"
MIR99AHG,myeloid leukemia,LncRNAs MONC and MIR100HG are regulators of hematopoiesis and oncogenes in the development of myeloid leukemia
MIR100HG,myeloid leukemia,LncRNAs MONC and MIR100HG are regulators of hematopoiesis and oncogenes in the development of myeloid leukemia
MALAT1,colorectal cancer,MALAT1 might be a potential predictor for tumour metastasis and prognosis
BC017743,hepatocellular carcinoma,BC017743 provide important insight about the lncRNAs in HCC pathogenesis
ENST00000395084,hepatocellular carcinoma,ENST00000395084 provide important insight about the lncRNAs in HCC pathogenesis
ZNF674-AS1,hepatocellular carcinoma,ZNF674-AS1 provide important insight about the lncRNAs in HCC pathogenesis
PRR26,hepatocellular carcinoma,PRR26 provide important insight about the lncRNAs in HCC pathogenesis
AK056988,hepatocellular carcinoma,AK056988 provide important insight about the lncRNAs in HCC pathogenesis
uc003yqb.1,hepatocellular carcinoma,uc003yqb.1 provide important insight about the lncRNAs in HCC pathogenesis
LINC01080,Alzheimer's disease,"single-nucleotide polymorphisms (SNPs) of long intergenic noncoding RNA (lincRNA) at the genome level indicated that a genetic variant, rs7990916, in the lincRNA 01080 (linc01080) may play an important role in the physiology and pathophysiology of the human brain."
UCA1,bladder cancer,Hsa-miR-1 plays a tumor suppressive role via downregulating lncRNA UCA1 in bladder cancer
BANCR,colorectal cancer,BANCR contributes to colorectal cancer migration by inducing epithelial-mesenchymal transition
URHC,hepatocellular carcinoma,Long non-coding RNA URHC regulates cell proliferation and apoptosis via ZAK through the ERK/MAPK signaling pathway in hepatocellular carcinoma
HOTAIR,lung cancer,"HOTAIR is overexpressed in metastatic lung cancer tissue, which is prospectively associated with the ability of HOTAIR to promote lung cancer cell motility and invasion"
AK307796,colorectal cancer,AK307796 may exert a partial or key role in the progress of lymph nodes metastasis of CRC
ENST00000425785,colorectal cancer,ENST00000425785 may exert a partial or key role in the progress of lymph nodes metastasis of CRC
AK021444,colorectal cancer,AK021444 may exert a partial or key role in the progress of lymph nodes metastasis of CRC
HOXB-AS3,colorectal cancer,HOXB-AS3 may exert a partial or key role in the progress of lymph nodes metastasis of CRC
EBIC,cervical cancer,"LncRNA-EBIC was an oncogenic lncRNA, which could promote tumor cell invasion in CC by binding to EZH2 and inhibiting E-cadherin expression"
SOX2-OT,breast cancer,SOX2OT plays a key role in the induction and/or maintenance of SOX2 expression in breast cancer
VTRNA2-1,gastric cancer,Nc886 is a putative tumor suppressor and could potentially be used as a diagnostic marker in gastric cancer
UCA1,bladder cancer,UCA1 promotes bladder cancer cell proliferation by inhibiting BRG1
H19,prostate cancer,"The H19-miR-675 axis acts as a suppressor of prostate cancer metastasis, which may have possible diagnostic and therapeutic potential for advanced prostate cancer"
AA174084,gastric cancer,AA174084 may have potential as marker for the early diagnosis of GC
ABHD11-AS1,gastric cancer,ABHD11-AS1 might be a potential biomarker for diagnosis of gastric cancer
UCA1,colorectal cancer,"UCA1, a long non-coding RNA up-regulated in colorectal cancer influences cell proliferation, apoptosis and cell cycle distribution"
BACE1-AS,Alzheimer's disease,Downregulation of lncRNA BACE1-AS expression in SH-SY5Y cells by siRNA silencing resulted in the attenuation of the ability of BACE1 to cleave APP and delayed the induction of SP formation in the SP AD SHSY5Y cell model
AC130710,gastric cancer,LncRNA-AC130710 targeting by miR-129-5p is upregulated in gastric cancer and associates with poor prognosis
SPRY4-IT1,non-small cell lung cancer,SPRY4-IT1 could be a biomarker for poor prognosis of NSCLC
BANCR,melanoma,Long non-coding RNA BANCR promotes proliferation in malignant melanoma by regulating MAPK pathway activation
HMlincRNA717,gastric cancer,LncRNA-HMlincRNA717 may play crucial roles during cancer occurrence and progression and may be a new potential biomarker of early gastric cancer
MRUL,gastric cancer,MRUL promotes ABCB1 expression and is a potential target to reverse the MDR phenotype of GC MDR cell sublines
HOTAIR,gallbladder cancer,"Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer"
HOTAIR,gastric cancer,HOTAIR expression is modulated during gastric cancer progression and therefore may participate in molecular processes relevant to malignant transformation and metastasis in gastric carcinoma.
H19,hepatocellular carcinoma,Inhibition of LncRNAH19 and miR-675 expression can promote migration and invasion of HCC cells via AKT/GSK-3β1/Cdc25A  signaling pathway
HOTAIR,renal cell carcinoma,"HOTAIR expression is correlated with the migration of RCC cells, and HOTAIR may be involved in the curcumin-induced inhibition of RCC metastasis"
MALAT1,cervical cancer,MALAT1 was able to promote cell migration and proliferation
TRPM2-AS,prostate cancer,TRPM2-AS knockdown led to PCa cell apoptosis
SOX2-OT,lung cancer,"Sox2ot plays an important role in regulating lung cancer cell proliferation, and may represent a novel prognostic indicator for the disease."
GAS5,colorectal cancer,GAS5-derived snoRNA expression was induced by DNA damage in a p53-dependent manner in colorectal cancer cell lines and their levels were not affected by DICER
PVT1,pleural mesothelioma,"PVT1 CNG promotes a malignant phenotype of MPM, with C-MYC CNG stimulating cell proliferation and PVT1 both stimulating proliferation and inhibiting apoptosis"
MALAT1,glioma,MALAT1 contributes to glioma development
PRNCR1,glioma,PRNCR1 contributes to glioma development
PCGEM1,glioma,PCGEM1 contributes to glioma development
H19,glioma,H19 contributes to glioma development
HOTAIR,glioma,HOTAIR contributes to glioma development
LINC-ROR,breast cancer,LincRNA-ROR induces epithelial-to-mesenchymal transition and contributes to breast cancer tumorigenesis and metastasis
H19,pancreatic cancer,H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT
LINC-ROR,hepatocellular carcinoma,"Extracellular vesicle lncRNA as mediators of the chemotherapeutic response, and support targeting linc-ROR to enhance chemosensitivity in HCC"
MALAT1,osteosarcoma,Knockdown of the putative Myc-6 target MALAT1 encoding long noncoding RNA remarkably impaired cell growth of MG63 cells
RP11-462C24.1,colorectal cancer,Low expression of novel lncRNA RP11-462C24.1 suggests a biomarker of poor prognosis in colorectal cancer
MYCNUT,neuroblastoma,The important roles of lncUSMycN and NonO in regulating N-Myc expression and neuroblastoma oncogenesis and provide the first evidence that amplification of long noncoding RNA genes can contribute to tumorigenesis.
CDKN2B-AS1,atherosclerosis,CDKN2B-AS1 plays an important role in atherosclerosis
UCA1,melanoma,Increased expression of UCA1 and Malat-1 lncRNAs might have a correlation with melanoma metastasis
MALAT1,melanoma,Increased expression of UCA1 and Malat-1 lncRNAs might have a correlation with melanoma metastasis
FOXCUT,oral squamous cell carcinoma,FOXCUT may be functionally involved in the tumor progression of OSCC
GAS5,pleural mesothelioma,"GAS5 levels modify cell proliferation in vitro, and that GAS5 expression in MPM tissue is associated with cell quiescence and podoplanin expression support a role of GAS5 in MPM biology"
GAS5,gastric cancer,Decreased expression of long noncoding RNA GAS5 indicates a poor prognosis and promotes cell proliferation in gastric cancer
CASC22,breast cancer,The lincRNA-ENST00000515084 exon may be a genetic modifier in the development of breast cancer
TCONS_00018278,hepatocellular carcinoma,These lncRNAs provided useful information for exploring potential therapeutic targets and diagnostic biomarkers of this cancer
AK093543,hepatocellular carcinoma,These lncRNAs provided useful information for exploring potential therapeutic targets and diagnostic biomarkers of this cancer
D16366,hepatocellular carcinoma,These lncRNAs provided useful information for exploring potential therapeutic targets and diagnostic biomarkers of this cancer
ENST00000501583,hepatocellular carcinoma,These lncRNAs provided useful information for exploring potential therapeutic targets and diagnostic biomarkers of this cancer
MALAT1,hepatocellular carcinoma,These lncRNAs provided useful information for exploring potential therapeutic targets and diagnostic biomarkers of this cancer
HIF1A-AS1,aortic aneurysm,BRG1 expression is increased in thoracic aortic aneurysms and regulates proliferation and apoptosis of vascular smooth muscle cells through the long non-coding RNA HIF1A-AS1 in vitro
Smad7,breast cancer,Transforming growth factor-β1-induced lncRNA-Smad7 inhibits apoptosis of mouse breast cancer JygMC(A) cells
MEG3,epithelial ovarian cancer,"MEG3 is epigenetically silenced in EOC due to promoter hypermethylation, which may contribute to the development of EOC"
MALAT1,gastric cancer,MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF
TUG1,non-small cell lung cancer,"P53-regulated long non-coding RNA TUG1 affects cell proliferation in human non-small cell lung cancer,"
HOTAIR,colon cancer,"HOTAIR may also be a valuable predictor for colon cancer management; furthermore, this lncRNA may be a potential target for cancer prevention and treatment"
BGLT3,chronic myeloid leukemia,LncRNA-BGL3 is regulated in the leukemic cells and showed that Bcr-Abl repressed lncRNA-BGL3 expression through c-Myc-dependent DNA methylation
PCA3,prostate cancer,"They are highly prostate-specific, posing as attractive biomarkers"
PCGEM1,prostate cancer,"They are highly prostate-specific, posing as attractive biomarkers"
PCAT1,prostate cancer,"They are highly prostate-specific, posing as attractive biomarkers"
ADAMTS9-AS2,glioma,ADAMTS9-AS2 is a novel tumor suppressor modulated by DNMT1 in glioma. LncRNA ADAMTS9-AS2 may serve as a potential biomarker and therapeutic target for glioma
HOTAIRM1,promyelocytic leukemia,HOTAIRM1 provides a regulatory link in myeloid maturation by modulating integrin-controlled cell cycle progression at the gene expression level.
LINC01315,nasopharyngeal carcinoma,High levels of lnc-C22orf32-1 and lnc-AL355149.1-1 were significantly associated with the male patients
lnc-AL355149.1-1,nasopharyngeal carcinoma,High levels of lnc-C22orf32-1 and lnc-AL355149.1-1 were significantly associated with the male patients
lnc-ZNF674-1,nasopharyngeal carcinoma,Increased expression of lnc-ZNF674-1 was associated with advanced tumor stages.
NCRUPAR,gastric cancer,NcRuPAR inhibits gastric cancer progression by down-regulating protease-activated receptor-1
IPW,Prader-Willi syndrome,"IPW is a regulator of the DLK1-DIO3 region, as its overexpression in PWS and parthenogenetic iPSCs resulted in downregulation of MEGs in this locus"
MALAT1,pancreatic ductal adenocarcinoma,MALAT1 might be considered as a potential prognostic indicator and may be a target for diagnosis and gene therapy for PDAC
FAS-AS1,non-Hodgkin's lymphomas,FAS-AS1 plays an important role in non-Hodgkin's lymphomas
SPRY4-IT1,esophageal squamous cell carcinoma,Long noncoding RNA SPRY4-IT1 is upregulated in esophageal squamous cell carcinoma and associated with poor prognosis
H19,gastric cancer,Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer
CDKN2B-AS1,gastric cancer,Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a
AK123657,colorectal cancer,"Three dysregulated lncRNAs, AK123657, BX648207 and BX649059 were required for efficient invasion and proliferation suppression in CRC cell lines"
BX648207,colorectal cancer,"Three dysregulated lncRNAs, AK123657, BX648207 and BX649059 were required for efficient invasion and proliferation suppression in CRC cell lines"
BX649059,colorectal cancer,"Three dysregulated lncRNAs, AK123657, BX648207 and BX649059 were required for efficient invasion and proliferation suppression in CRC cell lines"
CAHM,colorectal cancer,"CAHM, a long non-coding RNA gene hypermethylated in colorectal neoplasia"
MVIH,non-small cell lung cancer,Long non-coding RNA MVIH indicates a poor prognosis for non-small cell lung cancer and promotes cell proliferation and invasion
GAS5,breast cancer,Reduced GAS5 expression attenuates apoptosis induction by classical chemotherapeutic agents in breast cancer cells
PVT1,breast cancer,The GG genotype of SNP rs13281615 plays a role in breast cancer likely by influencing PVT1 expression
HOTAIR,gastric cancer,LncRNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer
ATB,hepatocellular carcinoma,"LncRNA-ATB, a mediator of TGF-β1 signaling, could predispose HCC patients to metastases and may serve as a potential target for antimetastatic therapies"
H19,hepatocellular carcinoma,Aflatoxin B1 promotes cell growth and invasion in hepatocellular carcinoma HepG2 cells through H19 and E2F1
HOTAIR,endometrial cancer,HOTAIR plays an important role in the carcinogenesis of endometrial cancer. Targeting HOTAIR may be a novel therapeutic strategy for endometrial cancer
MALAT1,hepatocellular carcinoma,MALAT1 and HOTAIR play important role in the pathophysiology of hepatocellular carcinoma
HOTAIR,hepatocellular carcinoma,MALAT1 and HOTAIR in the pathophysiology of hepatocellular carcinoma
lncRNA-CIR,osteoarthritis,LncRNA-CIR contributes to ECM degradation and plays a key role in the pathogenesis of OA
RUNXOR,hematopoietic malignancies,RUNXOR noncoding RNA may function as a previously unidentified candidate component that is involved in chromosomal translocation in hematopoietic malignancies
HOTAIR,cervical cancer,Overexpression of long noncoding RNA HOTAIR predicts a poor prognosis in patients with cervical cancer
CDKN2B-AS1,esophageal squamous cell carcinoma,The significant role of ANRIL is in the occurrence and development of ESCC through TGFβ11 signaling pathways
MALAT1,lung cancer,The long noncoding RNA MALAT1 induces lung cancer cell migration and plays a pivotal role in lung cancer metastasis
UCA1,bladder cancer,"Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1α-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration, and invasion"
HOTAIR,rheumatoid arthritis,PBMC and exosome-derived HOTAIR is a critical regulator and potent marker for rheumatoid arthritis
ACTA2-AS1,lung adenocarcinoma,Enhanced expression of long non-coding RNA ZXF1 promoted the invasion and metastasis in lung adenocarcinoma
CARL,myocardial infarction,Modulation of its level may provide a new approach for tackling apoptosis and myocardial infarction
WT1-AS,primary myelofibrosis,"Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations."
MEG3,primary myelofibrosis,"Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations."
CDKN2B-AS1,primary myelofibrosis,"Abnormal expression patterns of WT1-as, MEG3 and ANRIL long non-coding RNAs in CD34+ cells from patients with primary myelofibrosis and their clinical correlations."
91H,esophageal squamous cell carcinoma,Long non-coding RNA 91H contributes to the occurrence and progression of esophageal squamous cell carcinoma by inhibiting IGF2 expression
PCNA-AS1,hepatocellular carcinoma,Antisense long non-coding RNA PCNA-AS1 promotes tumor growth by regulating proliferating cell nuclear antigen in hepatocellular carcinoma.
GAS5,mantle cell lymphoma,Stimulation of expression of candidate tumor suppressor GAS5 is responsible for much of the cytotoxic and cytostatic effects of rapalogues in MCL
LINC00963,prostate cancer,Linc00963 was involved in the prostate cancer transition from androgen-dependent to androgen-independent and metastasis via the EGFR signaling  pathway
H19,gastric cancer,H19 affects cell proliferation and predicts a poor prognosis in patients with gastric cancer
TUSC8,cervical cancer,Low expression of long noncoding XLOC_010588 indicates a poor prognosis and promotes proliferation through upregulation of c-Myc in cervical cancer
LIPCAR,heart failure,LIPCAR is a novel biomarker of cardiac remodeling and predicts future death in patients with heart failure
HOTAIR,hepatocellular carcinoma,HOTAIR promotes cell migration and invasion via down-regulation of RNA binding motif protein 38 in hepatocellular carcinoma cells
HOTAIR,ovarian cancer,HOTAIR plays a vital role in EOC metastasis and could represent a novel prognostic marker and potential therapeutic target in patients with EOC
MALAT1,gallbladder cancer,MALAT1 might serve as an oncogenic lncRNA that promotes proliferation and metastasis of GBC and activates the ERK/MAPK pathway
BANCR,non-small cell lung cancer,"BANCR actively functions as a regulator of EMT during NSCLC metastasis, suggesting that BANCR could be a biomarker for poor prognosis of NSCLC"
UCA1,bladder cancer,UCA1 plays a pivotal role in bladder cancer progression and metastasis
LOC554202,breast cancer,Long non-coding RNA Loc554202 regulates proliferation and migration in breast cancer cells
LINC01158,esophageal squamous cell carcinoma,This noncoding RNA contributes to the development of ESCC by interacting with EZH2 to promote methylation of POU3F3
TDRG1,gastric cancer,TDRG1 plays an important role in gastric cancer
HOTAIR,small cell lung cancer,"HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer"
LINC-ROR,endometrial cancer,Linc-RoR has an important role during endometrial carcinogenesis
LINC00467,neuroblastoma,Knocking-down linc00467 expression with siRNA in neuroblastoma cells reduced the number of viable cells and increased the percentage of apoptotic cells
HOTAIR,colorectal cancer,"HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients"
CHRF,cardiac hypertrophy,CHRF regulates cardiac hypertrophy by targeting miR-489
HOTAIR,breast cancer,Bisphenol-A and diethylstilbestrol exposure induces the expression of breast cancer associated long noncoding RNA HOTAIR
MALAT1,breast cancer,"MALAT-1 decreasing by knocking down showed similar effects on proliferation, migration and invasion"
CYTOR,gastric cancer,LincRNA LINC00152 might be a novel biomarker for predicting gastric cancer
ENST00000435885,oesophageal squamous cell carcinoma,"The three-lncRNA signature is a new biomarker for the prognosis of patients with OSCC, enabling more accurate prediction of survival"
LINC01233,oesophageal squamous cell carcinoma,"The three-lncRNA signature is a new biomarker for the prognosis of patients with OSCC, enabling more accurate prediction of survival"
LINC01234,oesophageal squamous cell carcinoma,"The three-lncRNA signature is a new biomarker for the prognosis of patients with OSCC, enabling more accurate prediction of survival"
PCAT18,prostate cancer,PCAT18 is a potential therapeutic target and biomarker for metastatic PCa
MEG3,gastric cancer,The long non-coding RNA MEG3 was reported to be a tumor suppressor in a number of malignant tumors including gastric cancer
MALAT1,bladder cancer,Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long noncoding RNA MALAT1
CCAT2,non-small cell lung cancer,CCAT2 is a lung adenocarcinoma-specific lncRNA and promotes invasion of NSCLC and highlight its potential as a biomarker for lymph node metastasis
UCA1,bladder cancer,"UCA1 increases the cisplatin resistance of bladder cancer cells by enhancing the expression of Wnt6, and thus represents a potential target to overcome chemoresistance in bladder cancer."
MEG3,pituitary adenoma,MEG3 and HOTAIR expression may correlate with NFPA development and invasion
HOTAIR,pituitary adenoma,MEG3 and HOTAIR expression may correlate with NFPA development and invasion
lincRNA1611,pancreatic ductal adenocarcinoma,LincRNA1611 and Ppp3ca were high expression in PDAC and may serve as new potential targets for intervention of the disease
Ppp3ca,pancreatic ductal adenocarcinoma,LincRNA1611 and Ppp3ca were high expression in PDAC and may serve as new potential targets for intervention of the disease
H19,glioma,H19 promotes glioma cell invasion by deriving miR-675
UCA1,breast cancer,UCA1 promotes breast tumor growth by suppression of p27 (Kip1)
MALAT1,bladder cancer,MALAT1 inhibition may represent a promising therapeutic option for suppressing bladder cancer progression
MALAT1,diabetic retinopathy,"MALAT1, a conserved lncRNA, may become a potential therapeutic target for the prognosis, diagnosis, and treatment of DR"
PRNCR1,prostate cancer,PRNCR1 determine androgen receptor dependent gene expression in prostate cancer growth in vivo
PCGEM1,prostate cancer,PCGEM1 determine androgen receptor dependent gene expression in prostate cancer growth in vivo
GHET1,gastric cancer,GHET1 plays a pivotal role in gastric carcinoma cell proliferation via increasing c-Myc mRNA stability and expression
MALAT1,bladder cancer,Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1
ZNF300P1,ovarian cancer,"ZNF300P1 lincRNA expression is regulating cell polarity, motility, and adhesion and loss of expression may contribute to the metastatic potential of ovarian cancer cells"
H19,gastric cancer,The novel pathway H19/miR-675/RUNX1 regulates gastric cancer development and may serve as a potential target for gastric cancer therapy
CDKN2B-AS1,ischemic stroke,ANRIL may increase the risk of ischemic stroke through regulation of the CARD8 pathway
TC0101441,ovarian cancer,TC0101441 contributes to E2-induced EOC cell migration/invasion
GAS5,non-small cell lung cancer,GAS5 could serve as a potential diagnostic marker for NSCLC and may be a novel therapeutic target in patients with NSCLC
MEG3,tongue squamous cell carcinoma,MEG3 may play important antitumor effects in TSCC pathogenesis
CBR3-AS1,esophageal squamous cell carcinoma,"PlncRNA-1 plays an important role in ESCC cell proliferation.Overexpression of PlncRNA-1 is correlated with advanced tumor stage and lymph node metastasis, and may serve as a potential prognostic marker and therapeutic target for ESCC"
UCA1,tongue squamous cell carcinoma,Expression of UCA1 lncRNA was enhanced in TSCCs and may play a role in tumor metastasis
PRNCR1,colorectal cancer,SNPs in the lncRNA PRNCR1 may contribute to susceptibility to CRC
MALAT1,non-small cell lung cancer,MALAT1 might be applicable as a complementary biomarker within a panel in order to improve the entire diagnostic performance
LOC391533,pre-eclampsia,"Misregulation of LOC391533, LOC284100, and  CEACAMP8 might contribute to the mechanism underlying preeclampsia"
LOC284100,pre-eclampsia,"Misregulation of LOC391533, LOC284100, and  CEACAMP8 might contribute to the mechanism underlying preeclampsia"
CEACAMP8,pre-eclampsia,"Misregulation of LOC391533, LOC284100, and  CEACAMP8 might contribute to the mechanism underlying preeclampsia"
AK139328,reperfusion injury,Silencing of long noncoding RNA AK139328 attenuates ischemia/reperfusion injury in mouse livers
DQ786243,Crohn's disease,DQ786243 can be related with severity of CD
HOTAIR,endometrial cancer,HOTAIR is upregulated in endometrial carcinoma and correlates with poor prognosis
NEAT1,intrauterine growth restriction,The increase in NEAT1 and its co-localization with PSPC1 suggests an increase in paraspeckles in IUGR villous trophoblasts
OVAAL,ovarian cancer,"OVAAL is emerging as potent regulator of cell physiology, and recent studies highlight its role in tumor development"
HOTAIR,breast cancer,HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer
HULC,gastric cancer,HULC may play an important role in the growth and tumorigenesis of human GC
MALAT1,colorectal cancer,"The anti-tumor effects of resveratrol on CRC are through inhibiting Wnt/β1-catenin signaling, thus the expression of its target genes such  as c-Myc, MMP-7, as well as the expression of MALAT1"
SPRY4-IT1,pre-eclampsia,"SPRY4-IT1 is a novel lncRNA molecule, which might be associated with the pathogenesis of preeclampsia and might provide a new target for its early diagnosis and treatment."
H19,bladder cancer,H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression
PVT1,diabetic nephropathy,"Role of microRNA 1207-5P and its host gene, the long non-coding RNA PVT1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathy"
HOTAIR,glioma,HOTAIR is an important long noncoding RNA that primarily serves as a prognostic factor for glioma patient survival
PVT1,colorectal cancer,"PVT-1, which maps to 8q24, generates antiapoptotic activity in CRC, and abnormal expression of PVT-1 was a prognostic indicator for CRC patients"
CRNDE,colorectal cancer,CRNDE may correlate with their upregulation in colorectal cancer
TUC339,hepatocellular carcinoma,TUC339 was functionally implicated in modulating tumor cell growth and adhesion
HOTAIR,lung adenocarcinoma,Upregulation  of HOTAIR contributes to the cisplatin resistance of LAD cells
HOTAIR,esophageal squamous cell carcinoma,Upregulation of the long non-coding RNA HOTAIR promotes esophageal squamous cell carcinoma metastasis and poor prognosis
SMAD1-AS1,ventricular septal defects,SMAD1-AS1 plays an important role in VSD
RP11-473L15.2,ventricular septal defects,RP11-473L15.2 plays an important role in VSD
H19,osteosarcoma,Aberrant Hh signaling in mature osteoblasts is responsible for the pathogenesis of osteoblastic osteosarcoma through Yap1 and H19 overexpression
XIST,breast cancer,The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low XIST expression
HOTAIR,gastric cancer,HOTAIR plays a pivotal role in the development of gastric cancer
HOTAIR,esophageal squamous cell carcinoma,"HOTAIR, a prognostic factor in esophageal squamous cell carcinoma, inhibits WIF-1 expression and activates Wnt pathway"
HOTTIP,hepatocellular carcinoma,Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
SOX2-OT,esophageal squamous cell carcinoma,A part for SOX2OT spliced variants in tumor initiation and progression as well as regulating pluripotent state of stem cells
HOTAIR,non-small cell lung cancer,HOTAIR indicates a poor prognosis and promotes metastasis in non-small cell lung cancer
MEG3,non-small cell lung cancer,MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression
DQ786227,lung cancer,LncRNA-DQ786227 acts as an oncogene in malignantly transformed BEAS-2B cells induced by benzo(a)pyrene
AC068718.1,post-traumatic stress disorder,The non-coding RNA gene may play a crucial role in shaping the landscape of gene regulation with putative pathological effects that lead to phenotypic differences
CCAT2,breast cancer,CCAT2 upregulates cell migration and downregulates chemosensitivity to 5'FU in a rs6983267-independent manner
SCHLAP1,prostate cancer,SChLAP1 contributes to the development of lethal cancer at least in part by antagonizing the tumor-suppressive functions of the SWI/SNF complex
GAS5,bladder cancer,Downregulated GAS5 promotes bladder cancer cell proliferation
UCA1,bladder cancer,"Ets-2 regulates apoptosis process by regulating the expression of UCA1, moreover UCA1 may be involved in the activation of Akt signaling pathway by Ets-2 in bladder cancer cells"
TUG1,melanoma,Down-regulation of long non-coding RNA TUG1 suppresses melanoma cell proliferation and induces apoptosis via up regulating microRNA-9
GAS5,pancreatic cancer,Downregulation of gas5 increases pancreatic cancer cell proliferation by regulating CDK6
HOTAIR,oesophageal squamous cell carcinoma,HOTAIR-mediated gene regulation has a critical role in ESCC progression and is a novel epigenetic molecular target for treating ESCC patients
MEG3,gastric cancer,Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer
HNF1A-AS1,oesophageal adenocarcinoma,Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells
SUMO1P3,gastric cancer,Pseudogene-expressed lncRNA SUMO1P3 may be a potential biomarker in the diagnosis of gastric cancer
KCNQ1OT1,hepatocellular carcinoma,"The STR polymorphism within KCNQ1OT1 contributes to hepatocarcinogenesis, possibly by affecting KCNQ1OT1 and CDKN1C expression through a structure-dependent mechanism"
GAS6-AS1,non-small cell lung cancer,Low expression of long noncoding RNA GAS6 AS1 predicts a poor prognosis in patients with NSCLC
PRNCR1,prostate cancer,PRNCR1 may play an important role in the progression of castration resistant prostate cancer through mediating the expression of AR
H19,esophageal squamous cell carcinoma,"H19 CBS6 methylation potentially represents a novel clinically relevant epigenetic marker to identify individuals at increased risk for the occurrence, progression and prognosis of ESCC"
HOTAIR,prostate cancer,Genistein inhibited PCa cell growth through down-regulation of oncogenic HOTAIR that is also targeted by tumor suppressor miR-34a
T-ALL-R-LncR1,acute lymphoblastic leukemia,A novel long non-coding RNA T-ALL-R-LncR1 knockdown and Par-4 cooperate to induce cellular apoptosis in T-cell acute lymphoblastic leukemia cells
HOTAIR,gastric cancer,HOTAIR plays a role in gastric cancer progression
lincRNA-uc003opf.1,esophageal squamous cell carcinoma,Functional polymorphism rs11752942A>G in lincRNA uc003opf.1 exon might be a genetic modifier for the development of ESCC
HOTAIR,melanoma,"HOTAIR is associated with motility, invasion, and metastatic potential of metastatic melanoma"
HOTAIR,gastric cancer,Knockdown of long non-coding RNA HOTAIR suppresses tumor invasion and reverses epithelial-mesenchymal transition in gastric cancer
MALAT1,prostate cancer,MALAT-1 may be needed to maintain prostate tumorigenicity and it is involved in prostate cancer progression
NEAT1_2,amyotrophic lateral sclerosis,"NEAT1_2 lncRNA may act as a scaffold of RNAs and RNA binding proteins in the nuclei of ALS motor neurons, thereby modulating the functions of  ALS-associated RNA-binding proteins during the early phase of ALS"
CDKN2B-AS1,atherosclerosis,ANRIL is associated with atherosclerosis
CDKN2B-AS1,periodontitis,ANRIL is associated with periodontitis
CCAT2,colon cancer,"CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer"
Kcna2,neuropathic pain,Endogenous Kcna2 antisense RNA as a therapeutic target for the treatment of neuropathic pain.
MEG3,cervical cancer,MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis
HULC,hepatocellular carcinoma,The expression of HULC in plasma can be used as a noninvasive promising novel biomarker for the diagnosis and/or prognosis of HCC
HOTAIR,non-small cell lung cancer,HOTAIR enhances aggressive biological behavior and is associated with short disease-free survival in human non-small cell lung cancer
AK126698,non-small cell lung cancer,"Knockdown lncRNA AK126698 not only greatly decreased NKD2 which can negatively regulate Wnt/β1-catenin signaling but  also increased the accumulation and nuclear translocation of β1-catenin, and significantly depressed apoptosis rate induced by cisplatin in A549 cells"
MALAT1,prostate cancer,Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer
TUG1,osteosarcoma,Down-regulation of long non-coding RNA TUG1 inhibits osteosarcoma cell proliferation and promotes apoptosis
GHSROS,non-small cell lung cancer,"Engineered overexpression of GHSROS stimulated cell migration in the A549 and NCI H1299 non-small cell lung cancer cell lines, but suppressed cell migration in the Beas-2B normal lung-derived bronchoepithelial cell line"
HOTAIR,esophageal squamous cell carcinoma,HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival
MALAT1,nasopharyngeal carcinoma,"MALAT1 can enhance the proliferation, invasion, and metastasis of CNE-1 cells"
BLACAT1,bladder cancer,"Overexpressed linc-UBC1 physically associates with PRC2 complex, and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancer"
LOC285194,colorectal cancer,LOC285194 might be a novel prognostic indicator in colorectal cancer and may be a potential target for diagnosis and gene therapy
GAS5,prostate cancer,GAS5 regulates apoptosis in prostate cancer cell lines
LUCAT1,lung cancer,LUCAT1 may act downstream of NRF2 to regulate gene expression and mediate oxidative stress protection in airway epithelial cells
HOTAIR,lung cancer,The expression of HOTAIR and Col-1 was concurrently up-regulated in human non-small cell lung cancer
HOXA-AS2,promyelocytic leukemia,HOXA-AS2 is an apoptosis repressor in all trans retinoic acid treated NB4 promyelocytic leukemia cells
AC096655.1,gastric cancer,LncRNA AC096655.1-002 may be a potential biomarker in the diagnosis of gastric carcinoma
CTBP1-AS,prostate cancer,CTBP1-AS promotes prostate cancer
MIR7-3HG,liver cancer,Reduced expression of uc002mbe.2 may be associated with liver carcinogenesis
PCAT1,colorectal cancer,Overexpression of long noncoding RNA PCAT-1 is a novel biomarker of poor prognosis in patients with colorectal cancer
MIAT,schizophrenia,Dysregulation  of Gomafu leads to alternative splicing patterns that resemble those observed in  SZ for the archetypal SZ-associated genes DISC1 and ERBB4
GAS5,renal cell carcinoma,GAS5 functions as a tumor suppressor in renal cell carcinoma
Llme23,melanoma,Llme23 can function as an oncogenic RNA and directly associate the PSF-binding lncRNA with human melanoma
HOTAIR,ovarian cancer,"HOTAIR may play a role in ovarian cancer, and become a biomarker for malignant degree of ovarian cancer and may provide a novel therapeutic target for ovarian cancer"
PTCSC3,thyroid cancer,"A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells"
CCAT1,colorectal cancer,CCAT1 is up-regulated across the colon adenoma-carcinoma sequence
CK19,breast cancer,CK19 may play a role in tumorogenesis
PVT1,B-cell lymphoma,Deletion or methylation of CDKN2A/2B and PVT1 rearrangement occur frequently in highly aggressive B-cell lymphomas harboring 8q24 abnormality
LINC00312,nasopharyngeal carcinoma,"LINC00312 could represent a potential biomarker for metastasis, progression and prognosis in NPC"
PCGEM1,prostate cancer,PCGEM1 polymorphisms may contribute to PCa risk in Chinese men
CCAT1,colorectal cancer,CCAT1 TO-PNA-MB is a powerful diagnostic tool for the specific identification of CRC
XIST,hematologic cancer,XIST RNA is a potent suppressor of hematologic cancer in mice
CCDC26,glioma,CCDC26 plays an important role in glioma development
H19,bladder cancer,Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression
HOTAIR,breast cancer,HOTAIR overexpression potentially contributes towards breast cancer progression
H19,bladder cancer,H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression
AFAP1-AS1,esophageal adenocarcinoma,"Methylation of the long noncoding RNA AFAP1 AS1 is reduced in BE and EAC, and its expression inhibits cancer-related biologic functions of EAC cells"
CDKN2B-AS1,coronary artery disease,Complex regulatory variation affecting ANRIL and  CDKN2B gene expression may contribute to increased risk for clinically apparent and subclinical coronary artery disease and aortic disease
MEG3,meningioma,MEG3 may have a significant role as a novel long noncoding RNA tumour suppressor in meningiomas
MEG3,bladder cancer,Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer
HOTAIR,hepatocellular carcinoma,HOTAIR expression is associated with HCC progression
HOTAIR,nasopharyngeal carcinoma,Dysregulation of HOTAIR might play an important role in NPC progression
CDKN2B-AS1,myocardial infarction,CDKN2B-AS1 could be used as a useful genetic marker for the screening of MI
MALAT1,lung cancer,MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells
H19,hepatocellular carcinoma,"H19 contributes to carcinogenesis, including hepatocellular carcinoma"
MALAT1,urothelial cancer,MALAT1 plays an oncogenic role in urothelial carcinoma of the bladder
CCAT1,gastric cancer,"CCAT1, which could be activated by c-Myc, promotes the progression of gastric carcinoma"
HOTAIR,laryngeal squamous cell carcinoma,Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma
HOTAIR,breast cancer,Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer
CDKN2B-AS1,primary open-angle glaucoma,CDKN2B-AS1 genotype-glaucoma feature correlations in primary open-angle glaucoma patients
CDKN2B-AS1,neurofibromatosis,CDKN2B-AS1 plays an important role in neurofibroma
CDKN2B-AS1,coronary artery disease,ANRIL expression may involve in the mechanisms of chromosome 9p21 on CAD development
LINC00237,MOMO syndrome,LINC00237 could play a role in the pathogenesis of this syndrome and could provide new insights into hyperphagia related obesity and intellectual disability
RERT,hepatocellular carcinoma,"Rs10680577 contributes to hepatocarcinogenesis, possibly by affectingRERT-lncRNA structure and subsequently EGLN2 expression, making it a promising biomarker for early diagnosis of HCC"
TUG1,bladder urothelial carcinoma,TUG1 may have potential roles as a biomarker and/or a therapeutic target in bladder urothelial carcinoma
LINC00887,renal clear cell carcinoma,LINC00887 may exert a partial or key role in tumor development
X91348,renal clear cell carcinoma,X91348 may exert a partial or key role in tumor development
BC029135,renal clear cell carcinoma,BC029135 may exert a partial or key role in tumor development
LOC389332,renal clear cell carcinoma,LOC389332 may exert a partial or key role in tumor development
PVT1,multiple myeloma,PVT1 rearrangements may represent a novel molecular paradigm underlying the pathology of 8q24 rearrangement-positive multiple myeloma
H19,pre-eclampsia,Aberrantly lowered expression of H19 in placenta may participate in the excessive proliferation of trophoblast cells observed in early-onset severe preeclampsia
H19,gastric cancer,Up-regulated long non-coding RNA H19 contributes to proliferation of gastric cancer cells
MALAT1,bladder cancer,Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition
MVIH,hepatocellular carcinoma,Deregulation of lncRNA MVIH is a predictor for poor RFS of HCC patients after hepatectomy and could be utilized as a potential target for new adjuvant therapies against active angiogenesis
HULC,hepatocellular carcinoma,Up-regulated HULC by HBx promotes proliferation of hepatoma cells through suppressing p18
HOTAIR,pancreatic cancer,HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer
PTCSC3,papillary thyroid carcinoma,Long intergenic noncoding RNA gene (PTCSC3) that has the characteristics of a tumor suppressor
BANCR,melanoma,BANCR knockdown reduced melanoma cell migration
CDKN2B-AS1,neurofibromatosis,CDKN2B-AS1 plays an important role in neurofibromatosis
H19,Beckwith-Wiedemann syndrome,Gain of methylation (GOM) at the H19 differentially methylated region (H19-DMR) is one of several causative alterations in Beckwith-Wiedemann syndrome
